Progressively releasable implantable adjunct for use with a surgical stapling instrument

Information

  • Patent Grant
  • 10603039
  • Patent Number
    10,603,039
  • Date Filed
    Wednesday, September 30, 2015
    9 years ago
  • Date Issued
    Tuesday, March 31, 2020
    4 years ago
Abstract
A staple cartridge assembly is disclosed comprising, one, a plurality of staples removably stored within a surgical staple cartridge and, two, an implantable adjunct. The implantable adjunct is configured to be progressively released from the surgical staple cartridge during a firing progression of a firing assembly configured to travel through the surgical staple cartridge.
Description
BACKGROUND

The present invention relates to surgical instruments and, in various arrangements, to surgical stapling and cutting instruments and staple cartridges for use therewith that are designed to staple and cut tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

The features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows:



FIG. 1 is a perspective view of a surgical stapling and severing instrument comprising a handle, a shaft extending from the handle, and an end effector extending including an anvil and a staple cartridge;



FIG. 2 is a perspective view of a wedge sled of a staple cartridge of the surgical stapling and severing instrument of FIG. 1;



FIG. 3 is a perspective view of a two-piece knife and firing bar (“E-beam”) of the surgical stapling and severing instrument of FIG. 1;



FIG. 4 is a longitudinal cross-sectional view of an anvil in a closed position, a staple cartridge comprising a rigid support portion, and a compressible adjunct illustrated with staples being moved from an unfired position to a fired position during a firing sequence;



FIG. 5 is another cross-sectional view of the anvil and the staple cartridge of FIG. 4 illustrating the anvil in an open position after the firing sequence has been completed;



FIG. 6 is a side view of a compressible adjunct and a staple cartridge in accordance with at least one embodiment;



FIG. 7 is a transverse cross-sectional view of a staple cartridge assembly including a staple cartridge and a compressible layer, wherein a portion of the compressible adjunct has been removed for the purpose of illustration;



FIG. 8 is a partial perspective view of an end effector including a staple cartridge, a compressible layer, and a bonding layer, wherein a portion of the compressible layer has been removed for the purpose of illustration;



FIG. 9 is a transverse cross-sectional view of a compressible adjunct assembly attached to an anvil of a surgical instrument;



FIG. 10 is a transverse cross-sectional view of a compressible adjunct assembly attached to an anvil of a surgical instrument;



FIG. 11 is a transverse cross-sectional view of a compressible adjunct assembly attached to an anvil of a surgical instrument;



FIG. 12 a partial perspective view of an anvil assembled with an attachment layer, wherein a portion of the anvil has been removed for the purpose of illustration;



FIG. 13 is a perspective view of the attachment layer of FIG. 12;



FIG. 14 is a partial perspective view of tissue sandwiched between two compressible adjunct assemblies, wherein the tissue is stapled and cut using a surgical stapling and severing instrument according to at least one embodiment disclosed herein;



FIG. 15 is a transverse cross-sectional view of the tissue and compressible adjunct assemblies of FIG. 14;



FIG. 16 is a perspective view of an attachment layer including an intermediate section having a bar extending therefrom;



FIG. 17 is a transverse cross-sectional view of an anvil assembled with a compressible adjunct assembly including an attachment layer and a compressible layer;



FIG. 18 is a partial perspective view of a compressible adjunct assembly including a compressible layer and two attachment members in accordance with at least one embodiment described herein;



FIG. 19 is a cross-sectional view of an anvil assembled with the compressible adjunct assembly of FIG. 18 after the compressible adjunct assembly has been severed by a cutting edge;



FIG. 20 is a partial perspective view of a compressible adjunct assembly including a compressible layer and two attachment members in accordance with at least one embodiment described herein;



FIG. 21 is a perspective view of a compressible adjunct assembly including a compressible layer and two attachment members in accordance with at least one embodiment described herein;



FIG. 22 is a partial perspective view of a compressible adjunct assembly including a compressible layer and a plurality of attachment members in accordance with at least one embodiment described herein;



FIG. 23 is a transverse cross-sectional view of an anvil assembled with the compressible adjunct assembly of FIG. 22;



FIG. 24 is a partial longitudinal cross-sectional view of the compressible adjunct assembly of FIG. 22;



FIG. 25 is a partial perspective view of a compressible adjunct assembly including a compressible layer and a plurality of attachment members in accordance with at least one embodiment described herein;



FIG. 26 is a partial longitudinal cross-sectional view of an attachment member attached to a compressible layer in accordance with at least one embodiment described herein;



FIG. 27 is a partial longitudinal cross-sectional view of an attachment member attached to a compressible layer in accordance with at least one embodiment described herein;



FIG. 28 is a partial longitudinal cross-sectional view of an attachment member attached to a compressible layer in accordance with at least one embodiment described herein;



FIG. 29 is a partial perspective view of an anvil assembled with two attachment layers in accordance with at least one embodiment described herein;



FIG. 30 is a perspective view of attachment members of the attachment layers of FIG. 29;



FIG. 31 is a partial perspective view of a distal portion of the attachment layers of FIG. 29;



FIG. 32 is another partial perspective view of the distal portion of the attachment layers of FIG. 29;



FIG. 33 is a partial longitudinal cross-sectional view of the attachment layers of FIG. 29;



FIG. 34 is another partial perspective view of the distal portion of the attachment layers of FIG. 29;



FIG. 35 is a partial cross-sectional view of a staple cartridge assembly comprising an implantable adjunct in an attached configuration in accordance with at least one embodiment;



FIG. 36 is a partial cross-sectional view of the staple cartridge assembly of FIG. 35 where the implantable adjunct is in a detached configuration;



FIG. 37 is a partial side view of a surgical stapling assembly comprising a staple cartridge, a plurality of staples, and an implantable adjunct where the surgical stapling assembly has been partially fired and a portion of the implantable adjunct has been separated from the staple cartridge;



FIG. 38 is a partial cross-sectional view of the surgical stapling assembly of FIG. 37 illustrating a staple that has not been deployed from the staple cartridge;



FIG. 39 is a partial side view of a surgical stapling assembly comprising a staple cartridge, a plurality of barbed staples, and an implantable adjunct where the surgical stapling assembly has been partially fired and a portion of the implantable adjunct has been separated from the staple cartridge;



FIG. 40 is a partial cross-sectional view of the surgical stapling assembly of FIG. 39 illustrating a staple that has not been deployed from the staple cartridge;



FIG. 41 is partial perspective view of a staple cartridge assembly comprising a staple cartridge and an implantable adjunct residing at least partially within the staple cartridge in accordance with at least one embodiment;



FIG. 42 is a partial, end perspective view of a staple cartridge assembly comprising a staple cartridge and an implantable adjunct comprising a body portion and a plurality of attachment portions in accordance with at least one embodiment;



FIG. 43 is a perspective view of a sled of a firing assembly in accordance with at least one embodiment;



FIG. 44 is a partial side view of a surgical stapling assembly comprising the staple cartridge assembly of FIG. 42 which includes a staple cartridge and an implantable adjunct and a firing assembly comprising the sled of FIG. 43 where the surgical stapling assembly has been partially fired and a portion of the implantable adjunct has been detached from the staple cartridge;



FIG. 45 is a partial, end perspective view of a staple cartridge assembly comprising deck retaining features in accordance with at least one embodiment;



FIG. 46 illustrates an initial step of a method for assembling an implantable adjunct onto a staple cartridge;



FIG. 47 illustrates another step in the method depicted in FIG. 46;



FIG. 48 illustrates a subsequent step in the method depicted in FIGS. 46 and 47;



FIG. 49 is a detail view of a staple cartridge assembly in accordance with at least one embodiment comprising an implantable layer;



FIG. 50 is a detail view of the layer of FIG. 49 implanted against the tissue of a patient;



FIG. 51 is a perspective view of an implantable layer assembly in accordance with at least one embodiment;



FIG. 52 illustrates a fiber assembly including a first fiber comprised of a first material intertwined with a second fiber comprised of a second material;



FIG. 53 illustrates the fiber assembly of FIG. 52 being exposed to heat;



FIG. 54 illustrates the fiber assembly of FIG. 52 in a contracted state after being exposed to the heat;



FIG. 55 is a perspective view of an implantable layer in accordance with at least one embodiment;



FIG. 56 is a perspective view of the layer of FIG. 55 in a contracted state after being exposed to heat;



FIG. 57 is a perspective view of a staple cartridge assembly in accordance with at least one embodiment comprising an implantable layer;



FIG. 58 is a cross-sectional view of a staple cartridge assembly in accordance with at least one embodiment comprising staples having different unformed heights;



FIG. 59 illustrates the staples of FIG. 58 formed to different formed heights;



FIG. 60 illustrates a plurality of kinked fibers in accordance with at least one embodiment;



FIG. 61 is a perspective view of a kinked fiber of FIG. 60;



FIG. 62 is a partial perspective view of an implantable layer that does not comprise kinked fibers;



FIG. 63 is a partial perspective view of an implantable layer in accordance with at least one embodiment that comprises the kinked fibers of FIG. 60;



FIG. 64 is a perspective view of an implantable layer in accordance with at least one embodiment that comprises the kinked fibers of FIG. 60;



FIG. 65 illustrates a process for creating the kinked fibers of FIG. 60;



FIG. 66 illustrates a process for creating the kinked fibers of FIG. 60;



FIG. 67 illustrates a process for creating the kinked fibers of FIG. 60;



FIG. 68 is a perspective view of an implantable layer in accordance with at least one embodiment comprising the kinked fibers of FIG. 60 interwoven with another group of fibers;



FIG. 69 is a detail view of the implantable layer of FIG. 68;



FIG. 70 is another detail view of the implantable layer of FIG. 68;



FIG. 71 is a cross-sectional view of a staple cartridge assembly in accordance with at least one embodiment including an implantable layer;



FIG. 72 is a cross-sectional view of the implantable layer of FIG. 71;



FIG. 73 is a cross-sectional view of an implantable layer in accordance with at least one alternative embodiment;



FIG. 74 is a cross-sectional view of an implantable layer in accordance with at least one alternative embodiment;



FIG. 75 is a cross-sectional view of an implantable layer in accordance with at least one embodiment;



FIG. 76 is a cross-sectional view of the implantable layer of FIG. 75;



FIG. 77 is a cross-sectional view of an implantable layer in accordance with at least one embodiment;



FIG. 78 is a perspective view of an implantable layer assembly in accordance with at least one embodiment;



FIG. 79 is an exploded view of the implantable layer assembly of FIG. 78;



FIG. 80 is a partial cross-sectional view of an implantable layer in accordance with at least one embodiment;



FIG. 81 is a detail view of a portion of the implantable layer of FIG. 80;



FIG. 82 is a plan view of a portion of the implantable layer assembly of FIG. 78;



FIG. 83 illustrates the implantable layer portion of FIG. 82 in a stretched condition;



FIG. 84 is a plan view of a portion of the implantable layer assembly of FIG. 78;



FIG. 85 illustrates the implantable layer portion of FIG. 84 in a stretched condition;



FIG. 86 is a plan view of an implantable layer in accordance with at least one alternative embodiment;



FIG. 87 is a plan view of an implantable layer in accordance with at least one alternative embodiment;



FIG. 88 is a plan view of an implantable layer in accordance with at least one alternative embodiment;



FIGS. 89A-89C illustrate manufacturing processes for creating openings in an implantable layer in accordance with at least one embodiment;



FIG. 90 is a partial cross-sectional view of an implantable layer in accordance with at least one embodiment;



FIG. 91 is a partial perspective view of an implantable layer in accordance with at least one embodiment;



FIG. 92 is a partial cross-sectional view of the implantable layer of FIG. 91;



FIG. 93 is a perspective view of a partially-assembled compressible adjunct assembly including a plurality of fibrous tubular members;



FIG. 94 is a partial perspective view of the compressible adjunct assembly of FIG. 93 assembled and thermally treated in accordance with at least one embodiment described herein;



FIG. 95 is a partial perspective view of a compressible adjunct assembly being inserted into a heated mold in accordance with at least one embodiment described herein;



FIG. 96 is a cross-sectional view of the compressible adjunct assembly of FIG. 95 being subjected to a thermal pressing treatment in accordance with at least one embodiment described herein;



FIG. 97 is a partial perspective view of the compressible adjunct assembly of FIG. 95 after the thermal treatment is completed and after removal from the mold;



FIG. 98 is perspective view of a compressible adjunct assembly assembled with a staple cartridge in accordance with at least one embodiment described herein;



FIG. 99 is front view of the compressible adjunct assembly of FIG. 98, wherein a portion of the compressible adjunct assembly has been removed for the purpose of illustration;



FIG. 100 is a close-up of an internal portion of the compressible adjunct assembly of FIG. 99;



FIG. 101 is an illustration of a first plurality fibers and a second plurality of fibers, wherein the second plurality of fibers is melted and resolidified in accordance with at least one embodiment described herein;



FIG. 102 is an illustration of a compressible adjunct assembly in accordance with at least one embodiment described herein;



FIG. 103 is a cross-sectional view of the compressible adjunct assembly of FIG. 102 being subjected to a thermal pressing treatment in accordance with at least one embodiment described herein;



FIG. 104 is a partial cross-sectional view of a compressible adjunct assembly, wherein a portion of the compressible adjunct assembly has been removed for the purpose of illustration;



FIG. 105 is a partial cross-sectional view of a compressible adjunct assembly in accordance with at least one embodiment described herein;



FIG. 106 is a partial cross-sectional view of a compressible adjunct assembly in accordance with at least one embodiment described herein; and



FIG. 107 is a partial cross-sectional view of a compressible adjunct assembly in accordance with at least one embodiment described herein.





Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate various embodiments of the invention, in one form, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.


DETAILED DESCRIPTION

The Applicant of the present application owns the following U.S. patent applications that were filed on Sep. 30, 2015, and which are each herein incorporated by reference in their respective entireties:


U.S. patent application Ser. No. 14/871,036, entitled IMPLANTABLE LAYER COMPRISING PLASTICALLY DEFORMED FIBERS; now U.S. Pat. No. 10,327,777;


U.S. patent application Ser. No. 14/871,056, entitled IMPLANTABLE LAYER COMPRISING A CONSTRICTED CONFIGURATION; now U.S. Pat. No. 10,478,188;


U.S. patent application Ser. No. 14/871,078, entitled TUBULAR ABSORBABLE CONSTRUCTS; now U.S. Patent Application Publication No. 2017/0086832;


U.S. patent application Ser. No. 14/871,087, entitled IMPLANTABLE ADJUNCT COMPRISING BONDED LAYERS; now U.S. Patent Application Publication No. 2017/0086838;


U.S. patent application Ser. No. 14/871,107, entitled COMPRESSIBLE ADJUNCTS WITH BONDING NODES; now U.S. Pat. No 10,172,620;


U.S. patent application Ser. No. 14/871,057, entitled COMPRESSIBLE ADJUNCT WITH INTERMEDIATE SUPPORTING STRUCTURES; now U.S. Patent Application Publication No. 2017/0086829;


U.S. patent application Ser. No. 14/871,071, entitled COMPRESSIBLE ADJUNCT WITH CROSSING SPACER FIBERS; now U.S. Pat. No. 10,433,846;


U.S. patent application Ser. No. 14/871,083, entitled COMPRESSIBLE ADJUNCT WITH LOOPING MEMBERS; now U.S. Patent Application Publication No. 2017/0086827;


U.S. patent application Ser. No. 14/871,089, entitled WOVEN CONSTRUCTS WITH INTERLOCKED STANDING FIBERS; now U.S. Pat. No. 10,271,849;


U.S. patent application Ser. No. 14/871,119, entitled COMPRESSIBLE ADJUNCT AND METHODS FOR MAKING THE SAME; now U.S. Pat. No. 10,285,699;


U.S. patent application Ser. No. 14/871,131, entitled METHOD FOR APPLYING AN IMPLANTABLE LAYER TO A FASTENER CARTRIDGE; now U.S. Patent Application Publication No. 2017/0086842;


U.S. patent application Ser. No. 14/871,153, entitled COMPRESSIBLE ADJUNCT WITH ATTACHMENT REGIONS; now U.S. Pat. No. 10,524,788; and


U.S. patent application Ser. No. 14/871,195, entitled COMPRESSIBLE ADJUNCT ASSEMBLIES WITH ATTACHMENT LAYERS; now U.S. Pat. No. 10,307,160.


The Applicant of the present application also owns the U.S. patent applications identified below which are each herein incorporated by reference in their respective entireties:


U.S. patent application Ser. No. 12/894,311, entitled SURGICAL INSTRUMENTS WITH RECONFIGURABLE SHAFT SEGMENTS; now U.S. Pat. No. 8,763,877;


U.S. patent application Ser. No. 12/894,340, entitled SURGICAL STAPLE CARTRIDGES SUPPORTING NON-LINEARLY ARRANGED STAPLES AND SURGICAL STAPLING INSTRUMENTS WITH COMMON STAPLE-FORMING POCKETS; now U.S. Pat. No. 8,899,463;


U.S. patent application Ser. No. 12/894,327, entitled JAW CLOSURE ARRANGEMENTS FOR SURGICAL INSTRUMENTS; now U.S. Pat. No. 8,978,956;


U.S. patent application Ser. No. 12/894,351, entitled SURGICAL CUTTING AND FASTENING INSTRUMENTS WITH SEPARATE AND DISTINCT FASTENER DEPLOYMENT AND TISSUE CUTTING SYSTEMS; now U.S. Pat. No. 9,113,864;


U.S. patent application Ser. No. 12/894,338, entitled IMPLANTABLE FASTENER CARTRIDGE HAVING A NON-UNIFORM ARRANGEMENT; now U.S. Pat. No. 8,864,007;


U.S. patent application Ser. No. 12/894,369, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING A SUPPORT RETAINER; now U.S. Patent Application Publication No. 2012/0080344;


U.S. patent application Ser. No. 12/894,312, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING MULTIPLE LAYERS; now U.S. Pat. No. 8,925,782;


U.S. patent application Ser. No. 12/894,377, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE; now U.S. Pat. No. 8,393,514;


U.S. patent application Ser. No. 12/894,339, entitled SURGICAL STAPLING INSTRUMENT WITH COMPACT ARTICULATION CONTROL ARRANGEMENT; now U.S. Pat. No. 8,840,003;


U.S. patent application Ser. No. 12/894,360, entitled SURGICAL STAPLING INSTRUMENT WITH A VARIABLE STAPLE FORMING SYSTEM; now U.S. Pat. No. 9,113,862;


U.S. patent application Ser. No. 12/894,322, entitled SURGICAL STAPLING INSTRUMENT WITH INTERCHANGEABLE STAPLE CARTRIDGE ARRANGEMENTS; now U.S. Pat. No. 8,740,034;


U.S. patent application Ser. No. 12/894,350, entitled SURGICAL STAPLE CARTRIDGES WITH DETACHABLE SUPPORT STRUCTURES; now U.S. Patent Application Publication No. 2012/0080478;


U.S. patent application Ser. No. 12/894,383, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING BIOABSORBABLE LAYERS; now U.S. Pat. No. 8,752,699;


U.S. patent application Ser. No. 12/894,389, entitled COMPRESSIBLE FASTENER CARTRIDGE; now U.S. Pat. No. 8,740,037;


U.S. patent application Ser. No. 12/894,345, entitled FASTENERS SUPPORTED BY A FASTENER CARTRIDGE SUPPORT; now U.S. Pat. No. 8,783,542;


U.S. patent application Ser. No. 12/894,306, entitled COLLAPSIBLE FASTENER CARTRIDGE; now U.S. Pat. No. 9,044,227;


U.S. patent application Ser. No. 12/894,318, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF CONNECTED RETENTION MATRIX ELEMENTS; now U.S. Pat. No. 8,814,024;


U.S. patent application Ser. No. 12/894,330, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND AN ALIGNMENT MATRIX; now U.S. Pat. No. 8,757,465;


U.S. patent application Ser. No. 12/894,361, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX; now U.S. Pat. No. 8,529,600;


U.S. patent application Ser. No. 12/894,367, entitled FASTENING INSTRUMENT FOR DEPLOYING A FASTENER SYSTEM COMPRISING A RETENTION MATRIX; now U.S. Pat. No. 9,033,203;


U.S. patent application Ser. No. 12/894,388, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND A COVER; now U.S. Pat. No. 8,474,677;


U.S. patent application Ser. No. 12/894,376, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF FASTENER CARTRIDGES; now U.S. Pat. No. 9,044,228;


U.S. patent application Ser. No. 13/097,865, entitled SURGICAL STAPLER ANVIL COMPRISING A PLURALITY OF FORMING POCKETS; now U.S. Patent Application Publication No. 2012/0080488;


U.S. patent application Ser. No. 13/097,936, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER; now U.S. Pat. No. 8,657,176;


U.S. patent application Ser. No. 13/097,954, entitled STAPLE CARTRIDGE COMPRISING A VARIABLE THICKNESS COMPRESSIBLE PORTION; now U.S. Patent Application Publication No. 2012/0080340;


U.S. patent application Ser. No. 13/097,856, entitled STAPLE CARTRIDGE COMPRISING STAPLES POSITIONED WITHIN A COMPRESSIBLE PORTION THEREOF; now U.S. Patent Application Publication No. 2012/0080336;


U.S. patent application Ser. No. 13/097,928, entitled TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS; now U.S. Pat. No. 8,746,535;


U.S. patent application Ser. No. 13/097,891, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING AN ADJUSTABLE ANVIL; now U.S. Pat. No. 8,864,009;


U.S. patent application Ser. No. 13/097,948, entitled STAPLE CARTRIDGE COMPRISING AN ADJUSTABLE DISTAL PORTION; now U.S. Pat. No. 8,978,954;


U.S. patent application Ser. No. 13/097,907, entitled COMPRESSIBLE STAPLE CARTRIDGE ASSEMBLY; now U.S. Patent Application Publication No. 2012/0080338;


U.S. patent application Ser. No. 13/097,861, entitled TISSUE THICKNESS COMPENSATOR COMPRISING PORTIONS HAVING DIFFERENT PROPERTIES; now U.S. Pat. No. 9,113,865;


U.S. patent application Ser. No. 13/097,869, entitled STAPLE CARTRIDGE LOADING ASSEMBLY; now U.S. Pat. No. 8,857,694;


U.S. patent application Ser. No. 13/097,917, entitled COMPRESSIBLE STAPLE CARTRIDGE COMPRISING ALIGNMENT MEMBERS; now U.S. Pat. No. 8,777,004;


U.S. patent application Ser. No. 13/097,873, entitled STAPLE CARTRIDGE COMPRISING A RELEASABLE PORTION; now U.S. Pat. No. 8,740,038;


U.S. patent application Ser. No. 13/097,938, entitled STAPLE CARTRIDGE COMPRISING COMPRESSIBLE DISTORTION RESISTANT COMPONENTS; now U.S. Pat. No. 9,016,542;


U.S. patent application Ser. No. 13/097,924, entitled STAPLE CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2012/0083835;


U.S. patent application Ser. No. 13/242,029, entitled SURGICAL STAPLER WITH FLOATING ANVIL; now U.S. Pat. No. 8,893,949;


U.S. patent application Ser. No. 13/242,066, entitled CURVED END EFFECTOR FOR A STAPLING INSTRUMENT; now U.S. Patent Application Publication No. 2012/0080498;


U.S. patent application Ser. No. 13/242,086, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK; now U.S. Pat. No. 9,055,941;


U.S. patent application Ser. No. 13/241,912, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK ARRANGEMENT; now U.S. Pat. No. 9,050,084;


U.S. patent application Ser. No. 13/241,922, entitled SURGICAL STAPLER WITH STATIONARY STAPLE DRIVERS; now U.S. Patent Application Publication No. 2013/0075449;


U.S. patent application Ser. No. 13/241,637, entitled SURGICAL INSTRUMENT WITH TRIGGER ASSEMBLY FOR GENERATING MULTIPLE ACTUATION MOTIONS; now U.S. Pat. No. 8,789,741;


U.S. patent application Ser. No. 13/241,629, entitled SURGICAL INSTRUMENT WITH SELECTIVELY ARTICULATABLE END EFFECTOR; now U.S. Patent Application Publication No. 2012/0074200;


U.S. patent application Ser. No. 13/433,096, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF CAPSULES; now U.S. Patent Application Publication No. 2012/0241496;


U.S. patent application Ser. No. 13/433,103, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF LAYERS; now U.S. Patent Application Publication No. 2012/0241498;


U.S. patent application Ser. No. 13/433,098, entitled EXPANDABLE TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2012/0241491;


U.S. patent application Ser. No. 13/433,102, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A RESERVOIR; now U.S. Patent Application Publication No. 2012/0241497;


U.S. patent application Ser. No. 13/433,114, entitled RETAINER ASSEMBLY INCLUDING A TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2012/0241499;


U.S. patent application Ser. No. 13/433,136, entitled TISSUE THICKNESS COMPENSATOR COMPRISING AT LEAST ONE MEDICAMENT; now U.S. Patent Application Publication No. 2012/0241492;


U.S. patent application Ser. No. 13/433,141, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CONTROLLED RELEASE AND EXPANSION; now U.S. Patent Application Publication No. 2012/0241493;


U.S. patent application Ser. No. 13/433,144, entitled TISSUE THICKNESS COMPENSATOR COMPRISING FIBERS TO PRODUCE A RESILIENT LOAD; now U.S. Patent Application Publication No. 2012/0241500;


U.S. patent application Ser. No. 13/433,148, entitled TISSUE THICKNESS COMPENSATOR COMPRISING STRUCTURE TO PRODUCE A RESILIENT LOAD; now U.S. Patent Application Publication No. 2012/0241501;


U.S. patent application Ser. No. 13/433,155, entitled TISSUE THICKNESS COMPENSATOR COMPRISING RESILIENT MEMBERS; now U.S. Patent Application Publication No. 2012/0241502;


U.S. patent application Ser. No. 13/433,163, entitled METHODS FOR FORMING TISSUE THICKNESS COMPENSATOR ARRANGEMENTS FOR SURGICAL STAPLERS; now U.S. Patent Application Publication No. 2012/0248169;


U.S. patent application Ser. No. 13/433,167, entitled TISSUE THICKNESS COMPENSATORS; now U.S. Patent Application Publication No. 2012/0241503;


U.S. patent application Ser. No. 13/433,175, entitled LAYERED TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2012/0253298;


U.S. patent application Ser. No. 13/433,179, entitled TISSUE THICKNESS COMPENSATORS FOR CIRCULAR SURGICAL STAPLERS; now U.S. Patent Application Publication No. 2012/0241505;


U.S. patent application Ser. No. 13/763,028, entitled ADHESIVE FILM LAMINATE; now U.S. Patent Application Publication No. 2013/0146643;


U.S. patent application Ser. No. 13/433,115, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CAPSULES DEFINING A LOW PRESSURE ENVIRONMENT; now U.S. Patent Application Publication No. 2013/0256372;


U.S. patent application Ser. No. 13/433,118, entitled TISSUE THICKNESS COMPENSATOR COMPRISED OF A PLURALITY OF MATERIALS; now U.S. Patent Application Publication No. 2013/0256365;


U.S. patent application Ser. No. 13/433,135, entitled MOVABLE MEMBER FOR USE WITH A TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2013/0256382;


U.S. patent application Ser. No. 13/433,140, entitled TISSUE THICKNESS COMPENSATOR AND METHOD FOR MAKING THE SAME; now U.S. Patent Application Publication No. 2013/0256368;


U.S. patent application Ser. No. 13/433,129, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF MEDICAMENTS; now U.S. Patent Application Publication No. 2013/0256367;


U.S. patent application Ser. No. 11/216,562, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 7,669,746;


U.S. patent application Ser. No. 11/714,049, entitled SURGICAL STAPLING DEVICE WITH ANVIL HAVING STAPLE FORMING POCKETS OF VARYING DEPTHS, now U.S. Patent Application Publication No. 2007/0194082;


U.S. patent application Ser. No. 11/711,979, entitled SURGICAL STAPLING DEVICES THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Pat. No. 8,317,070;


U.S. patent application Ser. No. 11/711,975, entitled SURGICAL STAPLING DEVICE WITH STAPLE DRIVERS OF DIFFERENT HEIGHT, now U.S. Patent Application Publication No. 2007/0194079;


U.S. patent application Ser. No. 11/711,977, entitled SURGICAL STAPLING DEVICE WITH STAPLE DRIVER THAT SUPPORTS MULTIPLE WIRE DIAMETER STAPLES, now U.S. Pat. No. 7,673,781;


U.S. patent application Ser. No. 11/712,315, entitled SURGICAL STAPLING DEVICE WITH MULTIPLE STACKED ACTUATOR WEDGE CAMS FOR DRIVING STAPLE DRIVERS, now U.S. Pat. No. 7,500,979;


U.S. patent application Ser. No. 12/038,939, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 7,934,630;


U.S. patent application Ser. No. 13/020,263, entitled SURGICAL STAPLING SYSTEMS THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Pat. No. 8,636,187;


U.S. patent application Ser. No. 13/118,278, entitled ROBOTICALLY-CONTROLLED SURGICAL STAPLING DEVICES THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Patent Application Publication No. 2011/0290851;


U.S. patent application Ser. No. 13/369,629, entitled ROBOTICALLY-CONTROLLED CABLE-BASED SURGICAL END EFFECTORS, now U.S. Pat. No. 8,800,838;


U.S. patent application Ser. No. 12/695,359, entitled SURGICAL STAPLING DEVICES FOR FORMING STAPLES WITH DIFFERENT FORMED HEIGHTS, now U.S. Pat. No. 8,464,923;


U.S. patent application Ser. No. 13/072,923, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 8,567,656;


U.S. patent application Ser. No. 13/766,325, entitled LAYER OF MATERIAL FOR A SURGICAL END EFFECTOR; now U.S. Patent Application Publication No. 2013/0256380;


U.S. patent application Ser. No. 13/763,078, entitled ANVIL LAYER ATTACHED TO A PROXIMAL END OF AN END EFFECTOR; now U.S. Patent Application Publication No. 2013/0256383;


U.S. patent application Ser. No. 13/763,094, entitled LAYER COMPRISING DEPLOYABLE ATTACHMENT MEMBERS; now U.S. Patent Application Publication No. 2013/0256377;


U.S. patent application Ser. No. 13/763,106, entitled END EFFECTOR COMPRISING A DISTAL TISSUE ABUTMENT MEMBER; now U.S. Patent Application Publication No. 2013/0256378;


U.S. patent application Ser. No. 13/433,147, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CHANNELS; now U.S. Patent Application Publication No. 2013/0256369;


U.S. patent application Ser. No. 13/763,112, entitled SURGICAL STAPLING CARTRIDGE WITH LAYER RETENTION FEATURES; now U.S. Patent Application Publication No. 2013/0256379;


U.S. patent application Ser. No. 13/763,035, entitled ACTUATOR FOR RELEASING A TISSUE THICKNESS COMPENSATOR FROM A FASTENER CARTRIDGE; now U.S. Patent Application Publication No. 2013/0214030;


U.S. patent application Ser. No. 13/763,042, entitled RELEASABLE TISSUE THICKNESS COMPENSATOR AND FASTENER CARTRIDGE HAVING THE SAME; now U.S. Patent Application Publication No. 2013/0221063;


U.S. patent application Ser. No. 13/763,048, entitled FASTENER CARTRIDGE COMPRISING A RELEASABLE TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2013/0221064;


U.S. patent application Ser. No. 13/763,054, entitled FASTENER CARTRIDGE COMPRISING A CUTTING MEMBER FOR RELEASING A TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2014/0097227;


U.S. patent application Ser. No. 13/763,065, entitled FASTENER CARTRIDGE COMPRISING A RELEASABLY ATTACHED TISSUE THICKNESS COMPENSATOR; now U.S. Patent Application Publication No. 2013/0221065;


U.S. patent application Ser. No. 13/763,021, entitled STAPLE CARTRIDGE COMPRISING A RELEASABLE COVER; now U.S. Patent Application Publication No. 2014/0224686;


U.S. patent application Ser. No. 13/763,078, entitled ANVIL LAYER ATTACHED TO A PROXIMAL END OF AN END EFFECTOR; now U.S. Patent Application Publication No. 2013/0256383;


U.S. patent application Ser. No. 13/763,095, entitled LAYER ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES; now U.S. Patent Application Publication No. 2013/0161374;


U.S. patent application Ser. No. 13/763,147, entitled IMPLANTABLE ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES; now U.S. Patent Application Publication No. 2013/0153636;


U.S. patent application Ser. No. 13/763,192, entitled MULTIPLE THICKNESS IMPLANTABLE LAYERS FOR SURGICAL STAPLING DEVICES; now U.S. Patent Application Publication No. 2013/0146642;


U.S. patent application Ser. No. 13/763,161, entitled RELEASABLE LAYER OF MATERIAL AND SURGICAL END EFFECTOR HAVING THE SAME; now U.S. Patent Application Publication No. 2013/0153641;


U.S. patent application Ser. No. 13/763,177, entitled ACTUATOR FOR RELEASING A LAYER OF MATERIAL FROM A SURGICAL END EFFECTOR; now U.S. Patent Application Publication No. 2013/0146641;


U.S. patent application Ser. No. 13/763,037, entitled STAPLE CARTRIDGE COMPRISING A COMPRESSIBLE PORTION; now U.S. Patent Application Publication No. 2014/0224857;


U.S. patent application Ser. No. 13/433,126, entitled TISSUE THICKNESS COMPENSATOR COMPRISING TISSUE INGROWTH FEATURES; now U.S. Patent Application Publication No. 2013/0256366;


U.S. patent application Ser. No. 13/433,132, entitled DEVICES AND METHODS FOR ATTACHING TISSUE THICKNESS COMPENSATING MATERIALS TO SURGICAL STAPLING INSTRUMENTS; now U.S. Patent Application Publication No. 2013/0256373;


U.S. patent application Ser. No. 13/851,703, entitled FASTENER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR INCLUDING OPENINGS THEREIN; now U.S. Patent Application Publication No. 2014/0291382;


U.S. patent application Ser. No. 13/851,676, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A CUTTING MEMBER PATH; now U.S. Patent Application Publication No. 2014/0291379;


U.S. patent application Ser. No. 13/851,693, entitled FASTENER CARTRIDGE ASSEMBLIES; now U.S. Patent Application Publication No. 2014/0291381;


U.S. patent application Ser. No. 13/851,684, entitled FASTENER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR AND A GAP SETTING ELEMENT; now U.S. Patent Application Publication No. 2014/0291380;


U.S. patent application Ser. No. 14/187,387, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166724;


U.S. patent application Ser. No. 14/187,395, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166725;


U.S. patent application Ser. No. 14/187,400, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166726;


U.S. patent application Ser. No. 14/187,383, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING IMPLANTABLE LAYERS FOR USE WITH SURGICAL FASTENING INSTRUMENTS, now U.S. Patent Application Publication No. 2015/0238185;


U.S. patent application Ser. No. 14/187,386, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING ONE OR MORE PROPERTIES OF IMPLANTABLE LAYERS FOR USE WITH FASTENING INSTRUMENTS, now U.S. Patent Application Publication No. 2015/0239180;


U.S. patent application Ser. No. 14/187,390, entitled IMPLANTABLE LAYERS AND METHODS FOR MODIFYING THE SHAPE OF THE IMPLANTABLE LAYERS FOR USE WITH A SURGICAL FASTENING INSTRUMENT, now U.S. Patent Application Publication No. 2015/0238188;


U.S. patent application Ser. No. 14/187,389, entitled IMPLANTABLE LAYER ASSEMBLIES, now U.S. Patent Application Publication No. 2015/0238187;


U.S. patent application Ser. No. 14/187,385, entitled IMPLANTABLE LAYERS COMPRISING A PRESSED REGION, now U.S. Patent Application Publication No. 2015/0238191;


U.S. patent application Ser. No. 14/187,384, entitled FASTENING SYSTEM COMPRISING A FIRING MEMBER LOCKOUT, now U.S. Patent Application Publication No. 2015/0238186;


U.S. patent application Ser. No. 14/827,856, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT;


U.S. patent application Ser. No. 14/827,907, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT;


U.S. patent application Ser. No. 14/827,932, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT;


U.S. patent application Ser. No. 14/667,874, entitled MALLEABLE BIOABSORBABLE POLYMER ADHESIVE FOR RELEASABLY ATTACHING A STAPLE BUTTRESS TO A SURGICAL STAPLER;


U.S. patent application Ser. No. 14/300,954, entitled ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALING;


U.S. patent application Ser. No. 14/840,613, entitled DRUG ELUTING ADJUNCTS AND METHODS OF USING DRUG ELUTING ADJUNCTS;


U.S. patent application Ser. No. 14/498,145, entitled METHOD FOR CREATING A FLEXIBLE STAPLE LINE; and


U.S. patent application Ser. No. 14/865,306, entitled IMPLANTABLE ADJUNCT SYSTEMS FOR DETERMINING ADJUNCT SKEW.


Numerous specific details are set forth to provide a thorough understanding of the overall structure, function, manufacture, and use of the embodiments as described in the specification and illustrated in the accompanying drawings. Well-known operations, components, and elements have not been described in detail so as not to obscure the embodiments described in the specification. The reader will understand that the embodiments described and illustrated herein are non-limiting examples, and thus it can be appreciated that the specific structural and functional details disclosed herein may be representative and illustrative. Variations and changes thereto may be made without departing from the scope of the claims.


The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”) and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a surgical system, device, or apparatus that “comprises,” “has,” “includes” or “contains” one or more elements possesses those one or more elements, but is not limited to possessing only those one or more elements. Likewise, an element of a system, device, or apparatus that “comprises,” “has,” “includes” or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features.


The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” referring to the portion closest to the clinician and the term “distal” referring to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.


Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, the reader will readily appreciate that the various methods and devices disclosed herein can be used in numerous surgical procedures and applications including, for example, in connection with open surgical procedures. As the present Detailed Description proceeds, the reader will further appreciate that the various instruments disclosed herein can be inserted into a body in any way, such as through a natural orifice, through an incision or puncture hole formed in tissue, etc. The working portions or end effector portions of the instruments can be inserted directly into a patient's body or can be inserted through an access device that has a working channel through which an end effector and elongated shaft of a surgical instrument can be advanced.


A surgical stapling system can comprise a shaft and an end effector extending from the shaft. The end effector comprises a first jaw and a second jaw. The first jaw comprises a staple cartridge. The staple cartridge is insertable into and removable from the first jaw; however, other embodiments are envisioned in which a staple cartridge is not removable from, or at least readily replaceable from, the first jaw. The second jaw comprises an anvil configured to deform staples ejected from the staple cartridge. The second jaw is pivotable relative to the first jaw about a closure axis; however, other embodiments are envisioned in which the first jaw is pivotable relative to the second jaw. The surgical stapling system further comprises an articulation joint configured to permit the end effector to be rotated, or articulated, relative to the shaft. The end effector is rotatable about an articulation axis extending through the articulation joint. Other embodiments are envisioned which do not include an articulation joint.


The staple cartridge comprises a cartridge body. The cartridge body includes a proximal end, a distal end, and a deck extending between the proximal end and the distal end. In use, the staple cartridge is positioned on a first side of the tissue to be stapled and the anvil is positioned on a second side of the tissue. The anvil is moved toward the staple cartridge to compress and clamp the tissue against the deck. Thereafter, staples removably stored in the cartridge body can be deployed into the tissue. The cartridge body includes staple cavities defined therein wherein staples are removably stored in the staple cavities. The staple cavities are arranged in six longitudinal rows. Three rows of staple cavities are positioned on a first side of a longitudinal slot and three rows of staple cavities are positioned on a second side of the longitudinal slot. Other arrangements of staple cavities and staples may be possible.


The staples are supported by staple drivers in the cartridge body. The drivers are movable between a first, or unfired position, and a second, or fired, position to eject the staples from the staple cavities. The drivers are retained in the cartridge body by a retainer which extends around the bottom of the cartridge body and includes resilient members configured to grip the cartridge body and hold the retainer to the cartridge body. The drivers are movable between their unfired positions and their fired positions by a sled. The sled is movable between a proximal position adjacent the proximal end and a distal position adjacent the distal end. The sled comprises a plurality of ramped surfaces configured to slide under the drivers and lift the drivers, and the staples supported thereon, toward the anvil.


Further to the above, the sled is moved distally by a firing member. The firing member is configured to contact the sled and push the sled toward the distal end. The longitudinal slot defined in the cartridge body is configured to receive the firing member. The anvil also includes a slot configured to receive the firing member. The firing member further comprises a first cam which engages the first jaw and a second cam which engages the second jaw. As the firing member is advanced distally, the first cam and the second cam can control the distance, or tissue gap, between the deck of the staple cartridge and the anvil. The firing member also comprises a knife configured to incise the tissue captured intermediate the staple cartridge and the anvil. It is desirable for the knife to be positioned at least partially proximal to the ramped surfaces such that the staples are ejected ahead of the knife.


The staple cartridge can also include an implantable layer. The implantable layer is configured to be captured within a staple along with tissue when the staple is deployed by the corresponding driver. The implantable layer can comprise a buttress, a tissue thickness compensator, and/or other adjunct material. A tissue thickness compensator is configured to compensate for variations in tissue properties, such as variations in the thickness of tissue, for example, along a staple line. A tissue thickness compensator can be compressible and resilient. In use, a tissue thickness compensator prevents or limits the over-compression of stapled tissue while facilitating adequate tissue compression within and between staples.


The implantable layer of a staple cartridge can be releasably secured to the body of the staple cartridge. For example, the implantable layer can be releasably secured to the deck of the staple cartridge with a releasable adhesive, at least one attachment tab, and/or other attachment features. Additionally or alternatively, an implantable layer can be releasably secured to the first jaw or the second jaw. An implantable layer can be positioned on the cartridge-side of an end effector and/or the anvil-side of the end effector, for example.


An implantable layer can be configured to promote tissue ingrowth. In various instances, it is desirable to promote the ingrowth of tissue into an implantable layer to promote the healing of the treated tissue (e.g. stapled and/or incised tissue) and/or to accelerate the patient's recovery. More specifically, the ingrowth of tissue into an implantable layer may reduce the incidence, extent, and/or duration of inflammation at the surgical site. Tissue ingrowth into and/or around the implantable layer may manage the spread of infections at the surgical site, for example. The ingrowth of blood vessels, especially white blood cells, for example, into and/or around the implantable layer may fight infections in and/or around the implantable layer and the adjacent tissue. Tissue ingrowth may also encourage the acceptance of foreign matter (e.g. the implantable layer and the staples) by the patient's body and may reduce the likelihood of the patient's body rejecting the foreign matter. Rejection of foreign matter may cause infection and/or inflammation at the surgical site.


Turning to the Drawings wherein like numerals denote like components throughout the several views, FIG. 1 illustrates an exemplary surgical stapling and severing instrument 8010 suitable for use with an implantable adjunct such as, for example, a tissue thickness compensator. The surgical stapling and severing instrument 8010 can comprise an anvil 8014 which may be repeatedly opened and closed about its pivotal attachment to an elongate staple channel 8016. A staple applying assembly 8012 may comprise the anvil 8014 and the channel 8016, wherein the assembly 8012 can be proximally attached to an elongate shaft 8018 forming an implement portion 8022. When the staple applying assembly 8012 is closed, or at least substantially closed, the implement portion 8022 can present a sufficiently small cross-section suitable for inserting the staple applying assembly 8012 through a trocar.


In various circumstances, the staple cartridge assembly 8012 is manipulated by a handle 8020 connected to the elongate shaft 8018. The handle 8020 can comprise user controls such as a rotation knob 8030 that rotates the elongate shaft 8018 and the staple applying assembly 8012 about a longitudinal axis of the shaft 8018 and a closure trigger 8026, which can pivot in front of a pistol grip 8036 to close the staple applying assembly 8012. A closure release button 8038 is outwardly presented on the handle 8020 when the closure trigger 8026 is clamped such that the release button 8038 can be depressed to unclamp the closure trigger 8026 and open the staple applying assembly 8012, for example.


A firing trigger 8034, which can pivot in front of the closure trigger 8026, causes the staple applying assembly 8012 to simultaneously sever and staple tissue clamped therein. In various circumstances, multiple firing strokes can be employed using the firing trigger 8034 to reduce the amount of force required to be applied by the surgeon's hand per stroke. In certain embodiments, the handle 8020 can comprise one or more rotatable indicator wheels such as, for example, rotatable indicator wheel 8041 which can indicate the firing progress. A manual firing release lever 8042 can allow the firing system to be retracted before full firing travel has been completed, if desired, and, in addition, the firing release lever 8042 can allow a surgeon, or other clinician, to retract the firing system in the event that the firing system binds and/or fails.


Additional details on the surgical stapling and severing instrument 8010 and other surgical stapling and severing instruments suitable for use with the present disclosure are described, for example, in U.S. patent application Ser. No. 13/851,693, entitled FASTENER CARTRIDGE ASSEMBLY, and filed on Mar. 27, 2013, now U.S. Patent Application Publication No. 2014/0291381, the entire disclosure of which is incorporated herein by reference. Furthermore, powered surgical stapling and severing instruments can also be utilized with the present disclosure. See, for example, U.S. Patent Application Publication No. 2009/0090763, entitled POWERED SURGICAL STAPLING DEVICE, and filed on Aug. 12, 2008, the entire disclosure of which is incorporated herein by reference.


With reference to FIGS. 2 and 3, a firing assembly such as, for example, firing assembly 9090 can be utilized with the surgical stapling and severing instrument 8010 to advance a wedge sled 9126 which comprises a plurality of wedges 9204 configured to deploy staples from the staple applying assembly 8012 into tissue captured between the anvil 8014 and the elongate staple channel 8016. Furthermore, an E-beam 9102 at a distal portion of the firing assembly 9090 may fire the stales from the staple applying assembly 8012 as well as position the anvil 8014 relative to the elongate staple channel 8016 during firing. The E-beam 9102 includes a pair of top pins 9110, a pair of middle pins 9112 which may follow portion 9218 of the wedge sled 9126, and a bottom pin or foot 9114, as well as a sharp cutting edge 9116 which can be configured to sever the captured tissue as the firing assembly 9090 is advanced distally. In addition, integrally formed and proximally projecting top guide 9118 and middle guide 9120 bracketing each vertical end of the cutting edge 9116 may further define a tissue staging area 9122 assisting in guiding tissue to the sharp cutting edge 9116 prior to being severed. The middle guide 9120 may also serve to engage and fire the staple applying assembly 8012 by abutting a stepped central member 9124 of the wedge sled 9126 (FIG. 2) that effects staple formation by the staple applying assembly 8012.


In various circumstances, a staple cartridge can comprise means for compensating for the thickness of tissue captured within staples deployed from a staple cartridge. Referring to FIG. 4, a staple cartridge, such as staple cartridge 10000, for example, can be utilized with the surgical stapling and severing instrument 8010 and can include a rigid first portion, such as support portion 10010, for example, and a compressible second portion, such as tissue thickness compensator 10020, for example. The support portion 10010 can comprise a cartridge body and a plurality of staple cavities 10012. A staple 10030, for example, can be removably positioned in each staple cavity 10012. Referring primarily to FIGS. 4 and 5, each staple 10030 can comprise a base 10031 and one or more legs 10032 extending from the base 10031. Prior to the staples 10030 being deployed, the bases 10031 of the staples 10030 can be supported by staple drivers positioned within the support portion 10010 and, concurrently, the legs 10032 of the staples 10030 can be at least partially contained within the staple cavities 10012.


In various circumstances, the staples 10030 can be deployed between an unfired position and a fired position such that the legs 10032 move through the tissue thickness compensator 10020, penetrate through a top surface of the tissue thickness compensator 10020, penetrate the tissue T, and contact an anvil positioned opposite the staple cartridge 10000. As the legs 10032 are deformed against the anvil, the legs 10032 of each staple 10030 can capture a portion of the tissue thickness compensator 10020 and a portion of the tissue T within each staple 10030 and apply a compressive force to the tissue. Further to the above, the legs 10032 of each staple 10030 can be deformed downwardly toward the base 10031 of the staple to form a staple entrapment area in which the tissue T and the tissue thickness compensator 10020 can be captured. In various circumstances, the staple entrapment area can be defined between the inner surfaces of the deformed legs 10032 and the inner surface of the base 10031. The size of the entrapment area for a staple can depend on several factors such as the length of the legs, the diameter of the legs, the width of the base, and/or the extent in which the legs are deformed, for example.


In use, further to the above and referring primarily to FIG. 4, an anvil, such as anvil 8014 of the surgical stapling and severing instrument 8010, can be moved into a closed position opposite the staple cartridge 10000 by depressing the closure trigger 8026 to advance the E-beam 9102. The anvil 8014 can position tissue against the tissue thickness compensator 10020 and, in various circumstances, compress the tissue thickness compensator 10020 against the support portion 10010, for example. Once the anvil 8014 has been suitably positioned, the staples 10030 can be deployed, as also illustrated in FIG. 4.


In various circumstances, as mentioned above, a staple-firing sled 10050, which is similar in many respects to the sled 9126 (See FIG. 3), can be moved from a proximal end of the staple cartridge 10000 toward a distal end 10002, as illustrated in FIG. 5. As the firing assembly 9090 is advanced, the sled 10050 can contact the staple drivers 10040 and lift the staple drivers 10040 upwardly within the staple cavities 10012. In at least one example, the sled 10050 and the staple drivers 10040 can each comprise one or more ramps, or inclined surfaces, which can co-operate to move the staple drivers 10040 upwardly from their unfired positions. As the staple drivers 10040 are lifted upwardly within their respective staple cavities 10012, the staple drivers 10040 can lift the staples 10030 upwardly such that the staples 10030 can emerge from their staple cavities 10012. In various circumstances, the sled 10050 can move several staples upwardly at the same time as part of a firing sequence.


Referring to FIG. 5, the staple legs 10032 of the staples 10030 can extend into the compensator 10020 beyond the support portion 10010 when the staples 10030 are in their unfired positions. In various circumstances, the tips of the staple legs 10032, or any other portion of the staple legs 10032, may not protrude through a top tissue-contacting surface 10021 of the tissue thickness compensator 10020 when the staples 10030 are in their unfired positions. In certain circumstances, the tips of the staple legs 10032 can comprise sharp tips which can incise and penetrate the tissue thickness compensator 10020.


Referring to FIG. 6, a staple cartridge assembly 10 is illustrated. The staple cartridge assembly 10 includes a staple cartridge 12. The staple cartridge 12 is similar in many respects to the staple cartridge 10000. Like the staple cartridge 10000, the staple cartridge 12 includes a plurality of staples which are housed in a plurality of cavities or pockets 22 defined in the staple cartridge 12. Also, the plurality of staples of the staple cartridge 12 can be deployed by the surgical stapling and severing instrument 8010.


The staple cartridge 12 further includes a cartridge deck 16 with an outer surface 18. The staple cartridge 12 also includes a knife slot 20 that accommodates the cutting edge 9116 as it is advanced to cut tissue captured by the surgical stapling and severing instrument 8010. The plurality of pockets 22 may extend from the outer surface 18 into the staple cartridge 12 for housing the plurality of staples. Advancement of the sled 10050 through the staple cartridge 12 causes the staples of staple cartridge 12 to be deployed from their respective pockets 22 into tissue in the same, or substantially the same, manner that the staples 10030 are deployed from the staple cartridge 10000, as described above.


Referring again to FIG. 6, the staple cartridge assembly 10 further includes a tissue thickness compensator or compressible adjunct 14. The compressible adjunct 14 is attached to the outer surface 18 by partially melting the compressible adjunct 14 onto the outer surface 18 to allow the melted portions of the compressible adjunct 14 to flow onto the outer surface 18. The melted portions of the compressible adjunct 14 are resolidified by cooling, for example, which causes the compressible adjunct 14 to be attached to the outer surface 18.


In certain instances, the staple cartridge 12 may include one or more heating elements (not shown) configured to heat the outer surface 18. The heated outer surface 18 can melt the portions of the compressible adjunct 14 in contact therewith. Upon resolidifying, the melted portions of the compressible adjunct 14 can define attachment regions that secure the compressible adjunct 14 to the outer surface the outer surface 18.


In at least one instance, the outer surface 18 is heated uniformly. Alternatively, specific zones of the outer surface 18 are directly heated while other zones are not directly heated. The zones that are not directly heated can be referred to herein as “unheated.” The portions of the compressible adjunct 14 in contact with, or in close proximity to, the directly heated zones can be melted and then resolidified to define the attachment regions between the compressible adjunct 14 and the outer surface 18. The portions of the compressible adjunct 14 in contact with, or in close proximity to, the unheated zones remain unattached to the outer surface 18.


In at least one instance, the outer surface 18 is uniformly, or at least substantially uniformly, heated but certain zones of the outer surface 18 may have greater thermal conductivity than other zones of the outer surface 18. In such instances, the portions of the compressible adjunct 14 in contact with, or in close proximity to, the higher thermal conductivity zones can be melted and resolidified to define the attachment regions between the compressible adjunct 14 and the outer surface 18, while the portions of the compressible adjunct 14 in contact with, or in close proximity to, the lower thermal conductivity zones remain unattached to the outer surface 18.


As described above, selective or localized heating of certain zones of the outer surface 18 can be used to define or create discrete attachment regions between the compressible adjunct 14 and the outer surface 18. Alternatively, the compressible adjunct 14 can be especially designed, as illustrated in FIG. 6, to yield selective attachment regions in the presence of a uniformly heated outer surface 18.


In various instances, the zones of the outer surface 18 destined to bond with the compressible adjunct 14 are treated to improve the bond. In at least one instance, one or more of such bonding zones may comprise an irregular topography. For example, such bonding zones may comprise a greater roughness than the remainder of the outer surface 18. Under one non-limiting theory, the greater roughness may improve bonding with the melted portions of the compressible adjunct 14 by increasing the surface area available for contact with the melted portions of the compressible adjunct 14.


The desired roughness of the bonding zones can be achieved by any suitable process such as, for example, mechanical abrading, chemical etching, shot peening, laser peening, and/or plasma spraying. Other processes for producing the desired roughness are contemplated by the present disclosure.


Further to the above, the compressible adjunct 14 includes a body 24. The body 24 includes a face 26 positionable against at least a portion of the outer surface 18 of the staple cartridge 12. The face 26 may include a plurality of attachment regions 28 and a plurality of non-attachment regions 30, as illustrated in FIG. 6. Selective attachment of the compressible adjunct 14 to the outer surface 18 at the attachment regions 28 can reduce the force needed to release the compressible adjunct 14 from the cartridge deck 16 as compared to where the entire face of a compressible adjunct is attached to the surface 18.


The attachment regions 28 are comprised of one or more biocompatible materials. Likewise, the non-attachment regions 30 are comprised of one or more biocompatible materials. In various instances, at least one of the biocompatible materials forming the attachment regions 28 is excluded from the biocompatible materials forming the non-attachment regions 30. In such instances, the one or more biocompatible materials forming the non-attachment regions 30 have melting temperatures that are greater than the melting temperature of the excluded biocompatible material of the attachment regions 28. In certain instances, the attachment regions 28 are comprised of a biocompatible material “A”, a biocompatible material “B”, and a biocompatible material “C,” while the non-attachment regions 30 are comprised of the biocompatible material “A” and the biocompatible material “B” but exclude the biocompatible material “C.” In such instances, the biocompatible material “C” has a lower melting temperature than the biocompatible material “A” and the biocompatible material “B.” Upon heating the attachment regions 28 and the non-attachment regions 30 to the melting temperature of the biocompatible material “C,” the biocompatible material “C” melts and flows from the attachment regions 28 onto the outer surface 18. Once the biocompatible material “C” is resolidified bonding is established between the attachment regions 28 and the outer surface 18.


In at least one instance, the non-attachment regions 30 may be comprised of a first biocompatible material, and the attachment regions 28 may be comprised of a second biocompatible material which is different from the first biocompatible material. The second biocompatible material may have a lower melting temperature than the first biocompatible material. In such instances, exposing the face 26 to the outer surface 18, which is uniformly heated to a temperature greater than or equal to the melting temperature of the second biocompatible material but lower than the melting temperature of the first biocompatible material, causes the attachment regions 28 to melt and flow onto the outer surface 18. The non-attachment regions 30, however, will remain in their solid state as the temperature of the outer surface 18 is below the melting temperature of the first biocompatible material. Upon resolidifying, the attachment regions 28 releasably secure the body 24 of the compressible adjunct 14 to the outer surface 18 of the cartridge deck 16.


In various instances, one or more of the non-attachment regions 30 and/or one or more of the attachment regions 28 may comprise bioabsorbable materials such as, for example, polyglycolic acid (PGA) which is marketed under the trade name VICRYL, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, and/or polycaprolactone (PCL). In certain instances, one or more of the attachment regions 28 and/or the non-attachment regions 30 may comprise one or more composite materials that include two or more polymers, the polymers selected from a group including PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In at least one instance, the second biocompatible material is comprised of PDS.


In at least one instance, the compressible adjunct 14 is secured to the cartridge deck 16 by causing a temporary phase transition in the second biocompatible material of the attachment regions 28 while the compressible adjunct 14 is pressed, or positioned, against the cartridge deck 16. In certain instances, the temporary phase transition in the second biocompatible material is not accompanied by a phase transition in the first biocompatible material of the non-attachment regions 30.


In certain instances, the attachment regions 28 are resolidified by removing or deactivating the heat source. In at least one instance, the heat source is an oven, which is configured to receive the staple cartridge 12 and the compressible adjunct 14 positioned against the cartridge deck 16. The oven can be heated to a suitable temperature prior to and/or after receiving the staple cartridge 12 and the compressible adjunct 14. In at least one instance, the heat source can be a thermal resistance circuit, which can be activated to heat the outer surface 18. The thermal resistance circuit can be arranged under the cartridge deck 16, for example. Other suitable heat sources are contemplated by the present disclosure. In certain instances, the attachment regions 28 are resolidified by active cooling in addition to removing or deactivating the heat source. For example, a fan or any other cooling system can be employed to cool the attachment regions 28 to a temperature below the melting temperature of the second biocompatible material.


In at least one instance, the non-attachment regions 30 may be comprised of a plurality biocompatible materials with melting temperatures that are greater than a predetermined temperature. Likewise, the attachment regions 28 may be comprised of a plurality of biocompatible materials; however, the biocompatible materials of the attachment regions 28 include at least one biocompatible material having a melting temperature that is equal to or less than the predetermined melting temperature. Said another way, the biocompatible materials of the attachment regions 28 include at least one biocompatible material having a melting temperature that is less than the melting temperatures of the biocompatible materials of the non-attachment regions 30. Upon heating the face 26 of the compressible adjunct 14 to the predetermined temperature, the attachment regions 28 are melted, or at least partially melted, for bonding with the outer surface 18, while the non-attachment regions 30 remain in their solid phase and do not bond to the outer surface 18.


In various instances, further to the above, the non-attachment regions 30 need only exclude biocompatible materials with melting temperatures that are equal to or less than the melting temperature of the biocompatible material with the lowest melting temperature in the attachment regions 28. That said the attachment regions 28 need not be limited in composition to one biocompatible material. On the contrary, the attachment regions 28 can be comprised of a plurality of biocompatible materials as long as the plurality of biocompatible materials of the attachment regions 28 includes at least one biocompatible material with a melting temperature that is less than the melting temperature(s) of the biocompatible material(s) of the non-attachment regions 30.


Referring again to FIG. 6, the body 24 of the compressible adjunct 14 may include a fibrous construct comprising a plurality of fibers. Suitable compressible adjuncts may include meshes, other filamentous structures, non-woven structures, sponges, woven or non-woven materials, knit or non-knit materials, felts, salt eluted porous materials, molded porous materials, and/or 3D-printing generated adjuncts, for example. Other techniques for preparing the compressible adjunct 14 are contemplated by the present disclosure.


In at least one instance, the non-attachment regions 30 may include a first plurality of fibers, and the attachment regions 28 may include a second plurality of fibers different from the first plurality of fibers. For example, the second plurality of fibers may have a lower melting temperature than the first plurality of fibers. In such instances, exposing the face 26 of the compressible adjunct 14 to the outer surface 18, which is uniformly heated to a temperature which is greater than or equal to the melting temperature of the second plurality of fibers but lower than the melting temperature of the first plurality of fibers, causes the second plurality of fibers of the attachment regions 28 to melt and flow onto the outer surface 18. The first plurality of fibers of the non-attachment regions 30, however, will remain in their solid state as the temperature of the outer surface 18 is below the melting temperature of the first plurality of fibers.


The fibrous construct of the body 24 of the compressible adjunct 14 can be pressed onto or positioned against the outer surface 18 which is uniformly heated to a temperature sufficient to melt the fibers of the attachment regions 28 but not the fibers of the non-attachment regions 30. Upon resolidifying, the melted fibers of the attachment regions 28 secure the body 24 of the compressible adjunct 14 to the outer surface 18 of the cartridge deck 16.


In various instances, the outer surface 18 may comprise bonding zones for bonding with the attachment regions 28. In certain instances, the bonding zones are treated to improve the bond between the attachment regions 28 and the outer surface 18. In at least one instance, one or more of the bonding zones may comprise an irregular topography that increases the roughness of the bonding zones compared to the remainder of the outer surface 18. As described above, the increased roughness may correspond to an increase in the surface area of the bonding zones available for bonding with the attachment regions 28.


Referring to FIG. 7, a staple cartridge assembly 40 includes a staple cartridge 42 which is similar in many respects to the staple cartridges 12 and 10000. Like the staple cartridge 10000, the staple cartridge 42 includes a plurality of staples such as, for example, a plurality of staples 43 which are housed in the staple cartridge 42 in a plurality of cavities or pockets 52. Furthermore, like the staples of the staple cartridge 10000, the staples 43 can be deployed from the staple cartridge 42 into captured tissue by the surgical stapling and severing instrument 8010.


The staple cartridge 42 includes a cartridge deck 46. Like the cartridge deck 16, the cartridge deck 46 includes an outer surface such as, for example, an outer surface 48. The plurality of pockets 52 extend from the cartridge deck 46 into the staple cartridge 42 and are configured to house the plurality of staples 43, as illustrated in FIG. 7. When the staple cartridge 42 is used with the surgical stapling and severing instrument 8010, the advancement of the sled 10050 through the staple cartridge 42 causes the staples 43 to be deployed from their respective pockets 52 into tissue in the same, or substantially the same, manner that the staples 10030 are deployed from the staple cartridge 10000.


The staple cartridge assembly 40 includes a layer such as, for example, a tissue thickness compensator or compressible adjunct. In the illustrated in embodiment, the staple cartridge assembly 40 includes a compressible adjunct 14. The compressible adjunct 14 is assembled with, or positioned against, the cartridge deck 46 of the staple cartridge 42. The compressible adjunct 14 is secured to a plurality of bonding zones 56 on the cartridge deck 46, as described in greater detail below.


In certain instances, the bonding zones 56 can be arranged in rows. Each row may include a plurality of the bonding zones 56. In the embodiment illustrated in FIG. 7, the bonding zones 56 are arranged in three parallel rows 56a-56c extending along a length of the cartridge deck 46 on each side of the knife slot 20. Alternatively, the bonding zones 56 may be arranged in two parallel rows along a length of the cartridge deck 46 on each side of the knife slot 20. Alternatively, the bonding zones 56 may be arranged in a single row along a length of the cartridge deck 46 on each side of the knife slot 20. Alternatively, the bonding zones 56 may be arranged in non-parallel rows. In certain instances, the bonding zones 56 may be arranged along a perimeter, or a periphery, of the cartridge deck 46.


The middle row 56b is offset from the outer rows 56a, 56c. Said another way, a pair of the bonding zones of the outer rows 56a, 56c is laterally aligned with a gap between two consecutive bonding zones of the middle row 56b. The gap may include a pocket 52. In certain instances, a plurality of bonding zones 56 and a plurality of pockets 52 may be arranged in a row such that each bonding zone 56 is disposed between two consecutive pockets 52, as illustrated in FIG. 7. Other arrangements of the bonding zones 56 with respect to the cartridge deck 46 are contemplated by the present disclosure.


As illustrated in FIG. 7, the cartridge deck 42 may include a plurality of pocket extenders 54 which extend from the outer surface 48. The pocket extenders 54 can serve a number of functions. For example, the pockets extenders 54 may protect the legs of the staples 43 that extend outside the pockets 52 in their unfired positions. Also, the pocket extenders 54 may guide the staples 43 as they are being fired. A bonding zone 56 may extend between two adjacent pocket extenders 54 of two different pockets 52. Said another way, the bonding zone 56 may extend between two adjacent atraumatic pocket extenders 54 each protecting a staple leg of a different staple.


In certain instances, a plurality of pocket extenders 54 may be arranged with a plurality of bonding zones 56 in a row such as, for example, the rows 56a-56c. In at least one instance, each of the plurality of bonding zones 56 in such a row can be positioned between two consecutive atraumatic pocket extenders 54. For example, as illustrated in FIG. 7, a bonding zone 56′ is positioned between a distal staple 43a and proximal staple 43b such that the bonding zone 56′ extends between a first pocket extender 54a protecting a proximal leg 45 of the distal staple 43a and a second pocket extender 54b protecting a distal leg (not shown) of the proximal staple 43b.


As indicated above, the bonding zones 56 of the cartridge deck 46 may extend from the outer surface 48. In other words, the bonding zones 56 may be elevated, or stepped up, relative to the outer surface 48, as illustrated in FIG. 7. In various instances, the attachment regions 28 can be positioned on the bonding zones 56. The elevation of the bonding zones 56 relative to the outer surface 48 can prevent, or at least limit, overflow of the melted material of the attachment regions 28 outside the bonding zones 56, which can help maintain the attachment between the compressible adjunct 14 and the cartridge deck 46 to discrete regions defined by the bonding zones 56.


In various instances, the bonding zones 56 of the cartridge deck 46 are treated to improve their attachment to corresponding attachment regions 28 of the compressible adjunct 14. In at least one instance, one or more of the bonding zones 56 may comprise an irregular topography, as illustrated in FIG. 7. In other words, the bonding zones 56 may comprise a greater roughness than the remainder of the outer surface 48. The greater roughness improves bonding with the melted attachment regions 28. The desired roughness of the bonding zones can be achieved by any suitable process such as, for example, mechanical abrading, chemical etching, shot peening, laser peening, and/or plasma spraying. Other processes for producing the desired roughness are contemplated by the present disclosure.


In various instances, the cartridge deck 46 may further include one or more attachment members 58. The attachment members 58 aid in securing the compressible adjunct 14 to the cartridge deck 46. In certain instances, the attachment members 58 comprise barbs that can maintain an initial alignment between the bonding zone 56 and the corresponding attachment regions 48 of the compressible adjunct 14 during the melting and/or resolidifying processes used to bond the compressible adjunct 14 to the cartridge deck 46. The compressible adjunct 14 can be pressed against the cartridge deck 46 so that the attachment members 58 engage the face 26 of the compressible adjunct 14, and/or to establish an initial alignment between the bonding zones 56 and the attachment regions 28. The attachment regions 28 are then melted onto the bonding zones 56. Upon resolidifying, the attachment regions 58 secure the compressible adjunct 14 to the bonding zones 56.


Referring now to FIG. 8, a staple cartridge assembly 60 is assembled with a surgical stapling and severing instrument such as, for example, the surgical stapling and severing instrument 8010. The staple cartridge assembly 60 includes a staple cartridge 62. The staple cartridge 62 is similar in many respects to the staple cartridges 12, 42, and 10000. The staple cartridge 62 includes a cartridge deck 66, which includes an outer surface such as, for example, an outer surface 68. The staple cartridge assembly 60 further includes a compressible layer 64 and a bonding layer 65. The bonding layer 65 can be comprised of a plurality of bonding islands 67, as illustrated in FIG. 8. The bonding islands 67 can be spaced apart from one another and disposed on the outer surface 68 of the cartridge deck 66 in a predetermined arrangement. The bonding islands 67 are arranged in a pattern surrounding, or at least partially surrounding, the knife slot 20. Said another way, the bonding islands 67 are arranged in a pattern along a periphery, or a perimeter, of the knife slot 20. Other arrangements of the bonding islands 67 onto the outer surface 68 are contemplated by the present disclosure.


In certain instances, one or more of the bonding islands 67 comprise a cylindrical shape, as illustrated in FIG. 8. Other shapes are also contemplated by the present disclosure. For example, one or more bonding islands 67 may comprise a dome shape. In the embodiment illustrated in FIG. 8, a bonding island 67′ is disposed in the outer surface 68 at distal portion thereof, which is distal to the knife slot 20.


In various instances, the bonding islands 67 of the bonding layer 65 can be formed with the cartridge deck 66 during manufacturing. Alternatively, the bonding layer 65 can be attached to the cartridge deck 66 by the surgeon, for example. Any suitable attachment technique can be employed to secure the boding layer 65 to the cartridge deck 66. In at least one instance, the bonding layer 65 may include one or more connecting straps 69, for example. The connecting straps 69 also interconnect the bonding islands 67, and can be employed to secure the boding layer 65 to the cartridge deck 66, for example.


In any event, the compressible layer 64 can be secured to the cartridge deck 66 by pressing, or positioning, the compressible layer 64 against the melted, or at least partially melted, bonding islands 67, then allowing, or causing, the bonding islands 67 to resolidify. Said another way, the compressible layer 64 can be secured to the cartridge deck 66 by causing a temporary phase transition in the bonding islands 67 while the compressible layer 64 is pressed, or positioned, against the bonding islands 67.


In one embodiment, the compressible layer 64 is pressed, or positioned, against the bonding islands 67. Then, the bonding islands 67 are heated to a predetermined temperature which causes the bonding islands 67 to be melted, or at least partially melted. Finally, the bonding islands 67 are cooled, or allowed to cool, down below the predetermined temperature thereby causing the bonding islands 67 to resolidify and secure the compressible layer 64 to the cartridge deck 66. Alternatively, the bonding islands 67 can be heated to the predetermined temperature prior to pressing, or positioning, the compressible layer 64 against the bonding islands 67.


In certain instances, the bonding islands 67 are resolidified by removing or deactivating the heat source. In other instances, the bonding islands 67 are resolidified by active cooling in addition to removing or deactivating the heat source. For example, a fan or any other cooling system can be employed to cool the bonding islands 67 to a temperature below the predetermined temperature.


In at least one instance, the compressible layer 64 may be comprised of a first biocompatible material, and the bonding islands 67 may be comprised of a second biocompatible material which is different from the first biocompatible material. The second biocompatible material may have a lower melting temperature than the first biocompatible material. In such instances, heating the bonding islands 67 to the melting temperature of the second biocompatible material but lower than the melting temperature of the first biocompatible material, causes the bonding islands 67 to melt and flow into the compressible layer 64 and onto the outer surface 68. The compressible layer 64, however, will remain in a solid phase. Upon resolidifying, the bonding islands 67 secure the compressible layer 64 to the outer surface 68 of the cartridge deck 66.


In at least one instance, the compressible layer 64 is secured to the cartridge deck 66 by causing a temporary phase change or transition in the second biocompatible material of the bonding islands 67 while the compressible layer 64 is pressed, or positioned, against the cartridge deck 66. In certain instances, the temporary phase change in the second biocompatible material is not accompanied by a phase change in the first biocompatible material of the compressible layer 64.


In various instances, the compressible layer 64 and/or the bonding layer 67 may comprise bioabsorbable materials such as, for example, polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, and/or polycaprolactone (PCL). In certain instances, the compressible layer 64 and/or the bonding layer 67 may comprise composite materials that include two or more polymers, the polymers selected from a group including PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In at least one instance, the second biocompatible material is comprised of PDS, for example.


The reader will appreciate that the compressible adjuncts and/or layers of the present disclosure can be attached to an anvil such as, for example, the anvil 8014 of the surgical stapling and severing instrument 8010 in the same manner the compressible adjuncts and/or layers are attached to the staple cartridges of the present disclosure, and vice versa. For example, the compressible adjunct 14 can be attached to the anvil 8014 by uniformly heating the anvil 8014 to a temperature sufficient to melt the fibers of the attachment regions 28 but not the fibers of the non-attachment regions 30. Upon resolidifying, the melted fibers of the attachment regions 28 secure the body 24 of the compressible adjunct 14 to the anvil 8014. Likewise the bonding layer 65 can be employed to secure the compressible layer 64 to the anvil 8014 in the same manner the bonding layer 65 secures the compressible layer 64 to the staple cartridge 62.


Referring primarily to FIGS. 1 and 9, a surgical stapling and severing instrument such as, for example, the surgical stapling and severing instrument 8010 may include a compressible adjunct assembly 104. The compressible adjunct assembly 80 can be attached to a jaw member of the surgical stapling and severing instrument 8010. In at least one instance, the compressible adjunct assembly 104 is attached to an anvil such as, for example, an anvil 84 (FIG. 9), which is similar in many respects to the anvil 8014 (FIG. 1).


Alternatively, the compressible adjunct assembly 104 can be attached to a staple cartridge such as, for example, the staple cartridge 10000. In certain instances, a first compressible adjunct assembly 104 is attached to an anvil and a second compressible adjunct assembly 104 is attached to a staple cartridge of the same surgical stapling and severing instrument. In such instances, tissue is captured between the first and second compressible adjunct assemblies 104 upon transitioning the surgical stapling and severing instrument to a closed configuration.


Like the anvil 8014, the anvil 84 includes an elongate slot 86 that extends through a length of the anvil 84 defining a first outer surface 88 extending on a first side 90 of the elongate slot 86, and a second outer surface 92 extending on a second side 94 of the elongate slot 86, as illustrated in FIG. 9. In certain instances, the anvil 84 is movable relative to a staple cartridge such as, for example, the staple cartridge 10000 to capture tissue therebetween. Alternatively, the staple cartridge 10000 can be moved relative to the anvil 84 to capture tissue therebetween. Alternatively, the anvil 84 and the staple cartridge 10000 can be moved toward one another to capture the tissue therebetween. A firing assembly such as, for example, the firing assembly 9090 (FIG. 3) can be utilized with the surgical stapling and severing instrument 8010 to deploy staples from the staple applying assembly 8012 (FIG. 1) into tissue captured between the anvil 84 and the staple cartridge 10000, as described in greater detail above.


Referring to FIG. 9, the first outer surface 88 includes a plurality of pockets 96. Likewise, the second outer surface 92 includes a plurality of pockets 98. The pockets 96 and 98 can be configured to receive and deform the staples as they are deployed from the staple cartridge 10000, for example. Furthermore, the elongate slot 86 can be configured to accommodate the cutting edge 9116 (FIG. 3) as it is advanced to cut tissue captured by the surgical stapling and severing instrument 8010.


Referring to FIGS. 3 and 9, the anvil 84 may include an internal surface 100 that defines an internal space 102 within the anvil 84. The pins 9110 (FIG. 3) of the firing assembly 9090 can ride against the internal surface 102, and can be motivated through the internal space 102 as the firing assembly 9090 is advanced to deploy the staples into the tissue captured by the staple applying assembly 8012.


Referring again to FIG. 9, the compressible adjunct assembly 104 includes an attachment layer 106, a first compressible adjunct 108, and a second compressible adjunct 110. The attachment layer 106 can be configured to couple the first compressible adjunct 108 and the second compressible adjunct 110 to the anvil 84, as described in greater detail below. A first section 106a of the attachment layer 106 is positionable on the first side 90 of the elongate slot 86, and a second section 106b is positionable on the second side 94 of the elongate slot 86. The elongate slot 86 separates the first section 106a from the second section 106b. An intermediary section 106c of the attachment layer 106 extends between the first section 106a and the second section 106b. The intermediary section 106c bridges the elongate slot 86. In certain instances, the intermediary section 106c only partially bridges the elongate slot 86


In certain instances, the intermediary section 106c completely bridges the elongate slot 86. In at least one instance, the intermediary section 106c may be comprised of a plurality of bridging portions 107, as illustrated in FIG. 9. Each bridging portion 107 extends between the first section 106a and the second section 106b. The bridging portions 107 are spaced apart from one another. Gaps 109 in the intermediary section 106b separate the bridging portions 107. The gaps 109 expose the elongate slot 86.


As illustrated in FIG. 9, the bridging portions 107 can be strategically arranged along the elongate slot 86 to maintain the integrity of the attachment layer 106 while minimizing the firing force needed to drive the cutting edge 9116 (FIG. 3) as it is advanced to cut the intermediate layer 106c and tissue captured between a staple cartridge and the anvil 84. The gaps 109 and the bridging portions 107 alternate in position along at least a portion of the elongate slot 86.


Various techniques for manufacturing a compressible adjunct assembly such as, for example, the compressible adjunct assembly 104 are described in U.S. patent application Ser. No. 14/187,383, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING IMPLANTABLE LAYERS FOR USE WITH SURGICAL FASTENING INSTRUMENTS, and filed Feb. 24, 2014, now U.S. Patent Application Publication No. 2015/0238185, the entire disclosure of which is incorporated herein by reference. In at least one instance, the attachment layer 106 can be attached to the first compressible adjunct 108 and second compressible adjunct 110 during fabrication of the first compressible adjunct 108 and second compressible adjunct 110 using a lyophilization process, for example.


Alternatively, the attachment layer 106 can be attached to the first compressible adjunct 108 and second compressible adjunct 110 after fabrication of the first compressible adjunct 108 and second compressible adjunct 110. For example, as described in greater detail elsewhere herein, the first compressible adjunct 108 can be positioned, or pressed, against a partially melted first section 106a of the attachment layer 106. Upon resolidification, the first section 106a is attached to the first compressible adjunct 108. In a similar manner, the first section 106a can be attached to the first outer surface 88, the second section 106b can be attached to the outer surface 92, and the second section 106b can be attached to the second compressible adjunct 110, for example.


As illustrated in FIG. 9, the first section 106a of the attachment layer 106 extends between the first compressible adjunct 108 and the first outer surface 88. Likewise, the second section 106b of the attachment layer 106 may extend between the second compressible adjunct 110 and the outer surface 92. The first section 106a completely separates the first compressible adjunct 108 from the first outer surface 88. In addition, the second section 106b completely separates the second compressible adjunct 110 from the outer surface 92. Alternatively, a compressible adjunct assembly may comprise an attachment layer 206 that only partially separates one or more compressible adjuncts from an anvil. Said another way, the first section 106a may include one or more gaps configured to expose the first compressible adjunct 108 to the first outer surface 88. Likewise, the second section 106b may include one or more gaps configured to expose the second compressible adjunct 110 to the outer surface 92.


The attachment layer 106 comprises a height that is smaller than the height of the first compressible adjunct 108 and/or the height of the second compressible adjunct 110. Alternatively, the attachment layer 106 may comprise a height that is greater than or equal to the height of the first compressible adjunct 108 and/or the height of the second compressible adjunct 110. In at least one instance, the attachment layer 106 is comprised of a film, which can be attached to the first compressible adjunct 108 and/or the second compressible adjunct 108.


Referring to FIG. 10, a compressible adjunct assembly 204 may comprise an attachment layer 206 that partially separates a first compressible adjunct 208 from the first outer surface 88 and/or partially separates a second compressible adjunct 210 from the outer surface 92. The compressible adjunct assembly 204 is similar in many respects to the compressible adjunct assembly 104. The compressible adjunct assembly 204 can be assembled with the anvil 84.


The attachment layer 206 of the compressible adjunct assembly 204 includes a first section 206a positionable on the first side 90 of the elongate slot 86, and a second section 206b positionable on the second side 94 of the elongate slot 86. Also, an intermediary section 206c of the attachment layer 206 extends between the first section 206a and the second section 206b. The intermediary section bridges the elongate slot 86, as illustrated in FIG. 10. In certain instances, the intermediary section 206c only partially bridges the elongate slot 86.


The first compressible adjunct 208 of the compressible adjunct assembly 204 is attached to the first section 206a, and the second compressible adjunct 210 of the compressible adjunct assembly 204 is attached to the second section 206b. When the compressible adjunct assembly 204 is assembled with the anvil 84, as illustrated in FIG. 10, the first compressible adjunct 208 extends laterally beyond the first section 206a in a first direction away from the elongate slot 86. In addition, the first outer surface 88 also extends laterally beyond the first section 206a in the first direction. Likewise, the second compressible adjunct 210 extends laterally beyond the second section 206b in a second direction away from the elongate slot 86 and opposite the first direction. In addition, the outer surface 92 also extends laterally beyond the second section 206b in the second direction. In result, as illustrated in FIG. 10, an external portion 208a of the first compressible adjunct 208 is in direct contact with the outer surface 88 while a stepped internal portion 208b is separated from the outer surface 88 by the first section 206a of the attachment layer 206. Likewise, an external portion 210a of the second compressible adjunct 210 is in direct contact with the outer surface 92 while a stepped internal portion 210b is separated from the outer surface 92 by the second section 206b of the attachment layer 206.


The stepped internal portions 208b and 210b define first and second boundaries 208c and 210c, respectively. The attachment layer 206 extends laterally between the first boundary 208c and the second boundary 210c crossing the elongate slot 86 to interconnect the first compressible adjunct 208 and the second compressible adjunct 210. When the compressible adjunct assembly 204 is assembled with the anvil 84, as illustrated in FIG. 10, the attachment layer 206 is positioned against a central area of the anvil 84 extending between an inner row of the pockets 96 and an inner row of the pockets 98. In addition, the internal stepped portions 208b and 210b are separated from the anvil 84 by the attachment layer 206.


Further to the above, the first boundary 208c is interior to the inner row of the pockets 96, and the second boundary 210c is interior to the inner row of the pockets 98. The first section 206a of the attachment layer 206 is positioned against a portion of the outer surface 88 extending between the elongate slot 86 and the inner row of the pockets 96. In addition, the external portion 208a is directly positioned against the pockets 96 of the outer surface 88. Likewise, the second section 206b of the attachment layer 206 is positioned against a portion of the outer surface 92 extending between the elongate slot 86 and the inner row of the pockets 98. In addition, the external portion 210a is directly positioned against the pockets 98 of the outer surface 92. In certain instances, the boundaries 208c and 210c can be further spaced apart laterally to allow the attachment layer 206 to further encompass one or more of the rows of the pockets 96 and/or one or more of the rows of the pockets 98.


The attachment layer 206 comprises a height that is smaller than the height of the first compressible adjunct 208 and/or the height of the second compressible adjunct 210. Alternatively, the attachment layer 206 may comprise a height that is greater than or equal to the height of the first compressible adjunct 208 and/or the height of the second compressible adjunct 210. In at least one instance, the attachment layer 206 is comprised of a film, which can be attached to the internal stepped portion 208b of the first compressible adjunct 208 and/or to the internal stepped portion 210b of the second compressible adjunct 108.


Referring to FIGS. 11-15, a compressible adjunct assembly 304 includes an attachment layer 306 that includes a raised, elevated, or stepped up intermediary section 306c. The compressible adjunct assembly 304 is similar in many respects to the compressible adjunct assembly 104. For example, the compressible adjunct assembly 304 can be assembled with the anvil 84, as illustrated in FIG. 11. Also, the first compressible adjunct 108 of the compressible adjunct assembly 304 can be attached to a first section 306a of the attachment layer 306, and the second compressible adjunct 110 of the compressible adjunct assembly 304 can be attached to a second section 306b of the attachment layer 306, for example.


The intermediary section 306c is configured to protrude into a gap defined between the first compressible adjunct 108 and the second compressible adjunct 110. Alternatively, the intermediary section 306c can be configured to protrude into the elongate slot 86 when the compressible adjunct assembly 304 is assembled with the anvil 84, as illustrated in FIG. 12. In certain instances, the intermediary section 306c may include a first portion configured to protrude into the elongate slot 86 and a second portion configured to protrude into the gap defined between the first compressible adjunct 108 and the second compressible adjunct 110.


In certain instances, the intermediary section 306c serves as an alignment feature for aligning the first compressible adjunct 108 against the first section 306a of the attachment layer 306 and/or aligning the second compressible adjunct 110 against the second section 306b of the attachment layer 306. As illustrated in FIG. 11, the intermediary section 306c includes side walls 320 and 322. The first compressible adjunct 108 is configured to abut against the side wall 320, and the second compressible adjunct 108 is configured to abut against the side wall 322.


In certain instances, the intermediary section 306c serves as an alignment feature for aligning the attachment layer 306 in position against the anvil 84. As illustrated in FIGS. 12 and 13, the intermediary section 306c includes include a plurality of projections 307 that are insertable into the elongate slot 86. The projections 307 are spaced apart from one another and arranged longitudinally in a row along a length of the intermediary section 306c. In at least one instance, the projections 307 can be equidistant from one another. Alternatively, the projections 307 can be arranged closer to each other in a first portion of the intermediary section 306c than a second portion of the intermediary section 306c. In at least one instance, one or more of the projections 307 comprises a top surface with a rectangular, or at least substantially rectangular, shape. Other shapes are contemplated by the present disclosure such as, for example, a circular shape or a dome shape.


Further to the above, the projections 307 are arranged longitudinally in a row along a length of the elongate slot 86, and are dimensioned to fit into the elongate slot 86. The projections 307 serve as alignment features for aligning the attachment layer 306 in position against the anvil 84. In certain instances, the projections 307 can be dimensioned to fit into the gap defined between the first compressible adjunct 108 and the second compressible adjunct 110. The projections 307 can serve as alignment features for aligning the first compressible adjunct 108 against the first section 306a of the attachment layer 306 and/or aligning the second compressible adjunct 110 against the second section 306b of the attachment layer 306.


In at least one instance, the opening of the elongate slot 86 is slightly greater than the widths the projections 307. Alternatively, the opening of the elongate slot 86 can be slightly smaller than the widths the projections 307, which may cause the projections 307 to be slightly deformed as they are pressed into the elongate slot 86. The deformed projections 307 may serve as anchoring features for securing the compressible adjunct assembly 304 to the anvil 84.


Referring to FIGS. 14 and 15, tissue is sandwiched between the compressible adjunct assembly 304 and a compressible adjunct assembly 311. The tissue is stapled and cut using a surgical stapling and severing instrument such as, for example, the surgical stapling and severing instrument 8010. A plurality of staples 305 are deployed from a staple cartridge such as, for example, the staple cartridge 1000 (FIG. 17) to capture the tissue between the compressible adjunct assembly 304 and the compressible adjunct assembly 311. The captured tissue is severed along with the projections 307 of the attachment layer 306 as the cutting edge 9116 (FIG. 3) is advanced through the longitudinal slot 86. The compressible adjunct assembly 304, originally attached to the anvil 84, is now released from the anvil 84 and remains with the stapled tissue in the patient's body. Likewise, compressible adjunct assembly 311, originally attached to the staple cartridge 10000, is now released from the staple cartridge 10000 and remains with the stapled tissue in the patient's body.


In the embodiment illustrated in FIG. 16, the intermediary section 306c includes a bar 309 extending longitudinally along a length of the intermediary section 306c. The bar 309 comprises a top surface with a rectangular, or at least substantially rectangular, shape. Other shapes are contemplated by the present disclosure such as, for example, a dome shape or a curved shape. The bar 309 extends longitudinally along a length of the elongate slot 86, and is dimensioned to fit into the elongate slot 86. In at least one instance, the bar 309 is dimensioned to snuggly or tightly fit into the elongate slot 86. In at least one instance, the opening of the elongate slot 86 is slightly greater than the width of the bar 309. Alternatively, the opening of the elongate slot 86 can be slightly smaller than the width of the bar 309, which may cause of the bar 309 to be slightly deformed as it is pressed into the elongate slot 86. The deformed bar 309 may serve as an anchoring feature for securing the compressible adjunct assembly 304 to the anvil 84. In addition, the bar 309 can serve as an alignment feature for aligning the attachment layer 306 in position against the anvil 84.


Like the projections 307, the bar 309 can be dimensioned to fit into the gap defined between the first compressible adjunct 108 and the second compressible adjunct 110. The bar 309 can serve as an alignment feature for aligning the first compressible adjunct 108 against the first section 306a of the attachment layer 306 and/or aligning the second compressible adjunct 110 against the second section 306b of the attachment layer 306.


Referring to FIG. 17, a compressible adjunct assembly 404 is assembled with the anvil 84. The compressible adjunct assembly 404 is similar in many respects to the compressible adjunct assembly 104. For example, the compressible adjunct assembly 404 includes the attachment layer 106. As described above in greater detail, the attachment layer 106 includes the bridging portions 107 that extend between the first section 106a and the second section 106b.


As illustrated in FIG. 17, the compressible adjunct assembly 404 also includes a compressible layer or adjunct 408, which is similar in many respects to the compressible adjuncts 108 and 110. In addition, the compressible adjunct 408 includes a first compressible portion 408a positionable on the first side 90 of the elongate slot 86, and a second compressible portion 408b positionable on the second side 94 of the elongate slot 86. In other words, the elongate slot 86 separates the first compressible portion 408a from the second compressible portion 408b when the compressible adjunct assembly 404 is assembled with the anvil 84. An intermediary compressible portion 408c of the compressible adjunct 408 extends between the first compressible portion 408a and the second compressible portion 408b. The intermediary compressible portion 408c bridges the elongate slot 86, as illustrated in FIG. 17. In certain instances, the intermediary compressible portion 408c only partially bridges the elongate slot 86. In certain instances, the intermediary compressible portion 408c completely covers the elongate slot 86.


Referring to FIG. 17, the intermediary compressible portion 408c includes of a plurality of bridging portions 407 extending between the first compressible portion 408a and the second compressible portion 408b. The bridging portions 407 are spaced apart from one another in the same, or at least substantially the same, manner the bridging portions 107 of the attachment layer 106 are spaced from one another. The gaps 109 defined between the bridging portions 107 also extend between corresponding bridging portions 407 which are aligned with the bridging portions 107 such that the elongate slot 86 is exposed through the Gaps 109. In certain instances, however, the bridging portions 107 and the bridging portions 407 can be out of alignment preventing or reducing thorough gaps.


The attachment layer 106 comprises a height that is smaller than the height of the compressible adjunct 408. Said another way, the attachment layer 106 can be thinner than the compressible adjunct 408. Alternatively, in certain instances, the attachment layer 106 may comprise a height that is greater than or equal to the height of the compressible adjunct 408. In at least one instance, the attachment layer 106 is comprised of a film, which can be attached to the compressible adjunct 408 such that the bridging portions 407 are aligned with the bridging portions 107, as illustrated in FIG. 17.


Referring to FIGS. 18 and 16, a compressible adjunct assembly 504 includes a compressible layer 506, a first attachment member 508, and a second attachment member 510. It is envisioned that the compressible adjunct assembly 504 includes only one attachment member. Alternatively, the compressible adjunct assembly 504 may include three or more attachment members. As illustrated in FIG. 19, the compressible adjunct assembly 504 can be assembled with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 84 of the surgical stapling and severing instrument 8010. The attachment members 508 and 510 are configured to releasably attach the compressible layer 506 to the anvil 84.


Referring again to FIG. 19, the cutting edge 9116 has severed the compressible layer 506 of the compressible adjunct assembly 504 into a first compressible portion 506a on the first side 90 of the anvil 84 and a second compressible portion 506b on the second side 92 of the anvil 84. Tissue Captured by the surgical stapling and severing instrument 8010 can also be severed along with the compressible layer 506 by the cutting edge 9116 as the cutting edge 9116 is advanced through the elongate slot 86. A first portion of the severed tissue may be stapled was the first compressible portion 506a, and a second portion of the severed tissue may be stapled with the second compressible portion 506b.


In certain instances, the first compressible portion 506a and the second compressible portion 506b can be independent members that are separately attached to the anvil 84. In such instances, the cutting edge 9116 may not sever the compressible layer 506 while severing the captured tissue, as described above. Instead, the cutting edge 9116 may pass between the first compressible portion 506a and the second compressible portion 506b.


Referring again to FIGS. 18 and 16, the attachment members 508 and 510 are spaced apart from each other. A passage 512 extends between the attachment members 508 and 510 for accommodating the cutting edge 9116 as the cutting edge 9116 is advanced through the elongate slot 86. When the compressible adjunct assembly 504 is assembled with the anvil 84, the first attachment member 508 is matingly engaged with a first ledge 91 of the first side 90 of the anvil 84 and the second attachment member 510 is matingly engaged with a second ledge 93 of the second side 92 of the anvil 84. The attachment members 508 and 510 comprise “C” shaped profiles that are dimensioned and/or sufficiently resilient to snap fit around the ledges 93 and 95, respectively, to secure the compressible adjunct assembly to the anvil 84. Matting recesses 514 and 516 of the attachment members 508 and 510, respectively, are configured to receive the ledges 91 and 93, respectively.


Further to the above, the first attachment member 508 includes a first attachment portion 508a positionable against an internal portion 100′ of the internal surface 100. The internal portion 100′ may form a top surface of the first ledge 91. A second attachment portion 508b of the attachment member 508 is attached to an intermediate compressible portion 506c of the compressible layer 506. A coupling portion 508c interconnects the first attachment portion 508a and the second attachment portion 508b. The coupling portion 508c extends into the elongate slot 86, and is positioned against a side wall 95 of the ledge 91.


Like the first attachment member 508, the second attachment member 510 includes a first attachment portion 510a positionable against an internal portion 100″ of the internal surface 100. The internal portion 100″ may form a top surface of the second ledge 93. A second attachment portion 510b of the attachment member 510 is attached to the intermediate compressible portion 506c of the compressible layer 506. Like the coupling portion 508c, a coupling portion 510c interconnects the first attachment portion 510a and the second attachment portion 510b. The coupling portion 510c extends into the elongate slot 86, and is positioned against a side wall 97 of the ledge 97.


As illustrated in FIG. 18, the attachment members 508 and 510, when assembled with the compressible layer 506, are oriented such that second attachment member 510 is a mirror-image of the first attachment member 508. The attachment members 508 and 510 extend along the compressible layer 506 in parallel, or at least substantially in parallel, with each other. The space between the coupling portion 508c and the coupling portion 510c defines the passage 512 which is configured to accommodate the advancement of the cutting edge 9116, as described above. Furthermore, the pins 9110 (FIG. 3) of the firing assembly 9090 ride against the first attachment portions 508a and 510a as the firing assembly 9090 is advanced to deploy the staples into the tissue captured by the surgical stapling and severing instrument 8010.


Referring again to FIG. 18, the attachment members 508 and 510 extend along the entire length of the compressible layer 506. Alternatively, the attachment members 508 and 510 may extend along a portion of the length of the compressible layer 506. In at least one instance, the attachment members 508 and 510 may extend along a middle portion of the length of the compressible layer 506. In at least one instance, the first attachment member 508 extends along a first portion of the length of the compressible layer 506, while the second attachment member 510 extends along a second portion of the length of the compressible layer 506 that is different from the first portion.


In certain instances, one or both of the second attachment portions 508b and 510b can be embedded in the intermediate compressible portion 506c. In at least one instance, one or both of the second attachment portions 508b and 510b can be inserted, or partially inserted, into a solution that is lyophilized to produce the compressible layer 506. Alternatively, one or both of the second attachment portions 508b and 510b can be attached to the compressible layer 506 after fabrication of the compressible layer 506. Any suitable attachment technique can be employed in attaching the second attachment portions 508b and 510b to the compressible layer 506 such as, for example, a biocompatible adhesive.


Referring to FIG. 20, a compressible adjunct assembly 604 is depicted. The compressible adjunct assembly 604 is similar in many respects to the compressible adjunct assembly 504. For example, the compressible adjunct assembly 604 can be assembled with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 84 of the surgical stapling and severing instrument 8010. However, the compressible adjunct assembly 604 does not include spaced apart attachment members. Instead, the attachment members are united in the form of a single attachment layer 607 that is shaped to form the attachment portions 508a and 510a. The attachment layer 607 is configured to releasably attach the compressible adjunct assembly 604 to the anvil 84.


In at least one instance, the attachment layer 607 is formed as a flat, or at least substantially flat, layer or film which is modified to a desired shape that comprises the attachment portions 508a and 510a. Alternatively, the attachment layer 607 can take its desired shape during formation. For example, a mold comprising the desired shape can receive a melted biocompatible material, which is solidified inside the mold forming the desired shape of the attachment layer 607. Other techniques for manufacturing the attachment layer 607 are contemplated by the present disclosure.


Referring again to FIG. 20, the attachment layer 607 includes the second an intermediate attachment portion 609 which replaces the attachment portions 508b and 510b. The intermediate attachment portion 609 is attached to the intermediate compressible portion 506c. In at least one instance, the intermediate attachment portion 609 is embedded, or at least partially embedded, in the intermediate compressible portion 506c. Furthermore, coupling portions 508c and 510c protrude from opposite ends of the intermediate attachment portion 609, in a direction away from the intermediate compressible portion 506c of the compressible layer 506, to define the passage 512. The cutting edge 9116 is advanced through the passage 512 between the coupling portions 508c and 510c as it cuts through the intermediate attachment portion 609, the intermediate compressible portion 506c, and the captured tissue during the firing sequence.


Mating recesses 614 and 616 are defined between the attachment layer 607 and the compressible layer 506 on opposite sides from the passage 512, as illustrated in FIG. 20. The mating recesses 614 and 616 are configured to receive the ledges 91 and 93, respectively. When the compressible adjunct assembly 604 is assembled with the anvil 84, the ledge 91 is positioned between the first attachment portion 508a and the first compressible portion 506a of the compressible layer 506, and the ledge 93 is positioned between the first attachment portion 510a and the second compressible portion 506b of the compressible layer 506.


In certain instances, the attachment layer 607 and/or the compressible layer 506 may comprise variations in thickness and/or edge conditions to reduce the potential for tissue trauma in surrounding tissue and/or to help maintain the integrity of the compressible adjunct assembly 604 during attachment, manipulation, and/or release from the anvil 84. In at least one instance, the attachment layer 607 and/or the compressible layer 506 are reinforced with atraumatic and/or thicker edges.


Referring to FIG. 21, the attachment layer 607′ includes rolled edges 620 and 622, which reduce the potential for tissue trauma in surrounding tissue. In addition, the attachment layer 607′ is reinforced with relatively thicker regions 624 and 626 at the intermediate attachment portion 609 to improve the robustness of the compressible adjunct assembly 604 during attachment, manipulation, and/or release from the anvil 84. Other high stress areas in the compressible adjunct assembly 604 can also be reinforced in the same, or a similar, manner.


Referring now to FIGS. 22-24, a compressible adjunct assembly 704 includes the compressible layer 506 and a plurality of attachment members 708 that are spaced apart from one another and arranged longitudinally in a row along a length of the compressible layer 506. In certain instances, the attachment members 708 are arranged along a central portion of the compressible layer 506. In certain instances, the attachment members 708 are arranged along a distal portion and/or a proximal portion of the compressible layer 506. Like the attachment members 508 and 510, the attachment members 708 are configured to releasably attach the compressible layer 506 to the anvil 84. However, unlike the attachment members 508 and 510, each attachment member 708 is capable of being positioned against the ledges 95 and 97 simultaneously. The attachment members 708 are severed by the cutting edge 9116 as the cutting edge 9116 is advanced through the elongate slot 86 to cut the compressible layer 506 and the captured tissue.


The attachment members 708 each comprise a base 710, a stem 712 extending from the base, and a head or crown 714 extending from the stem 712. When the compressible adjunct assembly 704 is assembled with the anvil 84, the stem 712 is positioned in the elongate slot 86, as illustrated in FIG. 23, and the head 714 resides in the internal space 102 within the anvil 84. The head 714 comprises a transverse cross-sectional area that resembles the shape of a dome which extends laterally beyond the stem 712 to simultaneously engage the internal surfaces 100′ and 100″ of the anvil 84, as illustrated in FIG. 23. Other shapes of the head 714 are contemplated by the present disclosure.


Lateral extensions 716 and 718 of the head 714 comprise flat surfaces 720 and 722, respectively, which rest against the internal surfaces 100′ and 100″, respectively. The surfaces 720 and 722 need not be completely flat. In certain instances, the surfaces 720 and 722 can be roughened to improve traction against the internal surfaces 100′ and 100″. Gripping features may be incorporated into the surfaces 720 and 722. In certain instances, a biocompatible adhesive may be employed to bond the surfaces 720 and 722 to the internal surfaces 100′ and 100″, for example.


Referring again to FIG. 22, the head 714 and/or the stem 712 are configured to bend in the distal direction as the E-beam 9102 is advanced distally against the head 714 during the firing sequence. The proximally projecting top guide 9118 may push against the head 714 causing the head 714 to bend forward and downward to allow room for the passage of the E-beam 9102. The pins 9110 may pass on top of the lateral extensions 716 and 718. As the lateral extensions 716 and 718 flatten against the internal surfaces 100′ and 100″, the head 714 may assist in blocking tissue ahead of the E-beam 9102 from entering the internal space 102 and disrupting the advancement of the pins 9110. This added functionality can improve the performance of the firing assembly 9090 and reduce potential trauma to the treated tissue by preventing the treated tissue from being entrapped within the anvil 84. As illustrated in FIG. 22, the head 714 and the stem 712 comprise a reduced transverse cross-sectional area. In other words the head 714 and the stem 712 are substantially flattened to improve bending and/or facilitate insertion of the head 714 into the internal space 102. Also, in various instances, the head 714 and/or the stem 712 are comprised, or at least partially comprised, of a resilient biocompatible material to improve bending and/or facilitate insertion of the head 714 into the internal space 102.


Referring to FIG. 24, the base 710 is embedded in the compressible layer 506. In certain instances, the base 710 is only partially embedded in the compressible layer 506. In certain instances, the base 710 is not embedded into the compressible layer 506, but instead is attached to an exterior surface thereof. For example, a biocompatible adhesive can be employed to attach the base 710 to the compressible layer 506. As illustrated in FIG. 24, the base 710 defines an axis A-A which intersects an axis B-B defined by the stem 712 at an angle α. The angle α is 90°. In certain instances, the angle α is greater than 90°. In other instances, the angle α is less than 90°.


As illustrated in FIG. 24, the stem 712 protrudes from a proximal end portion of the base 710. Alternatively, the stem 712 may protrude from a distal end portion of the base 710. Alternatively, the stem 712 may protrude from a central portion of the base 710. As illustrated in FIG. 22, the base 712 comprises a rectangular shape. The rectangular-shaped he bases 710 are aligned longitudinally along the longitudinal slot 86 when the compressible adjunct assembly 704 is assembled with the anvil 84. Other shapes, sizes, and arrangements of the bases 712 are contemplated by the present disclosure. In at least one instance, a base 712 may comprise a circular shape and a stem 714 may protrude from the center of the circular base 712.


Referring now to FIGS. 25-28, a compressible adjunct assembly 804 includes a compressible layer 806 that is attached to a plurality of attachment members 808. The compressible adjunct assembly 804 is similar in many respects to the compressible adjunct assemblies 504, 604, and 704. For example, the compressible adjunct assembly 804 can be assembled with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 84 of the surgical stapling and severing instrument 8010. As described in greater detail below, the attachment members 808 releasably attach the compressible layer 806 to the anvil 84.


The compressible layer 806 includes an intermediate compressible portion 806c extending longitudinally between a first compressible portion 806a and a second compressible portion 806b. A plurality of slots 809 are defined in the intermediate compressible portion 806c. The slots 809 are spaced apart from one another and arranged longitudinally in a row along a length of the compressible layer 806. In certain instances, the slots 809 are arranged along a central portion of the intermediate compressible portion 806c of the compressible layer 806. In certain instances, the slots 809 are arranged along a distal portion and/or a proximal portion of the intermediate compressible portion 806c. When the compressible adjunct assembly 804 is assembled with the anvil 84, the slots 809 are aligned with the elongate slot 86 such that the cutting edge 9116 passes through the slots 809 during distal advancement of the cutting edge 9116. This reduces friction against the cutting edge 9116 which prolongs the life of the cutting edge 9116 and/or reduces the force required to advance the firing assembly 9090.


Referring to FIG. 25, the attachment members 808 are spaced apart from one another and arranged longitudinally along a length of the intermediate compressible portion 806c such that the attachment members 808 alternate between two sides 814 and 816 of a plane define by the slots 809. Other positions and arrangements of the attachment members 808 with respect to the compressible layer 806 are contemplated by the present disclosure. Each attachment member 808 is positioned against a slot 809. Alternatively, an attachment member 808 can be positioned between two consecutive slots 809.


The attachment members 808 comprise a generally curved shape which can improve the stiffness of the attachment members 808. Other shapes are contemplated by the present disclosure. As illustrated in FIG. 25, the attachment members 808 comprise a partial cylindrical frame with a concave side 820 facing away from the slots 809 and a convex side 818 facing toward the slots 809. The attachment members 808 further comprise a coupling portion 808c extending between an attachment portion 808a and a base 808b. The attachment portion 808a comprise lateral extensions 810 that are configured to rest against the internal surface 100′ or the internal surface 100″ to secure the compressible adjunct assembly 804 to the anvil 84.


Further to the above, the base 808b includes tabs 824 configured to secure the attachment member 808 to the compressible layer 806. In at least one instance, as illustrated in FIG. 26, a base 808b includes a single tab 824 that is received in a bifurcated portion 826 of the compressible layer 806. In at least one instance, as illustrated in FIG. 27, a base 808b includes two tabs 824 that are configured to receive a portion 828 of the compressible layer 806 therebetween. In at least one instance, as illustrated in FIG. 28, a base 808a includes a tab 824 that comprises a slot 830. The portion 828 of the compressible layer 806 can be twisted and inserted into the slot 830 to secure the attachment member 808 to the compressible layer 806.


Referring now to FIG. 29, a compressible adjunct assembly 904 is assembled with an anvil 984. The anvil 984 is similar in many respects to the anvil 84 (FIG. 9) and the anvil 8014 (FIG. 1). For example, the anvil 984 includes the elongate slot 86 which defines a first outer surface 988 extending on the first side 90 of the elongate slot 86, and a second outer surface 992 extending on the second side 94 of the elongate slot 86. Also, the anvil 984 is movable relative to a staple cartridge such as, for example, the staple cartridge 10000 to capture tissue therebetween. The outer surfaces 988 and 992 of the anvil 984 are stepped, as illustrated in FIG. 29. In other embodiments, however, an anvil can include planar outer surfaces that are not stepped. In at least one instance, an anvil may include a central surface that is offset from two lateral surfaces. Other anvils with various shapes and surfaces are contemplated by the present disclosure.


In any event, the compressible adjunct assembly 904 includes a first attachment layer 908 positionable against the first outer surface 988 and a second attachment layer 910 positionable against the second outer surface 992. As illustrated in FIG. 29, the first attachment layer 908 is releasably attached to the second attachment layer 910. Attachment members 916 and 918 extend laterally from the attachment layers 908 and 916, respectively. The attachment members 916 and 918 include interlocking portions 912 and 920, respectively, and distal end portions 914 and 922, respectively. The distal end portions 914 and 922 are tucked under the ledges 91 and 93, respectively, to secure the compressible adjunct assembly 904 to the anvil 984, as illustrated in FIG. 29. Although one pair of the attachment members 916 and 918 is shown, it is understood that the first layer 908 may include a plurality of the attachment members 916 which can be interlocked with a plurality of the attachment members 918 extending from the second layer 910.


Referring to FIG. 30, the interlocking portions 912 and 920 may include interlocking slots 913 and 921, respectively, which can be configured for mating engagement with one another. In at least one instance, a biocompatible adhesive can be employed to reinforce the engagement between the slot 913 and 921.


Referring to FIGS. 31-34, the attachment layers 908 and 910 are further joined by a distal end portion 930 that includes a bent or rolled tab 932 which is tucked or inserted into a distal end of the anvil 984 to secure the compressible adjunct assembly 904 to the anvil 984. As illustrated in FIG. 32, the distal end portion 930 can be comprised of two separated end portions 934 and 936 extending from the layers 908 and 910, respectively. The end portions 934 and 936 are joined together to form the distal end portion 930. As illustrated in FIG. 33, the end portions 934 and 936 may comprise dovetail-shaped transverse joints 938 and corresponding dovetail-shaped transverse slots 940 for mating engagement with the dovetail-shaped transverse joints 938. Other coupling features for attaching the end portions 934 and 936 to form the distal end portion 930 are contemplated by the present disclosure.


A staple cartridge assembly 1000 comprising a cartridge body 1010 and an implantable adjunct 1030 is depicted in FIGS. 35 and 36. The cartridge body 1010 comprises a cartridge deck, or adjunct facing surface, 1013 and a plurality of staple cavities 1015 defined in the deck 1013. The staple cartridge assembly 1000 further comprises a plurality of staples 1020 positioned in the staple cavities 1015 and a plurality of staple drivers 1011 configured to drive the staples 1020 out of the staple cavities 1015. Each staple 1020 comprises staple legs 1021 and a staple base 1023 from which the staple legs 1021 extend. In an unfired state, the staples 1020 are stored within the cartridge body 1010 such that the staple legs 1021 partially extend out of the staple cavity 1015 beyond, or above, the cartridge deck 1013. The staple legs 1021 can at least partially extend into the implantable adjunct 1030 when the staples 1020 are in their unfired state. Embodiments are envisioned in which the staple legs do not extend above the cartridge deck 1013 when the staples are in their unfired state.


The implantable adjunct 1030 comprises at least one attachment feature 1031 comprising deck-attachment portions 1033. Each attachment feature 1031 comprises a unitary structure, for example, and is configured to releasably hold, or attach, the implantable adjunct 1030 to the cartridge deck 1013. Each attachment feature 1031 traverses a staple cavity 1015 such that, when the staple 1020 in the staple cavity 1015 is deployed from the staple cavity 1015, the attachment feature 1031 is engaged, broken, and/or torn, by the staple base 1023 of the staple 1020 to release a portion of the implantable adjunct 1030 from the cartridge deck 1013. The attachment feature 1031 may traverse the cavity 1015 in a direction which is perpendicular to, or at an angle with respect to, the staple cavity 1015. As illustrated in FIGS. 35 and 36, the attachment features 1031 extend laterally across the staple cavities 1015. Various alternative embodiments are envisioned where multiple attachment features traverse each staple cavity 1015 such that the staple bases 1023 of the staples 1020 must engage and overcome multiple attachment features to release the adjunct 1030 from the cartridge deck 1013. Other embodiments are envisioned where one attachment portion spans multiple staple cavities requiring more than one staple to contact and dislodge the attachment portion.


The attachments features 1031 are attached to the adjunct 1030 in any suitable manner. In at least one instance, the attachments features 1031 comprise fibers which are woven into the adjunct 1030, for example. In at least one such instance, the adjunct 1030 is comprised of interwoven fibers and the attachment features 1031 are interwoven into the adjunct 1030. In certain instances, the attachment features 1031 are adhered to the adjunct 1030 utilizing at least one adhesive. In at least one such instance, the adjunct 1030 comprises a film and the attachment features 1031 are bonded to the film. In any event, the deck-attachment portions 1033 of the attachment features 1031 can be attached to the deck 1013 in any suitable manner. In at least one instance, the attachment portions 1033 can be adhered to the deck 1013 utilizing at least one adhesive. In certain instances, the attachment features 1031 of the adjunct 1030 can be heated and then pressed against the deck 1013 in order to attach the deck-attachment portions 1033 to the deck 1013.


Attaching the adjunct to the cartridge in the above-described manner permits segments of the adjunct to stay attached to the cartridge deck until the staples which capture such segments of the adjunct are deployed. Attaching the adjunct to the cartridge in this manner also provides multiple, distinct attachment locations which are progressively released as the firing assembly incises and staples tissue. For example, as the firing assembly travels from a proximal end of the staple cartridge assembly to a distal end of the staple cartridge assembly, the proximal-most staples are deployed from the staple cartridge before the distal-most staples are deployed which, as a result, releases the proximal end of the adjunct before the distal end of the adjunct. Stated another way, the attachment features that have not yet been engaged by their respective staples remain attached to the cartridge deck during the firing progression until the firing assembly reaches those staples.


Further to the above, FIG. 36 depicts a staple base 1023 of a staple 1020 after it has engaged and released an attachment feature 1031 of the adjunct 1030 from the cartridge deck 1013. The attachment feature 1031 comprises break-away portions which are configured to fail once a force is applied to the attachment feature 1031 by the staple base 1023 that exceeds a threshold force. Upon reaching the threshold force, the attachment feature 1031 is configured to break, rip, and/or tear in order to release the adjunct 1030 from the cartridge deck 1013. The deck-attachment portions 1033 are configured to remain attached to the cartridge deck 1013 when the attachment feature 1031 breaks. Other embodiments are envisioned where the detachment of the attachment portions 1033 from the cartridge deck 1013 are responsible for the release of the adjunct 1030 from the cartridge deck 1013. In such embodiments, the attachment feature 1031 disengages from the cartridge deck 1013 entirely.


In addition to or in lieu of the above, the deck 1013 can be treated and/or cleaned before the adjunct 1030 is attached to the deck 1013. Such treatment and/or cleaning can improve the bond between the adjunct 1030 and the deck 1013. In at least one instance, surfactants, soaps, and/or lubricants are used to facilitate the loading, or insertion, of the staples into the staple cavities and, in such instances, the deck 1013, or at least portions of the deck 1013, can be screened to prevent or inhibit surfactants, soaps, and/or lubricants from flowing onto the deck 1013. One such soap comprises sodium stearate, for example. In certain instances, lasers, plasma and/or IR heating can be utilized to clean the deck 1013, or at least portions of the deck 1013, in order to improve the adhesion between the attachment features 1031 and the deck 1013.


A surgical stapling assembly 1100 is depicted in FIG. 37 and FIG. 38. The surgical stapling assembly 1100 comprises an anvil 1160, a staple cartridge assembly 1110, and an implantable adjunct 1130. The staple cartridge assembly 1110 comprises a cartridge body comprising a plurality of staple cavities 1111 and a deck surface 1113, a plurality of staples 1120 removably stored within the staple cavities 1111, and a plurality of staple drivers 1140 configured to drive the staples 1120 out of the staple cavities 1111 toward the anvil 1160 of the surgical stapling assembly 1100. The staple cartridge assembly 1110 also comprises a sled 1150 configured to convert the linear motion of a firing assembly into vertical motion of the staple drivers 1140 to drive the staples 1120 out of the staple cavities 1111. The sled 1150 comprises an initial contact ramp 1151, an intermediate contact surface 1153, and a final contact ramp 1155 all configured to contact the staple drivers 1140 as the firing assembly drives the sled 1150 from a proximal end of the cartridge assembly 1110 to a distal end of the cartridge assembly 1110.


Each staple driver 1140 comprises three or more portions—an initial lift portion 1143 configured to be engaged by the initial contact ramp 1151 of the sled 1150 as the sled 1150 travels distally through the cartridge body—a bottom surface 1145 configured to be engaged by the intermediate contact surface 1153 and the final contact ramp 1155 of the sled 1150—and a top, or staple support, surface 1141. After the initial lift portion 1143 is engaged by the contact ramp 1151 of the sled 1150, the staple drivers 1140 are contacted by the intermediate contact surface 1153 and then the final contact ramp 1155 of the sled 1150. The final contact ramp 1155 of the sled 1150 is configured to drive the staple drivers 1140 such that the top surface 1141 is driven above the cartridge deck surface 1113. Lifting the top surface 1141 of the staple drivers 1140 beyond the cartridge deck 1113 permits the staple drivers 1140 to lift the adjunct 1130 and/or tissue T away from the cartridge deck surface 1113. More specifically, lifting the top surface 1141 of the staple drivers 1140 beyond the cartridge deck 1113 encourages the detachment of attachment portions 1131 of the adjunct 1130 from the cartridge deck 1113.


Further to the above, the attachment portions 1131 are attached to the cartridge deck 1113 intermediate the staple cavities 1111 defined in the deck 1113. During the longitudinal progression of the firing assembly, the adjunct 1130 is disengaged from the cartridge body at the attachment portions 1131. The attachment portions 1131 are configured to progressively release corresponding portions of the adjunct 1130 from the cartridge body one attachment portion 1131 at a time. More specifically, as a driver 1140 is lifted above the cartridge deck 1113 through a staple cavity opening, as discussed above, the attachment portions 1131 adjacent the staple cavity opening are released thereby releasing a corresponding portion of the adjunct 1130 from the cartridge deck 1113 while the attachment portions 1131 positioned distal to the detached attachment portions 1131 retain the adjunct 1130 against the cartridge deck 1113 until the subsequent drivers 1140 are lifted above the cartridge deck 1113.


In many instances, all of the staples stored in a staple cartridge are deployed from the staple cartridge. In such instances, the adjunct 1130 is entirely released from the deck 1113 by the staples during the firing process. In other instances, however, a surgeon may elect to not fire all of the staples from the staple cartridge. In such instances, the remaining adjunct that has not been stapled to the tissue remains attached to the cartridge deck 1113. The portion of the adjunct that has not been stapled to the tissue can be easily torn, or separated, from the portion of the adjunct that has been stapled to the tissue. The portion of the adjunct that has not been stapled to the tissue remains attached to the cartridge to limit, or eliminate, the amount of unstapled adjunct left in the patient. In various instances, the adjunct 1130 tears proximal of the last driver lifted above the cartridge deck 1113. In various other instances, the adjunct 1130 tears distal of the last driver lifted above the cartridge 1113.


Further to the above, the attachment portions 1131 can be created utilizing any suitable method. In at least one instance, a laser melting process can be utilized to create the attachment portions 1131. In certain instances, a heat staking process can be utilized to create the attachment portions 1131. In at least one instance, portions of a woven fiber adjunct can be pre-processed with discrete laser melting such that the fibers become sticky in the attachment portions 1131. Regardless of the manner used to create the attachment portions 1131, the adjunct 1130 can be held tightly over the staple cavities such that sufficient tension, shear, and/or pealing forces are applied to the attachment portions 1131 to detach the adjunct 1130 from the deck 1113.


A surgical stapling assembly 1200 is depicted in FIGS. 39 and 40. The surgical stapling assembly 1200 comprises an anvil 1260, a staple cartridge assembly 1210, and an implantable adjunct 1230. The staple cartridge assembly 1210 comprises a cartridge body comprising a plurality of staple cavities 1211 and a deck surface 1213, a plurality of staples 1220 removably stored within the staple cavities 1211, and a plurality of staple drivers 1240 configured to drive the staples 1220 out of the staple cavities 1211 and toward the anvil 1260 of the surgical stapling assembly 1200. The staple cartridge assembly 1210 also comprises a sled 1250 configured to convert the linear motion of the firing assembly into vertical motion of the staple drivers 1240 to drive the staples 1220 out of the staple cavities 1211. The sled 1250 comprises an initial contact ramp 1251 and a final contact ramp 1253 configured to contact the staple drivers 1240 as the firing assembly drives the sled 1250 from a proximal end of the cartridge assembly 1210 to a distal end of the cartridge assembly 1210.


The staple drivers 1240 comprise, one, initial lift portions 1243 configured to be engaged by the initial contact ramp 1251 of the sled 1250 as the sled 1250 travels distally through the cartridge body to initiate lifting of the drivers 1243, two, bottom surfaces 1245 configured to be engaged by the final contact ramp 1253 of the sled 1250 and, three, a top, or staple support, surface 1241. The legs of the staples 1220 are biased against the sidewalls of the staple cavities 1211 to hold the staples 1220 in the staple cavities 1211. The legs of the staples 1220 comprise staple tips 1221 having a barbed configuration configured to releasably retain, or hold, the adjunct 1230 to the cartridge body. As a result, the adjunct 1230 is held to the cartridge deck 1213 by the staple tips 1221 of a staple 1220 until the staple 1220 is driven out of the staple cavity 1211. As the staple 1220 is driven out of the staple cavity 1211, and owing to the interaction between the barbs, the adjunct 1230 is able to travel with the staple 1220 as the staple tips 1221 are moved toward the anvil 1260. The barbed configuration of the staple tips 1221 permit a progressive release of the adjunct 1230 from the cartridge deck 1213.


The staple tips 1221 are configured to progressively release the adjunct 1230 from the cartridge deck 1213 in a manner similar to those discussed above. As a proximal staple 1220 is ejected from the cartridge body, a distal staple 1220 retains the adjunct 1230 against the cartridge deck 1213. In the event that a clinician decides to remove the surgical stapling instrument from the stapling site after only partially firing the staple cartridge, the remaining adjunct that has not been stapled to the tissue remains attached to the cartridge deck 1213. The portion of the adjunct that has not been stapled to the tissue can be torn, or separated, from the portion of the adjunct that has been stapled to the tissue. The portion of the adjunct that has not been stapled to the tissue remains attached to the cartridge to limit, or eliminate, the amount of unstapled adjunct left in the patient. In various instances, the adjunct 1230 can comprise perforations, or discontinuities, for example, configured to permit tearing of the adjunct 1230 without difficulty. The perforations can be positioned between each staple cavity 1211, for example.


Further to the above, a staple leg of a staple 1220, for example, can have a first set of barbs configured to engage the adjunct 1230 when the staple 1220 is in its unfired position. As the staple 1220 is being fired, the first set of barbs can exit the adjunct 1230. As the first set of barbs exit the adjunct 1230, a second set of barbs can enter into the adjunct 1230. The second set of barbs can be engaged with the adjunct 1230 when the staple 1220 is in its fired position. In at least one instance, the first set of barbs can comprise two barbs while the second set of barbs can comprise two barbs, for example. Regardless of the number of barbs that are used, the first set of barbs can be positioned above the deck 1213 of the cartridge body when the staples 1220 are in their unfired position while the second set of barbs can be positioned below the top surface of the deck 1213 when the staples 1220 are in their unfired position.


As illustrated in FIG. 40, the barbs extend laterally outwardly; however, the barbs can extend in any suitable direction, such as laterally inwardly, for example. In addition to or in lieu of the above, a staple leg can comprise tip portions which extend inwardly to grip an adjunct.


A staple cartridge assembly 1300 is depicted in FIG. 41. The staple cartridge assembly 1300, configured for use with a surgical stapling instrument, comprises an implantable adjunct, or material, 1310 and a staple cartridge body 1301. The staple cartridge comprises a plurality of deck features such as staple cavities 1303 configured to removably store a plurality of staples therein and, in addition, a slot 1305 configured to receive a firing assembly therethrough. The implantable adjunct 1310 is attached, secured, and/or affixed to the cartridge body 1301 by thermoforming. For example, the cartridge body 1301 is heated to a specific temperature and then the implantable adjunct 1310 is pressed onto, into, and/or against the cartridge body 1301. Upon engagement with the cartridge body 1301, the implantable adjunct 1310 forms, or molds, into the deck features of the cartridge body 1301 providing attachment features 1311 configured to permit the progressive release of the adjunct 1310 from the cartridge body 1301. Similarly, a portion 1315 of the adjunct 1310 can conform to the configuration of the slot 1305. The portion 1315 can extend along the entirety of the slot 1305 or a portion of the slot 1305. In at least one instance, the portion 1315 is only positioned at the proximal end of the slot 1305, for example. One advantage of the staple cartridge assembly 1300 may include having an implantable adjunct with a more complex shape which custom fits with a corresponding staple cartridge while sustaining a simpler manufacturing process, for example.


In at least one embodiment, further to the above, the staples can be loaded into the cartridge body 1301 to form a sub-assembly which is then heated to a temperature above, at, or close to the glass transition temperature of the material, or materials, comprising the adjunct 1310. In at least one instance, the sub-assembly is heated to about 105 degrees Celsius, for example. The adjunct 1310 is then placed over the cartridge body 1301. At this point, the adjunct 1310 is unheated, or at room temperature; however, it is contemplated that the adjunct 1310 could be pre-heated. The adjunct 1310 is then pushed downwardly onto the cartridge body 1301 and, as a result, the cartridge body 1301 heats the adjunct 1310 to a temperature which is above, at, or close to the glass transition temperature of the material, or materials, comprising the adjunct 1310. In at least one instance, the adjunct 1310 is a foam comprised of PGA and/or PLA, for example. Owing to the fact that the foam is heated to a temperature above, at, or slightly below the glass transition temperature of the PGA and/or PLA, the foam can take a new permanent shape around the features of the cartridge body 1301 and/or the staples positioned therein. For instance, the cartridge body 1301 can include projections extending from the deck and, when the adjunct 1310 is pushed onto the heated deck projections, the adjunct 1310 can be permanently deformed around the deck projections. In such instances, the adjunct 1310 tightly grips the deck projections until the adjunct 1310 is pushed off of the projections by the staples. Similarly, the adjunct 1310 can permanently deform around and tightly grip the heated staple legs. In at least one instance, the diameter of the newly-formed holes can be about 10% smaller than the diameter of the staple legs, for example. In any event, the pressure applied to the adjunct 1310 can be removed at any suitable time. In at least one instance, the pressure is applied to the adjunct 1310 until the temperature of the cartridge body 1301, the staples, and the adjunct 1310 is well below, or at least below, the glass transition temperature of the materials comprising the adjunct 1310. Alternatively, the pressure can be removed when the temperature of the staple cartridge assembly 1300 is at or above the glass transition temperature of the materials comprising the adjunct 1310.



FIGS. 42-44 depict yet another surgical stapling assembly 1400. The surgical stapling assembly 1400 comprises an anvil 1460, a staple cartridge assembly 1410, and an implantable adjunct 1430. The staple cartridge assembly 1410 comprises a cartridge body comprising a plurality of staple cavities 1411, a deck surface 1413, and a slot 1415. The staple cartridge assembly 1410 further comprises a plurality of staples 1420 removably stored within the staple cavities 1411, and a plurality of staple drivers 1440 configured to drive the staples 1420 out of the staple cavities 1411 toward the anvil 1460 of the surgical stapling assembly 1400. The staple cartridge assembly 1410 also comprises a sled 1450 configured to convert the linear motion of a firing assembly into vertical motion of the staple drivers 1440 to drive the staples 1420 out of the staple cavities 1411. The sled 1450 comprises driver ramps 1451 configured to contact and drive the staple drivers 1440 toward the anvil 1460 and, in addition, a release portion 1453 configured to detach the adjunct 1430 from the deck 1413.


The release portion 1453 comprises lateral flanges which extend over a portion of the deck surface 1413. More specifically, the lateral flanges extend over the deck surface 1413 between the slot 1415 and the inner rows of staple cavities 1411. The adjunct 1430 comprises attachment portions 1431 configured to releasably hold the adjunct 1430 to the cartridge deck 1413 until the release portion 1453 of the sled 1450 engages the attachment portions 1431. As the firing assembly progresses through the staple cartridge assembly 1410, the release portion 1453 can act as a plow, for example, configured to plow, cut, incise, and/or slice the attachment portions 1431 as the release portion 1453 engages the attachment portions 1431. The attachment portions 1431 are engaged progressively as the firing assembly traverses the cartridge body from its proximal end toward its distal end.


Turning now to FIG. 45, a staple cartridge assembly 1500 is depicted. The staple cartridge assembly 1500 comprises a cartridge body 1510 comprising a cartridge deck 1513, attachment features 1515, deck features 1517, and a slot 1519. The staple cartridge assembly 1500 further comprises a plurality of staples 1520 and an implantable adjunct 1530 releasably held to the cartridge deck 1513 by the attachment features 1515. The deck features 1517 guide the staples 1520 as the staples 1520 are ejected from the staple cartridge 1510. The deck features 1517 also limit movement of the adjunct 1530 during clamping and/or cutting of the tissue captured by the surgical instrument employing the staple cartridge assembly 1500.


The attachment features 1515 comprise barbs, for example. Each barb 1515 comprises a sharp tip configured to puncture the adjunct 1530 and a retention shoulder configured to inhibit the barb 1515 from backing out of the adjunct 1530. The barbs 1515 can extend from the deck 1513 at any suitable location. For instance, the barbs 1515 can be arranged in longitudinal rows on opposite sides of the cartridge body 1510. In such instances, the adjunct 1530 can be held between the longitudinal rows of barbs 1515. The adjunct 1530 can be held taut, tensioned, or stretched between the rows of barbs 1515 which can facilitate the transection of the adjunct 1530 by a cutting member of a firing assembly passing through the longitudinal slot 1519. As the cutting member transects the adjunct 1530, the tension within the adjunct 1530 is released. Moreover, the transected portions of the adjunct 1530 may move, or migrate, laterally outwardly away from the longitudinal slot 1519 in response to the release of the tension within the adjunct 1530. Such movement of the transected adjunct portions may cause the transected adjunct portions to at least partially detach from the barbs 1515. In at least one instance, the retention shoulders of the barbs 1515 face laterally outwardly such that the lateral outward movement of the adjunct portions tends to release the adjunct portions from the barbs 1515.


As discussed above, an adjunct can be manufactured and then assembled to a staple cartridge. Turning now to FIGS. 46-48, a staple cartridge assembly 1600 comprises a cartridge body 1610 including staple cavities 1611 and a longitudinal slot 1613 defined therein. The staple cartridge assembly 1600 further comprises an implantable adjunct which is manufactured directly on the cartridge body 1610. As illustrated in FIG. 46, an implantable material 1630 can be dispensed on the deck of the cartridge body 1610. In various instances, the implantable material can comprise melt-blown non-woven material, for example. Such an instance is depicted in FIG. 47, for example. In at least one embodiment, electro-spinning is utilized to melt and blow a polymeric material onto the cartridge body 1610. In at least one such embodiment, the polymeric material is heated to a temperature which exceeds the glass transition temperature of the polymeric material, for example. In certain embodiments, the polymeric material is part of a solution. In either event, the polymeric material is flowable and is accelerated toward the cartridge body 1610. The polymeric material is accelerated by a mechanical spinning member, such as a spinneret, for example, and/or accelerated by applying a voltage differential between the polymeric material and a target. In various instances, the polymeric material is electrically charged. In at least one instance, the polymeric material comprises one or more magnetic materials embedded therein. The target can comprise the cartridge body 1610 and/or a metal plate positioned behind the cartridge body 1610, for example.


In some instances, further to the above, the melt-blown non-woven material extends over the edges of the cartridge body 1610 after it has been dispensed on the cartridge body 1610. Such excess material, referring to FIG. 48, can be trimmed such that the edges of the material 1630 are aligned with, or substantially aligned with, the edges of the cartridge body 1610. Such trimming can occur once the temperature of the melt-blown non-woven material has sufficiently cooled.


Further to the above, melt-blown non-woven material can be used to manufacture an implantable adjunct which is not formed directly on a cartridge body. In at least one such instance, a polymeric material is heated and blown into a cavity, or mold, to form an implantable adjunct. After the polymeric material has sufficiently cooled, the polymeric material can be trimmed to a suitable size. In addition to or in lieu of the above, a melt-blown non-woven material can be applied to a cartridge body to adhere an implantable adjunct to the cartridge body. In such instances, the adjunct can be pressed onto the melt-blown non-woven material while the material is still at least partially melted, for example.


Turning now to FIG. 49, a staple cartridge assembly 2000 comprises a cartridge body 2010 and an implantable layer 2030. The cartridge body 2010 comprises a deck 2011 and a plurality of staple cavities 2012 defined in the deck 2011. The layer 2030 is adjacent the deck 2011 and extends over the staple cavities 2012. A staple 2020 is removably positioned in each staple cavity 2012. Each staple 2020 is movable from an unfired position to a fired position by a firing member and/or staple driver system. As illustrated in FIG. 49, the tips 2021 of the staples 2020 extend above the deck 2011 and are partially embedded in the layer 2030 when the staples 2020 are in their unfired position; however, other embodiments are envisioned in which the tips 2021 do not extend above the deck 2011 and are not embedded in the layer 2030. When the staples 2020 are ejected from the staple cavities 2012, the staples 2020 capture portions of the layer 2030 therein and implant the layer 2030 against the patient tissue T, as illustrated in FIG. 50.


The layer 2030 is comprised of a plurality of first fibers and a plurality of second fibers. The first fibers are comprised of a first material and the second fibers are comprised of a second material which is different than the first material. The first material has a first thermal transition temperature in which the first material changes states. The second material has a second thermal transition temperature in which the second material changes states. In at least one instance, the first material has a first glass transition temperature and the second material has a second glass transition temperature which is different than the first glass transition temperature. When the first material exceeds its glass transition temperature, the first fibers will contract. Similarly, the second fibers will contract when the second material exceeds its glass transition temperature. A contraction of a fiber comprises a shortening of its longest length. More specifically, a fiber often comprises a strand which has a curved and/or twisted shape and, when the strand is heated above its glass transition temperature, the shape of the strand will tend to become more curved and/or twisted which shortens its longest length eventhough the overall length of the strand has not changed. In such instances, the configuration of the fibers will become less organized.


The first fibers and the second fibers of the layer 2030 can be mixed utilizing any suitable process. In at least one process, the first fibers and the second fibers can be interwoven, for example. For instance, the first fibers can be woven into a mesh and the second fibers can be interwoven into the mesh. After the fibers have been suitably mixed, the fibers can be exposed to heat. The fibers are heated to a temperature above the first thermal transition temperature but below the second thermal transition temperature. As a result, the first fibers contract and the second fibers do not contract, or at least they do not substantially contract. Nonetheless, the contraction of the first fibers will constrict the second fibers and change the overall shape of the layer 2030. More specifically, the contracting first fibers will pull the edges of the layer 2030 inwardly. Such inward movement of the edges can increase the thickness 2031 of the layer 2030. In certain instances, the layer will become puffy and/or bunch up. In any event, the heating processes described herein can allow a layer 2030 to assume a configuration which can compensate for variations of the tissue thickness captured in the staples.


The first and second materials of the layer 2030 can comprise any suitable materials. For example, the first material is a first polymer and the second material is a second polymer. For instance, the first material is polydioxanone (PDS) and the second material is polyglycolic acid (PGA), such as VICRYL manufactured by Ethicon, Inc., for example. The layer 2030 comprises more of the second material having a higher thermal transition temperature than the first material having a lower thermal transition temperature. In at least one example, the ratio of VICRYL, i.e., the second material, to PDS, i.e., the first material, is approximately 7:1. In at least one other example, the ratio of VICRYL, i.e., the second material, to PDS, i.e., the first material, is approximately 5:1. Other ratios and materials are possible.


Further to the above, various alternative embodiments are envisioned in which the layer 2030 is heated to a processing temperature such that the first fibers are heated above their thermal transition temperature and the second fibers are also heated above their thermal transition temperature. In at least one such instance where the first thermal transition temperature is below the second thermal transition temperature, the first fibers will contract more than the second fibers.


After the layer 2030 has been heated to achieve its desirable properties as described herein, the layer 2030 is cooled and/or permitted to cool below the first thermal transition temperature and the second thermal transition temperature. The layer 2030 is cooled below the first and second thermal transition temperatures before being assembled to the cartridge body 2010.


In various alternative embodiments, turning now to FIG. 57, a layer 2330 of a staple cartridge assembly 2300 is heated to a temperature that is above at least one of the first thermal transition temperature and the second thermal transition temperature and then positioned and/or pressed against a cartridge body 2310 of the cartridge assembly 2300. The layer 2330 is then cooled and/or permitted to cool.


Further to the above, the cartridge body 2310 comprises a deck 2311 and staple cavities 2312 defined in the deck 2311. The cartridge body 2310 further comprises posts 2315 extending upwardly from the deck 2311. When the heated layer 2330 is pressed against the deck 2311, the layer 2330 can conform to the features of the cartridge body 2310. For instance, portions of the layer 2330 can be wedged into the staple cavities 2312 and can assume the shape of the staple cavities 2312 to form projections 2332. Similarly, portions of the layer 2330 can form around the posts 2315 and assume the shape of the posts 2315 to form apertures 2335. Also, similarly, portions of the layer 2330 can be wedged into a longitudinal knife slot 2314 of the cartridge body 2310 to form tabs 2334.


Further to the above, the initial alignment between the heated layer 2330 and the cartridge body 2310 will determine how the features are formed on the bottom of the layer 2330. The cartridge body 2310 comprises one or more datums which can assist in the proper alignment between the layer 2330 and the cartridge body 2310. The cartridge body 2310 comprises alignment stops 2318 extending upwardly from the proximal end of the cartridge body 2310 which can be utilized to align the proximal end 2338 of the layer 2330 with the proximal end of the cartridge body 2310.


Turning now to FIG. 52, a first fiber 2231 and a second fiber 2232 are intertwined or interwoven. When the fibers 2231 and 2232 are exposed to heat, Q, the first fiber 2231 becomes less disorganized and begins to contract along its longest dimension, as illustrated in FIG. 52. As also illustrated in FIG. 52, the first fiber 2231 contracts relative to the second fiber 2232. While the first fiber 2231 contracts in its longest dimension, referring to FIG. 53, the first fiber 2231 expands in a lateral direction. As a result, the assembly of fibers 2231, 2232 can become resilient and can change shape under load.


The arrangement of the fibers 2231 and 2232 within a layer can be random. In certain instances, the arrangement of the fibers 2231 and 2232 within a layer can be at least partially organized. Turning now to FIG. 55, a layer 2230 comprises a mesh of second fibers 2232. The second fibers 2232 are attached, or interwoven, to one another at nodes 2235; however, various embodiments are envisioned in which the second fibers 2232 are not attached to each other. The second fibers 2232 are arranged in a lattice, or network, which extends along longitudinal axes 2233 and lateral axes 2234. The axes 2233 and 2234 are orthogonal, or substantially orthogonal, to each other; however, other embodiments are envisioned in which the lattice of second fibers 2232 are not arranged along an organized array of axes. The first fibers 2231 are interwoven into the mesh of the second fibers 2232. When the layer 2230 is exposed to a temperature which exceeds the first thermal transition temperature of the first material, the first fibers 2231 contract, as illustrated in FIG. 56. As a result, the layer 2230 assumes a laterally expanded configuration, referenced as layer 2230′.


Turning now to FIG. 51, a layer assembly 2130 comprises a first layer 2131, a second layer 2132, and a third layer 2133. The first layer 2131 comprises a plurality of first fibers 2134 interwoven with a plurality of second fibers 2135. Similarly, the third layer 2133 comprises a plurality of first fibers 2134 interwoven with a plurality of second fibers 2135. Similar to the above, the first fibers 2134 are comprised of a first material having a first thermal transition temperature and the second fibers 2135 are comprised of a second material having a second thermal transition temperature which is different than the first thermal transition temperature. The second layer 2132 is positioned intermediate the first layer 2131 and the third layer 2133. The second layer 2132 is comprised of a film; however, any suitable material could be utilized. The first layer 2131 and the third layer 2133 can be attached to the second layer 2132 utilizing one or more adhesives, for example. The second layer 2132 separates the first layer 2131 from the third layer 2133. In various instances, the second layer 2132 can permit the first layer 2131 and the third layer 2133 to be constricted independently of one another.


In various instances, further to the above, portions of a layer can be removed and/or modified utilizing any suitable process. Referring again to FIG. 57, one or more longitudinal slits 2337 can be created in the layer 2330 utilizing a laser cutting process, for example. Bridges 2336 are defined intermediate the slits 2337 and hold the two lateral halves of the layer 2330 together.


Turning now to FIG. 58, an end effector assembly 2400 comprises a staple cartridge body 2410 and an anvil 2490. The cartridge body 2410 comprises a deck 2411, a longitudinal knife slot 2414, and longitudinal rows of staple cavities defined on opposite sides of the slot 2414. More particularly, a first longitudinal row of staple cavities 2412a is disposed on each side of the longitudinal slot 2414, a second longitudinal row of staple cavities 2412b is disposed laterally relative to each first row of staple cavities 2412a, and a third longitudinal row of staple cavities 2412c is disposed laterally relative to each second row of staple cavities 2412b. A first staple 2020a is removably stored in each first staple cavity 2412a, a second staple 2020b is removably stored in each second staple cavity 2412b, and a third staple 2020c is removably stored in each third staple cavity 2412c.


Further to the above, the first staples 2020a each have a first unformed height, the second staples 2020b each have a second unformed height, and the third staples 2020c each have a third unformed height. The first unformed height is shorter than the second unformed height and the second unformed height is shorter than the third unformed height. Other embodiments are envisioned in which the first staples 2020a, the second staples 2020b, and/or the third staples 2020c have the same unformed height. U.S. Pat. No. 8,317,070, entitled SURGICAL STAPLING DEVICES THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, which issued on Nov. 27, 2012, is incorporated herein by reference in its entirety. The anvil 2490 comprises a first longitudinal row of forming pockets 2492a aligned with the staple cavities 2412a, a second longitudinal row of forming pockets 2492b aligned with the staple cavities 2412b, and a third longitudinal row of forming pockets 2492c aligned with the staple cavities 2412c. The staples 2020a, 2020b, and 2020c are ejected from the staple cavities 2412a, 2412b, and 2412c by a plurality of staple drivers positioned in the cartridge body 2410 which lift the staples 2020a, 2020b, and 2020c into contact with the forming pockets 2492a, 2492b, and 2492c, respectively.


Further to the above, the staple drivers positioned in the cartridge body 2410 and the forming pockets 2492a, 2492b, and 2492c of the anvil 2490 are configured to deform the staples 2020a, 2020b, and 2020c to different formed heights. More specifically, the first staples 2020a are deformed to a first formed height, the second staples 2020b are deformed to a second formed height which is taller than the first formed height, and the third staples 2020c are deformed to a third formed height which is taller than the second formed height. FIG. 59 illustrates such an arrangement. Other embodiments are envisioned in which the third formed height is the same as the second formed height.


Further to the above, referring again to FIG. 58, the deck 2411 of the cartridge body 2410 comprises a sloped support surface. The portion of the deck 2411 extending along the first longitudinal row of staple cavities 2412a is higher than the portion of the deck 2411 extending along the second longitudinal row of staple cavities 2412b. Similarly, the portion of the deck 2411 extending along the second longitudinal row of staple cavities 2412b is higher than the portion of the deck 2411 extending along the third longitudinal row of staple cavities 2412c. The deck 2411 comprises an arcuate surface. In various instances, the sloped support surface of the deck 2411 can include discrete stepped surfaces. For instance, the deck 2411 can include a first longitudinal step which extends along the first row of staple cavities 2412a, a second longitudinal step which extends along the second row of staple cavities 2412b, and/or a third longitudinal step which extends along the third row of staple cavities 2412c. The deck 2411 can further include sloped surfaces intermediate the first step and the second step and/or intermediate the second step and the third step.


Further to the above, the anvil 2490 includes a stepped tissue compression surface. For instance, the third longitudinal rows of forming pockets 2492c are defined in longitudinal steps. In alternative embodiments, the anvil 2490 comprises a flat tissue compression surface. In either event, tissue positioned between the cartridge body 2410 and the anvil 2490 is compressed to a suitable pressure therebetween when the end effector 2400 is in a clamped configuration, as illustrated in FIG. 58. Such tissue compression, however, is not uniform within the end effector 2400. For instance, the tissue adjacent the first row of staple cavities 2412a is compressed to a first pressure, the tissue adjacent the second row of staple cavities 2412b is compressed to a second pressure which is less than the first pressure, and the tissue adjacent the third row of staple cavities is compressed to a third pressure which is less than the second pressure. Other arrangements are contemplated.


The end effector 2400 further comprises implantable layers 2430 positioned over the deck 2411. For instance, a first layer 2430 is positioned on a first side of the longitudinal slot 2414 and a second layer 2430 is positioned on a second side of the longitudinal slot 2414. The layers 2430 define a longitudinal slot therebetween which is aligned, or at least substantially aligned, with the slot 2414 defined in the cartridge body 2410 and a longitudinal slot 2494 defined in the anvil 2490. The cartridge slot 2414, the layer slot, and the anvil slot 2494 are configured to permit a firing member to move longitudinally through the end effector 2400. In alternative embodiments, a layer positioned on the deck 2411 does not comprise a layer slot and a cutting portion of the firing member transects the layer as the firing member is moved distally.


The implantable layers described herein can be comprised of fibers which are interwoven together. Fibers 3000, for example, are illustrated in FIGS. 60 and 61. Each fiber 3000 comprises a strand which has been plastically deformed and includes one or more kinks defined therein. An implantable layer, such as layer 3030 illustrated in FIG. 63, for example, that comprises fibers 3000 is resilient and can compensate for variations in tissue thickness captured within staples 3020. The fibers 3000 are woven together to form an implantable layer which can act as a collective spring. Moreover, the fibers 3000 of the layer 3030 are soft as a result of their kinked configuration and are less likely to abrade tissue T as compared to previous implantable layers that do not include the fibers 3000, such as the layer 3130 depicted in FIG. 62, for example.


The fibers 3000 can be manufactured in any suitable manner. In various instances, a manufacturing process can utilize any suitable means for mechanically and/or thermally creating kinks in the fibers 3000 and/or otherwise plastically deforming the fibers 3000. Turning now to FIG. 65, a heated die can be utilized to plastically deform a strand 3000′ to form a continuous fiber 3000. The heated die comprises first and second sides 3050 wherein at least one of the sides is movable relative to the other side between an open position and a closed position. FIG. 65 illustrates the heated die in an open configuration. When the die is in its open configuration, a portion of the unformed strand 3000′ is positioned in the die between the open sides 3050. In at least one instance, the manufacturing process includes a spool 3060 configured to pull the strand 3000′ into the die. Each side 3050 of the die includes a heated surface 3051. The heated surfaces 3051 include a plurality of projections which are configured to contact the strand 3000′ and, through mechanical pressure and/or heating, plastically deform the strand 3000′. At such point, the continuous strand 3000′ becomes a continuous fiber 3000 which is wrapped around the spool 3060. The continuous fiber 3000 can be transected during a subsequent step in the manufacturing process, if desired.


Further to the above, turning now to FIG. 66, a manufacturing process includes one or more rotatable dies 3350. Each die 3350 is rotatable about an axis 3352 and includes a plurality of teeth 3351 extending around the die 3350. The teeth 3351 of the rotatable dies 3350 are intermeshed and deform the continuous strand 3000′ into the continuous fiber 3000 when the strand 3000′ passes through the intermeshed teeth 3351. Similar to the above, the dies 3350 are heated and apply heat (Q) to the strand 3000′. Turning now to FIG. 67, a manufacturing process includes a rotatable die 3450. The die 3450 is rotatable about an axis 3452 and includes teeth 3451 extending therefrom. A continuous strand 3000′ is wrapped around the perimeter of the die 3450 and is engaged with the teeth 3451. The teeth 3451 are heated and, when the teeth 3451 contact the strand 3000′, the strand 3000′ becomes a continuous kinked fiber 3000. A tensile force can be applied to the fiber 3000 to pull the fiber 3000 around the die 3450.


In addition to or in lieu of the above, the fibers 3000 can be deformed, or kinked, in any suitable manner. In various instances, air texturing and/or any other suitable form of texturing could be used, for example. Moreover, the intervals between the deformations, or kinks, in the fibers 3000 can be utilized to control the properties of the fibers 3000. Fibers 3000 having shorter intervals between the deformations, or kinks, will be less stiff than fibers 3000 having longer intervals between the deformations, or kinks Regardless of the manner of deformation used to deform the fibers 3000, the fibers 3000 can comprise any suitable cross-section. In at least one instance, the strands 3000′ can comprise a circular, or an at least substantially circular, cross-section which is at least partially flattened after the strands 3000′ have been deformed, or kinked to form the fibers 3000. In various instances, the fibers 3000 have an oblate cross-section where they have been deformed, for example.


Further to the above, the fibers 3000 can undergo a deformation, or kinking process, during one or more steps of a manufacturing process to form an implantable layer. In at least one process, the fibers 3000 are deformed, or kinked, before they are weaved together in a preliminary weaving process. Such a deformation process can utilize pressure and/or heat, for example. Alternatively, the fibers do not undergo a deformation process before the preliminary weaving process. In either event, once the fibers 3000 have been woven together, they are unwoven. The process of weaving and then unweaving the fibers 3000 deforms, or kinks, the fibers 3000. After the fibers 3000 have been unwoven, they may or may not undergo a deformation, or kinking, process. Such a deformation process can utilize pressure and/or heat, for example. After the fibers 3000 have undergone a suitable number of pre-kinking processes, the fibers 3000 are then re-woven into an implantable layer.


In various instances, further to the above, only the pre-kinked fibers 3000 are utilized to weave an implantable layer while, in other instances, the pre-kinked fibers 3000 are mixed with other fibers, such as unkinked fibers, for example. In at least one instance, a woven implantable layer comprises a first group of pre-kinked fibers 3000 comprised of a material and a second group of unkinked fibers comprised of the same material. In another instance, a woven implantable layer comprises a first group of pre-kinked fibers 3000 comprised of a first material and a second group of unkinked fibers comprised of a second material which is different than the first material. In yet another instance, a woven implantable layer comprises a first group of pre-kinked fibers 3000 which are kinked at a first interval and a second group of pre-kinked fibers which are kinked at a second interval which is different than the first interval. Implantable layers comprised of a first group of fibers having a higher stiffness interwoven with a second group of fibers having a higher stiffness, such as those described herein, for example, can provide the implantable layer with a desired modulus of elasticity.


The deformed, or kinked, fibers described herein can be woven into an implantable layer in any suitable manner. In various instances, an implantable layer can be woven such that it does not comprise seams. Turning now to FIG. 68, an implantable layer 3530 can be woven, or knitted, such that it comprises seams. The implantable layer 3530 comprises a top surface 3531, a bottom surface 3532, and interwoven fibers which are connected to each other along lateral seams 3533, longitudinal seams 3534, and internal seams 3535. Referring to FIG. 69, the layer 3530 is comprised of fibers 3000 and, in addition, fibers 3500. Referring to FIG. 70, the fibers 3000 and 3500 are interwoven to form the seams 3533, 3534, and 3535.


The seams 3533, 3534, and 3535 can be interwoven at a desired density to achieve a desired result. For instance, the density of the longitudinal seams 3534 is higher on the lateral sides of the layer 3530 than in the middle of the layer 3530. The middle of the layer 3530 is aligned with a cutting member of the stapling instrument when the layer 3530 is positioned on a staple cartridge and inserted into the stapling instrument. Owing to the lower density in the middle of the layer 3530 being aligned with the cutting member, the layer 3530 can be more easily transected by the cutting member while permitting the layer 3530 to have a different density in the regions which are captured by the staples. Also, for instance, the density of the lateral seams 3533 is higher in the middle of the layer 3530 than at the proximal and distal ends of the layer 3530. Owing to the lower density at the proximal end of the layer 3530, the cutting member can more easily begin its transection of the layer 3530. Similarly, the lower density at the distal end of the layer 3530 can assist the cutting member in finishing its cut as the cutting member slows down at the end of its stroke.


A layer 3230 is illustrated in FIG. 64. The layer 3230 comprises a top portion 3231, a bottom portion 3232, and an intermediate portion 3233 connecting the top portion 3231 and the bottom portion 3232. The intermediate portion 3233 spaces and positions the top portion 3231 relative to the bottom portion 3232. The portions 3231, 3232, and 3233 are comprised of kinked fibers 3000. The fibers 3000 are organized, or weaved, into lateral seams 3233 and longitudinal seams 3234. The density of the longitudinal seams 3234 is higher in the medial portion of the layer 3230 as compared to the lateral portions of the layer 3230.


Further to the above, turning now to FIGS. 71 and 72, a staple cartridge 3600 includes a cartridge body 3610 and an implantable layer 3630. The cartridge body 3610 comprises a deck 3611 configured to support the layer 3630. The layer 3630 comprises a top surface 3631, a bottom surface 3632, and is comprised of fibers 3633. The density 3634 of the fibers 3633 is higher in the middle of the layer 3630 than the lateral sides of the layer 3630. In fact, the higher density 3634 of the fibers 3633 is aligned with a longitudinal slot 3614 defined in the cartridge body 3610 which is configured to receive a cutting portion of the firing member. The higher density 3634 of the fibers 3633 in the middle of the layer 3630 can reduce buckling or movement of the layer 3630 relative to the cartridge body 3610.


Turning now to FIG. 73, an implantable layer 3730 comprises a top surface 3731, a bottom surface 3732, and a body comprised of interwoven fibers. The fibers are interwoven into lateral seams 3733 and longitudinal seams 3734. The fibers are interconnected to one another at weave points 3735. The weave points 3735 connect fibers that extend laterally and/or longitudinally within the implantable layer 3730. The weave points 3735 can connect the fibers within a lateral seam 3733. The weave points 3735 can connect fibers within a longitudinal seam 3734. The weave points 3735 can connect the lateral seams 3733 with the longitudinal seams 3734. The density of the weave points 3735 in the implantable layer 3730 can control the resiliency or elasticity of the implantable layer 3730. The portions of the layer 3730 having a higher weave point density may be less resilient than the portions of the layer 3730 having a lower weave point density. With regard to the embodiment depicted in FIG. 73, the lateral portions of the layer 3730 have a high weave point density while the medial portion of the layer 3730 has a low weave point density; however, any suitable arrangement of weave point densities could be utilized.


Turning now to FIG. 74, an implantable layer 3830 comprises a top surface 3831, a bottom surface 3832, and a body comprised of interwoven fibers. The fibers are interwoven into lateral seams 3833 and longitudinal seams 3834. The fibers are interconnected to one another at weave points 3835. The weave points 3835 connect fibers that extend laterally and/or longitudinally within the implantable layer 3830. The weave points 3835 can connect the fibers within a lateral seam 3833. The weave points 3835 can connect fibers within a longitudinal seam 3834. The weave points 3835 can connect the lateral seams 3833 with the longitudinal seams 3834.


In various instances, further to the above, the fibers that are interwoven into an implantable layer can have the same diameter and/or length. In other instances, the fibers can have different diameters and/or lengths. Referring again to FIG. 74, certain fibers of the implantable layer 3830 have a first diameter, or thickness, and other fibers have a second diameter, or thickness, which is larger than the first diameter. The thinner fibers are in the center of the implantable layer 3830 and the thicker fibers are in the lateral sides of the implantable layer 3830. When the cutting member of the surgical stapling instrument passes through the center of the implantable layer 3830, the thinner fibers can facilitate the cutting of the implantable layer 3830. Alternatively, the thicker fibers are in the center of the implantable layer 3830 which can inhibit the layer 3830 from buckling.


Turning now to FIGS. 75 and 76, an implantable adjunct 4030 comprises a plurality of layers. The adjunct 4030 comprises a first outside layer 4031 and a second outside layer 4035. The first outside layer 4031 is comprised of interwoven fibers. Similarly, the second outside layer 4035 is comprised of interwoven fibers. The fibers of the outside layers 4031, 4035 can be comprised of any suitable material, such as VICRYL and/or any of the materials described in the present application, for example. The adjunct 4030 further comprises a middle, or intermediate, layer 4033. The middle layer 4033 is also comprised of interwoven fibers. The middle layer 4033 can be comprised of the same materials as the outside layers 4031, 4035 and/or different materials.


Referring again to FIGS. 75 and 76, the adjunct 4030 further comprises a first bonding layer 4032 and a second bonding layer 4034. The first bonding layer 4032 is positioned intermediate the first outside layer 4031 and the middle layer 4033. The second bonding layer 4034 is positioned intermediate the second outside layer 4035 and the middle layer 4033. The first bonding layer 4032 is comprised of a material that has a lower melt temperature than the materials comprising the layers 4031, 4033, and 4035. Similarly, the second bonding layer 4034 is comprised of a material that has a lower melt temperature than the materials comprising the layers 4031, 4033, and 4035.


Further to the above, the layers 4031, 4032, 4033, 4034, and 4035 of the adjunct 4030 are stacked in the manner depicted in FIG. 75. The adjunct 4030 is then heated. The adjunct 4030 is heated such that the temperature of the bonding layers 4032 and 4034 equals or exceeds the melt temperature of the material comprising the bonding layers 4032 and 4034. When the bonding layers 4032 and 4034 are comprised of the same material, the bonding layers 4032 and 4034 will melt at the same temperature. This temperature can be referred to as the threshold melt temperature. When the first bonding layer 4032 is comprised of a first material having a first melt temperature and the second bonding layer 4034 is comprised of a second material having a second, or different, melt temperature, one of the layers 4032, 4034 will begin to melt before the other. In such instances, the threshold melt temperature comprises the higher of the first and second melt temperatures.


As the bonding layers 4032, 4034 are melting, the melted material penetrates the first outside layer 4031, the middle layer 4033, and/or the second layer 4035. The amount in which the melted layers 4032, 4034 penetrate into the layers 4031, 4033, 4035 can be dependent on several factors. For example, the layers 4031, 4033, and/or 4035 can be comprised of interwoven fibers and the amount in which the melted layers 4032, 4034 penetrate the fiber weaves can depend on the openness of the fiber weaves. For instance, the melted layers 4032, 4034 can penetrate deeper into a more open, or looser, weave than a more closed, or tighter, weave. Stated another way, the melted layers 4032, 4034 may not penetrate extensively into a tightly knit weave. The first outside layer 4031 and the second outside layer 4035 have the same, or at least substantially the same, weave density. In various alternative embodiments, the first outside layer 4031 and the second outside layer 4035 have different weave densities. In at least one such embodiment, turning now to FIG. 77, the second outside layer 4035″ of an alternative adjunct 4030″ has a tighter weave than the first outside layer 4031″. The first bonding layer 4032″ may penetrate deeper, or more extensively, into the first outside layer 4031″ than the second bonding layer 4034″ may penetrate into the second outside layer 4035″.


Referring again to FIG. 75, the middle layer 4033 of the adjunct layer 4030 comprises apertures 4036 defined therein. The apertures 4036 comprise throughholes. The melted bonding layers 4032, 4034 can enter into the apertures 4036 to improve, or increase, the bond between the bonding layers 4032, 4034 and the middle layer 4033. In alternative embodiments, the apertures 4036 may not extend entirely through the middle layer 4033. That said, such apertures 4036 may be sufficiently deep to receive a sufficient quantity of melted material to form an adequate bond with the bonding layers 4032, 4034. The first outside layer 4031 and/or the second outside layer 4035 may include apertures defined therein to improve, or increase, their bond with the first bonding layer 4032 and the second bonding layer 4034, respectively.


As discussed above, the adjunct 4030 is heated to melt, or at least partially melt, the bonding layers 4032, 4034. As also discussed above, the melted portions of the bonding layer 4032, 4034 flow into the layers 4031, 4033, and/or 4035. After the adjunct has been sufficiently heated, the adjunct 4030 is cooled and/or is permitted to cool. The adjunct 4030 can be placed in a refrigeration unit, set out in the open air, and/or exposed to a flow of air, for example. When the adjunct 4030 cools below the threshold melt temperature, the melted bonding layers 4032, 4034 can begin to solidify, thereby locking the layers 4031, 4032, 4033, 4034, and 4035 together. In various instances, the melted bonding layers 4032 and 4034 can assume a mechanically interlocked configuration with the layers 4031, 4033, and 4035, as illustrated in FIG. 76.


Further to the above, the layers 4031, 4033, and 4035 of the adjunct 4030 are comprised of materials having a melt temperature which is greater than the threshold melt temperature of the bonding layers 4032 and 4034. Moreover, the layers 4031, 4033, and 4035 are comprised of materials having a melt temperature which is greater than the highest processing temperature in which the adjunct 4030 is exposed to. As a result, the layers 4031, 4033, and 4035 will not melt while the bonding layers 4032 and 4034 are being melted. In at least one instance, the layers 4031, 4033, and 4035 are comprised of VICRYL, for example, and the bonding layers 4032 and 4034 are comprised of PDS, for example. In at least one such instance, the bonding layers 4032 and 4034 are comprised of a PDS film, for example.


In various embodiments, further to the above, each bonding layer 4032, 4034 can be comprised of two or more materials. In certain instances, each material comprising the bonding layers 4032, 4034 has a melt temperature which is equal to or below the maximum processing temperature of the adjunct 4030. In other instances, some of the materials comprising the bonding layers 4032, 4034 have a melt temperature equal to or below the maximum processing temperature while others have a melt temperature above the maximum processing temperature. In such embodiments, some portions of the layers 4032 and 4034 will melt and penetrate the adjacent layers 4032, 4033, and 4035 while other portions of the layers 4032 and 4034 will maintain their structural integrity.


Further to the above, each layer 4031, 4033, and 4035 can be comprised of two or more materials. In certain instances, each material comprising the layers 4031, 4033, 4035 has a melt temperature which is above the maximum processing temperature of the adjunct 4030. In other instances, some of the materials comprising the layers 4031, 4033, 4035 have a melt temperature above the maximum processing temperature while others have a melt temperature equal to or below the maximum processing temperature. In such embodiments, some portions of the layers 4031, 4033, 4035 will melt and mix with the melted portions of the adjacent bonding layers 4032, 4034 thereby improving the bond between the layers 4031, 4032, 4033, 4034, and 4035 once the temperature of the adjunct 4030 has cooled below the melt temperature of each of the materials comprising the adjunct 4030.


The adjunct 4030 is not pressed when it is exposed to heat. The melted materials of the adjunct 4030 flow in response to the natural forces, such as gravitational and/or capillary forces, for example, acting on the melted materials; however, embodiments are envisioned in which the adjunct 4030 is pressed when it is exposed to heat. Such pressure can improve the flow of the melted materials within the adjunct 4030 and improve the bond between the layers 4031, 4032, 4033, 4034, and 4035. The pressure can be removed from the adjunct 4030 while the melted portions are still flowable. Alternatively, the pressure can be removed after the melted portions have re-solidified.


The adjunct 4030 comprises five layers; however, an adjunct employing the principles disclosed herein may comprise any suitable number of layers. For example, an adjunct can comprise three layers including the first outer layer 4031, the second outer layer 4035, and a bonding layer positioned intermediate the first outer layer 4031 and the second outer layer 4035.


In various alternative embodiments, an adjunct may not utilize a bonding layer. For example, an adjunct can utilize the first outer layer 4031 and the second outer layer 4035 wherein one or both of the layers 4031, 4035 is comprised of a material which is melted to flow and directly bond the layers 4031, 4035 together. Similarly, an adjunct can utilize the outer layers 4031, 4035 and the middle layer 4033 positioned intermediate the outer layers 4031, 4035 wherein one or more of the layers 4031, 4033, 4035 is comprised of a material which is melted to flow and directly bond the layers 4031, 4035 to the middle layer 4033.


As discussed above, the layers 4031, 4033, and 4035 of adjunct 4030 are comprised of interwoven fibers. In certain instances, the layers 4031, 4033, and 4035 can have the same, or at least substantially the same, weave density. In other instances, at least one of the layers 4031, 4033, and 4035 can have a weave density which is different than the other layers. Referring again to FIG. 77, the adjunct 4030″ comprises a first outer layer 4031″, a first bonding layer 4032″, a spacer layer 4033″, a second bonding layer 4034″, and a second outer layer 4035″. The weave density of the second outer layer 4035″ is greater than the weave density of the first outer layer 4031″ Similarly, the weave density of the first outer layer 4031″ is greater than the weave density of the spacer layer 4033″.


As discussed above, the bonding layers 4032 and 4034 of the adjunct 4030, when melted, can penetrate the adjacent layers 4031, 4033, and 4035. The penetration of the bonding layers 4032 and 4034 into the layers 4031, 4033, and 4035 can change the stiffness of the layers 4031, 4033, and 4035. More specifically, the penetration of the bonding layers 4032, 4034 into the layers 4031, 4033, 4035 can increase the stiffness of the layers 4031, 4033, 4035, depending on the degree in which the bonding layers 4032, 4034 penetrate the layers 4031, 4033, 4035. In various instances, the bonding layers 4032, 4034 can strengthen, fixate, and/or support the fibers of the adjacent layers 4031, 4033, 4035.


Further to the above, the weave densities of the layers 4031, 4033, and/or 4035 can be selected so as to control the penetration of the layers 4032, 4034 therein. Referring now to FIGS. 91 and 92, an adjunct 4730 comprises a first outer layer 4731, an intermediate layer 4733, a first bonding layer 4732 positioned intermediate the first outer layer 4731 and the intermediate layer 4733, a second outer layer 4735, and a second bonding layer 4734 positioned intermediate the second outer layer 4735 and the intermediate layer 4733. Certain portions of the intermediate layer 4733 have a low, or loose, weave density while other portions of the intermediate layer 4733 have a high, or tight, weave density. When the adjunct 4730 is heated to a temperature that at least equals the melt temperature of the first bonding layer 4732, the first bonding layer 4732 penetrates deeper into the portions of the intermediate layer 4733 having a loose weave density than the portions of the intermediate layer 4733 having a tight weave density. In addition to or in lieu of the above, the weave densities of the first outside layer 4731 and/or the second outside layer 4735 can be adapted to control the penetration of the bonding layers 4732 and 4734 into the outside layers 4731 and 4735, respectively.


Further to the above, referring again to FIG. 75, the density, size, and/or depth of the apertures 4036 can be selected to control the depth in which the layers 4032 and 4034 penetrate into the spacer layer 4033. As a result of the above, the stiffness of the adjunct 4030 can be controlled. For instance, the adjunct 4030 can comprise a longitudinal path defined therein which has a lower stiffness than the other portions of the adjunct 4030. In such instances, a knife transecting the adjunct 4030 can transect the adjunct 4030 along a path having a low stiffness. In at least one instance, the proximal and distal ends of the adjunct 4030 can have a lower stiffness than the other portions of the adjunct 4030. In such instances, the adjunct 4030 may provide less resistance to the cutting and stapling thereof at the beginning and the end of the firing stroke.


In various alternative embodiments, an adjunct can comprise a bonding layer which does not penetrate, or at least substantially penetrate, the adjacent layers of the adjunct. In such embodiments, the bonding layer can join adjacent layers without substantially affecting the stiffness of the adjacent layers. Turning now to FIG. 90, an adjunct 4630 comprises a bonding layer 4632 which holds a first outer layer 4631 and an intermediate layer 4633 together without penetrating the first outer layer 4631 and/or the intermediate layer 4633. Similarly, the adjunct 4630 comprises a bonding layer 4634 which holds a second outer layer 4635 and the intermediate layer 4633 together without penetrating the second outer layer 4635 and/or the intermediate layer 4633.


As described above, an adjunct can comprise a bonding layer positioned intermediate first and second outer layers. Turning now to FIGS. 80 and 81, an adjunct 4230 comprises a first outer layer 4231, a second outer layer 4235, and an intermediate layer 4233 positioned intermediate the first outer layer 4231 and the second outer layer 4235. In this embodiment, the outer layers 4231 and 4235 are comprised of one or more materials having a lower melt temperature than the melt temperature of the materials comprising the intermediate layer 4233. As a result, the melt temperatures of the outside layers 4231 and 4235 define the threshold melt temperature of the adjunct 4230. The adjunct 4230 is exposed to a processing temperature which at least partially melts the outside layers 4231 and 4235 but does not melt the intermediate layer 4233.


In addition to or in lieu of the above, one or more layers of an implantable adjunct can include relief, or stretch, joints. Moreover, one or more layers of an implantable adjunct can include relief, or stretch, slots defined therein. Turning now to FIG. 78, an implantable adjunct 4130 comprises a first outside layer 4131, a second outside layer 4135, and a bonding layer 4133 positioned intermediate the first outside layer 4131 and the second outside layer 4135. Turning now to FIGS. 79 and 82, the first outside layer 4131 comprises relief joints 4137 which extend laterally through the layer 4131. As illustrated in FIG. 83, the lateral relief joints 4137 decrease the longitudinal stiffness of the layer 4131, and the adjunct 4130, and facilitate the longitudinal expansion of the layer 4131, and the adjunct 4130. The relief joints 4137 have the same length; however, alternative embodiments are envisioned in which one or more of the relief joints 4137 have lengths which are different than the lengths of the other relief joints 4137.


Referring again to FIG. 79, the second outside layer 4135 comprises relief joints 4136 which extend longitudinally through the layer 4135. The longitudinal joints 4136 extend between a proximal end and a distal end of the adjunct 4130. The longitudinal relief joints 4136 decrease the lateral stiffness of the layer 4131, and the adjunct 4130, and facilitate the lateral expansion of the layer 4131, and the adjunct 4130. The relief joints 4136 have the same length; however, alternative embodiments are envisioned in which one or more relief joints 4136 have lengths which are different than the lengths of the other relief joints 4136.


Referring to FIGS. 79 and 84, the bonding layer 4133 comprises an array of slits 4138 defined therein. The slits 4138 are arranged in longitudinal rows which extend along longitudinal axes. Each slit 4138 comprises an elongate configuration wherein the longest dimension of each slit 4138 is aligned with an axis of a longitudinal row. As illustrated in FIG. 85, the slits 4138 facilitate the longitudinal and/or lateral expansion of the layer 4133 and the adjunct 4130. The slits 4138 have the same configuration; however, alternative embodiments are envisioned in which one or more slits 4138 have configurations which are different than the configurations of the other slits 4138. In various instances, any suitable layer of an adjunct can include the slits 4138.


Turning now to FIG. 86, a layer 4233 of an adjunct comprises apertures 4238 defined therein which are configured to facilitate the longitudinal and/or lateral stretch of the layer 4233. Each aperture 4238 comprises a diamond configuration. The apertures 4238 defined in one row are offset laterally and longitudinally with respect to the apertures 4238 defined in an adjacent row. Turning now to FIG. 87, a layer 4333 of an adjunct comprises apertures 4338 defined therein which are configured to facilitate the longitudinal and/or lateral stretch of the layer 4333. Each aperture 4338 comprises a circular configuration. The apertures 4338 defined in one row are aligned with the apertures 4338 defined in an adjacent row. Turning now to FIG. 88, a layer 4433 of an adjunct comprises apertures 4438 defined therein which are configured to facilitate the longitudinal and/or lateral stretch of the layer 4433. Each aperture 4438 comprises a zig-zag slit that extends laterally and longitudinally. The apertures 4438 in one row are offset laterally and longitudinally with respect to the apertures 4438 in an adjacent row.


The apertures described herein can be created in a layer utilizing any suitable process. Turning now to FIG. 89A, a layer 4533 of an adjunct 4530 comprises a plurality of apertures 4538′ defined therein. The apertures 4538′ are burned in the layer 4533 utilizing a laser 4539′. Turning now to FIG. 89B, a rotatable die 4539″ is utilized to punch apertures 4538″ into the layer 4533. Turning now to FIG. 89C, a stamping die 4539′″ is utilized to punch apertures 4538′″ into the layer 4533.


Referring to FIG. 93, a compressible adjunct assembly 6000 includes an outer fibrous tubular member 6002, an inner fibrous tubular member 6010, a first intermediate fibrous tubular member 6004, a second intermediate fibrous tubular member 6006, and a third intermediate fibrous tubular member 6008. In certain instances, the compressible adjunct assembly 6000 may only include the inner and outer fibrous tubular members. Alternatively, the compressible adjunct assembly 6000 may include the inner and outer fibrous tubular members and only one of the intermediate fibrous tubular members. Alternatively, the compressible adjunct assembly 6000 may include the inner and outer fibrous tubular members and only two of the intermediate fibrous tubular members. Alternatively, the compressible adjunct assembly 6000 may include the inner and outer fibrous tubular members and more than three intermediate fibrous tubular members.


In certain instances, the inner fibrous tubular member 6010 can be switched with a core fibrous construct that is not hollow. In certain instances, the compressible adjunct assembly 6000 may be comprised of a plurality of hollow fibrous members that are not tubular or cylindrical in shape. In certain instances, the plurality of hollow fibrous members of the compressible adjunct assembly 6000 may comprise a square-shaped or rectangular transverse cross-sectional area. Other shapes are contemplated by the present disclosure.


Like other compressible adjunct assemblies of the present disclosure, the compressible adjunct assembly 6000 can be assembled with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010. In certain instances, a first compressible adjunct assembly 6000 can be assembled with the anvil 8014 and a second compressible adjunct assembly 6000 can be assembled with the staple cartridge 10000 such that tissue is captured between the first and second compressible adjunct assemblies 6000 when the surgical stapling and severing instrument 8010 is in a closed configuration. In either event, a plurality of staples can be deployed into a compressible adjunct assembly 6000 to fasten tissue captured by the surgical stapling and severing instrument 8010.


The fibrous tubular members of the compressible adjunct assembly 6000 are concentrically aligned along a longitudinal axis L-L and disposed around, or at least partially around, one another, as illustrated in FIG. 93. The second intermediate fibrous tubular member 6006 is disposed between the first and third intermediate fibrous tubular members 6004 and 6008. For the sake of brevity, the following discussion of the compressible adjunct assembly 6000 will focus on the second intermediate fibrous tubular member 6006 in addition to the outer and inner fibrous tubular members 6002 and 6010. The reader, however, will appreciate that the following discussion is equally applicable to the first and third intermediate fibrous tubular members 6004 and 6008.


Referring to FIG. 93, the inner fibrous tubular member 6010 is sized to fit, or at least partially fit, within the intermediate fibrous tubular member 6006 to define a cylindrical space or gap 6012 therebetween. Likewise, the intermediate fibrous tubular member 6006 is sized to fit, or at least partially fit, within the outer fibrous tubular member 6002 to define a cylindrical space or gap 6014 therebetween. As illustrated in FIG. 93, the inner fibrous tubular member 6010 extends, or at least partially extends, through the intermediate fibrous tubular member 6006 which extends, or at least partially extends, through the outer fibrous tubular member 6002.


Referring to FIG. 93, the fibrous tubular members of the compressible adjunct assembly 6000 are woven. In certain instances, one or more of the fibrous tubular members of the compressible adjunct assembly 6000 can be non-woven constructs. In at least one instance, the inner fibrous tubular member 6010 can be comprised of a non-woven fibrous construct that is not hollow. In any event, the fibers of the adjacent fibrous tubular members of the compressible adjunct assembly 6000 are intertwined, interrelated, and/or capable of interaction with one another.


One or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 includes at least one fiber that is constricted or shrunk in response to a thermal treatment of the compressible adjunct assembly 6000.


The at least one fiber is comprised of at least one biocompatible material that experiences a reduction in size when heated to the predetermined temperature. In at least one instance, the at least one biocompatible material is an elastomer. In certain instances, the at least one biocompatible material has a glass transition temperature below ambient temperature.


In certain instances, the thermal treatment comprises heating the compressible adjunct assembly 6000 to a predetermined temperature. For example, the compressible adjunct assembly 6000 can be inserted into an oven, which can be heated to the predetermined temperature. Other techniques for delivering the thermal treatment to the compressible adjunct assembly 6000 are contemplated by the present disclosure.


Further to the above, one or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 includes at least one fiber that has experienced a transition from a more ordered phase to a less ordered phase in response to the thermal treatment of the compressible adjunct assembly 6000. In at least one instance, the compressible adjunct assembly 6000 includes at least one fiber that has experienced an increase in entropy in response to the thermal treatment.


Referring to FIG. 94, the shrinkage or constriction of the at least one fiber reinforces the compressible adjunct assembly 6000 by causing the individual fibrous tubular members of the compressible adjunct assembly 6000 to be brought closer to one another thereby reducing the empty space therebetween. The shrinkage of the at least one fiber can densify the compressible adjunct assembly 6000 by causing the fibers of the fibrous tubular members to bunch up or cluster into more compact semi-organized or disorganized tubular structures. In result, as illustrated in FIG. 94, the individual fibrous tubular members may lose their uniform tubular frames and instead adopt irregular shapes with bulges and depressions that improve the structural integrity of the compressible adjunct assembly 6000.


Referring to FIG. 94, one or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 may comprise


bioabsorbable materials such as, for example, polyglycolic acid (PGA) which is marketed under the trade name VICRYL, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name MONOCRYL, and/or polycaprolactone (PCL). One or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 may comprise one or more composite materials that include two or more polymers, the polymers selected from a group including PGA, PLA, PDS, PHA, PGCL and/or PCL, for example.


Referring again to FIG. 93, one or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 includes a first plurality of fibers comprised of a first biocompatible material such as, for example, VICRYL, and a second plurality of fibers comprised of a second biocompatible material, different from the first biocompatible material, such as, for example PDS. The compressible adjunct assembly 6000 comprises more of the first biocompatible material than the second biocompatible material. In at least one instance, the ratio of the first biocompatible material of the first plurality of fibers to the second biocompatible material of the second plurality of fibers can be any value selected from a range of about 3:1 to about 10:1, for example. In at least one instance, the ratio of the first biocompatible material to the second biocompatible material can be any value selected from a range of about 4:1 to about 9:1, for example. In at least one instance, the ratio of the first biocompatible material to the second biocompatible material can be any value selected from a range of about 5:1 to about 8:1, for example. In at least one instance, the ratio of the first biocompatible material to the second biocompatible material is 7:1. In at least one instance, the ratio of the first biocompatible material to the second biocompatible material is about 5:1, for example. Other ratios of the first biocompatible material to the second biocompatible material are contemplated by the present disclosure.


In at least one instance, all the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 may comprise the same, or at least substantially the same, ratio of the first biocompatible material to the second biocompatible material. Alternatively, the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 may comprise different ratios of the first biocompatible material to the second biocompatible material.


The compressible adjunct assembly 6000 is heated to a predetermined temperature at which the second plurality of fibers experiences a reduction in size corresponding to an increase in Entropy in response to the thermal treatment. In certain instances, the first plurality of fibers and the second plurality of fibers are entangled such that the shrinkage of the second plurality of fibers causes some or all of the first plurality of fibers to be pulled together, which densities the compressible adjunct assembly 6000. In certain instances, the second plurality of fibers are in an outer fibrous tubular member of the compressible adjunct assembly 6000 while the first plurality of fibers are in an inner fibrous tubular member of the compressible adjunct assembly 6000. In such instances, the second plurality of fibers, while shrinking, may cause the outer fibrous tubular member to constrict the inner fibrous tubular member.


Referring now to FIGS. 95-97, a compressible adjunct assembly 6100 is similar in many respects to the compressible adjunct assembly 6000. For example, the compressible adjunct assembly 6100 comprises a plurality of fibrous tubular members 6102-6110 that are aligned concentrically and disposed around, or at least partially around, one another. Also, the compressible adjunct assembly 6100 can be assembled with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010. As discussed in greater detail below, the compressible adjunct assembly 6100 is modified into a desired shape by a thermal pressing process to be used with the surgical stapling and severing instrument 8010, for example.


As illustrated in FIG. 95, the compressible adjunct assembly 6100 is inserted into a mold 6020, which can be heated to a predetermined temperature. A predetermined external pressure is applied to the compressible adjunct assembly 6100 to modify the shape of the compressible adjunct assembly 6100 to the desired shape, as illustrated in FIG. 96. The compressible adjunct assembly 6100 is maintained under the predetermined conditions of temperature and pressure for a predetermined time period after which the compressible adjunct assembly 6100 is allowed to cool or is actively cooled below the predetermined temperature while the external pressure is maintained. Finally, the external pressure is removed, as illustrated in FIG. 96. Additional details of a thermal pressing process are described in U.S. patent application Ser. No. 14/187,383, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING IMPLANTABLE LAYERS FOR USE WITH SURGICAL FASTENING INSTRUMENTS, and filed Feb. 24, 2014, now U.S. Patent Application Publication No. 2015/0238185, the entire disclosure of which is incorporated herein by reference.


Referring again to FIGS. 95-97, one or more of the fibrous tubular members 6102-6110 of the compressible adjunct assembly 6100 has a plurality of fibers that comprises a biocompatible material with a glass transition temperature “Tg”. The predetermined temperature of the process described above is set to be greater than or equal to the glass transition temperature “Tg” but lower than the melting temperature of the biocompatible material. As illustrated in FIG. 96, a modifying member 6122 is employed to apply the predetermined external pressure to the compressible adjunct assembly 6100. The predetermined external pressure is set to a pressure sufficient to modify the compressible adjunct assembly 6100 to the desired shape. The value of the predetermined external pressure depends in part on the size of the mold 6120, the original size and/or shape of the compressible adjunct assembly 6100, and/or the desired size and/or shape of the compressible adjunct assembly 6100, for example.


In at least one instance, the predetermined pressure is maintained for approximately 10 minutes at the predetermined temperature and/or for approximately 10 minutes at a temperature below the predetermined temperature, for example. In certain instances, the predetermined pressure can be maintained for a period of time from about 30 seconds to about 8 hours, for example, at the predetermined temperature and/or for a period of time from about 30 seconds to about 8 hours, for example, at a temperature below the predetermined temperature. Other time periods for maintaining the predetermined temperature and/or pressure are contemplated by the present disclosure.


In certain instances, only the outer fibrous tubular member 6102 includes a biocompatible material comprising a glass transition temperature “Tg” below the predetermined temperature. Nonetheless, the modification to the outer fibrous tubular member 6102 by the thermal pressing process can be sufficient to cause the outer fibrous tubular member 6102 to hold the remaining fibrous tubular members 6104-6110, disposed within the outer fibrous tubular member 6102, in the desired shape.


In certain instances, the desired shape of the compressible adjunct assembly 6100 may comprise square-shaped or a rectangular transverse cross-sectional area. Other shapes are contemplated by the present disclosure. In at least one instance, the compressible adjunct assembly 6100 comprises a transverse cross-sectional area in the shape of a rectangular prism with edges and ends tapered flat or smashed flat for attachment to and/or alignment with an anvil such as, for example, the anvil 8014, and/or a staple cartridge such as, for example, the staple cartridge 10000.


Referring now to FIGS. 98-100, a compressible adjunct assembly 6200 is similar in many respects to the compressible adjunct assemblies 6000 and 6100. For example, the compressible adjunct assembly 6200 comprises a plurality of fibrous tubular members that are aligned concentrically and disposed around, or at least partially around, one another. Also, the compressible adjunct assembly 6200 is shrunk or constricted into a compact semi-organized or disorganized structure causing the individual fibrous tubular members to lose their uniform tubular frames and instead adopt irregular shapes with bulges 6214 and depressions 6216, as illustrated in FIG. 100, that improve the structural integrity of the compressible adjunct assembly 6200. Also, like the compressible adjunct assembly 6100, the compressible adjunct assembly 6200 has been transformed from an initial generally tubular shape to a desired shape, as illustrated in FIG. 99, during a thermal pressing process. The assembly 6200 is suitable for assembly with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010.


Referring to FIG. 98, the compressible adjunct assembly 6200 is assembled with a staple cartridge 6202 by inserting an attachment portion 6204 of the compressible adjunct assembly 6200 into an elongate slot 6206 of the staple cartridge 6202. The attachment portion 6204 is slightly larger than the elongate slot 6206. Accordingly, the attachment portion 6204 is deformed as it is inserted into the elongate slot 6206 and the friction built between the deformed attachment portion 6204 and the walls of the elongate slot 6206 holds the compressible adjunct assembly 6200 against and/or adjacent to a cartridge deck 6208 of the staple cartridge 6202. The attachment portion 6204 includes a laterally-extended apex portion 6210, as illustrated in FIG. 99, which improves the attachment of the compressible adjunct assembly 6200 to the staple cartridge 6202. In certain instances, additional or alternative attachment techniques can be employed to releasably attach the compressible adjunct assembly 6200 to the staple cartridge 6202. In at least one instance, a biocompatible glue can replace the attachment portion 6204 or can be used in addition to the attachment portion 6204. In the latter instance, the biocompatible glue can be applied to the attachment portion 6204 prior to its insertion into the elongate slot 6206, for example.


Further to the above, the compressible adjunct assembly 6200 includes a first compressible portion 6232 and a second compressible portion 6234. An elongate slot or a channel 6230 is defined between the first compressible portion 6232 and the second compressible portion 6234. The elongate slot 6230 extends, or at least partially extends, along a length of the elongate slot 6206 of the staple cartridge 6202 when the compressible adjunct assembly is assembled with the staple cartridge 6202. The attachment portion 6204 protrudes from a base 6236 defined at the bottom of the elongate slot 6230, as illustrated in FIG. 99. As the firing assembly 9090 (FIG. 3) is advanced to deploy the staples into the compressible adjunct assembly 6200 and the tissue captured by the surgical stapling and severing instrument 8010, the cutting edge 9116 (FIG. 3) is driven through the elongate slot 6230. In addition, the cutting edge 9116 may cut through the attachment portion 6204.


In certain instances, the attachment portion 6204 is torn from the base 6236 to release the compressible adjunct assembly 6200 from the staple cartridge 6202. Alternatively, the attachment portion 6204 is pulled out of the elongate slot 6206 of the staple cartridge 6202 as the compressible adjunct assembly 6200 is released from the staple cartridge 6202. In certain instances, the base 6236 remains intact, or at least partially intact, after the compressible adjunct assembly 6200 is released from the staple cartridge 6202. In such instances, the base 6236 continues to connect the first compressible portion 6232 and second compressible portion 6234 after the release is completed. Alternatively, the base 6236 can be severed or torn, which causes the first compressible portion 6232 and second compressible portion 6234 to be separated from one another.


The attachment portion 6204 continuously extends along a length of the elongate slot 6230. In certain instances, the attachment portion 6204 is divided into a plurality of attachment members that are spaced apart from one another and arranged longitudinally along a length of the elongate slot 6230. In at least one instance, the plurality of attachment members are equidistant from one another. Alternatively, the plurality of attachment members can be arranged closer to each other in a first portion of the elongate slot 6230 than a second portion of the elongate slot 6230. In certain instances, the attachment members can be concentrated at a proximal portion, a distal portion, and/or a central portion of the elongate slot 6230, for example.


In at least one instance, one or more of the plurality of attachment members may comprise a top surface with a rectangular, or an at least substantially rectangular, shape. Other shapes are contemplated by the present disclosure such as, for example, a circular shape or a dome shape. Like the attachment portion 6204, one or more of the attachment members may include a laterally extending end.


Referring to FIG. 101, one or more of the fibrous tubular members and/or fibrous constructs of the compressible adjunct assembly 6000 includes a first plurality of fibers 6050 comprised of a first biocompatible material, such as VICRYL, for example, and a second plurality of fibers 6052 comprised of a second biocompatible material that is different from the first biocompatible material, such as PDS, for example. As illustrated in FIG. 101, the plurality of second fibers 6052 can be melted and resolidified to bond and reinforce the plurality of first fibers 6050.


In certain instances, the compressible adjunct assembly 6000 can be heated to a predetermined temperature that is equal to or greater than the melting temperature of the second biocompatible material but less than the melting temperature of the first biocompatible material. In such instances, the plurality of second fibers 6052 are melted. The melted material flow along, onto, and/or between the plurality of first fibers 6050. Upon cooling, the melted fibers 6052 bond to the fibers 6050 and interconnect adjacent fibers thereby reinforcing the structure of the compressible adjunct assembly 6000, as illustrated in FIG. 101.


Referring to FIG. 102, a compressible adjunct assembly 6200 includes biocompatible fibers 6302 that are entangled to form a three-dimensional structure. In addition, the compressible adjunct assembly 6200 includes a bonding medium 6310 that defines nexus points or bonding nodes 6304 that reinforce the three-dimensional structure of the compressible adjunct assembly 6200. The bonding nodes 6304 include adjacent portions of the fibers 6302 that are surrounded, or at least partially surrounded, by the bonding medium 6310 which affixes such adjacent portions of the fibers 6302.


Referring again to FIG. 102, a first fiber 6302′ extends over a second fiber 6302″, while the bonding medium 6310 extends between adjacent portions of the fibers 6302′ and 6302″. The bonding medium 6310 is attached to the adjacent portions of the fibers 6302′ and 6302″ defining a bonding node 6304′. Other arrangements of the fibers 6302 and the bonding nodes 6304 are contemplated by the present disclosure. In at least one instance, the bonding medium 6310 may join an end portion of one fiber with an intermediate portion of another fiber to define a bonding node, for example.


The bonding nodes 6304 define load bearing zones within the compressible adjunct assembly 6200, which are characterized by an increased density and/or a greater stiffness compared to surrounding zones which lack the bonding nodes 6304. The load bearing zones can be employed as attachment regions for securing the compressible adjunct assembly 6200 to a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010.


In certain instances, a first compressible adjunct assembly 6200 can be assembled with the anvil 8014 and a second compressible adjunct assembly 6200 can be assembled with the staple cartridge 10000 such that tissue is captured between the first and second compressible adjunct assemblies 6300 when the surgical stapling and severing instrument 8010 is in a closed configuration. Also, a plurality of staples can be deployed into the compressible adjunct assembly 6200 to fasten tissue captured by the surgical stapling and severing instrument 8010, as described in greater detail elsewhere in the present disclosure.


Referring again to FIG. 10A, the compressible adjunct assembly 6200 is fabricated from a plurality of the fibers 6302 and a plurality of bonding fibers that are reshaped or altered to form the bonding medium 6310. The fibers 6302 and the bonding fibers are entangled into a three-dimensional structure that ultimately forms the compressible adjunct assembly 6200. The fibers 6302 are fabricated, or at least partially fabricated, from a first biocompatible material with a first melting point, while the bonding fibers are fabricated, or at least partially fabricated, from a second biocompatible material with a second melting point that is less than the first melting point of the first biocompatible material. Furthermore, the fibers 6302 lack or exclude the second biocompatible material of the bonding fibers; however, small amounts of the second biocompatible material can be present in the fiber 6302 in certain embodiments.


In certain instances, the fibers 6302 can be fabricated from a plurality of biocompatible materials with melting points that are greater than the melting point(s) of the biocompatible material(s) of the bonding fibers. Similarly, the bonding fibers can be fabricated from a plurality of biocompatible material with melting points that are less than the melting point(s) of the biocompatible material(s) of the fibers 6302.


Further to the above, the three-dimensional structure of the entangled fibers 6302 and bonding fibers can be subjected to one or more thermal pressing treatments. Predetermined pressures and/or temperatures are applied to a three-dimensional structure of the entangled fibers 6302 and bonding fibers resulting in the formation of the compressible adjunct assembly 6200. In certain instances, the pressure can be removed and the three-dimensional structure is only subjected to the predetermined temperature. In other instances, the pressure can be substituted with tension that may stretch the three-dimensional structure. In certain instances, various combinations of pressure and tension can be employed to mold the three-dimensional structure into a desired shape.


Referring to FIG. 103, the mold 6120 and the modifying member 6122 are employed to implement the thermal pressing treatment. The three-dimensional structure, which ultimately becomes, the compressible adjunct assembly 6200, is inserted into the mold 6120. The modifying member 6122 is then operated to apply a predetermined pressure to the three-dimensional structure to bring the three-dimensional structure to a desired shape. The applied pressure brings adjacent portions of the fibers 6302 and the bonding fibers into a closer proximity in preparation for the transition of the bonding fibers into the bonding medium 6310.


While the predetermined pressure is maintained, the mold is heated to bring the three-dimensional structure to the predetermined temperature. The predetermined temperature is a temperature, or range of temperatures, capable of melting the bonding fibers but not the fibers 6302. Said another way, the predetermined temperature is any temperature, or range of temperatures, greater than or equal to the melting point of the second biocompatible material but less than the melting point of the first biocompatible material. The melted bonding fibers flow along, onto, and/or between the fibers 6302.


As the system is actively cooled or allowed to cool to a temperature lower than the predetermined temperature, the bonding medium 6310 is resolidified causing the formation of the bonding nodes 6304 between adjacent portions of the fibers 6302. Furthermore, the bonding medium 6310 may coat, or at least partially coat, at least portions of the fibers 6302 along their lengths, as illustrated in FIG. 104. The predetermined pressure can be maintained during cooling. The predetermined pressure can also be maintained for a predetermined period of time after the cooling is completed. When the pressure is removed, the newly formed bonding nodes 6304 maintain, or at least partially maintain, the new shape of the compressible adjunct assembly 6200.


In certain instances, the predetermined pressure causes the three-dimensional structure to decrease in height. In at least one instance, the reduction in height is selected from a range of values of about 1% to about 200%, for example. Other values for the reduction in height that is caused by the application of the predetermined pressure are contemplated by the present disclosure. Similar reductions in length and/or width are also contemplated by the present disclosure. In instances where tension is applied, one or more of the dimensions of three-dimensional structure may experience an increase in value. In any event, as illustrated in FIG. 103, the resulting compressible adjunct assembly 6200 comprises a shape suitable for assembly with a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010.


In at least one instance, the predetermined pressure is maintained for approximately 10 minutes before heating, approximately 10 minutes at the predetermined temperature, and/or approximately 10 minutes at a temperature below the predetermined temperature, for example. In certain instances, the predetermined pressure can be maintained for a period of time from about 30 seconds to about 8 hours, for example, before heating, for a period of time from about 30 seconds to about 8 hours, for example, at the predetermined temperature, and/or for a period of time from about 30 seconds to about 8 hours, for example, at a temperature below the predetermined temperature. Other time periods for maintaining the predetermined temperature and/or pressure are contemplated by the present disclosure.


As illustrated in FIG. 102, the fibers 6302 of the compressible adjunct assembly 6200 are disorganized and randomly entangled. Accordingly, the bonding nodes 6304 of the compressible adjunct assembly 6200 are also disorganized and randomly positioned within the compressible adjunct assembly 6200. Alternatively, it may be desirable to produce compressible adjunct assemblies with bonding nodes that are organized into a planned framework. To do so, the fibers of the three-dimensional structure are systematically organized in a planned pattern. In at least one instance, the fibers are knitted or woven into a matrix or network with intersection points that are designed to give rise to bonding nodes.


Referring to FIG. 104, a compressible adjunct assembly 6400 is similar in many respects to the compressible adjunct assembly 6200. For example, the compressible adjunct assembly 6400 can be releasably attached to a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010. In addition, the compressible adjunct assembly 6400 includes first fibers 6402 spaced apart from one another and generally arranged in a first direction, and second fibers 6403 which are also spaced apart from one another and generally arranged in a second direction intersecting the first direction. The first fibers 6402 and the second fibers 6403 are intertwined forming a matrix or network of fibers with a plurality of intersection points.


The compressible adjunct assembly 6400 also includes bonding fibers that are melted and resolidified to form a bonding medium 6410 that defines bonding nodes 6404 at the intersection points between the first fibers 6402 and the second fibers 6403. A bonding node 6404 may include portions of one or more fibers 6402 and portions of one or more fibers 6403. The bonding fibers can be strategically arranged adjacent to the fibers 6402 and/or 6403 to allow the bonding medium 6410 to flow along, onto, and/or between the fibers 6402 and/or 6403.


Referring again to FIG. 104, the framework defined by the first fibers 6402 and the second fibers 6403 is embedded, or at least partially embedded, in the bonding medium 6410. In certain instances, a bonding node 6404 is formed at an intersection point between a fiber 6402 and a fiber 6403. In certain instances, a bonding node 6404 is formed at an intersection point between three fibers including one fiber 6402 and two fibers 6403, or two fibers 6402 and one fiber 6403. Other bonding nodes 6404 may comprise various other combinations of the fibers 6402 and 6403.


The distance between adjacent fibers of the compressible adjunct assembly 6400 can determine, at least in part, the extent to which such space is filled or bridged by the bonding medium 6410. The greater the distance between adjacent fibers the less likely it is for the melted bonding fibers to bridge the gap between such adjacent fibers. The fluidity of the melted bonding fibers and/or the thickness of the bonding fibers can also determine whether the bonding medium 6410 is capable of filling or bridging a space therebetween. Spaces that remain unfilled define gaps 6408 that can be in different shapes and sizes, as illustrated in FIG. 104. The number and size of the gaps 6408 determine, among other things, the porosity of the compressible adjunct assembly 6400. Accordingly, the porosity of the compressible adjunct assembly 6400 can be increased by increasing the distances between the adjacent fibers. Alternatively, the porosity of the compressible adjunct assembly 6400 can be decreased by decreasing the distances between the adjacent fibers. In at least one instance, a gap 6408 is defined by a plurality of fibers including two of the fibers 6402 and two of the fibers 6403 that intersect to form four bonding nodes 6404 around the gap 6408.


Referring now to FIG. 105, a compressible adjunct assembly 6500 is similar in many respects to the compressible adjunct assemblies 6300 and 6400. For example, the compressible adjunct assembly 6400 can be releasably attached to a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010.


In addition, the compressible adjunct assembly 6500 includes a top portion 6512 and a bottom portion 6514 which is spaced apart from the top portion 6512. A plurality of fibers 6502 and a plurality of fibers 6503 extend between the top portion 6512 and the bottom portion 6514. The fibers 6502 are spaced apart and extend in parallel, or at least substantially in parallel, to one another in a first direction defined by an axis A-A. Likewise, the fibers 6503 are spaced apart and extend in parallel, or at least substantially in parallel, to one another in a second direction defined by an axis B-B. The top portion 6512 and the bottom portion 6514 are parallel, or at least substantially parallel, to one another. The axis A-A intersects the top portion 6512 and the bottom portion 6514 at an angle α1 while the axis B-B intersects the top portion 6512 and the bottom portion 6514 at an angle α2. The angle α2 is greater than the angle α1.


In certain instances, the angle α2 is greater than 90° and the angle α1 is less than 90°, for example. In at least one instance, the angle α1 is selected from a range of about 45° to about 85°, for example. In at least one instance, the angle α2 is selected from a range of about 135° to about 175°, for example. In at least one instance, the angle α1 is about 60°, for example. In at least one instances, the angle α2 is about 150°, for example. Other values for the angles α1 and α2 are contemplated by the present disclosure.


Further to the above, each fiber 6502 includes an intermediate portion 6502b extending between two end portions 6502a and 6502c. Likewise, each fiber 6503 includes an intermediate portion 6503b extending between two end portions 6503a and 6503c. The intermediate portions 6502b and 6503b intersect forming an angle α3 therebetween, as illustrated in FIG. 105. The angle α3 s less than 90°. In certain instances, the angle α3 is selected from a range of about 15° to about 85°, for example. In at least one instance, the angle α3 is about 35°, for example. Other values for the angle α3 are contemplated by the present disclosure.


Referring again to FIG. 105, an end portion 6502a of a fiber 6502 intersects an end portion 6503a of an adjacent fiber 6503 and defines an angle α4 therebetween. The end portions 6502a and 6503a are anchored to the top portion 6512 at their points of intersection. Likewise, an end portion 6502c intersects an end portion 6503c defining an angle α5 therebetween. The end portions 6502c and 6503c are anchored to the bottom portion 6514 at their points of intersection. In certain instances, the angles α4 and α5 are the same, or at least substantially the same. In at least one instance, the angles α4 and α5 are selected from a range of about 15 to about 85, for example.


Further to the above, the compressible adjunct assembly 6500 includes a bonding medium 6510 that defines nexus points or bonding nodes that reinforce the three-dimensional structure of the compressible adjunct assembly 6500. Bonding nodes 6504a include intersecting the end portions 6502a and 6503a that are surrounded, or at least partially surrounded, by the bonding medium 6510 which affixes the intersecting end portions 6502a and 6503a. Likewise, bonding nodes 6504c include intersecting the end portions 6502c and 6503c that are surrounded, or at least partially surrounded, by the bonding medium 6510 which affixes the intersecting end portions 6502c and 6503c. The compressible adjunct assembly 6500 includes bonding nodes 6504b that include intersecting the intermediate portions 6502b and 6503b that are surrounded, or at least partially surrounded, by the bonding medium 6510 which affixes the intersecting intermediate portions 6502b and 6503b. Like the compressible adjunct assembly 6200, the compressible adjunct assembly 6500 also includes bonding fibers that are melted and resolidified to form the bonding medium 6510 in the same, or at least substantially the same, manner the bonding medium 6310 is formed.


Referring again to FIG. 105, the bonding nodes 6504a are aligned in a top row 6516, the bonding nodes 6504c are aligned in a bottom row 6518, and the bonding nodes 6504b are aligned in an intermediate row 6520 between the top row 6516 and the bottom row 6518. The intermediate row 6520 of the bonding nodes 6504b is out of alignment with the top row 6516 of the bonding nodes 6504a and the bottom row 6518 of the bonding nodes 6504c. Said another way, a bonding node 6504b is aligned with a first gap between two consecutive bonding nodes 6504a, and a second gap between two consecutive bonding nodes 6504c. This arrangement improves the stability of the compressible adjunct assembly 6500. The intermediate row 6520 is equidistant, or at least substantially equidistant, from the rows 6516 and 6518. In certain instances, the intermediate row 6520 is closer to the top row 6516 than the bottom row 6518. Alternatively, in other instances, the intermediate row 6520 can be closer to the bottom row 6518 than the top row 6516. The reader will appreciate that the terms top and bottom as used herein are for convenience purposes only. The compressible adjunct assembly 6500 can be turned up side down such that the bottom row 6516 is on the top and the top row 6518 is on the bottom.


Referring again to FIG. 105, the bonding medium 6510 at the bonding nodes 6504b prevents, or at least resists, translation of the transecting fibers 6502 and 6503 relative to one another. This arrangement can, at least in part, increase the column strength of the compressible adjunct assembly 6500 and/or improve its spring rate. Although the compressible adjunct assembly 6500 is depicted to only have three rows of bonding nodes. It is understood that this number of rows is provided as an example. In certain instances, the compressible adjunct assembly 6500 may include only two rows of bonding nodes. Alternatively, the compressible adjunct assembly 6500 may include four or more rows of bonding nodes.


In certain instances, a first building block of the compressible adjunct assembly 6500 includes five bonding nodes, wherein a central bonding node 6504b is suspended between two first bonding nodes 6504a and two first bonding nodes 6504c. The central bonding node 6504b is tethered to each of the four bonding nodes 6502a and 6502c by a portion of either a fiber 6502 or a fiber 6503. Tethering portions 6522 are not covered by the bonding medium 6510. A second building block of the compressible adjunct assembly 6500 may be positioned on a first side of the first building block. The second building block may also be comprised of five bonding nodes, and may share bonding nodes with the first building block. Moreover, a third building block of the compressible adjunct assembly 6500 may be positioned on a second side of the first building block opposite the first side, for example, such that the first building block is positioned between the second building block and the third building block. The third building block may also be comprised of five bonding nodes, and may share bonding nodes with the first building block.


Referring again to FIG. 105, as described above, the tethering portions 6522 of the fibers 6502 and 6503 are not covered by the bonding medium 6510. Alternatively, one or more of the tethering portions 6522 can be covered, or at least partially covered, by the bonding medium 6510 to increase the stiffness of the building blocks of the compressible adjunct assembly 6500, which increases the overall stiffness of the compressible adjunct assembly 6500. It is envisioned that the stiffness of the compressible adjunct assembly 6500 can be controlled by varying the stiffness of the tethering portions 6522 to selectively produce a more or less compressible adjunct 6522.


Referring now to FIG. 106, a compressible adjunct assembly 6600 is similar in many respects to the compressible adjunct assemblies 6300, 6400, and 6500. For example, the compressible adjunct assembly 6600 can be releasably attached to a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010. Also, the compressible adjunct assembly 6600 includes the top portion 6512 and the bottom portion 6514.


Further to the above, the compressible adjunct assembly 6600 includes a plurality of building blocks 6630. As illustrated in FIG. 106, a building block 6630 includes a first fiber 6602, a second fiber 6603, and a bonding fiber. The bonding fiber is melted and resolidified to form a bonding medium 6610 in the same, or at least substantially the same, manner that the bonding mediums 6310, 6410, and 6510 are formed. The fibers 6602 and 6603 in a building block 6630 extend in parallel, or at least substantially in parallel, with one another between the top portion 6512 and the bottom portion 6514. An inner transverse distance “A” separates the fibers 6602 and 6603. The bonding fiber extends, or at least partially extends, between the top portion 6512 and the bottom portion 6514 along a transverse axis Z-Z defined in the space between the fibers 6602 and 6603.


Referring again to FIG. 106, the bonding medium 6610 defines nexus points or bonding nodes 6604 that reinforce the three-dimensional structure of the compressible adjunct assembly 6600. The bonding nodes 6604 include adjacent portions of the fibers 6302 and 6603 that are surrounded, or at least partially surrounded, by the bonding medium 6110 which affixes such adjacent portions of the fibers 6302 and 6603. The fibers 6602 and 6603 are completely embedded in the bonding medium 6610. Alternatively, in certain instances, the fibers 6602 and 6603 are only partially embedded in, or covered by, the bonding medium 6610.


The inner transverse distance “A” within a building block 6630 of the compressible adjunct assembly 6600 can determine, at least in part, the extent to which such space is filled or bridged by the bonding medium 6610. The fluidity of the melted bonding fibers and/or the thickness of the bonding fibers can also determine whether the bonding medium 6610 is capable of filling or bridging the inner transverse distance “A”. Spaces that remain unfilled define gaps 6608 that can be in different shapes and sizes, as illustrated in FIG. 106. The number and size of the gaps 6608 determine, among other things, the porosity of the compressible adjunct assembly 6600. Accordingly, the porosity of the compressible adjunct assembly 6600 within a building block 6630 can be increased by increasing the inner transverse distance “A”. Alternatively, the porosity of the compressible adjunct assembly 6600 within a building block 6630 can be decreased by decreasing the inner transverse distance “A”.


Referring again to FIG. 106, adjacent building blocks 6630 are spaced apart with sufficient space therebetween to prevent flow of the melted bonding fibers between the adjacent building blocks 6630. An intermediate distance “B” is defined between adjacent building blocks 6630. The intermediate distance “B” is greater than the inner transverse distance “A”. The intermediate distance “B” is also greater than an outer transverse distance “C” defined by the building blocks 6630. In at least one instance, the ratio of the outer transverse distance “C” to the intermediate distance “B” is any ratio selected from a range of about 0.1, for example, to about 0.9, for example. In at least one instance, the ratio of the outer transverse distance “C” to the intermediate distance “B” is any ratio selected from a range of about 0.2, for example, to about 0.8, for example. In at least one instance, the ratio of the outer transverse distance “C” to the intermediate distance “B” is any ratio selected from a range of about 0.3, for example, to about 0.7, for example. In at least one instance, the ratio of the outer transverse distance “C” to the intermediate distance “B” is about 0.4, for example. Other values for the ratio of the outer transverse distance “C” to the intermediate distance “B” are contemplated by the present disclosure.


Referring now to FIG. 107, a compressible adjunct assembly 6700 is similar in many respects to the compressible adjunct assemblies 6300, 6400, 6500, and 6600. For example, the compressible adjunct assembly 6700 can be releasably attached to a jaw member of a surgical stapling and severing instrument such as, for example, the anvil 8014 and/or the staple cartridge 10000 of the surgical stapling and severing instrument 8010. Also, the compressible adjunct assembly 6700 includes the top portion 6512, the bottom portion 6514, and a plurality of building blocks 6730 that include the first fiber 6602 and the second fiber 6603. In addition, the building blocks 6730 include angled bonding fibers that are melted and resolidified to form a bonding medium 6710 in the same, or at least substantially the same, manner that the bonding mediums 6310, 6410, 6510 and 6610 are formed.


Referring now to FIG. 107, the bonding medium 6710 within a building block 6730 extends, or at least partially extends, along an axis z-z that transects the top portion 6512 and the bottom portion 6514 at an angle α1. The angle α1 is less than 90°. In certain instances, the angle α1 is in a range of about 15° to about 85°. In at least one instance, the angle α1 is about 45°. Other values for the angle α1 are contemplated by the present disclosure.


The bonding medium 6710 within a building block 6730 includes a first bonding portion 6710a extending between the top portion 6512 and a first fiber 6602 on a first side of the fiber 6602. A second bonding portion 6710b extends between a second side of the first fiber 6602 and a first side of a fiber 6603 extending in parallel, or at least substantially in parallel, with the first fiber 6602. In addition, a third bonding portion 6710c extends between a second side of the second fiber 6603 and the bottom portion 6214. The first bonding portion 6710a affixes the first fiber 6602 to the top portion 6512 and the third bonding portion 6710c affixes the second fiber 6603 to the bottom portion 6514. In addition, the second bonding portion 6710b affixes the first fiber 6602 to the second fiber 6603. Such an arrangement stabilizes the building block 6730 by providing additional anchors for the fibers 6602 and 6603 in the form of the bonding portions 6710a and 6710c, respectively, and by affixing the first fiber 6602 to the second fiber 6603 via the second bonding portion 6710b, as illustrated in FIG. 107.


Further to the above, the fiber portion 6710a, 5710b, and 6710c extend along an axis z-z at an intersection angles α2 and α3. In at least one instance, the intersection angles α2 and α3 are the same. In at least one instance, the intersection angles α2 and α3 are different. In at least one instance, one or both of the intersection angles α2 and α3 are in a range of about 105° to about 175°, for example. In at least one instance, one or both of the intersection angles α2 and α3 are in a range of about 125° to about 165°, for example. Other values for the intersection angles α2 and α3 are contemplated by the present disclosure.


Further to the above, an implantable layer, or adjunct, can be manufactured and/or modified utilizing any suitable process to provide the layer with desirable properties. In various instances, an implantable adjunct can be manufactured utilizing fused filament fabrication, for example. In at least one such instance, a polymeric filament, for example, is fed into an extruder, heated, and then forced through a nozzle into a mold and/or directly onto a staple cartridge. The filament is fed into an extruder by a pinch system which can control the direction and/or rate in which the filament is fed into the extruder. The filament is at least partially melted by a heater block. The heater block can be positioned upstream with respect to the nozzle and/or within the nozzle. The mold and/or staple cartridge is positioned on a movable bed which can be moved relative to the nozzle. Such a fused filament fabrication process can be used to control the porosity within the implantable adjunct. In at least one instance, the heated polymeric filament is dispensed in interconnected patterns utilizing triangles, arcs, hexagonal shapes, and/or any suitable polygonal shapes, for example. Moreover, the heated polymeric material can be dispensed in one layer or a plurality of layers stacked on one another. The pattern(s) and the number of layers in which the polymeric material is dispensed can control the porosity of the implantable adjunct. A more porous implantable adjunct can promote tissue in-growth into the implantable adjunct. In addition, such a process can create an implantable adjunct without using a lyophilization process and/or dioxane, for example.


Further to the above, a laser process can be utilized to create openings in an implantable adjunct. In at least one instance, a laser can be utilized to cut holes into an extruded film comprised of PGA and/or PCL, for example. The film can comprise a thickness of approximately 0.003″, for example, and the holes can comprise a diameter of approximately 0.001″, for example. The holes can be microvoids, for example, and can comprise any suitably-shaped perimeter, such as round, hexagonal, and/or triangular, for example. Any suitable number of holes can be created. For example, hundreds of holes could be utilized in an implantable adjunct. The holes can be uniformly distributed, or distributed in any suitable manner. In various instances, the holes can be distributed in a pattern including rows which are aligned laterally, longitudinally, and/or diagonally, for example. In various instances, several layers of extruded film can be stacked and bonded to one another to form the implantable adjunct. For instance, four or five film layers could be used, for example. Also, for instance, the film layers can be bonded by heating the film layers above the glass transition temperature of at least one of the film layers without utilizing an adhesive. The layers of film can have the same pattern of holes, or different patterns. In certain instances, at least one of the layers has apertures while at least one of the layers does not. In various instances, the laser process could be utilized to remove bulk shapes from the implantable adjunct, or a layer of the implantable adjunct. In at least one such instance, a line could be formed in a layer along the longitudinal cut line and/or toward the outer perimeter of the implantable adjunct, for example, to create a stepped effect, especially when such a layer is stacked with and bonded to another layer not having such bulk shapes removed. In various instances, the laser process can be utilized to create a feathering effect along the outer edges of the implantable adjunct and/or along the inner lines discussed above, for example. For instance, the laser process can be utilized to reduce the thickness of the implantable adjunct along the perimeter, and/or within an opening defined in the implantable adjunct, from approximately 0.006″ to approximately 0.002″ to 0.003″, for example. Moreover, the laser process can be utilized to make any other suitable localized changes to the implantable adjunct. For instance, the density of the holes in the portions of the adjunct that are captured by the staples can be tuned to soften the adjunct in those areas. In at least one instance, the holes can be limited to certain zones. For example, stronger, non-hole zones can be created in the adjunct which are aligned with the staple legs while weaker, hole-zones are aligned with the staple crowns or bases. The reverse of the above-described example is also possible. Although a laser process can be utilized to modify an implantable adjunct comprised of film, for example, the laser process could be utilized to modify an implantable adjunct comprised of foam and/or melt-blown non-woven material, for example. In addition to or in lieu of the laser process described above, water-cutting, stamping, punching and/or piercing, for example, could be utilized. Also, in addition to or in lieu of the laser process described above, an implantable adjunct can undergo a dimpling process which can locally stretch the adjunct. The dimples can have a thickness that is thinner than the non-dimpled areas of the adjunct. The dimples can be used in the same or similar manner as the holes to achieve the same or similar results. In various instances, the dimples and/or holes can be present in any suitable layer of an adjunct. In at least one instance, the dimples and/or holes are buried, or present in an inner layer, of the adjunct, for example. In certain instances, the selective use of low molecular weight polymers within an adjunct comprised of high molecular weight polymers can be utilized to create softer regions within the adjunct. Ultimately, the processes described above can be utilized to create a compliant, highly elastic, and stretchable implantable adjunct having a porosity which is sufficient to promote tissue ingrowth.


EXAMPLES
Example 1

A method of applying an implantable layer to a cartridge body comprising the steps of obtaining a staple cartridge body including staple cavities, heating a polymeric material, and accelerating the heated polymeric material toward the staple cartridge body such that an implantable layer is formed over the staple cavities.


Example 2

The method of Example 1, further comprising the step of inserting staples into the staple cavities before the accelerating step.


Example 3

The method of Examples 1 or 2, further comprising the steps of cooling the heated polymeric material and trimming the polymeric material after the cooling step.


Example 4

The method of Example 3, wherein the cartridge body comprises a periphery, and wherein the implantable layer is trimmed according to the periphery during the trimming step.


Example 5

The method of Examples 1, 2, 3, or 4, wherein the heating step comprises heating the polymeric material above its glass transition temperature.


Example 6

The method of Examples 1, 2, 3, 4, or 5, wherein the heating step comprises heating the polymeric material above its melt temperature.


Example 7

The method of Examples 1, 2, 3, 4, 5, or 6, further comprising the steps of heating a second polymeric material and accelerating the second heated polymeric material toward the staple cartridge body such that a second implantable layer is formed over the staple cavities.


Example 8

The method of Examples 1, 2, 3, 4, 5, 6, or 7, wherein the heated polymeric material comprises a first heated polymeric material, and wherein the accelerating step comprises accelerating a second heated polymeric material with the first heated polymeric material toward the staple cartridge body.


Example 9

The method of Examples 1, 2, 3, 4, 5, 6, 7, or 8, wherein the method is performed without mixing the polymeric material with a solvent.


Example 10

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, or 9, wherein the method is performed without mixing the polymeric material with dioxane.


Example 11

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, wherein the accelerating step comprises accelerating the polymeric material utilizing an electric charge.


Example 12

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11, wherein the accelerating step comprises accelerating the polymeric material utilizing a voltage differential.


Example 13

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, wherein the accelerating step comprises accelerating the polymeric material utilizing a spinning member.


Example 14

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or 13, wherein the accelerating step comprises pouring the polymeric material onto the staple cartridge body utilizing gravity.


Example 15

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14, wherein the accelerating step comprises the steps of applying a translational acceleration to the polymeric material and applying a rotational acceleration to the polymeric material.


Example 16

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15, wherein the accelerating step comprises creating a random, porous polymeric structure on the staple cartridge body.


Example 17

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, wherein the heating step comprises liquefying the polymeric material.


Example 18

The method of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, wherein the heating step does not comprise liquefying the polymeric material.


Example 19

A method of applying an implantable layer to a cartridge body comprising the steps of obtaining a staple cartridge body including staple cavities, heating a polymeric material, and applying the heated polymeric material directly onto the staple cartridge body such that an implantable layer is formed over the staple cavities.


Example 20

A method of applying an implantable layer to a cartridge body comprising the steps of obtaining a staple cartridge body including staple cavities, heating a material, and accelerating the heated material toward the staple cartridge body such that an implantable layer is formed over the staple cavities.


Example 21

A staple cartridge assembly comprising a cartridge body comprising a deck, a plurality of staples and an implantable layer positioned over the deck. The implantable layer comprises a first plurality of fibers comprised of a first material having a first thermal transition temperature and a second plurality of fibers comprised of a second material having a second thermal transition temperature, wherein the second thermal transition temperature is lower than the first thermal transition temperature, wherein the second material is intermixed with the first material, and wherein the second fibers are contracted within the layer during a process which exposes the layer to a process temperature which exceeds the second thermal transition temperature.


Example 22

The staple cartridge assembly of Example 21, wherein the second plurality of fibers are arranged in a structural lattice frame, and wherein the structural lattice frame contracts during the process.


Example 23

The staple cartridge assembly of Examples 21 or 22, wherein the second material comprises polydioxanone.


Example 24

The staple cartridge assembly of Examples 21, 22, or 23, wherein the first material comprises polyglycolic acid.


Example 25

The staple cartridge assembly of Examples 21, 22, 23, or 24, wherein the implantable layer is part of an implantable layer assembly which further comprises a laminate film.


Example 26

The staple cartridge assembly of Examples 21, 22, 23, 24, or 25, wherein the process temperature is less than the first thermal transition temperature.


Example 27

A staple cartridge assembly comprising a cartridge body comprising a deck, a plurality of staples, and an implantable layer positioned over the deck. The implantable layer comprises a mesh comprised of a first material having a first thermal transition temperature and fibers comprised of a second material having a second thermal transition temperature, wherein the first thermal transition temperature is lower than the second thermal transition temperature, wherein the fibers are interwoven with the mesh, and wherein the mesh is constricted during a process which exposes the layer to a process temperature which exceeds the first thermal transition temperature.


Example 28

The staple cartridge assembly of Example 27, wherein the first material comprises polydioxanone.


Example 29

The staple cartridge assembly of Examples 27 or 28, wherein the second material comprises polyglycolic acid.


Example 30

The staple cartridge assembly of Examples 27, 28, or 29, wherein the implantable layer is part of an implantable layer assembly which further comprises a laminate film.


Example 31

The staple cartridge assembly of Examples 27, 28, 29, or 30, wherein the process temperature is less than the second thermal transition temperature.


Example 32

A staple cartridge assembly comprising a cartridge body comprising a deck, a plurality of staples, and an implantable layer positioned over the deck. The implantable layer comprises a first plurality of fibers comprised of a first material having a first glass transition temperature and a second plurality of fibers comprised of a second material having a second glass transition temperature, wherein the second glass transition temperature is lower than the first glass transition temperature, wherein the second material is interwoven with the first material, and wherein the second glass transition temperature has been previously exceeded to contract the second fibers.


Example 33

The staple cartridge assembly of Example 32, wherein the first material comprises polydioxanone.


Example 34

The staple cartridge assembly of Examples 32 or 33, wherein the second material comprises polyglycolic acid.


Example 35

The staple cartridge assembly of Examples 32, 33, or 34, wherein the implantable layer is part of an implantable layer assembly which further comprises a laminate film.


Example 36

A method of manufacturing an implantable layer, the method comprising the steps of obtaining first fibers comprised of a first material having a first thermal transition temperature, obtaining second fibers comprised of a second material having a second thermal transition temperature, wherein the second thermal transition temperature is lower than the first thermal transition temperature, intermixing the first fibers with the second fibers, and heating the second fibers to a processing temperature which exceeds the second thermal transition temperature so that the second fibers contract after the intermixing step.


Example 37

The method of Example 36, wherein the intermixing step comprises interweaving the first fibers and the second fibers.


Example 38

The method of Examples 36 or 37, wherein the processing temperature does not exceed the first thermal transition temperature.


Example 39

The method of Examples 36, 37, or 38, wherein the intermixing step comprises interweaving the first fibers into a mesh of the second fibers.


Example 40

A compressible adjunct for use with a surgical instrument, wherein the compressible adjunct comprises a hollow fibrous construct and a core fibrous construct housed within the hollow fibrous construct, wherein the hollow fibrous construct comprises at least one biocompatible material that experienced at least one transition from a more ordered phase to a less ordered phase in response to heating the hollow fibrous construct to a predetermined temperature.


Example 41

The compressible adjunct of Example 40, wherein the at least one transition constricts the hollow fibrous construct around the core fibrous construct.


Example 42

The compressible adjunct of Examples 40 or 41, wherein the at least one transition comprises an increase in entropy.


Example 43

The compressible adjunct of Examples 40, 41, or 42, wherein the at least one biocompatible material is an elastomer.


Example 44

The compressible adjunct of Examples 40, 41, 42, or 43, wherein the core fibrous construct comprises the at least one biocompatible material.


Example 45

The compressible adjunct of Examples 40, 41, 42, 43, or 44, wherein the hollow fibrous construct is transitioned from a first size to a second size smaller than the first size in response to the at least one transition.


Example 46

The compressible adjunct of Examples 40, 41, 42, 43, 44, or 45, further comprising an elongate slot, wherein the elongate slot extends along a length of the hollow fibrous construct, and wherein the elongate slot extends along a length of the core fibrous construct.


Example 47

A compressible adjunct for use with a surgical instrument, the compressible adjunct comprising a hollow fibrous construct comprising a first fibrous tubular member defining a space within and a second fibrous tubular member treated with at least one thermal treatment, wherein the hollow fibrous construct extends at least partially through the space.


Example 48

The compressible adjunct of Example 47, wherein the first fibrous tubular member is shrunk around the second fibrous tubular member in response to the at least one thermal treatment.


Example 49

The compressible adjunct of Examples 47 or 48, wherein the first fibrous tubular member comprises at least one biocompatible material that experienced at least one transition from a more ordered phase to a less ordered phase in response to the at least one thermal treatment.


Example 50

The compressible adjunct of Examples 47, 48, or 49, wherein the hollow fibrous construct comprises at least one biocompatible material that experienced a temporary phase transition in response to the at least one thermal treatment.


Example 51

The compressible adjunct of Examples 49 or 50, wherein the at least one biocompatible material is an elastomer.


Example 52

The compressible adjunct of Examples 49, 50, or 51, wherein the at least one biocompatible material is absorbable.


Example 53

The compressible adjunct of Examples 47, 48, 49, 50, 51, or 52, wherein the hollow fibrous construct comprises a first biocompatible material that experienced a temporary phase change in response to the at least one thermal treatment and a second biocompatible material that remained in a solid phase during the at least one thermal treatment.


Example 54

The compressible adjunct of Example 47, wherein the hollow fibrous construct is transitioned from a first size to a second size smaller than the first size in response to the at least one thermal treatment.


Example 55

A method for preparing a compressible adjunct for use with a surgical instrument, the method comprising providing a first fibrous tubular member defining a space there within, providing a second fibrous tubular member sized to fit into the space, inserting the second fibrous tubular member into the space, and effecting an at least one change in at least one of the first fibrous tubular member and the second fibrous tubular member through at least one thermal treatment.


Example 56

The method of Example 55, wherein the effecting step comprises shrinking the first fibrous tubular member around the second fibrous tubular member.


Example 57

The method of Examples 55 or 56, wherein at least one of the first fibrous tubular member and the second fibrous tubular member comprises at least one biocompatible material, and wherein the effecting step comprises effecting a temporary phase change in the at least one biocompatible material.


Example 58

The method of Examples 55, 56, or 57, wherein at least one of the first fibrous tubular member and the second fibrous tubular member comprises at least one biocompatible material, and wherein the effecting step comprises at least one transition in the at least one biocompatible material from a more ordered phase to a less ordered phase.


Example 59

The method of Examples 55, 56, 57, or 58, wherein the effecting step comprises at least one change in size in the at least one of the first fibrous tubular member around the second fibrous tubular member.


Example 60

A staple cartridge assembly comprising a cartridge body comprising a deck, a plurality of staples, and an implantable layer positioned over the deck, wherein the implantable layer comprises a plurality of interwoven fibers, and wherein each fiber comprises a strand having a kinked configuration.


Example 61

The staple cartridge assembly of Example 60, wherein the kinked configuration of the fibers is produced by exposing the fibers to heat.


Example 62

The staple cartridge assembly of Examples 60 or 61, wherein the kinked fibers are interwoven into a first woven zone and a second woven zone, wherein the first woven zone has a first density and the second woven zone has a second density, and wherein the first density is different than the second density.


Example 63

The staple cartridge assembly of Example 62, wherein the implantable layer comprises a perimeter, wherein the second density is greater than the first density, and wherein the second woven zone is defined along the perimeter.


Example 64

The staple cartridge assembly of Example 62, wherein the cartridge body comprises a longitudinal slot configured to receive a cutting portion, wherein the first density is less than the second density, and wherein the first woven zone is aligned with the longitudinal slot.


Example 65

The staple cartridge assembly of Examples 62 or 63, further comprising an anchor extending over the implantable layer to releasably hold the layer to the cartridge body, wherein the second density is greater than the first density, and wherein the anchor is aligned with the second woven zone.


Example 66

The staple cartridge assembly of Example 65, wherein the cartridge body further comprises a longitudinal slot, wherein the longitudinal slot is configured to receive a cutting member, and wherein the cutting member is configured to transect the anchor as the cutting member moves within the longitudinal slot.


Example 67

The staple cartridge assembly of Examples 65 or 66, further comprising a proximal end, wherein the anchor and the second woven zone are adjacent the proximal end.


Example 68

The staple cartridge assembly of Example 67, further comprising a distal end opposite the proximal end, a distal anchor extending over the implantable layer to releasably hold the layer to the cartridge body, and a third woven zone defined in the layer having a third density which is greater than the first density, wherein the distal anchor is aligned with the third woven zone.


Example 69

The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, or 68, wherein the cartridge body comprises a first longitudinal row of staple cavities and a second longitudinal row of staple cavities, wherein the first woven zone is aligned with the first row of staple cavities and the second woven zone is aligned with the second row of staple cavities.


Example 70

The staple cartridge assembly of Examples 60, 61, 62, 63, 64, 65, 66, 67, 68, or 69, wherein the kinked fibers are interwoven into a first woven zone and a second woven zone, wherein the first woven zone has a first modulus of elasticity and the second woven zone has a second modulus of elasticity, and wherein the first modulus of elasticity is different than the second modulus of elasticity.


Example 71

The staple cartridge assembly of Example 70, wherein the implantable layer comprises a perimeter, wherein the second density is greater than the first density, and wherein the second woven zone is defined along the perimeter.


Example 72

The staple cartridge assembly of Examples 70 or 71, wherein the cartridge body comprises a longitudinal slot configured to receive a cutting portion, wherein the first modulus of elasticity is less than the second modulus of elasticity, and wherein the first woven zone is aligned with the longitudinal slot.


Example 73

The staple cartridge assembly of Examples 70 or 71, further comprising an anchor extending over the implantable layer to releasably hold the layer to the cartridge body, wherein the second modulus of elasticity is greater than the first modulus of elasticity, and wherein the anchor is aligned with the second woven zone.


Example 74

The staple cartridge assembly of Example 73, wherein the cartridge body further comprises a longitudinal slot, wherein the longitudinal slot is configured to receive a cutting member, and wherein the cutting member is configured to transect the anchor as the cutting member moves within the longitudinal slot.


Example 75

The staple cartridge assembly of Examples 73 or 74, further comprising a proximal end, wherein the anchor and the second woven zone are adjacent the proximal end.


Example 76

The staple cartridge assembly of Example 75, further comprising a distal end opposite the proximal end, a distal anchor extending over the implantable layer to releasably hold the layer to the cartridge body, and a third woven zone defined in the layer having a third modulus of elasticity which is greater than the first modulus of elasticity, wherein the distal anchor is aligned with the third woven zone.


Example 77

The staple cartridge assembly of Examples 70, 71, 72, 73, 74, 75, or 76, wherein the cartridge body comprises a first longitudinal row of staple cavities and a second longitudinal row of staple cavities, wherein the first woven zone is aligned with the first row of staple cavities and the second woven zone is aligned with the second row of staple cavities.


Example 78

A method of manufacturing an implantable layer, the method comprising the steps of obtaining fibers, weaving the fibers, unweaving the fibers after the weaving step, kinking the fibers after the unweaving step, and reweaving the fibers into an implantable layer after the kinking step.


Example 79

The method of Example 78, wherein the reweaving step comprises knitting the fibers into a fluffy fabric.


Example 80

A compressible adjunct for use with a surgical instrument including a staple cartridge deck, wherein the compressible adjunct comprises a first biocompatible material, a second biocompatible material with a lower melting temperature than the first biocompatible material, and a body comprising a face positionable against a length of the staple cartridge deck. The face comprises a plurality of attachment regions spaced apart from one another, wherein the plurality of attachment regions include the second biocompatible material, and wherein the face is selectively attachable to the staple cartridge deck at the plurality of attachment regions. The face further comprises a plurality of non-attachment regions extending between the plurality of attachment regions, wherein the second biocompatible material is selectively disposed outside the non-attachment regions.


Example 81

The compressible adjunct of Example 80, wherein the plurality of attachment regions define an attachment pattern.


Example 82

The compressible adjunct of Examples 80 or 81, wherein the body comprises a woven fibrous construct.


Example 83

The compressible adjunct of Examples 80, 81, or 82, wherein at least one of the first biocompatible material and the second biocompatible material is absorbable.


Example 84

The compressible adjunct of Examples 80, 81, 82, or 83 wherein the second biocompatible material is poly-p-dioxanone (PDS).


Example 85

A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck comprising an outer surface. The staple cartridge further comprises a fibrous construct comprising, one, a body comprising a first plurality of fibers comprised of a first biocompatible material having a first melting temperature and, two, a face positioned against the outer surface of the cartridge deck. The face comprises a plurality of attachment regions spaced apart from one another, wherein each of the plurality of attachment regions comprises a second plurality of fibers comprised of a second biocompatible material having a second melting temperature lower than the first melting temperature and a plurality of non-attachment regions extending between the plurality of attachment regions, wherein the non-attachment regions exclude the second plurality of fibers, and wherein the face is selectively attached to the outer surface at the plurality of attachment regions by temporarily heating the face to a temperature greater than or equal to the second melting temperature but less than the first melting temperature.


Example 86

The staple cartridge assembly of Example 85, wherein the plurality of attachment regions define an attachment pattern.


Example 87

The staple cartridge assembly of Examples 85 or 86, wherein the fibrous construct is a woven fibrous construct.


Example 88

The staple cartridge assembly of Examples 85, 86, or 87, wherein at least one of the first biocompatible material and the second biocompatible material is absorbable.


Example 89

The staple cartridge assembly of Examples 85, 86, 87, or 88, wherein the second biocompatible material is poly-p-dioxanone (PDS).


Example 90

The staple cartridge assembly of Examples 85, 86, 87, 88, or 89, wherein the cartridge deck further comprises at least one attachment member configured to secure the fibrous construct to the outer surface.


Example 91

The staple cartridge assembly of Example 90, wherein the at least one attachment member comprises a mechanical barb.


Example 92

The staple cartridge assembly of Examples 85, 86, 87, 88, 89, 90, or 91, wherein the outer surface comprises a plurality of rough zones.


Example 93

The staple cartridge assembly of Example 92, wherein the rough zones are etched into the outer surface.


Example 94

A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck. The cartridge deck comprises an outer surface comprising a plurality of attachment zones spaced apart from one another and a plurality of bonding islands, wherein each of the plurality of bonding islands is disposed within one of the attachment zones, and wherein each of the plurality of bonding islands is comprised of a first biocompatible material. The staple cartridge assembly further comprises a compressible layer positioned against the cartridge deck, wherein the compressible layer is comprised of a second biocompatible material different from the first biocompatible material, and wherein the compressible layer is secured to the cartridge deck by a temporary phase transition in the first biocompatible material.


Example 95

The staple cartridge assembly of Example 94, wherein the temporary phase transition in the first biocompatible material is not accompanied by a phase transition in the second biocompatible material.


Example 96

The staple cartridge assembly of Examples 94 or 95, wherein the cartridge deck further comprises at least one attachment member configured to secure the compressible layer to the cartridge deck.


Example 97

The staple cartridge assembly of Example 96, wherein the at least one attachment member comprises a mechanical barb.


Example 98

The staple cartridge assembly of Examples 94, 95, 96, or 97, wherein the attachment zones are etched into the outer surface.


Example 99

A surgical instrument comprising a jaw member comprising an elongate slot extending along a longitudinal axis, a first outer surface on a first side of the elongate slot, and a second outer surface on a second side of the elongate slot opposite the first side. The surgical instrument further comprises a compressible adjunct assembly comprising an attachment layer comprising a first section on the first side of the elongate slot, wherein the first section is attached to the first outer surface, a second section on the second side of the elongate slot, wherein the second section is attached to the second outer surface, and an intermediary section extending between the first section and the second section, wherein the intermediary section at least partially bridges the elongate slot. The compressible adjunct assembly further comprises a first compressible adjunct on the first side of the elongate slot, and a second compressible adjunct on the second side of the elongate slot, wherein the first compressible adjunct is spaced apart from the second compressible adjunct, wherein the first section is attached to the first compressible adjunct, and wherein the second section is attached to the second compressible adjunct.


Example 100

The surgical instrument of Example 99, wherein the intermediary section comprises a bar extending along a length of the intermediary section, wherein the bar is stepped up from the first section, and wherein the bar is stepped up from the second section.


Example 101

The surgical instrument of Example 100, wherein the bar is aligned longitudinally with the elongate slot.


Example 102

The surgical instrument of Examples 100 or 101, wherein the bar protrudes into a gap defined between the first compressible adjunct and the second compressible adjunct.


Example 103

The surgical instrument of Examples 100, 101, or 102 wherein the bar protrudes into the elongate slot.


Example 104

The surgical instrument of Examples 99, 100, 101, 102, or 103, wherein the intermediary section comprises at least one anchoring feature for securing the compressible adjunct assembly to the jaw member.


Example 105

The surgical instrument of Examples 99, 100, 101, 102, 103, or 104, wherein the intermediary section comprises a plurality of projections spaced apart from one another.


Example 106

The surgical instrument of Example 105, wherein the projections are aligned longitudinally with the elongate slot.


Example 107

The surgical instrument of Examples 105 or 106, wherein the projections protrude into a gap defined between the first compressible adjunct and the second compressible adjunct.


Example 108

The surgical instrument of Examples 105, 106, or 107, wherein the projections protrude into the elongate slot.


Example 109

The surgical instrument of Examples 100, 101, 102, 103, 104, 105, 106, 107, or 108, wherein the attachment layer comprises a film.


Example 110

The surgical instrument of Examples 100, 101, 102, 103, 104, 105, 106, 107, 108, or 109, wherein the attachment layer is thinner than the first compressible adjunct, and wherein the attachment layer is thinner than the second compressible adjunct.


Example 111

The surgical instrument of Examples 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, or 110, wherein the first section completely separates the first compressible adjunct from the first outer surface, and wherein the second section completely separates the second compressible adjunct from the second outer surface.


Example 112

The surgical instrument of Examples 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, or 111, wherein the first compressible adjunct extends laterally beyond the first section in a first direction away from the elongate slot, and wherein the first outer surface extends laterally beyond the first section in the first direction.


Example 113

The surgical instrument of Example 112, wherein the second compressible adjunct extends laterally beyond the second section in a second direction away from the elongate slot, wherein the second outer surface extends laterally beyond the second compressible adjunct in the second direction, and wherein the second direction is opposite the first direction.


Example 114

The surgical instrument of Examples 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, or 113, wherein the first outer surface comprises a first plurality of pockets, wherein the second outer surface comprises a second plurality of pockets, wherein the attachment layer is positioned between the first plurality of pockets and the second plurality of pockets.


Example 115

A surgical instrument comprising a jaw member comprising an elongate slot extending along a longitudinal axis, a first outer surface on a first side of the elongate slot, and a second outer surface on a second side of the elongate slot opposite the first side. The surgical instrument further comprises a compressible adjunct assembly comprising a compressible layer comprising a first compressible portion on the first side of the elongate slot, a second compressible portion on the second side of the elongate slot, and a first plurality of bridging portions separated by a plurality of gaps, wherein the first plurality of bridging portions extend between the first compressible portion and the second compressible portion, wherein the first plurality of bridging portions are arranged along a length of the elongate slot, and wherein each of the first plurality of bridging portions bridges the elongate slot. The compressible adjunct assembly further comprises an attachment layer comprising a first attachment portion on the first side of the elongate slot, wherein the first attachment portion is attached to the first outer surface, and wherein the first attachment portion is attached to the first compressible portion, and a second attachment portion on the second side of the elongate slot, wherein the second attachment portion is attached to the second outer surface, and wherein the second attachment portion is attached to the second compressible portion. The attachment layer further comprises a second plurality of bridging portions separated by the plurality of gaps, wherein the second plurality of bridging portions extend between the first attachment portion and the second attachment portion, wherein the second plurality of bridging portions are arranged along the length of the elongate slot, and wherein each of the second plurality of bridging portions bridges the elongate slot.


Example 116

The surgical instrument of Example 115, wherein the attachment layer comprises a film.


Example 117

The surgical instrument of Examples 115 or 116, wherein the attachment layer is thinner than the compressible layer.


Example 118

A surgical instrument comprising an anvil comprising an elongate slot extending along a longitudinal axis, an internal surface defining an internal gap connected to the elongate slot, a first outer surface on a first side of the elongate slot, and a second outer surface on a second side of the elongate slot opposite the first side. The surgical instrument further comprises a compressible adjunct assembly comprising a compressible layer comprising a first compressible portion on the first side of the elongate slot a second compressible portion on the second side of the elongate slot, and an intermediate compressible portion extending between the first compressible portion and the second compressible portion, wherein the intermediate compressible portion bridges the slot. The compressible adjunct assembly further comprises at least one attachment member comprising a first attachment portion positioned against the internal surface, a second attachment portion attached to the intermediate compressible portion, and a coupling portion connecting the first attachment portion to the second attachment portion.


Example 119

The surgical instrument of Example 118, wherein the coupling portion extends into the elongate slot.


Example 120

The surgical instrument of Examples 118 or 119, wherein the second attachment portion is embedded in the intermediate compressible portion.


Example 121

A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly is configured to receive a firing actuation such that, upon receiving the firing actuation, a firing assembly is configured to translate through the staple cartridge assembly from a proximal end to a distal end during a firing progression, and wherein the staple cartridge assembly comprises a cartridge body, a plurality of staples removably stored within the cartridge body, and an implantable adjunct. The implantable adjunct comprises a body portion and a plurality of distinct attachment portions configured to retain the implantable adjunct against the cartridge body, wherein the firing assembly is configured to engage each attachment portion during the firing progression, and wherein the attachment portions are progressively released from the cartridge body during the advancement of the firing assembly from the proximal end to the distal end.


Example 122

The staple cartridge assembly of Example 121, wherein each staple is configured to separate each attachment portion from the cartridge body.


Example 123

The staple cartridge assembly of Examples 121 or 122, wherein the firing assembly is configured to lift the implantable adjunct away from the cartridge body to release the implantable adjunct from the cartridge body.


Example 124

The staple cartridge assembly of Examples 121, 122, or 123, further comprising a plurality of drivers, wherein the cartridge body comprises a deck surface, wherein the firing assembly is configured to lift the drivers above the deck surface.


Example 125

The staple cartridge assembly of Examples 121, 122, 123, or 124, wherein the cartridge body comprises a plurality of staple cavities, and wherein the attachment portions extend at least partially into the staple cavities.


Example 126

The staple cartridge assembly of Examples 121, 122, 123, 124, or 125, wherein the implantable adjunct comprises a unitary piece of material.


Example 127

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, or 126, wherein the cartridge body comprises a slot, wherein the attachment portions are positioned adjacent the slot, and wherein the firing assembly comprises a release portion configured to engage the attachment portions to release the implantable adjunct from the cartridge body as the firing assembly advances from the proximal end to the distal end.


Example 128

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, 126, or 127, wherein the implantable adjunct comprises a first portion and second portion wherein the first portion is configured to be detached from the second portion, and wherein the second portion is configured to be retained against the cartridge body by a staple that has not been deployed by the firing assembly.


Example 129

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, 126, 127, or 128, wherein the implantable adjunct further comprises a discontinuity, and wherein the first portion is detachable from the second portion at the discontinuity.


Example 130

The staple cartridge assembly of Example 129, wherein the discontinuity comprises at least one perforation.


Example 131

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, 126, 127, 128, 129, or 130 wherein each staple comprises a pair of staple legs, and wherein each staple leg comprises a barb embedded in the implantable adjunct.


Example 132

The staple cartridge assembly of Example 131, wherein the barbs extend outwardly.


Example 133

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, or 132, wherein the cartridge body comprises a plurality of staple cavities, and wherein each attachment portion extends over a staple cavity.


Example 134

The staple cartridge assembly of Examples 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, or 133, wherein the staples engage the attachment portions and detach the attachment portions from the cartridge body when the staples are ejected from the cartridge body.


Example 135

A staple cartridge assembly comprising a cartridge body comprising a proximal end, a distal end, a deck, a plurality of staple cavities defined in the deck, and a longitudinal slot defined in the deck extending from the proximal end toward the distal end. The staple cartridge assembly further comprises a plurality of staples removably stored within the staple cavities, a firing member configured to eject the staples from the staple cavities during a firing progression of the firing member from the proximal end toward the distal end, and an implantable adjunct. The implantable adjunct comprises a body portion and a plurality of distinct attachment portions configured to releasably retain the implantable adjunct against the cartridge body, wherein the firing member is configured to progressively release the attachment portions from the cartridge body during the firing progression.


Example 136

The staple cartridge assembly of Example 135, wherein the firing member extends over the deck and directly engages the attachment portions.


Example 137

The staple cartridge assembly of Examples 135 or 136, wherein the staple cavities are arranged in longitudinal rows, wherein the longitudinal rows comprise inner longitudinal rows adjacent the longitudinal slot, and wherein the attachment portions are positioned intermediate the longitudinal slot and the inner longitudinal rows.


Example 138

The staple cartridge assembly of Example 137, wherein the firing member slides along the deck between the longitudinal slot and the inner longitudinal rows.


Example 139

A method for assembling a surgical stapling assembly for use with a surgical stapling instrument, the surgical stapling assembly comprising a staple cartridge, a plurality of staples, and a fibrous adjunct positioned at least partially on the staple cartridge, the method comprising pouring fibrous adjunct material onto a mold resembling the staple cartridge, allowing the fibrous adjunct material to cool, removing the fibrous adjunct material from the mold, and placing the fibrous adjunct material onto the staple cartridge, wherein the fibrous adjunct material maintains a continuous, fibrous structure upon being placed onto the staple cartridge.


Example 140

A staple cartridge assembly comprising a cartridge body comprising a deck, staples removably stored in the cartridge body, and an implantable adjunct positioned over the deck. The implantable adjunct comprises a first outer layer comprised of interwoven fibers, a second outer layer comprised of interwoven fibers, and a bonding layer positioned intermediate the first outer layer and the second outer layer, wherein the bonding layer is comprised of a meltable material having a threshold melt temperature, and wherein the adjunct has previously been exposed to a temperature in excess of the threshold melt temperature such that the bonding layer is bonded with the first outer layer and the second outer layer.


Example 141

The staple cartridge assembly of Example 140, wherein the interwoven fibers of the first outer layer are comprised of a first material having a first melt temperature which is greater than the threshold melt temperature, and wherein the interwoven fibers of the first outer layer have not been melted.


Example 142

The staple cartridge assembly of Example 141, wherein the interwoven fibers of the second outer layer are comprised of a second material having a second melt temperature which is different than the first melt temperature and greater than the threshold melt temperature, and wherein the interwoven fibers of the second outer layer have not been melted.


Example 143

The staple cartridge assembly of Examples 140, 141, or 142, wherein the bonding layer comprises a first bonding layer, and wherein the adjunct further comprises a spacer layer comprised of a material having a melt temperature which is greater than the threshold melt temperature and a second bonding layer comprised of the meltable material, wherein the first bonding layer is positioned intermediate the first outer layer and the spacer layer, and wherein the second bonding layer is positioned intermediate the second outer layer and the spacer layer.


Example 144

The staple cartridge assembly of Example 143, wherein the spacer layer comprises a plurality of openings defined therein which are configured to receive melted portions of the first bonding layer and the second bonding layer when the adjunct is exposed to a temperature in excess of the threshold melt temperature.


Example 145

The staple cartridge assembly of Examples 143 or 144, wherein melted portions of the first bonding layer has penetrated the first outside layer, and wherein melted portions of the second bonding layer has penetrated the second outside layer.


Example 146

The staple cartridge assembly of Examples 143, 144, or 145, wherein the plurality of openings are arranged in a first density in a first portion of the spacer layer and a second density in a second portion of the spacer layer, wherein the first density is greater than the second density, and wherein the bond between the first portion and the bonding layers is stronger than the bond between the second portion and the bonding layers.


Example 147

The staple cartridge assembly of Examples 143, 144, 145, or 146, wherein the spacer layer comprises a lofted weave.


Example 148

The staple cartridge assembly of Examples 140, 141, 142, 143, 144, 145, 146, or 147, wherein the bonding layer comprises a PDS film.


Example 149

The staple cartridge assembly of Examples 140, 141, 142, 143, 144, 145, 146, 147, or 148, wherein the bonding layer comprises apertures defined therein.


Example 150

The staple cartridge assembly of Examples 140, 141, 142, 143, 144, 145, 146, 147, 148, or 149, wherein the bonding layer has penetrated the first outside layer and the second outside layer.


Example 151

The staple cartridge assembly of Examples 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, or 150, wherein the first outside layer and the second outside layer include meltable portions which are comprised of the meltable material, and wherein the meltable portions of the first outside layer and the second outside layer are merged with the bonding layer after the adjunct is exposed to a temperature in excess of the threshold melt temperature.


Example 152

A staple cartridge assembly comprising a cartridge body comprising a deck, staples removably stored in the cartridge body, and an implantable layer assembly positioned over the deck. The implantable layer comprises a first layer, a second layer, and a bonding layer positioned intermediate the first layer and the second layer, wherein the bonding layer is comprised of a meltable material having a threshold melt temperature, and wherein the implantable layer assembly has been previously exposed to a temperature at least equaling the threshold melt temperature such that the bonding layer is bonded with at least one of the first layer and the second layer.


Example 153

The staple cartridge assembly of Example 152, wherein the bonding layer is mechanically bonded to the first layer and the second layer.


Example 154

The staple cartridge assembly of Examples 152 or 153, wherein the interwoven fibers of the first layer are comprised of a first material having a first melt temperature which is greater than the threshold melt temperature, and wherein the interwoven fibers of the first layer have not been melted.


Example 155

The staple cartridge assembly of Example 154, wherein the interwoven fibers of the second layer are comprised of a second material having a second melt temperature which is different than the first melt temperature and greater than the threshold melt temperature, and wherein the interwoven fibers of the second layer have not been melted.


Example 156

The staple cartridge assembly of Examples 152, 153, 154, or 155, wherein the bonding layer comprises a first bonding layer, and wherein the implantable layer assembly further comprises a spacer layer comprised of a material having a melt temperature which is greater than the threshold melt temperature and a second bonding layer comprised of the meltable material, wherein the first bonding layer is positioned intermediate the first layer and the spacer layer, and wherein the second bonding layer is positioned intermediate the second layer and the spacer layer.


Example 157

The staple cartridge assembly of Example 156, wherein the spacer layer comprises a plurality of openings defined therein which are configured to receive melted portions of the first bonding layer and the second bonding layer when the adjunct is exposed to a temperature that at least equals the threshold melt temperature.


Example 158

The staple cartridge assembly of Example 157, wherein the plurality of openings are arranged in a first density in a first portion of the spacer layer and a second density in a second portion of the spacer layer, wherein the first density is greater than the second density, and wherein a bond between the first portion and the bonding layers is stronger than a bond between the second portion and the bonding layers.


Example 159

The staple cartridge assembly of Examples 156, 157, or 158, wherein melted portions of the first bonding layer has penetrated the first layer, and wherein melted portions of the second bonding layer has penetrated the second layer.


Example 160

A method of manufacturing a staple cartridge assembly comprising the steps of obtaining a first layer, a second layer, and a bonding layer, positioning the bonding layer intermediate the first layer and the second layer, heating the bonding layer to a temperature which at least partially melts the bonding layer, obtaining a cartridge body, positioning staples in the cartridge body, and attaching the first layer, the second layer, and the bonding layer to the cartridge body.


Example 161

The method of Example 160, wherein the heating step does not melt the first layer and the second layer.


Example 162

A staple cartridge assembly for use with a surgical stapler, wherein the staple cartridge assembly comprises a staple cartridge comprising a cartridge body, a cartridge deck, and a plurality of staples deployable from the cartridge body through the cartridge deck. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the compressible adjunct comprises a plurality of unaltered fibers comprising a first fiber including a first fiber portion and a second fiber including a second fiber portion extending over the first fiber portion. The compressible adjunct further comprises a plurality of altered fibers that are melted and resolidified and a node comprising the first fiber portion, the second fiber portion, and at least a portion of the plurality of altered fibers, wherein the at least a portion of the plurality of altered fibers affixes the first fiber portion and the second fiber portion.


Example 163

The staple cartridge assembly of Example 162, wherein the first fiber and the second fiber are comprised of a first biocompatible material comprising a first melting point.


Example 164

The staple cartridge assembly of Example 163, wherein the plurality of altered fibers comprises a second biocompatible material comprising a second melting point lower than the first melting point.


Example 165

The staple cartridge assembly of Example 164, wherein the first fiber is at least partially covered with the second biocompatible material.


Example 166

The staple cartridge assembly of Examples 162, 163, 164, or 165, wherein the plurality of unaltered fibers further comprises a third fiber including a third fiber portion extending over the first fiber portion.


Example 167

The staple cartridge assembly of Examples 162, 163, 164, 165, or 166, wherein the node releasably attaches the compressible adjunct to the cartridge deck.


Example 168

The staple cartridge assembly of Examples 162, 163, 164, 165, 166, or 167, further comprising a plurality of nodes defining attachment zones.


Example 169

The staple cartridge assembly of Example 168, further comprising unattached zones between the attachment zones.


Example 170

The staple cartridge assembly of Example 169, wherein the attachment zones comprise greater densities than the unattached zones.


Example 171

A staple cartridge assembly for use with a surgical stapler, wherein the staple cartridge assembly comprises a staple cartridge comprising a cartridge body, a cartridge deck, and a plurality of staples deployable from the cartridge body through the cartridge deck. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the compressible adjunct comprises a plurality of unaltered fibers comprising a first fiber including a first fiber portion and a second fiber including a second fiber portion extending over the first fiber portion. The compressible adjunct further comprises a plurality of altered fibers melted and resolidified to define a bonding medium and a node comprising the first fiber portion, the second fiber portion, and at least a portion of the bonding medium at least partially surrounding the first fiber portion and the second fiber portion.


Example 172

The staple cartridge assembly of Example 171, wherein the first fiber and the second fiber are comprised of a first biocompatible material comprising a first melting point.


Example 173

The staple cartridge assembly of Example 172, wherein the plurality of altered fibers comprises a second biocompatible material comprising a second melting point lower than the first melting point.


Example 174

The staple cartridge assembly of Example 173, wherein the first fiber is at least partially covered with the second biocompatible material.


Example 175

The staple cartridge assembly of Examples 171, 172, 173, or 174, wherein the plurality of unaltered fibers further comprises a third fiber including a third fiber portion extending over the first fiber portion.


Example 176

The staple cartridge assembly of Examples 171, 172, 173, 174, or 175, wherein the node releasably attaches the compressible adjunct to the cartridge deck.


Example 177

The staple cartridge assembly of Examples 171, 172, 173, 174, 175, or 176, further comprising a plurality of nodes defining attachment zones.


Example 178

The staple cartridge assembly of Example 177, further comprising non-attachment zones between the attachment zones.


Example 179

The staple cartridge assembly of Example 178, wherein the attachment zones comprise greater densities than the non-attachment zones.


Example 180

A staple cartridge assembly for use with a surgical stapler, wherein the staple cartridge assembly comprises a staple cartridge comprising a cartridge body, a cartridge deck, and a plurality of staples deployable from the cartridge body through the cartridge deck. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the compressible adjunct comprises a plurality of fibers comprising a first fiber including a first fiber portion and a second fiber including a second fiber portion spaced apart from the first fiber portion. The compressible adjunct further comprises a bonding fiber melted and resolidified, wherein the bonding fiber comprises a bonding fiber portion extending between the first fiber portion and the second fiber portion, wherein the bonding fiber portion is attached to the first fiber portion, and wherein the bonding fiber portion is attached to second fiber portion.


Example 181

The staple cartridge assembly of Example 180, wherein the first fiber and the second fiber are comprised of a first biocompatible material comprising a first melting point, and wherein the bonding fiber comprises a second biocompatible material comprising a second melting point lower than the first melting point.


Various embodiments are disclosed including adjuncts attached to and/or positioned on a staple cartridge. It should be understood that such teachings are applicable to embodiments in which an adjunct is attached to and/or positioned on an anvil of a surgical instrument. In fact, embodiments are envisioned in which a first adjunct is attached to and/or positioned on a cartridge and a second adjunct is attached to and/or positioned on an anvil.


The compressible adjuncts of the present disclosure can be positioned against a cartridge deck of a staple cartridge such as, for example, the cartridge deck 16 of the staple cartridge 12. In at least one instance, a compressible adjunct can be positioned against a cartridge deck of a staple cartridge prior to loading the staple cartridge onto a surgical instrument such as, for example, the surgical stapling and severing instrument 8010 (FIG. 1). Alternatively, a compressible adjunct can be positioned against a cartridge deck of a staple cartridge after the staple cartridge has been loaded into the surgical stapling and severing instrument. A loading unit can be employed to deposit a compressible adjunct onto the cartridge deck of the staple cartridge. The loading unit may include various attachment features and/or placement features for manipulating and positioning the compressible adjunct against the cartridge deck. Once the compressible adjunct is correctly positioned against the cartridge deck, the loading unit can release the compressible adjunct.


Further to the above, a compressible adjunct can be positioned against a cartridge deck without attachment to the staple cartridge. Alternatively, a compressible adjunct can be attached to the staple cartridge prior to or after the staple cartridge is loaded into the surgical stapling and severing instrument. For example, the compressible adjunct can be partially melted onto the cartridge deck then resolidified by cooling which causes the compressible adjunct to bond to the cartridge deck. Various attachment features can also be employed to attach a compressible adjunct to a staple cartridge such as, for example, sutures, straps, barbs, and/or other mechanical attachment mechanisms.


The entire disclosures of:


U.S. Pat. No. 5,403,312, entitled ELECTROSURGICAL HEMOSTATIC DEVICE, which issued on Apr. 4, 1995;


U.S. Pat. No. 7,000,818, entitled SURGICAL STAPLING INSTRUMENT HAVING SEPARATE DISTINCT CLOSING AND FIRING SYSTEMS, which issued on Feb. 21, 2006;


U.S. Pat. No. 7,422,139, entitled MOTOR-DRIVEN SURGICAL CUTTING AND FASTENING INSTRUMENT WITH TACTILE POSITION FEEDBACK, which issued on Sep. 9, 2008;


U.S. Pat. No. 7,464,849, entitled ELECTRO-MECHANICAL SURGICAL INSTRUMENT WITH CLOSURE SYSTEM AND ANVIL ALIGNMENT COMPONENTS, which issued on Dec. 16, 2008;


U.S. Pat. No. 7,670,334, entitled SURGICAL INSTRUMENT HAVING AN ARTICULATING END EFFECTOR, which issued on Mar. 2, 2010;


U.S. Pat. No. 7,753,245, entitled SURGICAL STAPLING INSTRUMENTS, which issued on Jul. 13, 2010; U.S. Pat. No. 8,393,514, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE, which issued on Mar. 12, 2013;


U.S. patent application Ser. No. 11/343,803, entitled SURGICAL INSTRUMENT HAVING RECORDING CAPABILITIES; now U.S. Pat. No. 7,845,537;


U.S. patent application Ser. No. 12/031,573, entitled SURGICAL CUTTING AND FASTENING INSTRUMENT HAVING RF ELECTRODES, filed Feb. 14, 2008;


U.S. patent application Ser. No. 12/031,873, entitled END EFFECTORS FOR A SURGICAL CUTTING AND STAPLING INSTRUMENT, filed Feb. 15, 2008, now U.S. Pat. No. 7,980,443;


U.S. patent application Ser. No. 12/235,782, entitled MOTOR-DRIVEN SURGICAL CUTTING INSTRUMENT, now U.S. Pat. No. 8,210,411;


U.S. patent application Ser. No. 12/249,117, entitled POWERED SURGICAL CUTTING AND STAPLING APPARATUS WITH MANUALLY RETRACTABLE FIRING SYSTEM, now U.S. Pat. No. 8,608,045;


U.S. patent application Ser. No. 12/647,100, entitled MOTOR-DRIVEN SURGICAL CUTTING INSTRUMENT WITH ELECTRIC ACTUATOR DIRECTIONAL CONTROL ASSEMBLY, filed Dec. 24, 2009; now U.S. Pat. No. 8,220,688;


U.S. patent application Ser. No. 12/893,461, entitled STAPLE CARTRIDGE, filed Sep. 29, 2012, now U.S. Pat. No. 8,733,613;


U.S. patent application Ser. No. 13/036,647, entitled SURGICAL STAPLING INSTRUMENT, filed Feb. 28, 2011, now U.S. Pat. No. 8,561,870;


U.S. patent application Ser. No. 13/118,241, entitled SURGICAL STAPLING INSTRUMENTS WITH ROTATABLE STAPLE DEPLOYMENT ARRANGEMENTS, now U.S. Pat. No. 9,072,535;


U.S. patent application Ser. No. 13/524,049, entitled ARTICULATABLE SURGICAL INSTRUMENT COMPRISING A FIRING DRIVE, filed on Jun. 15, 2012; now U.S. Pat. No. 9,101,358;


U.S. patent application Ser. No. 13/800,025, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, filed on Mar. 13, 2013, now U.S. Patent Application Publication No. 2014/0263551;


U.S. patent application Ser. No. 13/800,067, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, filed on Mar. 13, 2013, now U.S. Patent Application Publication No. 2014/0263552;


U.S. Patent Application Publication No. 2007/0175955, entitled SURGICAL CUTTING AND FASTENING INSTRUMENT WITH CLOSURE TRIGGER LOCKING MECHANISM, filed Jan. 31, 2006; and


U.S. Patent Application Publication No. 2010/0264194, entitled SURGICAL STAPLING INSTRUMENT WITH AN ARTICULATABLE END EFFECTOR, filed Apr. 22, 2010, now U.S. Pat. No. 8,308,040, are hereby incorporated by reference herein.


Although the various embodiments of the devices have been described herein in connection with certain disclosed embodiments, many modifications and variations to those embodiments may be implemented. Also, where materials are disclosed for certain components, other materials may be used. Furthermore, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. The foregoing description and following claims are intended to cover all such modification and variations.


The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


By way of example only, aspects described herein may be processed before surgery. First, a new or used instrument may be obtained and when necessary cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container may keep the instrument sterile until it is opened in a medical facility. A device also may be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, plasma peroxide, or steam.


While this invention has been described as having exemplary designs, the present invention may be further modified within the spirit and scope of the disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

Claims
  • 1. A staple cartridge assembly for use with a surgical stapling instrument, wherein said staple cartridge assembly is configured to receive a firing actuation such that, upon receiving the firing actuation, a firing assembly is configured to translate through said staple cartridge assembly from a proximal end to a distal end during a firing progression, and wherein said staple cartridge assembly comprises: a cartridge body comprising a deck surface;a plurality of staples removably stored within said cartridge body; andan implantable adjunct, comprising: a body portion; anda plurality of distinct attachment portions configured to retain said implantable adjunct against said cartridge body, wherein said attachment portions are disposed onto said deck surface, wherein the firing assembly is configured to engage each said attachment portion during the firing progression, and wherein said attachment portions are progressively released from said cartridge body during the advancement of the firing assembly from the proximal end to the distal end.
  • 2. The staple cartridge assembly of claim 1, wherein each said staple is configured to separate each said attachment portion from said cartridge body.
  • 3. The staple cartridge assembly of claim 1, wherein the firing assembly is configured to lift said implantable adjunct away from said cartridge body to release said implantable adjunct from said cartridge body.
  • 4. The staple cartridge assembly of claim 3, further comprising a plurality of drivers, wherein said cartridge body comprises a deck surface, wherein the firing assembly is configured to lift said drivers above said deck surface.
  • 5. The staple cartridge assembly of claim 1, wherein said cartridge body comprises a plurality of staple cavities, and wherein said attachment portions extend at least partially into said staple cavities.
  • 6. The staple cartridge assembly of claim 1, wherein said implantable adjunct comprises a unitary piece of material.
  • 7. The staple cartridge assembly of claim 1, wherein said cartridge body comprises a slot, wherein said attachment portions are positioned adjacent said slot, and wherein the firing assembly comprises a release portion configured to engage said attachment portions to release said implantable adjunct from said cartridge body as the firing assembly advances from the proximal end to the distal end.
  • 8. The staple cartridge assembly of claim 1, wherein said implantable adjunct comprises a first portion and second portion wherein said first portion is configured to be detached from said second portion, and wherein said second portion is configured to be retained against said cartridge body by a said staple that has not been deployed by the firing assembly.
  • 9. The staple cartridge assembly of claim 8, wherein said implantable adjunct further comprises a discontinuity, and wherein said first portion is detachable from said second portion at said discontinuity.
  • 10. The staple cartridge assembly of claim 9, wherein said discontinuity comprises at least one perforation.
  • 11. The staple cartridge assembly of claim 8, wherein each said staple comprises a pair of staple legs, and wherein each said staple leg comprises a barb embedded in said implantable adjunct.
  • 12. The staple cartridge assembly of claim 11, wherein said barbs extend outwardly.
  • 13. The staple cartridge assembly of claim 1, wherein said cartridge body comprises a plurality of staple cavities, and wherein each said attachment portion extends over a said staple cavity.
  • 14. The staple cartridge assembly of claim 13, wherein said staples engage said attachment portions and detach said attachment portions from said cartridge body when said staples are ejected from said cartridge body.
  • 15. A staple cartridge assembly, comprising: a cartridge body, comprising: a proximal end;a distal end;a deck;a plurality of staple cavities defined in said deck; anda longitudinal slot defined in said deck extending from said proximal end toward said distal end;a plurality of staples removably stored within said staple cavities;a firing member configured to eject said staples from said staple cavities during a firing progression of said firing member from said proximal end toward said distal end; andan implantable adjunct, comprising: a body portion; anda plurality of distinct attachment portions configured to releasably retain said implantable adjunct against said cartridge body, wherein said attachment portions extend along said deck, wherein said firing member is configured to progressively release said attachment portions from said cartridge body during said firing progression.
  • 16. The staple cartridge assembly of claim 15, wherein said firing member extends over said deck and directly engages said attachment portions.
  • 17. The staple cartridge assembly of claim 15, wherein said staple cavities are arranged in longitudinal rows, wherein said longitudinal rows comprise inner longitudinal rows adjacent said longitudinal slot, and wherein said attachment portions are positioned intermediate said longitudinal slot and said inner longitudinal rows.
  • 18. The staple cartridge assembly of claim 17, wherein said firing member slides along said deck between said longitudinal slot and said inner longitudinal rows.
  • 19. A method for assembling a surgical stapling assembly for use with a surgical stapling instrument, said surgical stapling assembly comprising a staple cartridge, a plurality of staples, and a fibrous adjunct positioned at least partially on said staple cartridge, said method comprising: pouring fibrous adjunct material onto a mold resembling said staple cartridge;applying a predetermined external pressure to said fibrous adjunct material;allowing said fibrous adjunct material to cool while the application of the predetermined external pressure is maintained;removing said fibrous adjunct material from said mold; andplacing said fibrous adjunct material onto said staple cartridge, wherein said fibrous adjunct material maintains a continuous, fibrous structure upon being placed onto said staple cartridge.
US Referenced Citations (6097)
Number Name Date Kind
66052 Smith Jun 1867 A
662587 Blake Nov 1900 A
670748 Weddeler Mar 1901 A
719487 Minor Feb 1903 A
804229 Hutchinson Nov 1905 A
951393 Hahn Mar 1910 A
1188721 Bittner Jun 1916 A
1306107 Elliott Jun 1919 A
1314601 McCaskey Sep 1919 A
1677337 Grove Jul 1928 A
1794907 Kelly Mar 1931 A
1849427 Hook Mar 1932 A
1944116 Stratman Jan 1934 A
1954048 Jeffrey et al. Apr 1934 A
2037727 La Chapelle Apr 1936 A
2132295 Hawkins Oct 1938 A
2161632 Nattenheimer Jun 1939 A
D120434 Gold May 1940 S
2211117 Hess Aug 1940 A
2214870 West Sep 1940 A
2224882 Peck Dec 1940 A
2318379 Davis et al. May 1943 A
2329440 La Place Sep 1943 A
2377581 Shaffrey Jun 1945 A
2406389 Lee Aug 1946 A
2441096 Happe May 1948 A
2448741 Scott et al. Sep 1948 A
2450527 Smith Oct 1948 A
2507872 Unsinger May 1950 A
2526902 Rublee Oct 1950 A
2527256 Jackson Oct 1950 A
2578686 Fish Dec 1951 A
2638901 Sugarbaker May 1953 A
2674149 Benson Apr 1954 A
2701489 Osborn Feb 1955 A
2711461 Happe Jun 1955 A
2742955 Dominguez Apr 1956 A
2804848 O'Farrell et al. Sep 1957 A
2808482 Zanichkowsky et al. Oct 1957 A
2853074 Olson Sep 1958 A
2887004 Stewart May 1959 A
2957353 Lewis Oct 1960 A
2959974 Emrick Nov 1960 A
3032769 Palmer May 1962 A
3060972 Sheldon Oct 1962 A
3075062 Iaccarino Jan 1963 A
3078465 Bobrov Feb 1963 A
3079606 Bobrov et al. Mar 1963 A
3080564 Strekopitov et al. Mar 1963 A
3166072 Sullivan, Jr. Jan 1965 A
3180236 Beckett Apr 1965 A
3196869 Scholl Jul 1965 A
3204731 Bent et al. Sep 1965 A
3266494 Brownrigg et al. Aug 1966 A
3269630 Fleischer Aug 1966 A
3269631 Takaro Aug 1966 A
3275211 Hirsch et al. Sep 1966 A
3317103 Cullen et al. May 1967 A
3317105 Astafjev et al. May 1967 A
3357296 Lefever Dec 1967 A
3359978 Smith, Jr. Dec 1967 A
3377893 Shorb Apr 1968 A
3480193 Ralston Nov 1969 A
3490675 Green et al. Jan 1970 A
3494533 Green et al. Feb 1970 A
3499591 Green Mar 1970 A
3503396 Pierie et al. Mar 1970 A
3509629 Kidokoro May 1970 A
3551987 Wilkinson Jan 1971 A
3568675 Harvey Mar 1971 A
3572159 Tschanz Mar 1971 A
3583393 Takahashi Jun 1971 A
3589589 Akopov Jun 1971 A
3598943 Barrett Aug 1971 A
3608549 Merrill Sep 1971 A
3618842 Bryan Nov 1971 A
3638652 Kelley Feb 1972 A
3640317 Panfili Feb 1972 A
3643851 Green et al. Feb 1972 A
3650453 Smith, Jr. Mar 1972 A
3661666 Foster et al. May 1972 A
3662939 Bryan May 1972 A
3688966 Perkins et al. Sep 1972 A
3695646 Mommsen Oct 1972 A
3709221 Riely Jan 1973 A
3717294 Green Feb 1973 A
3726755 Shannon Apr 1973 A
3727904 Gabbey Apr 1973 A
3734207 Fishbein May 1973 A
3740994 De Carlo, Jr. Jun 1973 A
3744495 Johnson Jul 1973 A
3746002 Haller Jul 1973 A
3747603 Adler Jul 1973 A
3747692 Davidson Jul 1973 A
3751902 Kingsbury et al. Aug 1973 A
3752161 Bent Aug 1973 A
3799151 Fukaumi et al. Mar 1974 A
3808452 Hutchinson Apr 1974 A
3815476 Green et al. Jun 1974 A
3819100 Noiles et al. Jun 1974 A
3821919 Knohl Jul 1974 A
3836171 Hayashi et al. Sep 1974 A
3837555 Green Sep 1974 A
3841474 Maier Oct 1974 A
3851196 Hinds Nov 1974 A
3863639 Kleaveland Feb 1975 A
3883624 McKenzie et al. May 1975 A
3885491 Curtis May 1975 A
3892228 Mitsui Jul 1975 A
3894174 Cartun Jul 1975 A
3902247 Fleer et al. Sep 1975 A
3940844 Colby et al. Mar 1976 A
3944163 Hayashi et al. Mar 1976 A
3950686 Randall Apr 1976 A
3952747 Kimmell, Jr. Apr 1976 A
3955581 Spasiano et al. May 1976 A
3959879 Sellers Jun 1976 A
RE28932 Noiles et al. Aug 1976 E
3972734 King Aug 1976 A
3981051 Brumlik Sep 1976 A
4025216 Hives May 1977 A
4027746 Kine Jun 1977 A
4034143 Sweet Jul 1977 A
4038987 Komiya Aug 1977 A
4054108 Gill Oct 1977 A
4060089 Noiles Nov 1977 A
4066133 Voss Jan 1978 A
4085337 Moeller Apr 1978 A
4100820 Evett Jul 1978 A
4106446 Yamada et al. Aug 1978 A
4106620 Brimmer et al. Aug 1978 A
4108211 Tanaka Aug 1978 A
4111206 Vishnevsky et al. Sep 1978 A
4127227 Green Nov 1978 A
4129059 Van Eck Dec 1978 A
4132146 Uhlig Jan 1979 A
4135517 Reale Jan 1979 A
4154122 Severin May 1979 A
4169990 Lerdman Oct 1979 A
4180285 Reneau Dec 1979 A
4185701 Boys Jan 1980 A
4190042 Sinnreich Feb 1980 A
4198734 Brumlik Apr 1980 A
4198982 Fortner et al. Apr 1980 A
4207898 Becht Jun 1980 A
4213562 Garrett et al. Jul 1980 A
4226242 Jarvik Oct 1980 A
4239431 Davini Dec 1980 A
4241861 Fleischer Dec 1980 A
4244372 Kapitanov et al. Jan 1981 A
4250436 Weissman Feb 1981 A
4261244 Becht et al. Apr 1981 A
4272002 Moshofsky Jun 1981 A
4272662 Simpson Jun 1981 A
4274304 Curtiss Jun 1981 A
4274398 Scott, Jr. Jun 1981 A
4275813 Noiles Jun 1981 A
4278091 Borzone Jul 1981 A
4289131 Mueller Sep 1981 A
4289133 Rothfuss Sep 1981 A
4290542 Fedotov et al. Sep 1981 A
D261356 Robinson Oct 1981 S
4293604 Campbell Oct 1981 A
4296654 Mercer Oct 1981 A
4296881 Lee Oct 1981 A
4304236 Conta et al. Dec 1981 A
4305539 Korolkov et al. Dec 1981 A
4312363 Rothfuss et al. Jan 1982 A
4312685 Riedl Jan 1982 A
4317451 Cerwin et al. Mar 1982 A
4319576 Rothfuss Mar 1982 A
4321002 Froehlich Mar 1982 A
4321746 Grinage Mar 1982 A
4328839 Lyons et al. May 1982 A
4331277 Green May 1982 A
4340331 Savino Jul 1982 A
4347450 Colligan Aug 1982 A
4348603 Huber Sep 1982 A
4349028 Green Sep 1982 A
4350151 Scott Sep 1982 A
4353371 Cosman Oct 1982 A
4357940 Muller Nov 1982 A
4361057 Kochera Nov 1982 A
4366544 Shima et al. Dec 1982 A
4369013 Abildgaard et al. Jan 1983 A
4373147 Carlson, Jr. Feb 1983 A
4376380 Burgess Mar 1983 A
4379457 Gravener et al. Apr 1983 A
4380312 Landrus Apr 1983 A
4382326 Rabuse May 1983 A
4383634 Green May 1983 A
4393728 Larson et al. Jul 1983 A
4394613 Cole Jul 1983 A
4396139 Hall et al. Aug 1983 A
4397311 Kanshin et al. Aug 1983 A
4402445 Green Sep 1983 A
4406621 Bailey Sep 1983 A
4408692 Sigel et al. Oct 1983 A
4409057 Molenda et al. Oct 1983 A
4415112 Green Nov 1983 A
4416276 Newton et al. Nov 1983 A
4417890 Dennehey et al. Nov 1983 A
4423456 Zaidenweber Dec 1983 A
4428376 Mericle Jan 1984 A
4429695 Green Feb 1984 A
4430997 DiGiovanni et al. Feb 1984 A
4434796 Karapetian et al. Mar 1984 A
4438659 Desplats Mar 1984 A
4442964 Becht Apr 1984 A
4448194 DiGiovanni et al. May 1984 A
4451743 Suzuki et al. May 1984 A
4452376 Klieman et al. Jun 1984 A
4454887 Kruger Jun 1984 A
4461305 Cibley Jul 1984 A
4467805 Fukuda Aug 1984 A
4468597 Baumard et al. Aug 1984 A
4469481 Kobayashi Sep 1984 A
4470414 Imagawa et al. Sep 1984 A
4471780 Menges et al. Sep 1984 A
4471781 Di Giovanni et al. Sep 1984 A
4473077 Noiles et al. Sep 1984 A
4475679 Fleury, Jr. Oct 1984 A
4478220 Di Giovanni et al. Oct 1984 A
4480641 Failla et al. Nov 1984 A
4485816 Krumme Dec 1984 A
4485817 Swiggett Dec 1984 A
4486928 Tucker et al. Dec 1984 A
4488523 Shichman Dec 1984 A
4489875 Crawford et al. Dec 1984 A
4493983 Taggert Jan 1985 A
4494057 Hotta Jan 1985 A
4499895 Takayama Feb 1985 A
4500024 DiGiovanni et al. Feb 1985 A
D278081 Green Mar 1985 S
4503842 Takayama Mar 1985 A
4505272 Utyamyshev et al. Mar 1985 A
4505273 Braun et al. Mar 1985 A
4505414 Filipi Mar 1985 A
4506671 Green Mar 1985 A
4512038 Alexander et al. Apr 1985 A
4520817 Green Jun 1985 A
4522327 Korthoff et al. Jun 1985 A
4526174 Froehlich Jul 1985 A
4527724 Chow et al. Jul 1985 A
4530357 Pawloski et al. Jul 1985 A
4530453 Green Jul 1985 A
4531522 Bedi et al. Jul 1985 A
4532927 Miksza, Jr. Aug 1985 A
4540202 Amphoux et al. Sep 1985 A
4548202 Duncan Oct 1985 A
4556058 Green Dec 1985 A
4560915 Soultanian Dec 1985 A
4565109 Tsay Jan 1986 A
4565189 Mabuchi Jan 1986 A
4566620 Green et al. Jan 1986 A
4569346 Poirier Feb 1986 A
4569469 Mongeon et al. Feb 1986 A
4571213 Ishimoto Feb 1986 A
4573468 Conta et al. Mar 1986 A
4573469 Golden et al. Mar 1986 A
4573622 Green et al. Mar 1986 A
4576165 Green et al. Mar 1986 A
4576167 Noiles Mar 1986 A
4580712 Green Apr 1986 A
4585153 Failla et al. Apr 1986 A
4586501 Claracq May 1986 A
4586502 Bedi et al. May 1986 A
4589416 Green May 1986 A
4589582 Bilotti May 1986 A
4589870 Citrin et al. May 1986 A
4591085 Di Giovanni May 1986 A
RE32214 Schramm Jul 1986 E
4597753 Turley Jul 1986 A
4600037 Hatten Jul 1986 A
4604786 Howie, Jr. Aug 1986 A
4605001 Rothfuss et al. Aug 1986 A
4605004 Di Giovanni et al. Aug 1986 A
4606343 Conta et al. Aug 1986 A
4607636 Kula et al. Aug 1986 A
4607638 Crainich Aug 1986 A
4608981 Rothfuss et al. Sep 1986 A
4610250 Green Sep 1986 A
4610383 Rothfuss et al. Sep 1986 A
4612933 Brinkerhoff et al. Sep 1986 A
D286180 Korthoff Oct 1986 S
D286442 Korthoff et al. Oct 1986 S
4617893 Donner et al. Oct 1986 A
4617914 Ueda Oct 1986 A
4619262 Taylor Oct 1986 A
4619391 Sharkany et al. Oct 1986 A
D287278 Spreckelmeier Dec 1986 S
4628459 Shinohara et al. Dec 1986 A
4628636 Folger Dec 1986 A
4629107 Fedotov et al. Dec 1986 A
4632290 Green et al. Dec 1986 A
4633861 Chow et al. Jan 1987 A
4633874 Chow et al. Jan 1987 A
4634419 Kreizman et al. Jan 1987 A
4635638 Weintraub et al. Jan 1987 A
4641076 Linden Feb 1987 A
4642618 Johnson et al. Feb 1987 A
4643173 Bell et al. Feb 1987 A
4643731 Eckenhoff Feb 1987 A
4646722 Silverstein et al. Mar 1987 A
4646745 Noiles Mar 1987 A
4652820 Maresca Mar 1987 A
4654028 Suma Mar 1987 A
4655222 Florez et al. Apr 1987 A
4662555 Thornton May 1987 A
4663874 Sano et al. May 1987 A
4664305 Blake, III et al. May 1987 A
4665916 Green May 1987 A
4667674 Korthoff et al. May 1987 A
4669647 Storace Jun 1987 A
4671278 Chin Jun 1987 A
4671280 Dorband et al. Jun 1987 A
4671445 Barker et al. Jun 1987 A
4672964 Dee et al. Jun 1987 A
4675944 Wells Jun 1987 A
4676245 Fukuda Jun 1987 A
4679460 Yoshigai Jul 1987 A
4679719 Kramer Jul 1987 A
4684051 Akopov et al. Aug 1987 A
4688555 Wardle Aug 1987 A
4691703 Auth et al. Sep 1987 A
4693248 Failla Sep 1987 A
4698579 Richter et al. Oct 1987 A
4700703 Resnick et al. Oct 1987 A
4705038 Sjostrom et al. Nov 1987 A
4708141 Inoue et al. Nov 1987 A
4709120 Pearson Nov 1987 A
4715520 Roehr, Jr. et al. Dec 1987 A
4719917 Barrows et al. Jan 1988 A
4721099 Chikama Jan 1988 A
4724840 McVay et al. Feb 1988 A
4727308 Huljak et al. Feb 1988 A
4728020 Green et al. Mar 1988 A
4728876 Mongeon et al. Mar 1988 A
4729260 Dudden Mar 1988 A
4730726 Holzwarth Mar 1988 A
4741336 Failla et al. May 1988 A
4743214 Tai-Cheng May 1988 A
4744363 Hasson May 1988 A
4747820 Hornlein et al. May 1988 A
4750902 Wuchinich et al. Jun 1988 A
4752024 Green et al. Jun 1988 A
4754909 Barker et al. Jul 1988 A
4761326 Barnes et al. Aug 1988 A
4763669 Jaeger Aug 1988 A
4767044 Green Aug 1988 A
D297764 Hunt et al. Sep 1988 S
4773420 Green Sep 1988 A
4777780 Holzwarth Oct 1988 A
4781186 Simpson et al. Nov 1988 A
4784137 Kulik et al. Nov 1988 A
4787387 Burbank, III et al. Nov 1988 A
D298967 Hunt Dec 1988 S
4790225 Moody et al. Dec 1988 A
4790314 Weaver Dec 1988 A
4805617 Bedi et al. Feb 1989 A
4805823 Rothfuss Feb 1989 A
4807628 Peters et al. Feb 1989 A
4809695 Gwathmey et al. Mar 1989 A
4815460 Porat et al. Mar 1989 A
4817643 Olson Apr 1989 A
4817847 Redtenbacher et al. Apr 1989 A
4819853 Green Apr 1989 A
4821939 Green Apr 1989 A
4827911 Broadwin et al. May 1989 A
4828542 Hermann May 1989 A
4828944 Yabe et al. May 1989 A
4830855 Stewart May 1989 A
4832158 Farrar et al. May 1989 A
4833937 Nagano May 1989 A
4834720 Blinkhorn May 1989 A
4838859 Strassmann Jun 1989 A
4844068 Arata et al. Jul 1989 A
4848637 Pruitt Jul 1989 A
4856078 Konopka Aug 1989 A
4860644 Kohl et al. Aug 1989 A
4862891 Smith Sep 1989 A
4863423 Wallace Sep 1989 A
4865030 Polyak Sep 1989 A
4868530 Ahs Sep 1989 A
4869414 Green et al. Sep 1989 A
4869415 Fox Sep 1989 A
4873977 Avant et al. Oct 1989 A
4875486 Rapoport et al. Oct 1989 A
4880015 Nierman Nov 1989 A
4890613 Golden et al. Jan 1990 A
4892244 Fox et al. Jan 1990 A
4893622 Green et al. Jan 1990 A
4894051 Shiber Jan 1990 A
4896584 Stoll et al. Jan 1990 A
4896678 Ogawa Jan 1990 A
4900303 Lemelson Feb 1990 A
4903697 Resnick et al. Feb 1990 A
4909789 Taguchi et al. Mar 1990 A
4915100 Green Apr 1990 A
4919679 Averill et al. Apr 1990 A
4921479 Grayzel May 1990 A
4925082 Kim May 1990 A
4928699 Sasai May 1990 A
4930503 Pruitt Jun 1990 A
4930674 Barak Jun 1990 A
4931047 Broadwin et al. Jun 1990 A
4931737 Hishiki Jun 1990 A
4932960 Green et al. Jun 1990 A
4933800 Yang Jun 1990 A
4933843 Scheller et al. Jun 1990 A
D309350 Sutherland et al. Jul 1990 S
4938408 Bedi et al. Jul 1990 A
4941623 Pruitt Jul 1990 A
4943182 Hoblingre Jul 1990 A
4944443 Oddsen et al. Jul 1990 A
4946067 Kelsall Aug 1990 A
4948327 Crupi, Jr. Aug 1990 A
4949707 LeVahn et al. Aug 1990 A
4951860 Peters et al. Aug 1990 A
4951861 Schulze et al. Aug 1990 A
4955959 Tompkins et al. Sep 1990 A
4957212 Duck et al. Sep 1990 A
4962877 Hervas Oct 1990 A
4964559 Deniega et al. Oct 1990 A
4964863 Kanshin et al. Oct 1990 A
4965709 Ngo Oct 1990 A
4973274 Hirukawa Nov 1990 A
4973302 Armour et al. Nov 1990 A
4978049 Green Dec 1990 A
4978333 Broadwin et al. Dec 1990 A
4979952 Kubota et al. Dec 1990 A
4984564 Yuen Jan 1991 A
4986808 Broadwin et al. Jan 1991 A
4987049 Komamura et al. Jan 1991 A
4988334 Hornlein et al. Jan 1991 A
4995877 Ams et al. Feb 1991 A
4995959 Metzner Feb 1991 A
4996975 Nakamura Mar 1991 A
5002543 Bradshaw et al. Mar 1991 A
5002553 Shiber Mar 1991 A
5005754 Van Overloop Apr 1991 A
5009661 Michelson Apr 1991 A
5012411 Policastro et al. Apr 1991 A
5014898 Heidrich May 1991 A
5014899 Presty et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5018515 Gilman May 1991 A
5018657 Pedlick et al. May 1991 A
5024652 Dumenek et al. Jun 1991 A
5024671 Tu et al. Jun 1991 A
5025559 McCullough Jun 1991 A
5027834 Pruitt Jul 1991 A
5030226 Green et al. Jul 1991 A
5031814 Tompkins et al. Jul 1991 A
5035040 Kerrigan et al. Jul 1991 A
5038109 Goble et al. Aug 1991 A
5038247 Kelley et al. Aug 1991 A
5040715 Green et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5061269 Muller Oct 1991 A
5062491 Takeshima et al. Nov 1991 A
5062563 Green et al. Nov 1991 A
5065929 Schulze et al. Nov 1991 A
5071052 Rodak et al. Dec 1991 A
5071430 de Salis et al. Dec 1991 A
5074454 Peters Dec 1991 A
5077506 Krause Dec 1991 A
5079006 Urquhart Jan 1992 A
5080556 Carreno Jan 1992 A
5083695 Foslien et al. Jan 1992 A
5084057 Green et al. Jan 1992 A
5088979 Filipi et al. Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5089606 Cole et al. Feb 1992 A
5094247 Hernandez et al. Mar 1992 A
5098004 Kerrigan Mar 1992 A
5098360 Hirota Mar 1992 A
5100042 Gravener et al. Mar 1992 A
5100420 Green et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5104397 Vasconcelos et al. Apr 1992 A
5104400 Berguer et al. Apr 1992 A
5106008 Tompkins et al. Apr 1992 A
5108368 Hammerslag et al. Apr 1992 A
5109722 Hufnagle et al. May 1992 A
5111987 Moeinzadeh et al. May 1992 A
5116349 Aranyi May 1992 A
D327323 Hunt Jun 1992 S
5119009 McCaleb et al. Jun 1992 A
5122156 Granger et al. Jun 1992 A
5124990 Williamson Jun 1992 A
5129570 Schulze et al. Jul 1992 A
5137198 Nobis et al. Aug 1992 A
5139513 Segato Aug 1992 A
5141144 Foslien et al. Aug 1992 A
5142932 Moya et al. Sep 1992 A
5155941 Takahashi et al. Oct 1992 A
5156315 Green et al. Oct 1992 A
5156609 Nakao et al. Oct 1992 A
5156614 Green et al. Oct 1992 A
5158567 Green Oct 1992 A
D330699 Gill Nov 1992 S
5163598 Peters et al. Nov 1992 A
5168605 Bartlett Dec 1992 A
5170925 Madden et al. Dec 1992 A
5171247 Hughett et al. Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171253 Klieman Dec 1992 A
5173053 Swanson et al. Dec 1992 A
5173133 Morin et al. Dec 1992 A
5176677 Wuchinich Jan 1993 A
5176688 Narayan et al. Jan 1993 A
5187422 Izenbaard et al. Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
5188111 Yates et al. Feb 1993 A
5190517 Zieve et al. Mar 1993 A
5190544 Chapman et al. Mar 1993 A
5190560 Woods et al. Mar 1993 A
5190657 Heagle et al. Mar 1993 A
5192288 Thompson et al. Mar 1993 A
5195505 Josefsen Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5197648 Gingold Mar 1993 A
5197649 Bessler et al. Mar 1993 A
5197966 Sommerkamp Mar 1993 A
5197970 Green et al. Mar 1993 A
5200280 Karasa Apr 1993 A
5201750 Hocherl et al. Apr 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5207672 Roth et al. May 1993 A
5207697 Carusillo et al. May 1993 A
5209747 Knoepfler May 1993 A
5209756 Seedhom et al. May 1993 A
5211649 Kohler et al. May 1993 A
5211655 Hasson May 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217478 Rexroth Jun 1993 A
5219111 Bilotti et al. Jun 1993 A
5220269 Chen et al. Jun 1993 A
5221036 Takase Jun 1993 A
5221281 Klicek Jun 1993 A
5222945 Basnight Jun 1993 A
5222963 Brinkerhoff et al. Jun 1993 A
5222975 Crainich Jun 1993 A
5222976 Yoon Jun 1993 A
5223675 Taft Jun 1993 A
D338729 Sprecklemeier et al. Aug 1993 S
5234447 Kaster et al. Aug 1993 A
5236269 Handy Aug 1993 A
5236424 Imran Aug 1993 A
5236440 Hlavacek Aug 1993 A
5239981 Anapliotis Aug 1993 A
5240163 Stein et al. Aug 1993 A
5242457 Akopov et al. Sep 1993 A
5244462 Delahuerga et al. Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5253793 Green et al. Oct 1993 A
5258007 Spetzler et al. Nov 1993 A
5258008 Wilk Nov 1993 A
5258009 Conners Nov 1993 A
5258010 Green et al. Nov 1993 A
5258012 Luscombe et al. Nov 1993 A
5259366 Reydel et al. Nov 1993 A
5259835 Clark et al. Nov 1993 A
5260637 Pizzi Nov 1993 A
5261877 Fine et al. Nov 1993 A
5261922 Hood Nov 1993 A
5263629 Trumbull et al. Nov 1993 A
5263937 Shipp Nov 1993 A
5263973 Cook Nov 1993 A
5264218 Rogozinski Nov 1993 A
5268622 Philipp Dec 1993 A
5271543 Grant et al. Dec 1993 A
5271544 Fox et al. Dec 1993 A
RE34519 Fox et al. Jan 1994 E
5275322 Brinkerhoff et al. Jan 1994 A
5275323 Schulze et al. Jan 1994 A
5275608 Forman et al. Jan 1994 A
5279416 Malec et al. Jan 1994 A
5281216 Klicek Jan 1994 A
5282806 Haber et al. Feb 1994 A
5282829 Hermes Feb 1994 A
5284128 Hart Feb 1994 A
5285381 Iskarous et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5286253 Fucci Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290271 Jernberg Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292053 Bilotti et al. Mar 1994 A
5293024 Sugahara et al. Mar 1994 A
5297714 Kramer Mar 1994 A
5304204 Bregen Apr 1994 A
D347474 Olson May 1994 S
5307976 Olson et al. May 1994 A
5308576 Green et al. May 1994 A
5309387 Mori et al. May 1994 A
5309927 Welch May 1994 A
5312023 Green et al. May 1994 A
5312024 Grant et al. May 1994 A
5312329 Beaty et al. May 1994 A
5313935 Kortenbach et al. May 1994 A
5313967 Lieber et al. May 1994 A
5314424 Nicholas May 1994 A
5314445 Heidmueller nee Degwitz et al. May 1994 A
5314466 Stern et al. May 1994 A
5318221 Green et al. Jun 1994 A
5320627 Sorensen et al. Jun 1994 A
D348930 Olson Jul 1994 S
5326013 Green et al. Jul 1994 A
5329923 Lundquist Jul 1994 A
5330487 Thornton et al. Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5331971 Bales et al. Jul 1994 A
5332142 Robinson et al. Jul 1994 A
5333422 Warren et al. Aug 1994 A
5333772 Rothfuss et al. Aug 1994 A
5333773 Main et al. Aug 1994 A
5334183 Wuchinich Aug 1994 A
5336130 Ray Aug 1994 A
5336229 Noda Aug 1994 A
5336232 Green et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5341724 Vatel Aug 1994 A
5341807 Nardella Aug 1994 A
5341810 Dardel Aug 1994 A
5342380 Hood Aug 1994 A
5342381 Tidemand Aug 1994 A
5342385 Norelli et al. Aug 1994 A
5342395 Jarrett et al. Aug 1994 A
5342396 Cook Aug 1994 A
5343382 Hale et al. Aug 1994 A
5343391 Mushabac Aug 1994 A
5344059 Green et al. Sep 1994 A
5344060 Gravener et al. Sep 1994 A
5344454 Clarke et al. Sep 1994 A
5346504 Ortiz et al. Sep 1994 A
5348259 Blanco et al. Sep 1994 A
5350355 Sklar Sep 1994 A
5350388 Epstein Sep 1994 A
5350391 Iacovelli Sep 1994 A
5350400 Esposito et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5352235 Koros et al. Oct 1994 A
5352238 Green et al. Oct 1994 A
5354250 Christensen Oct 1994 A
5354303 Spaeth et al. Oct 1994 A
5356006 Alpern et al. Oct 1994 A
5356064 Green et al. Oct 1994 A
5358506 Green et al. Oct 1994 A
5358510 Luscombe et al. Oct 1994 A
5359231 Flowers et al. Oct 1994 A
D352780 Glaeser et al. Nov 1994 S
5359993 Slater et al. Nov 1994 A
5360305 Kerrigan Nov 1994 A
5360428 Hutchinson, Jr. Nov 1994 A
5361902 Abidin et al. Nov 1994 A
5364001 Bryan Nov 1994 A
5364002 Green et al. Nov 1994 A
5364003 Williamson, IV Nov 1994 A
5366133 Geiste Nov 1994 A
5366134 Green et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5368015 Wilk Nov 1994 A
5368592 Stern et al. Nov 1994 A
5369565 Chen et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5372124 Takayama et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5372602 Burke Dec 1994 A
5374277 Hassler Dec 1994 A
5375588 Yoon Dec 1994 A
5376095 Ortiz Dec 1994 A
5379933 Green et al. Jan 1995 A
5381649 Webb Jan 1995 A
5381782 DeLaRama et al. Jan 1995 A
5381943 Allen et al. Jan 1995 A
5382247 Cimino et al. Jan 1995 A
5383460 Jang et al. Jan 1995 A
5383880 Hooven Jan 1995 A
5383881 Green et al. Jan 1995 A
5383882 Buess et al. Jan 1995 A
5383888 Zvenyatsky et al. Jan 1995 A
5383895 Holmes et al. Jan 1995 A
5388568 van der Heide Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5389102 Green et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5391180 Tovey et al. Feb 1995 A
5392979 Green et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5395033 Byrne et al. Mar 1995 A
5395034 Allen et al. Mar 1995 A
5395312 Desai Mar 1995 A
5395384 Duthoit et al. Mar 1995 A
5397046 Savage et al. Mar 1995 A
5397324 Carroll et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5403276 Schechter et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5404106 Matsuda Apr 1995 A
5404870 Brinkerhoff et al. Apr 1995 A
5404960 Wada et al. Apr 1995 A
5405072 Zlock et al. Apr 1995 A
5405073 Porter Apr 1995 A
5405344 Williamson et al. Apr 1995 A
5405360 Tovey Apr 1995 A
5407293 Crainich Apr 1995 A
5408409 Glassman et al. Apr 1995 A
5409498 Braddock et al. Apr 1995 A
5409703 McAnalley et al. Apr 1995 A
D357981 Green et al. May 1995 S
5411481 Allen et al. May 1995 A
5411508 Bessler et al. May 1995 A
5413107 Oakley et al. May 1995 A
5413267 Solyntjes et al. May 1995 A
5413268 Green et al. May 1995 A
5413272 Green et al. May 1995 A
5413573 Koivukangas May 1995 A
5415334 Williamson et al. May 1995 A
5415335 Knodell, Jr. May 1995 A
5417203 Tovey et al. May 1995 A
5417361 Williamson, IV May 1995 A
5419766 Chang et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5422567 Matsunaga Jun 1995 A
5423471 Mastri et al. Jun 1995 A
5423809 Klicek Jun 1995 A
5423835 Green et al. Jun 1995 A
5425745 Green et al. Jun 1995 A
5427298 Tegtmeier Jun 1995 A
5431322 Green et al. Jul 1995 A
5431323 Smith et al. Jul 1995 A
5431654 Nic Jul 1995 A
5431668 Burbank, III et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437681 Meade et al. Aug 1995 A
5438302 Goble Aug 1995 A
5438997 Sieben et al. Aug 1995 A
5439155 Viola Aug 1995 A
5439156 Grant et al. Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5441191 Linden Aug 1995 A
5441193 Gravener Aug 1995 A
5441483 Avitall Aug 1995 A
5441494 Ortiz Aug 1995 A
5443197 Malis et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5444113 Sinclair et al. Aug 1995 A
5445155 Sieben Aug 1995 A
5445304 Plyley et al. Aug 1995 A
5445604 Lang Aug 1995 A
5445644 Pietrafitta et al. Aug 1995 A
5447265 Vidal et al. Sep 1995 A
5447417 Kuhl et al. Sep 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5449365 Green et al. Sep 1995 A
5449370 Vaitekunas Sep 1995 A
5452836 Huitema et al. Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5454378 Palmer et al. Oct 1995 A
5454822 Schob et al. Oct 1995 A
5454827 Aust et al. Oct 1995 A
5456401 Green et al. Oct 1995 A
5456917 Wise et al. Oct 1995 A
5458279 Plyley Oct 1995 A
5458579 Chodorow et al. Oct 1995 A
5462215 Viola et al. Oct 1995 A
5464013 Lemelson Nov 1995 A
5464144 Guy et al. Nov 1995 A
5464300 Crainich Nov 1995 A
5465819 Weilant et al. Nov 1995 A
5465894 Clark et al. Nov 1995 A
5465895 Knodel et al. Nov 1995 A
5465896 Allen et al. Nov 1995 A
5466020 Page et al. Nov 1995 A
5467911 Tsuruta et al. Nov 1995 A
5468253 Bezwada et al. Nov 1995 A
5470006 Rodak Nov 1995 A
5470007 Plyley et al. Nov 1995 A
5470008 Rodak Nov 1995 A
5470009 Rodak Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471129 Mann Nov 1995 A
5472132 Savage et al. Dec 1995 A
5472442 Klicek Dec 1995 A
5473204 Temple Dec 1995 A
5474057 Makower et al. Dec 1995 A
5474223 Viola et al. Dec 1995 A
5474566 Alesi et al. Dec 1995 A
5474570 Kockerling et al. Dec 1995 A
5476206 Green et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5476481 Schondorf Dec 1995 A
5478003 Green et al. Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5480089 Blewett Jan 1996 A
5480409 Riza Jan 1996 A
5482197 Green et al. Jan 1996 A
5483952 Aranyi Jan 1996 A
5484095 Green et al. Jan 1996 A
5484398 Stoddard Jan 1996 A
5484451 Akopov et al. Jan 1996 A
5485947 Olson et al. Jan 1996 A
5485952 Fontayne Jan 1996 A
5487499 Sorrentino et al. Jan 1996 A
5487500 Knodel et al. Jan 1996 A
5489058 Plyley et al. Feb 1996 A
5489256 Adair Feb 1996 A
5489290 Furnish Feb 1996 A
5490819 Nicholas et al. Feb 1996 A
5492671 Krafft Feb 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5498164 Ward et al. Mar 1996 A
5498838 Furman Mar 1996 A
5501654 Failla et al. Mar 1996 A
5503320 Webster et al. Apr 1996 A
5503635 Sauer et al. Apr 1996 A
5503638 Cooper et al. Apr 1996 A
5505363 Green et al. Apr 1996 A
5507425 Ziglioli Apr 1996 A
5507426 Young et al. Apr 1996 A
5509596 Green et al. Apr 1996 A
5509916 Taylor Apr 1996 A
5511564 Wilk Apr 1996 A
5514129 Smith May 1996 A
5514149 Green et al. May 1996 A
5514157 Nicholas et al. May 1996 A
5518163 Hooven May 1996 A
5518164 Hooven May 1996 A
5520609 Moll et al. May 1996 A
5520634 Fox et al. May 1996 A
5520678 Heckele et al. May 1996 A
5520700 Beyar et al. May 1996 A
5522817 Sander et al. Jun 1996 A
5522831 Sleister et al. Jun 1996 A
5527264 Moll et al. Jun 1996 A
5527320 Carruthers et al. Jun 1996 A
5529235 Boiarski et al. Jun 1996 A
D372086 Grasso et al. Jul 1996 S
5531305 Roberts et al. Jul 1996 A
5531744 Nardella et al. Jul 1996 A
5531856 Moll et al. Jul 1996 A
5533521 Granger Jul 1996 A
5533581 Barth et al. Jul 1996 A
5533661 Main et al. Jul 1996 A
5535934 Boiarski et al. Jul 1996 A
5535935 Vidal et al. Jul 1996 A
5535937 Boiarski et al. Jul 1996 A
5540375 Bolanos et al. Jul 1996 A
5540705 Meade et al. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5541489 Dunstan Jul 1996 A
5542594 McKean et al. Aug 1996 A
5542949 Yoon Aug 1996 A
5543119 Sutter et al. Aug 1996 A
5543695 Culp et al. Aug 1996 A
5544802 Crainich Aug 1996 A
5547117 Hamblin et al. Aug 1996 A
5549583 Sanford et al. Aug 1996 A
5549621 Bessler et al. Aug 1996 A
5549627 Kieturakis Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5549637 Crainich Aug 1996 A
5551622 Yoon Sep 1996 A
5553624 Francese et al. Sep 1996 A
5553675 Pitzen et al. Sep 1996 A
5553765 Knodel et al. Sep 1996 A
5554148 Aebischer et al. Sep 1996 A
5554169 Green et al. Sep 1996 A
5556020 Hou Sep 1996 A
5556416 Clark et al. Sep 1996 A
5558533 Hashizawa et al. Sep 1996 A
5558665 Kieturakis Sep 1996 A
5558671 Yates Sep 1996 A
5560530 Bolanos et al. Oct 1996 A
5560532 DeFonzo et al. Oct 1996 A
5561881 Klinger et al. Oct 1996 A
5562239 Boiarski et al. Oct 1996 A
5562241 Knodel et al. Oct 1996 A
5562682 Oberlin et al. Oct 1996 A
5562690 Green et al. Oct 1996 A
5562701 Huitema et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5563481 Krause Oct 1996 A
5564615 Bishop et al. Oct 1996 A
5569161 Ebling et al. Oct 1996 A
5569270 Weng Oct 1996 A
5569284 Young et al. Oct 1996 A
5571090 Sherts Nov 1996 A
5571100 Goble et al. Nov 1996 A
5571116 Bolanos et al. Nov 1996 A
5571285 Chow et al. Nov 1996 A
5571488 Beerstecher et al. Nov 1996 A
5573169 Green et al. Nov 1996 A
5573543 Akopov et al. Nov 1996 A
5574431 McKeown et al. Nov 1996 A
5575054 Klinzing et al. Nov 1996 A
5575789 Bell et al. Nov 1996 A
5575799 Bolanos et al. Nov 1996 A
5575803 Cooper et al. Nov 1996 A
5575805 Li Nov 1996 A
5577654 Bishop Nov 1996 A
5578052 Koros et al. Nov 1996 A
5579978 Green et al. Dec 1996 A
5580067 Hamblin et al. Dec 1996 A
5582611 Tsuruta et al. Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5582907 Pall Dec 1996 A
5583114 Barrows et al. Dec 1996 A
5584425 Savage et al. Dec 1996 A
5586711 Plyley et al. Dec 1996 A
5588579 Schnut et al. Dec 1996 A
5588580 Paul et al. Dec 1996 A
5588581 Conlon et al. Dec 1996 A
5591170 Spievack et al. Jan 1997 A
5591187 Dekel Jan 1997 A
5597107 Knodel et al. Jan 1997 A
5599151 Daum et al. Feb 1997 A
5599279 Slotman et al. Feb 1997 A
5599344 Paterson Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5599852 Scopelianos et al. Feb 1997 A
5601224 Bishop et al. Feb 1997 A
5601573 Fogelberg et al. Feb 1997 A
5601604 Vincent Feb 1997 A
5602449 Krause et al. Feb 1997 A
5603443 Clark et al. Feb 1997 A
5605272 Witt et al. Feb 1997 A
5605273 Hamblin et al. Feb 1997 A
5607094 Clark et al. Mar 1997 A
5607095 Smith et al. Mar 1997 A
5607433 Polla et al. Mar 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5607474 Athanasiou et al. Mar 1997 A
5609285 Grant et al. Mar 1997 A
5609601 Kolesa et al. Mar 1997 A
5611709 McAnulty Mar 1997 A
5613499 Palmer et al. Mar 1997 A
5613937 Garrison et al. Mar 1997 A
5613966 Makower et al. Mar 1997 A
5614887 Buchbinder Mar 1997 A
5615820 Viola Apr 1997 A
5618294 Aust et al. Apr 1997 A
5618303 Marlow et al. Apr 1997 A
5618307 Donlon et al. Apr 1997 A
5619992 Guthrie et al. Apr 1997 A
5620289 Curry Apr 1997 A
5620326 Younker Apr 1997 A
5620452 Yoon Apr 1997 A
5624398 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626587 Bishop et al. May 1997 A
5626595 Sklar et al. May 1997 A
5628446 Geiste et al. May 1997 A
5628743 Cimino May 1997 A
5628745 Bek May 1997 A
5630539 Plyley et al. May 1997 A
5630540 Blewett May 1997 A
5630541 Williamson, IV et al. May 1997 A
5630782 Adair May 1997 A
5632432 Schulze et al. May 1997 A
5632433 Grant et al. May 1997 A
5633374 Humphrey et al. May 1997 A
5634584 Okorocha et al. Jun 1997 A
5636779 Palmer Jun 1997 A
5636780 Green et al. Jun 1997 A
5638582 Klatt et al. Jun 1997 A
5639008 Gallagher et al. Jun 1997 A
D381077 Hunt Jul 1997 S
5643291 Pier et al. Jul 1997 A
5643294 Tovey et al. Jul 1997 A
5643319 Green et al. Jul 1997 A
5645209 Green et al. Jul 1997 A
5647526 Green et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5649937 Bito et al. Jul 1997 A
5649956 Jensen et al. Jul 1997 A
5651491 Heaton et al. Jul 1997 A
5651762 Bridges Jul 1997 A
5651821 Uchida Jul 1997 A
5653373 Green et al. Aug 1997 A
5653374 Young et al. Aug 1997 A
5653677 Okada et al. Aug 1997 A
5653721 Knodel et al. Aug 1997 A
5653748 Strecker Aug 1997 A
5655698 Yoon Aug 1997 A
5657417 Di Troia Aug 1997 A
5657429 Wang et al. Aug 1997 A
5657921 Young et al. Aug 1997 A
5658238 Suzuki et al. Aug 1997 A
5658281 Heard Aug 1997 A
5658298 Vincent et al. Aug 1997 A
5658300 Bito et al. Aug 1997 A
5658307 Exconde Aug 1997 A
5662258 Knodel et al. Sep 1997 A
5662260 Yoon Sep 1997 A
5662662 Bishop et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5667517 Hooven Sep 1997 A
5667526 Levin Sep 1997 A
5667527 Cook Sep 1997 A
5669544 Schulze et al. Sep 1997 A
5669904 Platt, Jr. et al. Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5669918 Balazs et al. Sep 1997 A
5673840 Schulze et al. Oct 1997 A
5673841 Schulze et al. Oct 1997 A
5673842 Bittner et al. Oct 1997 A
5674286 D'Alessio et al. Oct 1997 A
5678748 Plyley et al. Oct 1997 A
5680981 Mililli et al. Oct 1997 A
5680982 Schulze et al. Oct 1997 A
5680983 Plyley et al. Oct 1997 A
5681341 Lunsford et al. Oct 1997 A
5683349 Makower et al. Nov 1997 A
5685474 Seeber Nov 1997 A
5686090 Schilder et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5690269 Bolanos et al. Nov 1997 A
5692668 Schulze et al. Dec 1997 A
5693020 Rauh Dec 1997 A
5693042 Boiarski et al. Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5695494 Becker Dec 1997 A
5695502 Pier et al. Dec 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5697542 Knodel et al. Dec 1997 A
5697543 Burdorff Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5700270 Peyser et al. Dec 1997 A
5700276 Benecke Dec 1997 A
5702387 Arts et al. Dec 1997 A
5702408 Wales et al. Dec 1997 A
5702409 Rayburn et al. Dec 1997 A
5704087 Strub Jan 1998 A
5704534 Huitema et al. Jan 1998 A
5706997 Green et al. Jan 1998 A
5706998 Plyley et al. Jan 1998 A
5707392 Kortenbach Jan 1998 A
5709334 Sorrentino et al. Jan 1998 A
5709335 Heck Jan 1998 A
5709680 Yates et al. Jan 1998 A
5709706 Kienzle et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5712460 Carr et al. Jan 1998 A
5713128 Schrenk et al. Feb 1998 A
5713505 Huitema Feb 1998 A
5713895 Lontine et al. Feb 1998 A
5713896 Nardella Feb 1998 A
5713920 Bezwada et al. Feb 1998 A
5715604 Lanzoni Feb 1998 A
5715987 Kelley et al. Feb 1998 A
5715988 Palmer Feb 1998 A
5716366 Yates Feb 1998 A
5718359 Palmer et al. Feb 1998 A
5718360 Green et al. Feb 1998 A
5718548 Cotellessa Feb 1998 A
5718714 Livneh Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
D393067 Geary et al. Mar 1998 S
5724025 Tavori Mar 1998 A
5725536 Oberlin et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728113 Sherts Mar 1998 A
5728121 Bimbo et al. Mar 1998 A
5730758 Allgeyer Mar 1998 A
5732821 Stone et al. Mar 1998 A
5732871 Clark et al. Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5733308 Daugherty et al. Mar 1998 A
5735445 Vidal et al. Apr 1998 A
5735848 Yates et al. Apr 1998 A
5735874 Measamer et al. Apr 1998 A
5738474 Blewett Apr 1998 A
5738629 Moll et al. Apr 1998 A
5738648 Lands et al. Apr 1998 A
5741271 Nakao et al. Apr 1998 A
5743456 Jones et al. Apr 1998 A
5747953 Philipp May 1998 A
5749889 Bacich et al. May 1998 A
5749893 Vidal et al. May 1998 A
5749896 Cook May 1998 A
5749968 Melanson et al. May 1998 A
5752644 Bolanos et al. May 1998 A
5752965 Francis et al. May 1998 A
5752970 Yoon May 1998 A
5755717 Yates et al. May 1998 A
5758814 Gallagher et al. Jun 1998 A
5762255 Chrisman et al. Jun 1998 A
5762256 Mastri et al. Jun 1998 A
5766188 Igaki Jun 1998 A
5766205 Zvenyatsky et al. Jun 1998 A
5769303 Knodel et al. Jun 1998 A
5769748 Eyerly et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5769892 Kingwell Jun 1998 A
5772379 Evensen Jun 1998 A
5772578 Heimberger et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5773991 Chen Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5778939 Hok-Yin Jul 1998 A
5779130 Alesi et al. Jul 1998 A
5779131 Knodel et al. Jul 1998 A
5779132 Knodel et al. Jul 1998 A
5782396 Mastri et al. Jul 1998 A
5782397 Koukline Jul 1998 A
5782748 Palmer et al. Jul 1998 A
5782749 Riza Jul 1998 A
5782859 Nicholas et al. Jul 1998 A
5784934 Izumisawa Jul 1998 A
5785232 Vidal et al. Jul 1998 A
5785647 Tompkins et al. Jul 1998 A
5787897 Kieturakis Aug 1998 A
5791231 Cohn et al. Aug 1998 A
5792135 Madhani et al. Aug 1998 A
5792162 Jolly et al. Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5792573 Pitzen et al. Aug 1998 A
5794834 Hamblin et al. Aug 1998 A
5796188 Bays Aug 1998 A
5797536 Smith et al. Aug 1998 A
5797537 Oberlin et al. Aug 1998 A
5797538 Heaton et al. Aug 1998 A
5797637 Ervin Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797927 Yoon Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797959 Castro et al. Aug 1998 A
5799857 Robertson et al. Sep 1998 A
5800379 Edwards Sep 1998 A
5800423 Jensen Sep 1998 A
5804726 Geib et al. Sep 1998 A
5804936 Brodsky et al. Sep 1998 A
5806676 Wasgien Sep 1998 A
5807376 Viola et al. Sep 1998 A
5807378 Jensen et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5809441 McKee Sep 1998 A
5810721 Mueller et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5813813 Daum et al. Sep 1998 A
5814055 Knodel et al. Sep 1998 A
5814057 Oi et al. Sep 1998 A
5816471 Plyley et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817109 McGarry et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5820009 Melling et al. Oct 1998 A
5823066 Huitema et al. Oct 1998 A
5824333 Scopelianos et al. Oct 1998 A
5826776 Schulze et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5829662 Allen et al. Nov 1998 A
5830598 Patterson Nov 1998 A
5833690 Yates et al. Nov 1998 A
5833695 Yoon Nov 1998 A
5833696 Whitfield et al. Nov 1998 A
5836503 Ehrenfels et al. Nov 1998 A
5836960 Kolesa et al. Nov 1998 A
5839369 Chatterjee et al. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5841284 Takahashi Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843096 Igaki et al. Dec 1998 A
5843097 Mayenberger et al. Dec 1998 A
5843122 Riza Dec 1998 A
5843132 Ilvento Dec 1998 A
5843169 Taheri Dec 1998 A
5846254 Schulze et al. Dec 1998 A
5847566 Marritt et al. Dec 1998 A
5849011 Jones et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5849023 Mericle Dec 1998 A
5851179 Ritson et al. Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5855311 Hamblin et al. Jan 1999 A
5855583 Wang et al. Jan 1999 A
5860581 Robertson et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5865361 Milliman et al. Feb 1999 A
5865638 Trafton Feb 1999 A
5868361 Rinderer Feb 1999 A
5868760 McGuckin, Jr. Feb 1999 A
5868790 Vincent et al. Feb 1999 A
5871135 Williamson, IV et al. Feb 1999 A
5873885 Weidenbenner Feb 1999 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5878607 Nunes et al. Mar 1999 A
5878937 Green et al. Mar 1999 A
5878938 Bittner et al. Mar 1999 A
5881777 Bassi et al. Mar 1999 A
5891094 Masterson et al. Apr 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891558 Bell et al. Apr 1999 A
5893506 Powell Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893878 Pierce Apr 1999 A
5894979 Powell Apr 1999 A
5897552 Edwards et al. Apr 1999 A
5897562 Bolanos et al. Apr 1999 A
5899824 Kurtz et al. May 1999 A
5899914 Zirps et al. May 1999 A
5901895 Heaton et al. May 1999 A
5902312 Frater et al. May 1999 A
5903117 Gregory May 1999 A
5904647 Ouchi May 1999 A
5904693 Dicesare et al. May 1999 A
5904702 Ek et al. May 1999 A
5906577 Beane et al. May 1999 A
5906625 Bito et al. May 1999 A
5907211 Hall et al. May 1999 A
5908402 Blythe Jun 1999 A
5908427 McKean et al. Jun 1999 A
5909062 Krietzman Jun 1999 A
5911353 Bolanos et al. Jun 1999 A
5915616 Viola et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5918791 Sorrentino et al. Jul 1999 A
5919198 Graves, Jr. et al. Jul 1999 A
5921956 Grinberg et al. Jul 1999 A
5924864 Loge et al. Jul 1999 A
5928137 Green Jul 1999 A
5928256 Riza Jul 1999 A
5931847 Bittner et al. Aug 1999 A
5931853 McEwen et al. Aug 1999 A
5937951 Izuchukwu et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941442 Geiste et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5944172 Hannula Aug 1999 A
5944715 Goble et al. Aug 1999 A
5946978 Yamashita Sep 1999 A
5947984 Whipple Sep 1999 A
5947996 Logeman Sep 1999 A
5948030 Miller et al. Sep 1999 A
5948429 Bell et al. Sep 1999 A
5951301 Younker Sep 1999 A
5951516 Bunyan Sep 1999 A
5951552 Long et al. Sep 1999 A
5951574 Stefanchik et al. Sep 1999 A
5951575 Bolduc et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5954259 Viola et al. Sep 1999 A
5964394 Robertson Oct 1999 A
5964774 McKean et al. Oct 1999 A
5966126 Szabo Oct 1999 A
5971916 Koren Oct 1999 A
5973221 Collyer et al. Oct 1999 A
D416089 Barton et al. Nov 1999 S
5976122 Madhani et al. Nov 1999 A
5977746 Hershberger et al. Nov 1999 A
5980248 Kusakabe et al. Nov 1999 A
5984949 Levin Nov 1999 A
5988479 Palmer Nov 1999 A
5990379 Gregory Nov 1999 A
5993466 Yoon Nov 1999 A
5997528 Bisch et al. Dec 1999 A
5997552 Person et al. Dec 1999 A
6001108 Wang et al. Dec 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6007521 Bidwell et al. Dec 1999 A
6010054 Johnson et al. Jan 2000 A
6010513 Tormala et al. Jan 2000 A
6010520 Pattison Jan 2000 A
6012494 Balazs Jan 2000 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6015417 Reynolds, Jr. Jan 2000 A
6017322 Snoke et al. Jan 2000 A
6017354 Culp et al. Jan 2000 A
6017356 Frederick et al. Jan 2000 A
6018227 Kumar et al. Jan 2000 A
6019745 Gray Feb 2000 A
6022352 Vandewalle Feb 2000 A
6023641 Thompson Feb 2000 A
6024708 Bales et al. Feb 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024748 Manzo et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6027501 Goble et al. Feb 2000 A
6030384 Nezhat Feb 2000 A
6032849 Mastri et al. Mar 2000 A
6033105 Barker et al. Mar 2000 A
6033378 Lundquist et al. Mar 2000 A
6033399 Gines Mar 2000 A
6033427 Lee Mar 2000 A
6036641 Taylor et al. Mar 2000 A
6036667 Manna et al. Mar 2000 A
6037724 Buss et al. Mar 2000 A
6037927 Rosenberg Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039734 Goble Mar 2000 A
6042601 Smith Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6043626 Snyder et al. Mar 2000 A
6045560 McKean et al. Apr 2000 A
6047861 Vidal et al. Apr 2000 A
6049145 Austin et al. Apr 2000 A
6050172 Corves et al. Apr 2000 A
6050472 Shibata Apr 2000 A
6050989 Fox et al. Apr 2000 A
6050990 Tankovich et al. Apr 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053390 Green et al. Apr 2000 A
6053899 Slanda et al. Apr 2000 A
6053922 Krause et al. Apr 2000 A
6054142 Li et al. Apr 2000 A
RE36720 Green et al. May 2000 E
6056735 Okada et al. May 2000 A
6056746 Goble et al. May 2000 A
6059806 Hoegerle May 2000 A
6062360 Shields May 2000 A
6063020 Jones et al. May 2000 A
6063025 Bridges et al. May 2000 A
6063050 Manna et al. May 2000 A
6063095 Wang et al. May 2000 A
6063097 Oi et al. May 2000 A
6063098 Houser et al. May 2000 A
6065679 Levie et al. May 2000 A
6065919 Peck May 2000 A
6066132 Chen et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6071233 Ishikawa et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6074401 Gardiner et al. Jun 2000 A
6077280 Fossum Jun 2000 A
6077286 Cuschieri et al. Jun 2000 A
6077290 Marini Jun 2000 A
6079606 Milliman et al. Jun 2000 A
6080181 Jensen et al. Jun 2000 A
6082577 Coates et al. Jul 2000 A
6083191 Rose Jul 2000 A
6083223 Baker Jul 2000 A
6083234 Nicholas et al. Jul 2000 A
6083242 Cook Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6086600 Kortenbach Jul 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble Jul 2000 A
6099537 Sugai et al. Aug 2000 A
6099551 Gabbay Aug 2000 A
6102271 Longo et al. Aug 2000 A
6104162 Sainsbury et al. Aug 2000 A
6104304 Clark et al. Aug 2000 A
6106511 Jensen Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110187 Donlon Aug 2000 A
6113618 Nic Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6119913 Adams et al. Sep 2000 A
6120433 Mizuno et al. Sep 2000 A
6120462 Hibner et al. Sep 2000 A
6123241 Walter et al. Sep 2000 A
6123701 Nezhat Sep 2000 A
H001904 Yates et al. Oct 2000 H
6126058 Adams et al. Oct 2000 A
6126359 Dittrich et al. Oct 2000 A
6126670 Walker et al. Oct 2000 A
6131789 Schulze et al. Oct 2000 A
6131790 Piraka Oct 2000 A
6132368 Cooper Oct 2000 A
6134962 Sugitani Oct 2000 A
6139546 Koenig et al. Oct 2000 A
6142149 Steen Nov 2000 A
6142933 Longo et al. Nov 2000 A
6147135 Yuan et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6151323 O'Connell et al. Nov 2000 A
6152935 Kammerer et al. Nov 2000 A
6155473 Tompkins et al. Dec 2000 A
6156056 Kearns et al. Dec 2000 A
6157169 Lee Dec 2000 A
6159146 El Gazayerli Dec 2000 A
6159200 Verdura et al. Dec 2000 A
6159224 Yoon Dec 2000 A
6162208 Hipps Dec 2000 A
6162220 Nezhat Dec 2000 A
6162537 Martin et al. Dec 2000 A
6165175 Wampler et al. Dec 2000 A
6165184 Verdura et al. Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6167185 Smiley et al. Dec 2000 A
6168605 Measamer et al. Jan 2001 B1
6171305 Sherman Jan 2001 B1
6171316 Kovac et al. Jan 2001 B1
6171330 Benchetrit Jan 2001 B1
6173074 Russo Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6175290 Forsythe et al. Jan 2001 B1
6179195 Adams et al. Jan 2001 B1
6179776 Adams et al. Jan 2001 B1
6181105 Cutolo et al. Jan 2001 B1
6182673 Kindermann et al. Feb 2001 B1
6185356 Parker et al. Feb 2001 B1
6186142 Schmidt et al. Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6202914 Geiste et al. Mar 2001 B1
6206894 Thompson et al. Mar 2001 B1
6206897 Jamiolkowski et al. Mar 2001 B1
6206904 Ouchi Mar 2001 B1
6209414 Uneme Apr 2001 B1
6210403 Klicek Apr 2001 B1
6213999 Platt, Jr. et al. Apr 2001 B1
6214028 Yoon et al. Apr 2001 B1
6220368 Ark et al. Apr 2001 B1
6221007 Green Apr 2001 B1
6221023 Matsuba et al. Apr 2001 B1
6223100 Green Apr 2001 B1
6223835 Habedank et al. May 2001 B1
6224617 Saadat et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6228083 Lands et al. May 2001 B1
6228084 Kirwan, Jr. May 2001 B1
6228089 Wahrburg May 2001 B1
6228098 Kayan et al. May 2001 B1
6231565 Tovey et al. May 2001 B1
6234178 Goble et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238384 Peer May 2001 B1
6241139 Milliman et al. Jun 2001 B1
6241140 Adams et al. Jun 2001 B1
6241723 Heim et al. Jun 2001 B1
6245084 Mark et al. Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6248117 Blatter Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6249105 Andrews et al. Jun 2001 B1
6250532 Green et al. Jun 2001 B1
6251485 Harris et al. Jun 2001 B1
D445745 Norman Jul 2001 S
6254534 Butler et al. Jul 2001 B1
6254619 Garabet et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258107 Balazs et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261679 Chen et al. Jul 2001 B1
6264086 McGuckin, Jr. Jul 2001 B1
6264087 Whitman Jul 2001 B1
6264617 Bales et al. Jul 2001 B1
6270508 Klieman et al. Aug 2001 B1
6270916 Sink et al. Aug 2001 B1
6273876 Klima et al. Aug 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6283981 Beaupre Sep 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296640 Wampler et al. Oct 2001 B1
6302311 Adams et al. Oct 2001 B1
6302743 Chiu et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6306149 Meade Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6309397 Julian et al. Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6309403 Minor et al. Oct 2001 B1
6312435 Wallace et al. Nov 2001 B1
6315184 Whitman Nov 2001 B1
6319510 Yates Nov 2001 B1
6320123 Reimers Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6324339 Hudson et al. Nov 2001 B1
6325799 Goble Dec 2001 B1
6325805 Ogilvie et al. Dec 2001 B1
6325810 Hamilton Dec 2001 B1
6328498 Mersch Dec 2001 B1
6330965 Milliman et al. Dec 2001 B1
6331181 Tierney et al. Dec 2001 B1
6331761 Kumar et al. Dec 2001 B1
6333029 Vyakarnam et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6334861 Chandler et al. Jan 2002 B1
6336926 Goble Jan 2002 B1
6338737 Toledano Jan 2002 B1
6343731 Adams et al. Feb 2002 B1
6346077 Taylor et al. Feb 2002 B1
6348061 Whitman Feb 2002 B1
D454951 Bon Mar 2002 S
6352503 Matsui et al. Mar 2002 B1
6352532 Kramer et al. Mar 2002 B1
6355699 Vyakarnam et al. Mar 2002 B1
6356072 Chass Mar 2002 B1
6358224 Tims et al. Mar 2002 B1
6358263 Mark et al. Mar 2002 B2
6358459 Ziegler et al. Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6364888 Niemeyer et al. Apr 2002 B1
6366441 Ozawa et al. Apr 2002 B1
6370981 Watarai Apr 2002 B2
6371114 Schmidt et al. Apr 2002 B1
6373152 Wang et al. Apr 2002 B1
6377011 Ben-Ur Apr 2002 B1
6383201 Dong May 2002 B1
6387092 Burnside et al. May 2002 B1
6387113 Hawkins et al. May 2002 B1
6387114 Adams May 2002 B2
6391038 Vargas et al. May 2002 B2
6392854 O'Gorman May 2002 B1
6394998 Wallace et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6398797 Bombard et al. Jun 2002 B2
6402766 Bowman et al. Jun 2002 B2
6406440 Stefanchik Jun 2002 B1
6406472 Jensen Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
H002037 Yates et al. Jul 2002 H
6412639 Hickey Jul 2002 B1
6413274 Pedros Jul 2002 B1
6415542 Bates et al. Jul 2002 B1
6416486 Wampler Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6419695 Gabbay Jul 2002 B1
6423079 Blake, III Jul 2002 B1
RE37814 Allgeyer Aug 2002 E
6428070 Takanashi et al. Aug 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6429611 Li Aug 2002 B1
6430298 Kettl et al. Aug 2002 B1
6432065 Burdorff et al. Aug 2002 B1
6436097 Nardella Aug 2002 B1
6436107 Wang et al. Aug 2002 B1
6436110 Bowman et al. Aug 2002 B2
6436115 Beaupre Aug 2002 B1
6436122 Frank et al. Aug 2002 B1
6439439 Rickard et al. Aug 2002 B1
6439446 Perry et al. Aug 2002 B1
6440146 Nicholas et al. Aug 2002 B2
6441577 Blumenkranz et al. Aug 2002 B2
D462758 Epstein et al. Sep 2002 S
6443973 Whitman Sep 2002 B1
6445530 Baker Sep 2002 B1
6447518 Krause et al. Sep 2002 B1
6447523 Middleman et al. Sep 2002 B1
6447799 Ullman Sep 2002 B1
6447864 Johnson et al. Sep 2002 B2
6450391 Kayan et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6454781 Witt et al. Sep 2002 B1
6457625 Tormala et al. Oct 2002 B1
6458077 Boebel et al. Oct 2002 B1
6458147 Cruise et al. Oct 2002 B1
6460627 Below et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6468286 Mastri et al. Oct 2002 B2
6471106 Reining Oct 2002 B1
6471659 Eggers et al. Oct 2002 B2
6478210 Adams et al. Nov 2002 B2
6482200 Shippert Nov 2002 B2
6482217 Pintor et al. Nov 2002 B1
6485490 Wampler et al. Nov 2002 B2
6485503 Jacobs et al. Nov 2002 B2
6485667 Tan Nov 2002 B1
6486286 McGall et al. Nov 2002 B1
6488196 Fenton, Jr. Dec 2002 B1
6488197 Whitman Dec 2002 B1
6488659 Rosenman Dec 2002 B1
6491201 Whitman Dec 2002 B1
6491690 Goble et al. Dec 2002 B1
6491701 Tierney et al. Dec 2002 B2
6492785 Kasten et al. Dec 2002 B1
6494882 Lebouitz et al. Dec 2002 B1
6494885 Dhindsa Dec 2002 B1
6494888 Laufer et al. Dec 2002 B1
6494896 D'Alessio et al. Dec 2002 B1
6498480 Manara Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6500194 Benderev et al. Dec 2002 B2
6503139 Coral Jan 2003 B2
6503257 Grant et al. Jan 2003 B2
6503259 Huxel et al. Jan 2003 B2
6505768 Whitman Jan 2003 B2
6506197 Rollero et al. Jan 2003 B1
6510854 Goble Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6512360 Goto et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6516073 Schulz et al. Feb 2003 B1
6517528 Pantages et al. Feb 2003 B1
6517535 Edwards Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6517566 Hovland et al. Feb 2003 B1
6520971 Perry et al. Feb 2003 B1
6520972 Peters Feb 2003 B2
6522101 Malackowski Feb 2003 B2
6524180 Simms et al. Feb 2003 B1
6525499 Naganuma Feb 2003 B2
6527782 Hogg et al. Mar 2003 B2
6527785 Sancoff et al. Mar 2003 B2
6530942 Fogarty et al. Mar 2003 B2
6532958 Buan et al. Mar 2003 B1
6533157 Whitman Mar 2003 B1
6533723 Lockery et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6535764 Imran et al. Mar 2003 B2
6539297 Weiberle et al. Mar 2003 B2
D473239 Cockerill Apr 2003 S
6539816 Kogiso et al. Apr 2003 B2
6543456 Freeman Apr 2003 B1
6545384 Pelrine et al. Apr 2003 B1
6547786 Goble Apr 2003 B1
6550546 Thurler et al. Apr 2003 B2
6551333 Kuhns et al. Apr 2003 B2
6554861 Knox et al. Apr 2003 B2
6555770 Kawase Apr 2003 B2
6558378 Sherman et al. May 2003 B2
6558379 Batchelor et al. May 2003 B1
6558429 Taylor May 2003 B2
6561187 Schmidt et al. May 2003 B2
6565560 Goble et al. May 2003 B1
6566619 Gillman et al. May 2003 B2
6569085 Kortenbach et al. May 2003 B2
6569171 DeGuillebon et al. May 2003 B2
6578751 Hartwick Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6582427 Goble et al. Jun 2003 B1
6582441 He et al. Jun 2003 B1
6583533 Pelrine et al. Jun 2003 B2
6585144 Adams et al. Jul 2003 B2
6585664 Burdorff et al. Jul 2003 B2
6586898 King et al. Jul 2003 B2
6587750 Gerbi et al. Jul 2003 B2
6588277 Giordano et al. Jul 2003 B2
6588643 Bolduc et al. Jul 2003 B2
6588931 Betzner et al. Jul 2003 B2
6589118 Soma et al. Jul 2003 B1
6589164 Flaherty Jul 2003 B1
6592538 Hotchkiss et al. Jul 2003 B1
6592597 Grant et al. Jul 2003 B2
6594552 Nowlin et al. Jul 2003 B1
6596296 Nelson et al. Jul 2003 B1
6596304 Bayon et al. Jul 2003 B1
6596432 Kawakami et al. Jul 2003 B2
6599295 Tornier et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
D478665 Isaacs et al. Aug 2003 S
D478986 Johnston et al. Aug 2003 S
6601749 Sullivan et al. Aug 2003 B2
6602252 Mollenauer Aug 2003 B2
6602262 Griego et al. Aug 2003 B2
6603050 Heaton Aug 2003 B2
6605078 Adams Aug 2003 B2
6605669 Awokola et al. Aug 2003 B2
6605911 Klesing Aug 2003 B1
6607475 Doyle et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6613069 Boyd et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6620111 Stephens et al. Sep 2003 B2
6620166 Wenstrom, Jr. et al. Sep 2003 B1
6625517 Bogdanov et al. Sep 2003 B1
6626834 Dunne et al. Sep 2003 B2
H002086 Amsler Oct 2003 H
6629630 Adams Oct 2003 B2
6629974 Penny et al. Oct 2003 B2
6629988 Weadock Oct 2003 B2
6635838 Kornelson Oct 2003 B1
6636412 Smith Oct 2003 B2
6638108 Tachi Oct 2003 B2
6638285 Gabbay Oct 2003 B2
6638297 Huitema Oct 2003 B1
RE38335 Aust et al. Nov 2003 E
6641528 Torii Nov 2003 B2
6644532 Green et al. Nov 2003 B2
6645201 Utley et al. Nov 2003 B1
6646307 Yu et al. Nov 2003 B1
6648816 Irion et al. Nov 2003 B2
6648901 Fleischman et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
D484243 Ryan et al. Dec 2003 S
D484595 Ryan et al. Dec 2003 S
D484596 Ryan et al. Dec 2003 S
6656177 Truckai et al. Dec 2003 B2
6656193 Grant et al. Dec 2003 B2
6659940 Adler Dec 2003 B2
6660008 Foerster et al. Dec 2003 B1
6663623 Oyama et al. Dec 2003 B1
6663641 Kovac et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6667825 Lu et al. Dec 2003 B2
6669073 Milliman et al. Dec 2003 B2
6670806 Wendt et al. Dec 2003 B2
6671185 Duval Dec 2003 B2
D484977 Ryan et al. Jan 2004 S
6676660 Wampler et al. Jan 2004 B2
6677687 Ho et al. Jan 2004 B2
6679269 Swanson Jan 2004 B2
6679410 Wursch et al. Jan 2004 B2
6681978 Geiste et al. Jan 2004 B2
6681979 Whitman Jan 2004 B2
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685698 Morley et al. Feb 2004 B2
6685727 Fisher et al. Feb 2004 B2
6689153 Skiba Feb 2004 B1
6692507 Pugsley et al. Feb 2004 B2
6692692 Stetzel Feb 2004 B2
6695198 Adams et al. Feb 2004 B2
6695199 Whitman Feb 2004 B2
6695774 Hale et al. Feb 2004 B2
6695849 Michelson Feb 2004 B2
6696814 Henderson et al. Feb 2004 B2
6697048 Rosenberg et al. Feb 2004 B2
6698643 Whitman Mar 2004 B2
6699177 Wang et al. Mar 2004 B1
6699214 Gellman Mar 2004 B2
6699235 Wallace et al. Mar 2004 B2
6704210 Myers Mar 2004 B1
6705503 Pedicini et al. Mar 2004 B1
6709445 Boebel et al. Mar 2004 B2
6712773 Viola Mar 2004 B1
6716223 Leopold et al. Apr 2004 B2
6716232 Vidal et al. Apr 2004 B1
6716233 Whitman Apr 2004 B1
6720734 Norris Apr 2004 B2
6722550 Ricordi et al. Apr 2004 B1
6722552 Fenton, Jr. Apr 2004 B2
6723087 O'Neill et al. Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
6723109 Solingen Apr 2004 B2
6726697 Nicholas et al. Apr 2004 B2
6726706 Dominguez Apr 2004 B2
6729119 Schnipke et al. May 2004 B2
6736825 Blatter et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6740030 Martone et al. May 2004 B2
6743230 Lutze et al. Jun 2004 B2
6744385 Kazuya et al. Jun 2004 B2
6747121 Gogolewski Jun 2004 B2
6747300 Nadd et al. Jun 2004 B2
6749560 Konstorum et al. Jun 2004 B1
6749600 Levy Jun 2004 B1
6752768 Burdorff et al. Jun 2004 B2
6752816 Culp et al. Jun 2004 B2
6754959 Guiette, III et al. Jun 2004 B1
6755195 Lemke et al. Jun 2004 B1
6755338 Hahnen et al. Jun 2004 B2
6755843 Chung et al. Jun 2004 B2
6756705 Pulford, Jr. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6761685 Adams et al. Jul 2004 B2
6762339 Klun et al. Jul 2004 B1
6764445 Ramans et al. Jul 2004 B2
6766957 Matsuura et al. Jul 2004 B2
6767352 Field et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6769590 Vresh et al. Aug 2004 B2
6769594 Orban, III Aug 2004 B2
6770027 Banik et al. Aug 2004 B2
6770070 Balbierz Aug 2004 B1
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773438 Knodel et al. Aug 2004 B1
6775575 Bommannan et al. Aug 2004 B2
6777838 Miekka et al. Aug 2004 B2
6780151 Grabover et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6783524 Anderson et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786864 Matsuura et al. Sep 2004 B2
6786896 Madhani et al. Sep 2004 B1
6788018 Blumenkranz Sep 2004 B1
6790173 Saadat et al. Sep 2004 B2
6793652 Whitman et al. Sep 2004 B1
6793661 Hamilton et al. Sep 2004 B2
6793663 Kneifel et al. Sep 2004 B2
6793669 Nakamura et al. Sep 2004 B2
6796921 Buck et al. Sep 2004 B1
6799669 Fukumura et al. Oct 2004 B2
6802822 Dodge Oct 2004 B1
6802843 Truckai et al. Oct 2004 B2
6802844 Ferree Oct 2004 B2
6805273 Bilotti et al. Oct 2004 B2
6806808 Watters et al. Oct 2004 B1
6808525 Latterell et al. Oct 2004 B2
6810359 Sakaguchi Oct 2004 B2
6814154 Chou Nov 2004 B2
6814741 Bowman et al. Nov 2004 B2
6817508 Racenet et al. Nov 2004 B1
6817509 Geiste et al. Nov 2004 B2
6817974 Cooper et al. Nov 2004 B2
6818018 Sawhney Nov 2004 B1
6820791 Adams Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6821282 Perry et al. Nov 2004 B2
6821284 Sturtz et al. Nov 2004 B2
6827246 Sullivan et al. Dec 2004 B2
6827712 Tovey et al. Dec 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6828902 Casden Dec 2004 B2
6830174 Hillstead et al. Dec 2004 B2
6831629 Nishino et al. Dec 2004 B2
6832998 Goble Dec 2004 B2
6834001 Myono Dec 2004 B2
6835173 Couvillon, Jr. Dec 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6836611 Popovic et al. Dec 2004 B2
6837846 Jaffe et al. Jan 2005 B2
6837883 Moll et al. Jan 2005 B2
6838493 Williams et al. Jan 2005 B2
6840423 Adams et al. Jan 2005 B2
6841967 Kim et al. Jan 2005 B2
6843403 Whitman Jan 2005 B2
6843789 Goble Jan 2005 B2
6843793 Brock et al. Jan 2005 B2
6846307 Whitman et al. Jan 2005 B2
6846308 Whitman et al. Jan 2005 B2
6846309 Whitman et al. Jan 2005 B2
6847190 Schaefer et al. Jan 2005 B2
6849071 Whitman et al. Feb 2005 B2
6850817 Green Feb 2005 B1
6852122 Rush Feb 2005 B2
6852330 Bowman et al. Feb 2005 B2
6853879 Sunaoshi Feb 2005 B2
6858005 Ohline et al. Feb 2005 B2
6859882 Fung Feb 2005 B2
RE38708 Bolanos et al. Mar 2005 E
D502994 Blake, III Mar 2005 S
6861142 Wilkie et al. Mar 2005 B1
6861954 Levin Mar 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6863694 Boyce et al. Mar 2005 B1
6863924 Ranganathan et al. Mar 2005 B2
6866178 Adams et al. Mar 2005 B2
6866668 Giannetti et al. Mar 2005 B2
6866671 Tierney et al. Mar 2005 B2
6867248 Martin et al. Mar 2005 B1
6869430 Balbierz et al. Mar 2005 B2
6869435 Blake, III Mar 2005 B2
6872214 Sonnenschein et al. Mar 2005 B2
6874669 Adams et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6878106 Herrmann Apr 2005 B1
6884392 Malkin et al. Apr 2005 B2
6884428 Binette et al. Apr 2005 B2
6886730 Fujisawa et al. May 2005 B2
6887710 Call et al. May 2005 B2
6889116 Jinno May 2005 B2
6893435 Goble May 2005 B2
6894140 Roby May 2005 B2
6895176 Archer et al. May 2005 B2
6899538 Matoba May 2005 B2
6899593 Moeller et al. May 2005 B1
6905057 Swayze et al. Jun 2005 B2
6905497 Truckai et al. Jun 2005 B2
6905498 Hooven Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6911033 de Guillebon et al. Jun 2005 B2
6911916 Wang et al. Jun 2005 B1
6913579 Truckai et al. Jul 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6913613 Schwarz et al. Jul 2005 B2
6921397 Corcoran et al. Jul 2005 B2
6921412 Black et al. Jul 2005 B1
6923093 Ullah Aug 2005 B2
6923803 Goble Aug 2005 B2
6923819 Meade et al. Aug 2005 B2
6925849 Jairam Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6928902 Eyssallenne Aug 2005 B1
6929641 Goble et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6931830 Liao Aug 2005 B2
6932218 Kosann et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6936042 Wallace et al. Aug 2005 B2
6936948 Bell et al. Aug 2005 B2
D509297 Wells Sep 2005 S
D509589 Wells Sep 2005 S
6938706 Ng Sep 2005 B2
6939358 Palacios et al. Sep 2005 B2
6942662 Goble et al. Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6945444 Gresham et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6951562 Zwirnmann Oct 2005 B2
6953138 Dworak et al. Oct 2005 B1
6953139 Milliman et al. Oct 2005 B2
6953461 McClurken et al. Oct 2005 B2
6957758 Aranyi Oct 2005 B2
6958035 Friedman et al. Oct 2005 B2
6959851 Heinrich Nov 2005 B2
6959852 Shelton, IV et al. Nov 2005 B2
6960107 Schaub et al. Nov 2005 B1
6960163 Ewers et al. Nov 2005 B2
6960220 Marino et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6963792 Green Nov 2005 B1
6964363 Wales et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6968908 Tokunaga et al. Nov 2005 B2
6969385 Moreyra Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6971988 Orban, III Dec 2005 B2
6972199 Lebouitz et al. Dec 2005 B2
6974435 Daw et al. Dec 2005 B2
6974462 Sater Dec 2005 B2
6978921 Shelton, IV et al. Dec 2005 B2
6978922 Bilotti et al. Dec 2005 B2
6981628 Wales Jan 2006 B2
6981941 Whitman et al. Jan 2006 B2
6981978 Gannoe Jan 2006 B2
6984203 Tartaglia et al. Jan 2006 B2
6984231 Goble et al. Jan 2006 B2
6986451 Mastri et al. Jan 2006 B1
6988649 Shelton, IV et al. Jan 2006 B2
6988650 Schwemberger et al. Jan 2006 B2
6989034 Hammer et al. Jan 2006 B2
6990731 Haytayan Jan 2006 B2
6990796 Schnipke et al. Jan 2006 B2
6993200 Tastl et al. Jan 2006 B2
6993413 Sunaoshi Jan 2006 B2
6994708 Manzo Feb 2006 B2
6995729 Govari et al. Feb 2006 B2
6996433 Burbank et al. Feb 2006 B2
6997931 Sauer et al. Feb 2006 B2
6997935 Anderson et al. Feb 2006 B2
6998736 Lee et al. Feb 2006 B2
6998816 Wieck et al. Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7000819 Swayze et al. Feb 2006 B2
7000911 McCormick et al. Feb 2006 B2
7001380 Goble Feb 2006 B2
7001408 Knodel et al. Feb 2006 B2
7004174 Eggers et al. Feb 2006 B2
7007176 Goodfellow et al. Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7008435 Cummins Mar 2006 B2
7009039 Yayon et al. Mar 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014640 Kemppainen et al. Mar 2006 B2
7018357 Emmons Mar 2006 B2
7018390 Turovskiy et al. Mar 2006 B2
7021669 Lindermeir et al. Apr 2006 B1
7022131 Derowe et al. Apr 2006 B1
7023159 Gorti et al. Apr 2006 B2
7025064 Wang et al. Apr 2006 B2
7025732 Thompson et al. Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7025774 Freeman et al. Apr 2006 B2
7025775 Gadberry et al. Apr 2006 B2
7028570 Ohta et al. Apr 2006 B2
7029435 Nakao Apr 2006 B2
7029439 Roberts et al. Apr 2006 B2
7030904 Adair et al. Apr 2006 B2
7032798 Whitman et al. Apr 2006 B2
7032799 Viola et al. Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7035716 Harris et al. Apr 2006 B2
7035762 Menard et al. Apr 2006 B2
7036680 Flannery May 2006 B1
7037314 Armstrong May 2006 B2
7037344 Kagan et al. May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7041868 Greene et al. May 2006 B2
7043852 Hayashida et al. May 2006 B2
7044350 Kameyama et al. May 2006 B2
7044352 Shelton, IV et al. May 2006 B2
7044353 Mastri et al. May 2006 B2
7046082 Komiya et al. May 2006 B2
7048687 Reuss et al. May 2006 B1
7048745 Tierney et al. May 2006 B2
7052454 Taylor May 2006 B2
7052494 Goble et al. May 2006 B2
7052499 Steger et al. May 2006 B2
7055730 Ehrenfels et al. Jun 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7056284 Martone et al. Jun 2006 B2
7056330 Gayton Jun 2006 B2
7059331 Adams et al. Jun 2006 B2
7059508 Shelton, IV et al. Jun 2006 B2
7063671 Couvillon, Jr. Jun 2006 B2
7063712 Vargas et al. Jun 2006 B2
7064509 Fu et al. Jun 2006 B1
7066879 Fowler et al. Jun 2006 B2
7066944 Laufer et al. Jun 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7070083 Jankowski Jul 2006 B2
7070559 Adams et al. Jul 2006 B2
7070597 Truckai et al. Jul 2006 B2
7071287 Rhine et al. Jul 2006 B2
7075770 Smith Jul 2006 B1
7077856 Whitman Jul 2006 B2
7080769 Vresh et al. Jul 2006 B2
7081114 Rashidi Jul 2006 B2
7083073 Yoshie et al. Aug 2006 B2
7083075 Swayze et al. Aug 2006 B2
7083571 Wang et al. Aug 2006 B2
7083615 Peterson et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7083626 Hart et al. Aug 2006 B2
7086267 Dworak et al. Aug 2006 B2
7087049 Nowlin et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7087071 Nicholas et al. Aug 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090683 Brock et al. Aug 2006 B2
7090684 McGuckin, Jr. et al. Aug 2006 B2
7091412 Wang et al. Aug 2006 B2
7093492 Treiber et al. Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094247 Monassevitch et al. Aug 2006 B2
7094916 DeLuca et al. Aug 2006 B2
7096972 Orozco, Jr. Aug 2006 B2
7097089 Marczyk Aug 2006 B2
7097644 Long Aug 2006 B2
7097650 Weller et al. Aug 2006 B2
7098794 Lindsay et al. Aug 2006 B2
7100949 Williams et al. Sep 2006 B2
7101187 Deconinck et al. Sep 2006 B1
7101371 Dycus et al. Sep 2006 B2
7101394 Hamm et al. Sep 2006 B2
7104741 Krohn Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7108701 Evens et al. Sep 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112214 Peterson et al. Sep 2006 B2
RE39358 Goble Oct 2006 E
7114642 Whitman Oct 2006 B2
7116100 Mock et al. Oct 2006 B1
7118020 Lee et al. Oct 2006 B2
7118528 Piskun Oct 2006 B1
7118563 Weckwerth et al. Oct 2006 B2
7118582 Wang et al. Oct 2006 B1
7119534 Butzmann Oct 2006 B2
7121446 Arad et al. Oct 2006 B2
7121773 Mikiya et al. Oct 2006 B2
7122028 Looper et al. Oct 2006 B2
7125403 Julian et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7126303 Farritor et al. Oct 2006 B2
7126879 Snyder Oct 2006 B2
7128253 Mastri et al. Oct 2006 B2
7128254 Shelton, IV et al. Oct 2006 B2
7128748 Mooradian et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7133601 Phillips et al. Nov 2006 B2
7134364 Kageler et al. Nov 2006 B2
7134587 Schwemberger et al. Nov 2006 B2
7135027 Delmotte Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7137981 Long Nov 2006 B2
7139016 Squilla et al. Nov 2006 B2
7140527 Ehrenfels et al. Nov 2006 B2
7140528 Shelton, IV Nov 2006 B2
7141055 Abrams et al. Nov 2006 B2
7143923 Shelton, IV et al. Dec 2006 B2
7143924 Scirica et al. Dec 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7143926 Shelton, IV et al. Dec 2006 B2
7146191 Kerner et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7147139 Schwemberger et al. Dec 2006 B2
7147140 Wukusick et al. Dec 2006 B2
7147637 Goble Dec 2006 B2
7147648 Lin Dec 2006 B2
7147650 Lee Dec 2006 B2
7150748 Ebbutt et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7153314 Laufer et al. Dec 2006 B2
7155316 Sutherland et al. Dec 2006 B2
7156863 Sonnenschein et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7161036 Oikawa et al. Jan 2007 B2
7161580 Bailey et al. Jan 2007 B2
7162758 Skinner Jan 2007 B2
7163563 Schwartz et al. Jan 2007 B2
7166133 Evans et al. Jan 2007 B2
7168604 Milliman et al. Jan 2007 B2
7170910 Chen et al. Jan 2007 B2
7171279 Buckingham et al. Jan 2007 B2
7172104 Scirica et al. Feb 2007 B2
7172593 Trieu et al. Feb 2007 B2
7172615 Morriss et al. Feb 2007 B2
7174636 Lowe Feb 2007 B2
7177533 McFarlin et al. Feb 2007 B2
7179223 Motoki et al. Feb 2007 B2
7179267 Nolan et al. Feb 2007 B2
7182239 Myers Feb 2007 B1
7182763 Nardella Feb 2007 B2
7183737 Kitagawa Feb 2007 B2
7187960 Abreu Mar 2007 B2
7188758 Viola et al. Mar 2007 B2
7189207 Viola Mar 2007 B2
7190147 Gileff et al. Mar 2007 B2
7195627 Amoah et al. Mar 2007 B2
7196911 Takano et al. Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7199537 Okamura et al. Apr 2007 B2
7202576 Dechene et al. Apr 2007 B1
7202653 Pai Apr 2007 B2
7204404 Nguyen et al. Apr 2007 B2
7204835 Latterell et al. Apr 2007 B2
7207233 Wadge Apr 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7207472 Wukusick et al. Apr 2007 B2
7207556 Saitoh et al. Apr 2007 B2
7208005 Frecker et al. Apr 2007 B2
7210609 Leiboff et al. May 2007 B2
7211081 Goble May 2007 B2
7211084 Goble et al. May 2007 B2
7211092 Hughett May 2007 B2
7211979 Khatib et al. May 2007 B2
7213736 Wales et al. May 2007 B2
7214224 Goble May 2007 B2
7215517 Takamatsu May 2007 B2
7217285 Vargas et al. May 2007 B2
7220260 Fleming et al. May 2007 B2
7220272 Weadock May 2007 B2
7225959 Patton et al. Jun 2007 B2
7225963 Scirica Jun 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226450 Athanasiou et al. Jun 2007 B2
7228505 Shimazu et al. Jun 2007 B2
7229408 Douglas et al. Jun 2007 B2
7234624 Gresham et al. Jun 2007 B2
7235072 Sartor et al. Jun 2007 B2
7235089 McGuckin, Jr. Jun 2007 B1
7235302 Jing et al. Jun 2007 B2
7237708 Guy et al. Jul 2007 B1
7238195 Viola Jul 2007 B2
7238901 Kim et al. Jul 2007 B2
7239657 Gunnarsson Jul 2007 B1
7241288 Braun Jul 2007 B2
7241289 Braun Jul 2007 B2
7246734 Shelton, IV Jul 2007 B2
7247161 Johnston et al. Jul 2007 B2
7249267 Chapuis Jul 2007 B2
7252641 Thompson et al. Aug 2007 B2
7252660 Kunz Aug 2007 B2
7255012 Hedtke Aug 2007 B2
7255696 Goble et al. Aug 2007 B2
7256695 Hamel et al. Aug 2007 B2
7258262 Mastri et al. Aug 2007 B2
7258546 Beier et al. Aug 2007 B2
7260431 Libbus et al. Aug 2007 B2
7265374 Lee et al. Sep 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267679 McGuckin, Jr. et al. Sep 2007 B2
7272002 Drapeau Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
D552623 Vong et al. Oct 2007 S
7275674 Racenet et al. Oct 2007 B2
7276044 Ferry et al. Oct 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278562 Mastri et al. Oct 2007 B2
7278563 Green Oct 2007 B1
7278949 Bader Oct 2007 B2
7278994 Goble Oct 2007 B2
7282048 Goble et al. Oct 2007 B2
7283096 Geisheimer et al. Oct 2007 B2
7286850 Frielink et al. Oct 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7289139 Amling et al. Oct 2007 B2
7293685 Ehrenfels et al. Nov 2007 B2
7295893 Sunaoshi Nov 2007 B2
7295907 Lu et al. Nov 2007 B2
7296722 Ivanko Nov 2007 B2
7296724 Green et al. Nov 2007 B2
7297149 Vitali et al. Nov 2007 B2
7300373 Jinno et al. Nov 2007 B2
7300431 Dubrovsky Nov 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7303106 Milliman et al. Dec 2007 B2
7303107 Milliman et al. Dec 2007 B2
7303108 Shelton, IV Dec 2007 B2
7303502 Thompson Dec 2007 B2
7303556 Metzger Dec 2007 B2
7306597 Manzo Dec 2007 B2
7308998 Mastri et al. Dec 2007 B2
7311238 Liu Dec 2007 B2
7313430 Urquhart et al. Dec 2007 B2
7314473 Jinno et al. Jan 2008 B2
7322859 Evans Jan 2008 B2
7322975 Goble et al. Jan 2008 B2
7322994 Nicholas et al. Jan 2008 B2
7324572 Chang Jan 2008 B2
7326203 Papineau et al. Feb 2008 B2
7326213 Benderev et al. Feb 2008 B2
7328828 Ortiz et al. Feb 2008 B2
7328829 Arad et al. Feb 2008 B2
7330004 DeJonge et al. Feb 2008 B2
7331340 Barney Feb 2008 B2
7331343 Schmidt et al. Feb 2008 B2
7331403 Berry et al. Feb 2008 B2
7331406 Wottreng, Jr. et al. Feb 2008 B2
7331969 Inganas et al. Feb 2008 B1
7334717 Rethy et al. Feb 2008 B2
7334718 McAlister et al. Feb 2008 B2
7335199 Goble et al. Feb 2008 B2
7336045 Clermonts Feb 2008 B2
7336048 Lohr Feb 2008 B2
7336184 Smith et al. Feb 2008 B2
7337774 Webb Mar 2008 B2
7338505 Belson Mar 2008 B2
7338513 Lee et al. Mar 2008 B2
7341555 Ootawara et al. Mar 2008 B2
7341591 Grinberg Mar 2008 B2
7343920 Toby et al. Mar 2008 B2
7344532 Goble et al. Mar 2008 B2
7344533 Pearson et al. Mar 2008 B2
7346344 Fontaine Mar 2008 B2
7346406 Brotto et al. Mar 2008 B2
7348763 Reinhart et al. Mar 2008 B1
7348875 Hughes et al. Mar 2008 B2
RE40237 Bilotti et al. Apr 2008 E
7351258 Ricotta et al. Apr 2008 B2
7354447 Shelton, IV et al. Apr 2008 B2
7354502 Polat et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7357806 Rivera et al. Apr 2008 B2
7361168 Makower et al. Apr 2008 B2
7361195 Schwartz et al. Apr 2008 B2
7362062 Schneider et al. Apr 2008 B2
7364060 Milliman Apr 2008 B2
7364061 Swayze et al. Apr 2008 B2
7367485 Shelton, IV et al. May 2008 B2
7368124 Chun et al. May 2008 B2
7371210 Brock et al. May 2008 B2
7371403 McCarthy et al. May 2008 B2
7377918 Amoah May 2008 B2
7377928 Zubik et al. May 2008 B2
RE40388 Gines Jun 2008 E
7380695 Doll et al. Jun 2008 B2
7380696 Shelton, IV et al. Jun 2008 B2
7384403 Sherman Jun 2008 B2
7384417 Cucin Jun 2008 B2
7386365 Nixon Jun 2008 B2
7386730 Uchikubo Jun 2008 B2
7388217 Buschbeck et al. Jun 2008 B2
7388484 Hsu Jun 2008 B2
7391173 Schena Jun 2008 B2
7394190 Huang Jul 2008 B2
7396356 Mollenauer Jul 2008 B2
7397364 Govari Jul 2008 B2
7398707 Morley et al. Jul 2008 B2
7398907 Racenet et al. Jul 2008 B2
7398908 Holsten et al. Jul 2008 B2
7400107 Schneider et al. Jul 2008 B2
7400752 Zacharias Jul 2008 B2
7401000 Nakamura Jul 2008 B2
7401721 Holsten et al. Jul 2008 B2
7404449 Bermingham et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7404509 Ortiz et al. Jul 2008 B2
7404822 Viart et al. Jul 2008 B2
7407074 Ortiz et al. Aug 2008 B2
7407075 Holsten et al. Aug 2008 B2
7407076 Racenet et al. Aug 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7407078 Shelton, IV et al. Aug 2008 B2
7408310 Hong et al. Aug 2008 B2
7410085 Wolf et al. Aug 2008 B2
7410086 Ortiz et al. Aug 2008 B2
7410483 Danitz et al. Aug 2008 B2
7413563 Corcoran et al. Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7418078 Blanz et al. Aug 2008 B2
RE40514 Mastri et al. Sep 2008 E
7419080 Smith et al. Sep 2008 B2
7419081 Ehrenfels et al. Sep 2008 B2
7419321 Tereschouk Sep 2008 B2
7419495 Menn et al. Sep 2008 B2
7422136 Marczyk Sep 2008 B1
7422138 Bilotti et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7424965 Racenet et al. Sep 2008 B2
7427607 Suzuki Sep 2008 B2
D578644 Shumer et al. Oct 2008 S
7430772 Van Es Oct 2008 B2
7431188 Marczyk Oct 2008 B1
7431189 Shelton, IV et al. Oct 2008 B2
7431230 McPherson et al. Oct 2008 B2
7431694 Stefanchik et al. Oct 2008 B2
7431730 Viola Oct 2008 B2
7434715 Shelton, IV et al. Oct 2008 B2
7434717 Shelton, IV et al. Oct 2008 B2
7435249 Buysse et al. Oct 2008 B2
7438209 Hess et al. Oct 2008 B1
7438718 Milliman et al. Oct 2008 B2
7439354 Lenges et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7441685 Boudreaux Oct 2008 B1
7442201 Pugsley et al. Oct 2008 B2
7443547 Moreno et al. Oct 2008 B2
7448525 Shelton, IV et al. Nov 2008 B2
7450010 Gravelle et al. Nov 2008 B1
7451904 Shelton, IV Nov 2008 B2
7455208 Wales et al. Nov 2008 B2
7455676 Holsten et al. Nov 2008 B2
7455682 Viola Nov 2008 B2
D582934 Byeon Dec 2008 S
7461767 Viola et al. Dec 2008 B2
7462187 Johnston et al. Dec 2008 B2
7464845 Chou Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7464847 Viola et al. Dec 2008 B2
7464848 Green et al. Dec 2008 B2
7464849 Shelton, IV et al. Dec 2008 B2
7467740 Shelton, IV et al. Dec 2008 B2
7467849 Silverbrook et al. Dec 2008 B2
7472814 Mastri et al. Jan 2009 B2
7472815 Shelton, IV et al. Jan 2009 B2
7472816 Holsten et al. Jan 2009 B2
7473221 Ewers et al. Jan 2009 B2
7473253 Dycus et al. Jan 2009 B2
7473263 Johnston et al. Jan 2009 B2
7476237 Taniguchi et al. Jan 2009 B2
7479608 Smith Jan 2009 B2
7481347 Roy Jan 2009 B2
7481348 Marczyk Jan 2009 B2
7481349 Holsten et al. Jan 2009 B2
7481824 Boudreaux et al. Jan 2009 B2
7485124 Kuhns et al. Feb 2009 B2
7485133 Cannon et al. Feb 2009 B2
7485142 Milo Feb 2009 B2
7487899 Shelton, IV et al. Feb 2009 B2
7489055 Jeong et al. Feb 2009 B2
7490749 Schall et al. Feb 2009 B2
7491232 Bolduc et al. Feb 2009 B2
7494039 Racenet et al. Feb 2009 B2
7494499 Nagase et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7500979 Hueil et al. Mar 2009 B2
7501198 Barlev et al. Mar 2009 B2
7503474 Hillstead et al. Mar 2009 B2
7506790 Shelton, IV Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7507202 Schoellhorn Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7510534 Burdorff et al. Mar 2009 B2
7510566 Jacobs et al. Mar 2009 B2
7513407 Chang Apr 2009 B1
7513408 Shelton, IV et al. Apr 2009 B2
7517356 Heinrich Apr 2009 B2
7524320 Tierney et al. Apr 2009 B2
7527632 Houghton et al. May 2009 B2
7530984 Sonnenschein et al. May 2009 B2
7530985 Takemoto et al. May 2009 B2
7533906 Luettgen et al. May 2009 B2
7534259 Lashinski et al. May 2009 B2
7540867 Jinno et al. Jun 2009 B2
7542807 Bertolero et al. Jun 2009 B2
7543730 Marczyk Jun 2009 B1
7546939 Adams et al. Jun 2009 B2
7546940 Milliman et al. Jun 2009 B2
7547287 Boecker et al. Jun 2009 B2
7547312 Bauman et al. Jun 2009 B2
7549563 Mather et al. Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7549998 Braun Jun 2009 B2
7552854 Wixey et al. Jun 2009 B2
7553173 Kowalick Jun 2009 B2
7553275 Padget et al. Jun 2009 B2
7554343 Bromfield Jun 2009 B2
7556185 Viola Jul 2009 B2
7556186 Milliman Jul 2009 B2
7556647 Drews et al. Jul 2009 B2
7559449 Viola Jul 2009 B2
7559450 Wales et al. Jul 2009 B2
7559452 Wales et al. Jul 2009 B2
7559937 de la Torre et al. Jul 2009 B2
7561637 Jonsson et al. Jul 2009 B2
7562910 Kertesz et al. Jul 2009 B2
7563269 Hashiguchi Jul 2009 B2
7563862 Sieg et al. Jul 2009 B2
7565993 Milliman et al. Jul 2009 B2
7566300 Devierre et al. Jul 2009 B2
7567045 Fristedt Jul 2009 B2
7568603 Shelton, IV et al. Aug 2009 B2
7568604 Ehrenfels et al. Aug 2009 B2
7568619 Todd et al. Aug 2009 B2
7575144 Ortiz et al. Aug 2009 B2
7578825 Huebner Aug 2009 B2
D600712 LaManna et al. Sep 2009 S
7583063 Dooley Sep 2009 B2
7584880 Racenet et al. Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7588174 Holsten et al. Sep 2009 B2
7588175 Timm et al. Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7588177 Racenet Sep 2009 B2
7591783 Boulais et al. Sep 2009 B2
7591818 Bertolero et al. Sep 2009 B2
7593766 Faber et al. Sep 2009 B2
7597229 Boudreaux et al. Oct 2009 B2
7597230 Racenet et al. Oct 2009 B2
7597693 Garrison Oct 2009 B2
7597699 Rogers Oct 2009 B2
7598972 Tomita Oct 2009 B2
7600663 Green Oct 2009 B2
7604118 Iio et al. Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7604151 Hess et al. Oct 2009 B2
7604668 Farnsworth et al. Oct 2009 B2
7607557 Shelton, IV et al. Oct 2009 B2
D604325 Ebeling et al. Nov 2009 S
7611038 Racenet et al. Nov 2009 B2
7611474 Hibner et al. Nov 2009 B2
7615003 Stefanchik et al. Nov 2009 B2
7615067 Lee et al. Nov 2009 B2
7617961 Viola Nov 2009 B2
D605201 Lorenz et al. Dec 2009 S
D607010 Kocmick Dec 2009 S
7624902 Marczyk et al. Dec 2009 B2
7624903 Green et al. Dec 2009 B2
7625370 Hart et al. Dec 2009 B2
7630841 Comisky et al. Dec 2009 B2
7631793 Rethy et al. Dec 2009 B2
7631794 Rethy et al. Dec 2009 B2
7635074 Olson et al. Dec 2009 B2
7635922 Becker Dec 2009 B2
7637409 Marczyk Dec 2009 B2
7637410 Marczyk Dec 2009 B2
7638958 Philipp et al. Dec 2009 B2
7641091 Olson et al. Jan 2010 B2
7641092 Kruszynski et al. Jan 2010 B2
7641093 Doll et al. Jan 2010 B2
7641095 Viola Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644783 Roberts et al. Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645230 Mikkaichi et al. Jan 2010 B2
7648055 Marczyk Jan 2010 B2
7648457 Stefanchik et al. Jan 2010 B2
7648519 Lee et al. Jan 2010 B2
7650185 Maile et al. Jan 2010 B2
7651017 Ortiz et al. Jan 2010 B2
7651498 Shifrin et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7655004 Long Feb 2010 B2
7655288 Bauman et al. Feb 2010 B2
7655584 Biran et al. Feb 2010 B2
7656131 Embrey et al. Feb 2010 B2
7658311 Boudreaux Feb 2010 B2
7658312 Vidal et al. Feb 2010 B2
7658705 Melvin et al. Feb 2010 B2
7659219 Biran et al. Feb 2010 B2
7661448 Kim et al. Feb 2010 B2
7662161 Briganti et al. Feb 2010 B2
7665646 Prommersberger Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7669746 Shelton, IV Mar 2010 B2
7669747 Weisenburgh, II et al. Mar 2010 B2
7670334 Hueil et al. Mar 2010 B2
7673780 Shelton, IV et al. Mar 2010 B2
7673781 Swayze et al. Mar 2010 B2
7673782 Hess et al. Mar 2010 B2
7673783 Morgan et al. Mar 2010 B2
7674253 Fisher et al. Mar 2010 B2
7674255 Braun Mar 2010 B2
7674263 Ryan Mar 2010 B2
7674270 Layer Mar 2010 B2
7682307 Danitz et al. Mar 2010 B2
7682367 Shah et al. Mar 2010 B2
7682686 Curro et al. Mar 2010 B2
7686201 Csiky Mar 2010 B2
7686804 Johnson et al. Mar 2010 B2
7686826 Lee et al. Mar 2010 B2
7688028 Phillips et al. Mar 2010 B2
7691098 Wallace et al. Apr 2010 B2
7691103 Fernandez et al. Apr 2010 B2
7691106 Schenberger et al. Apr 2010 B2
7694864 Okada et al. Apr 2010 B2
7694865 Scirica Apr 2010 B2
7695485 Whitman et al. Apr 2010 B2
7695493 Saadat et al. Apr 2010 B2
7699204 Viola Apr 2010 B2
7699835 Lee et al. Apr 2010 B2
7699844 Utley et al. Apr 2010 B2
7699846 Ryan Apr 2010 B2
7699856 Van Wyk et al. Apr 2010 B2
7699859 Bombard et al. Apr 2010 B2
7699860 Huitema et al. Apr 2010 B2
7699868 Frank et al. Apr 2010 B2
7703653 Shah et al. Apr 2010 B2
7705559 Powell et al. Apr 2010 B2
7708180 Murray et al. May 2010 B2
7708181 Cole et al. May 2010 B2
7708182 Viola May 2010 B2
7708758 Lee et al. May 2010 B2
7712182 Zeiler et al. May 2010 B2
7713190 Brock et al. May 2010 B2
7714239 Smith May 2010 B2
7714334 Lin May 2010 B2
7717312 Beetel May 2010 B2
7717313 Criscuolo et al. May 2010 B2
7717846 Zirps et al. May 2010 B2
7717873 Swick May 2010 B2
7717915 Miyazawa May 2010 B2
7717926 Whitfield et al. May 2010 B2
7718180 Karp May 2010 B2
7718556 Matsuda et al. May 2010 B2
7721930 McKenna et al. May 2010 B2
7721931 Shelton, IV et al. May 2010 B2
7721933 Ehrenfels et al. May 2010 B2
7721934 Shelton, IV et al. May 2010 B2
7721936 Shalton, IV et al. May 2010 B2
7722527 Bouchier et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
7722610 Viola et al. May 2010 B2
7725214 Diolaiti May 2010 B2
7726171 Langlotz et al. Jun 2010 B2
7726537 Olson et al. Jun 2010 B2
7726538 Holsten et al. Jun 2010 B2
7726539 Holsten et al. Jun 2010 B2
7727954 McKay Jun 2010 B2
7728553 Carrier et al. Jun 2010 B2
7729742 Govari Jun 2010 B2
7731072 Timm et al. Jun 2010 B2
7731073 Wixey et al. Jun 2010 B2
7731724 Huitema et al. Jun 2010 B2
7735703 Morgan et al. Jun 2010 B2
7736254 Schena Jun 2010 B2
7736306 Brustad et al. Jun 2010 B2
7736374 Vaughan et al. Jun 2010 B2
7738971 Swayze et al. Jun 2010 B2
7740159 Shelton, IV et al. Jun 2010 B2
7742036 Grant et al. Jun 2010 B2
7743960 Whitman et al. Jun 2010 B2
7744624 Bettuchi Jun 2010 B2
7744627 Orban, III et al. Jun 2010 B2
7744628 Viola Jun 2010 B2
7747146 Milano et al. Jun 2010 B2
7748587 Haramiishi et al. Jul 2010 B2
7748632 Coleman et al. Jul 2010 B2
7749204 Dhanaraj et al. Jul 2010 B2
7751870 Whitman Jul 2010 B2
7753245 Boudreaux et al. Jul 2010 B2
7753246 Scirica Jul 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7757924 Gerbi et al. Jul 2010 B2
7758594 Lamson et al. Jul 2010 B2
7758612 Shipp Jul 2010 B2
7762462 Gelbman Jul 2010 B2
7762998 Birk et al. Jul 2010 B2
7766207 Mather et al. Aug 2010 B2
7766209 Baxter, III et al. Aug 2010 B2
7766210 Shelton, IV et al. Aug 2010 B2
7766821 Brunnen et al. Aug 2010 B2
7766894 Weitzner et al. Aug 2010 B2
7770658 Ito et al. Aug 2010 B2
7770773 Whitman et al. Aug 2010 B2
7770774 Mastri et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7770776 Chen et al. Aug 2010 B2
7771396 Stefanchik et al. Aug 2010 B2
7772720 McGee et al. Aug 2010 B2
7772725 Siman-Tov Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7776060 Mooradian et al. Aug 2010 B2
7776065 Griffiths et al. Aug 2010 B2
7778004 Nerheim et al. Aug 2010 B2
7779737 Newman, Jr. et al. Aug 2010 B2
7780054 Wales Aug 2010 B2
7780055 Scirica et al. Aug 2010 B2
7780309 McMillan et al. Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7780685 Hunt et al. Aug 2010 B2
7784662 Wales et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7787256 Chan et al. Aug 2010 B2
7789283 Shah Sep 2010 B2
7789875 Brock et al. Sep 2010 B2
7789883 Takashino et al. Sep 2010 B2
7789889 Zubik et al. Sep 2010 B2
7793812 Moore et al. Sep 2010 B2
7794475 Hess et al. Sep 2010 B2
7798386 Schall et al. Sep 2010 B2
7799039 Shelton, IV et al. Sep 2010 B2
7799044 Johnston et al. Sep 2010 B2
7799965 Patel et al. Sep 2010 B2
7803151 Whitman Sep 2010 B2
7806871 Li et al. Oct 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810690 Bilotti et al. Oct 2010 B2
7810691 Boyden et al. Oct 2010 B2
7810692 Hall et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7811275 Birk et al. Oct 2010 B2
7814816 Alberti et al. Oct 2010 B2
7815092 Whitman et al. Oct 2010 B2
7815565 Stefanchik et al. Oct 2010 B2
7815662 Spivey et al. Oct 2010 B2
7819296 Hueil et al. Oct 2010 B2
7819297 Doll et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Shelton, IV et al. Oct 2010 B2
7819799 Merril et al. Oct 2010 B2
7819884 Lee et al. Oct 2010 B2
7819886 Whitfield et al. Oct 2010 B2
7823592 Bettuchi et al. Nov 2010 B2
7823760 Zemlok et al. Nov 2010 B2
7824401 Manzo et al. Nov 2010 B2
7824422 Benchetrit Nov 2010 B2
7824426 Racenet et al. Nov 2010 B2
7828189 Holsten et al. Nov 2010 B2
7828794 Sartor Nov 2010 B2
7828808 Hinman et al. Nov 2010 B2
7831292 Quaid et al. Nov 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832611 Boyden et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7833234 Bailly et al. Nov 2010 B2
7835823 Sillman et al. Nov 2010 B2
7836400 May et al. Nov 2010 B2
7837079 Holsten et al. Nov 2010 B2
7837080 Schwemberger Nov 2010 B2
7837081 Holsten et al. Nov 2010 B2
7837425 Saeki et al. Nov 2010 B2
7837685 Weinberg et al. Nov 2010 B2
7837687 Harp Nov 2010 B2
7837694 Tethrake et al. Nov 2010 B2
7838789 Stoffers et al. Nov 2010 B2
7839109 Carmen, Jr. et al. Nov 2010 B2
7841503 Sonnenschein et al. Nov 2010 B2
7842025 Coleman et al. Nov 2010 B2
7842028 Lee Nov 2010 B2
7843158 Prisco Nov 2010 B2
7845533 Marczyk et al. Dec 2010 B2
7845534 Viola et al. Dec 2010 B2
7845535 Scircia Dec 2010 B2
7845536 Viola et al. Dec 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846085 Silverman et al. Dec 2010 B2
7846149 Jankowski Dec 2010 B2
7848066 Yanagishima Dec 2010 B2
7850623 Griffin et al. Dec 2010 B2
7850642 Moll et al. Dec 2010 B2
7850982 Stopek et al. Dec 2010 B2
7854735 Houser et al. Dec 2010 B2
7854736 Ryan Dec 2010 B2
7857183 Shelton, IV Dec 2010 B2
7857184 Viola Dec 2010 B2
7857185 Swayze et al. Dec 2010 B2
7857186 Baxter, III et al. Dec 2010 B2
7857813 Schmitz et al. Dec 2010 B2
7861906 Doll et al. Jan 2011 B2
7862502 Pool et al. Jan 2011 B2
7862546 Conlon et al. Jan 2011 B2
7862579 Ortiz et al. Jan 2011 B2
7866525 Scirica Jan 2011 B2
7866527 Hall et al. Jan 2011 B2
7866528 Olson et al. Jan 2011 B2
7870989 Viola et al. Jan 2011 B2
7871418 Thompson et al. Jan 2011 B2
7871440 Schwartz et al. Jan 2011 B2
7875055 Cichocki, Jr. Jan 2011 B2
7879063 Khosravi Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7883461 Albrecht et al. Feb 2011 B2
7883465 Donofrio et al. Feb 2011 B2
7886951 Hessler Feb 2011 B2
7886952 Scirica et al. Feb 2011 B2
7887530 Zemlok et al. Feb 2011 B2
7887535 Lands et al. Feb 2011 B2
7887536 Johnson et al. Feb 2011 B2
7887563 Cummins Feb 2011 B2
7891531 Ward Feb 2011 B1
7891532 Mastri et al. Feb 2011 B2
7892200 Birk et al. Feb 2011 B2
7892245 Liddicoat et al. Feb 2011 B2
7893586 West et al. Feb 2011 B2
7896214 Farascioni Mar 2011 B2
7896215 Adams et al. Mar 2011 B2
7896869 DiSilvestro et al. Mar 2011 B2
7896877 Hall et al. Mar 2011 B2
7896895 Boudreaux et al. Mar 2011 B2
7896897 Gresham et al. Mar 2011 B2
7898198 Murphree Mar 2011 B2
7900805 Shelton, IV et al. Mar 2011 B2
7900806 Chen et al. Mar 2011 B2
7901381 Birk et al. Mar 2011 B2
7905380 Shelton, IV et al. Mar 2011 B2
7905381 Baxter, III et al. Mar 2011 B2
7905881 Masuda et al. Mar 2011 B2
7905889 Catanese, III et al. Mar 2011 B2
7905890 Whitfield et al. Mar 2011 B2
7905902 Huitema et al. Mar 2011 B2
7909039 Hur Mar 2011 B2
7909191 Baker et al. Mar 2011 B2
7909220 Viola Mar 2011 B2
7909221 Viola et al. Mar 2011 B2
7909224 Prommersberger Mar 2011 B2
7913891 Doll et al. Mar 2011 B2
7913893 Mastri et al. Mar 2011 B2
7914521 Wang et al. Mar 2011 B2
7914543 Roth et al. Mar 2011 B2
7914551 Ortiz et al. Mar 2011 B2
7918230 Whitman et al. Apr 2011 B2
7918376 Knodel et al. Apr 2011 B1
7918377 Measamer et al. Apr 2011 B2
7918845 Saadat et al. Apr 2011 B2
7918848 Lau et al. Apr 2011 B2
7918861 Brock et al. Apr 2011 B2
7918867 Dana et al. Apr 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922063 Zemlok et al. Apr 2011 B2
7922743 Heinrich et al. Apr 2011 B2
7923144 Kohn et al. Apr 2011 B2
7926691 Viola et al. Apr 2011 B2
7927328 Orszulak et al. Apr 2011 B2
7928281 Augustine Apr 2011 B2
7930040 Kelsch et al. Apr 2011 B1
7930065 Larkin et al. Apr 2011 B2
7931660 Aranyi et al. Apr 2011 B2
7931695 Ringeisen Apr 2011 B2
7931877 Steffens et al. Apr 2011 B2
7934630 Shelton, IV et al. May 2011 B2
7934631 Balbierz et al. May 2011 B2
7934896 Schnier May 2011 B2
7935773 Hadba et al. May 2011 B2
7936142 Otsuka et al. May 2011 B2
7938307 Bettuchi May 2011 B2
7941865 Seman, Jr. et al. May 2011 B2
7942303 Shah May 2011 B2
7942890 D'Agostino et al. May 2011 B2
7944175 Mori et al. May 2011 B2
7945792 Cherpantier May 2011 B2
7945798 Carlson et al. May 2011 B2
7946453 Voegele et al. May 2011 B2
7947011 Birk et al. May 2011 B2
7950560 Zemlok et al. May 2011 B2
7950561 Aranyi May 2011 B2
7951071 Whitman et al. May 2011 B2
7951166 Orban, III et al. May 2011 B2
7954682 Giordano et al. Jun 2011 B2
7954684 Boudreaux Jun 2011 B2
7954685 Viola Jun 2011 B2
7954686 Baxter, III et al. Jun 2011 B2
7954687 Zemlok et al. Jun 2011 B2
7955253 Ewers et al. Jun 2011 B2
7955257 Frasier et al. Jun 2011 B2
7955322 Devengenzo et al. Jun 2011 B2
7955327 Sartor et al. Jun 2011 B2
7955380 Chu et al. Jun 2011 B2
7959050 Smith et al. Jun 2011 B2
7959051 Smith et al. Jun 2011 B2
7959052 Sonnenschein et al. Jun 2011 B2
7963432 Knodel et al. Jun 2011 B2
7963433 Whitman et al. Jun 2011 B2
7963913 Devengenzo et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7963964 Santilli et al. Jun 2011 B2
7964206 Suokas et al. Jun 2011 B2
7966236 Noriega et al. Jun 2011 B2
7966269 Bauer et al. Jun 2011 B2
7966799 Morgan et al. Jun 2011 B2
7967178 Scirica et al. Jun 2011 B2
7967179 Olson et al. Jun 2011 B2
7967180 Scirica Jun 2011 B2
7967181 Viola et al. Jun 2011 B2
7967791 Franer et al. Jun 2011 B2
7967839 Flock et al. Jun 2011 B2
7972298 Wallace et al. Jul 2011 B2
7972315 Birk et al. Jul 2011 B2
7976213 Bertolotti et al. Jul 2011 B2
7976563 Summerer Jul 2011 B2
7979137 Tracey et al. Jul 2011 B2
7980443 Scheib et al. Jul 2011 B2
7981132 Dubrul et al. Jul 2011 B2
7987405 Turner et al. Jul 2011 B2
7988015 Mason, II et al. Aug 2011 B2
7988026 Knodel et al. Aug 2011 B2
7988027 Olson et al. Aug 2011 B2
7988028 Farascioni et al. Aug 2011 B2
7988779 Disalvo et al. Aug 2011 B2
7992757 Wheeler et al. Aug 2011 B2
7993360 Hacker et al. Aug 2011 B2
7994670 Ji Aug 2011 B2
7997054 Bertsch et al. Aug 2011 B2
7997468 Farascioni Aug 2011 B2
7997469 Olson et al. Aug 2011 B2
8002696 Suzuki Aug 2011 B2
8002784 Jinno et al. Aug 2011 B2
8002785 Weiss et al. Aug 2011 B2
8002795 Beetel Aug 2011 B2
8006365 Levin et al. Aug 2011 B2
8006885 Marczyk Aug 2011 B2
8006889 Adams et al. Aug 2011 B2
8007370 Hirsch et al. Aug 2011 B2
8007465 Birk et al. Aug 2011 B2
8007479 Birk et al. Aug 2011 B2
8007511 Brock et al. Aug 2011 B2
8007513 Nalagatla et al. Aug 2011 B2
8008598 Whitman et al. Aug 2011 B2
8011550 Aranyi et al. Sep 2011 B2
8011551 Marczyk et al. Sep 2011 B2
8011553 Mastri et al. Sep 2011 B2
8011555 Tarinelli et al. Sep 2011 B2
8012170 Whitman et al. Sep 2011 B2
8016176 Kasvikis et al. Sep 2011 B2
8016177 Bettuchi et al. Sep 2011 B2
8016178 Olson et al. Sep 2011 B2
8016849 Wenchell Sep 2011 B2
8016855 Whitman et al. Sep 2011 B2
8016858 Whitman Sep 2011 B2
8016881 Furst Sep 2011 B2
8020742 Marczyk Sep 2011 B2
8020743 Shelton, IV Sep 2011 B2
8021375 Aldrich et al. Sep 2011 B2
8025199 Whitman et al. Sep 2011 B2
8025896 Malaviya et al. Sep 2011 B2
8028882 Viola Oct 2011 B2
8028883 Stopek Oct 2011 B2
8028884 Sniffin et al. Oct 2011 B2
8028885 Smith et al. Oct 2011 B2
8029510 Hoegerle Oct 2011 B2
8031069 Cohn et al. Oct 2011 B2
8033438 Scirica Oct 2011 B2
8033439 Racenet et al. Oct 2011 B2
8033440 Wenchell et al. Oct 2011 B2
8034077 Smith et al. Oct 2011 B2
8034337 Simard Oct 2011 B2
8034363 Li et al. Oct 2011 B2
8035487 Malackowski Oct 2011 B2
8037591 Spivey et al. Oct 2011 B2
8038045 Bettuchi et al. Oct 2011 B2
8038046 Smith et al. Oct 2011 B2
8038686 Huitema et al. Oct 2011 B2
8043207 Adams Oct 2011 B2
8043328 Hahnen et al. Oct 2011 B2
8044536 Nguyen et al. Oct 2011 B2
8044604 Hagino et al. Oct 2011 B2
8047236 Perry Nov 2011 B2
8048503 Farnsworth et al. Nov 2011 B2
8052636 Moll et al. Nov 2011 B2
8056787 Boudreaux et al. Nov 2011 B2
8056788 Mastri et al. Nov 2011 B2
8056789 White et al. Nov 2011 B1
8057508 Shelton, IV Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8060250 Reiland et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8061576 Cappola Nov 2011 B2
8062236 Soltz Nov 2011 B2
8062330 Prommersberger et al. Nov 2011 B2
8063619 Zhu et al. Nov 2011 B2
8066158 Vogel et al. Nov 2011 B2
8066166 Demmy et al. Nov 2011 B2
8066167 Measamer et al. Nov 2011 B2
8066168 Vidal et al. Nov 2011 B2
8066720 Knodel et al. Nov 2011 B2
D650074 Hunt et al. Dec 2011 S
D650789 Arnold Dec 2011 S
8070033 Milliman et al. Dec 2011 B2
8070034 Knodel Dec 2011 B1
8070035 Holsten et al. Dec 2011 B2
8070743 Kagan et al. Dec 2011 B2
8074858 Marczyk Dec 2011 B2
8074861 Ehrenfels et al. Dec 2011 B2
8075476 Vargas Dec 2011 B2
8075571 Vitali et al. Dec 2011 B2
8079950 Stern et al. Dec 2011 B2
8079989 Birk et al. Dec 2011 B2
8080004 Downey et al. Dec 2011 B2
8083118 Milliman et al. Dec 2011 B2
8083119 Prommersberger Dec 2011 B2
8083120 Shelton, IV et al. Dec 2011 B2
8084001 Burns et al. Dec 2011 B2
8084969 David et al. Dec 2011 B2
8085013 Wei et al. Dec 2011 B2
8087563 Milliman et al. Jan 2012 B2
8089509 Chatenever et al. Jan 2012 B2
8091753 Viola Jan 2012 B2
8091756 Viola Jan 2012 B2
8092443 Bischoff Jan 2012 B2
8092932 Phillips et al. Jan 2012 B2
8093572 Kuduvalli Jan 2012 B2
8096458 Hessler Jan 2012 B2
8096459 Ortiz et al. Jan 2012 B2
8097017 Viola Jan 2012 B2
8100310 Zemlok Jan 2012 B2
8100824 Hegeman et al. Jan 2012 B2
8100872 Patel Jan 2012 B2
8102138 Sekine et al. Jan 2012 B2
8102278 Deck et al. Jan 2012 B2
8105350 Lee et al. Jan 2012 B2
8107925 Natsuno et al. Jan 2012 B2
8108033 Drew et al. Jan 2012 B2
8108072 Zhao et al. Jan 2012 B2
8109426 Milliman et al. Feb 2012 B2
8110208 Hen Feb 2012 B1
8113405 Milliman Feb 2012 B2
8113408 Wenchell et al. Feb 2012 B2
8113410 Hall et al. Feb 2012 B2
8114017 Bacher Feb 2012 B2
8114100 Smith et al. Feb 2012 B2
8118206 Zand et al. Feb 2012 B2
8118207 Racenet et al. Feb 2012 B2
8120301 Goldberg et al. Feb 2012 B2
8122128 Burke, II et al. Feb 2012 B2
8123103 Milliman Feb 2012 B2
8123523 Carron et al. Feb 2012 B2
8123766 Bauman et al. Feb 2012 B2
8123767 Bauman et al. Feb 2012 B2
8125168 Johnson et al. Feb 2012 B2
8127975 Olson et al. Mar 2012 B2
8127976 Scirica et al. Mar 2012 B2
8128624 Couture et al. Mar 2012 B2
8128643 Aranyi et al. Mar 2012 B2
8128645 Sonnenschein et al. Mar 2012 B2
8128662 Altarac et al. Mar 2012 B2
8132703 Milliman et al. Mar 2012 B2
8132705 Viola et al. Mar 2012 B2
8132706 Marczyk et al. Mar 2012 B2
8133500 Ringeisen et al. Mar 2012 B2
8134306 Drader et al. Mar 2012 B2
8136711 Beardsley et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8136713 Hathaway et al. Mar 2012 B2
8137339 Jinno et al. Mar 2012 B2
8140417 Shibata Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8141763 Milliman Mar 2012 B2
8142200 Crunkilton et al. Mar 2012 B2
8142425 Eggers Mar 2012 B2
8142461 Houser et al. Mar 2012 B2
8142515 Therin et al. Mar 2012 B2
8143520 Cutler Mar 2012 B2
8146790 Milliman Apr 2012 B2
8147421 Farquhar et al. Apr 2012 B2
8147456 Fisher et al. Apr 2012 B2
8147485 Wham et al. Apr 2012 B2
8152041 Kostrzewski Apr 2012 B2
8152756 Webster et al. Apr 2012 B2
8154239 Katsuki et al. Apr 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8157148 Scirica Apr 2012 B2
8157151 Ingmanson et al. Apr 2012 B2
8157152 Holsten et al. Apr 2012 B2
8157153 Shelton, IV et al. Apr 2012 B2
8157793 Omori et al. Apr 2012 B2
8161977 Shelton, IV et al. Apr 2012 B2
8162138 Bettenhausen et al. Apr 2012 B2
8162197 Mastri et al. Apr 2012 B2
8162668 Toly Apr 2012 B2
8162933 Francischelli et al. Apr 2012 B2
8162965 Reschke et al. Apr 2012 B2
8167185 Shelton, IV et al. May 2012 B2
8167622 Zhou May 2012 B2
8167895 D'Agostino et al. May 2012 B2
8167898 Schaller et al. May 2012 B1
8170241 Roe et al. May 2012 B2
8172004 Ho May 2012 B2
8172120 Boyden et al. May 2012 B2
8172122 Kasvikis et al. May 2012 B2
8172124 Shelton, IV et al. May 2012 B2
8177776 Humayun et al. May 2012 B2
8177797 Shimoji et al. May 2012 B2
8179705 Chapuis May 2012 B2
8180458 Kane et al. May 2012 B2
8181839 Beetel May 2012 B2
8181840 Milliman May 2012 B2
8182422 Bayer et al. May 2012 B2
8182444 Uber, III et al. May 2012 B2
8183807 Tsai et al. May 2012 B2
8186555 Shelton, IV et al. May 2012 B2
8186556 Viola May 2012 B2
8186558 Sapienza May 2012 B2
8186560 Hess et al. May 2012 B2
8191752 Scirica Jun 2012 B2
8192350 Ortiz et al. Jun 2012 B2
8192460 Orban, III et al. Jun 2012 B2
8192651 Young et al. Jun 2012 B2
8196795 Moore et al. Jun 2012 B2
8196796 Shelton, IV et al. Jun 2012 B2
8197501 Shadeck et al. Jun 2012 B2
8197502 Smith et al. Jun 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8201720 Hessler Jun 2012 B2
8201721 Zemlok et al. Jun 2012 B2
8202549 Stucky et al. Jun 2012 B2
8205779 Ma et al. Jun 2012 B2
8205780 Sorrentino et al. Jun 2012 B2
8205781 Baxter, III et al. Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8210414 Bettuchi et al. Jul 2012 B2
8210415 Ward Jul 2012 B2
8210416 Milliman et al. Jul 2012 B2
8210721 Chen et al. Jul 2012 B2
8211125 Spivey Jul 2012 B2
8214019 Govari et al. Jul 2012 B2
8215531 Shelton, IV et al. Jul 2012 B2
8215532 Marczyk Jul 2012 B2
8215533 Viola et al. Jul 2012 B2
8220468 Cooper et al. Jul 2012 B2
8220688 Laurent et al. Jul 2012 B2
8220690 Hess et al. Jul 2012 B2
8221424 Cha Jul 2012 B2
8221433 Lozier et al. Jul 2012 B2
8225799 Bettuchi Jul 2012 B2
8225979 Farascioni et al. Jul 2012 B2
8226553 Shelton, IV et al. Jul 2012 B2
8226635 Petrie et al. Jul 2012 B2
8226675 Houser et al. Jul 2012 B2
8226715 Hwang et al. Jul 2012 B2
8227946 Kim Jul 2012 B2
8228020 Shin et al. Jul 2012 B2
8228048 Spencer Jul 2012 B2
8229549 Whitman et al. Jul 2012 B2
8231040 Zemlok et al. Jul 2012 B2
8231042 Hessler et al. Jul 2012 B2
8231043 Tarinelli et al. Jul 2012 B2
8235272 Nicholas et al. Aug 2012 B2
8236010 Ortiz et al. Aug 2012 B2
8236011 Harris et al. Aug 2012 B2
8236020 Smith et al. Aug 2012 B2
8237388 Jinno et al. Aug 2012 B2
8240537 Marczyk Aug 2012 B2
8241271 Millman et al. Aug 2012 B2
8241284 Dycus et al. Aug 2012 B2
8241308 Kortenbach et al. Aug 2012 B2
8241322 Whitman et al. Aug 2012 B2
8245594 Rogers et al. Aug 2012 B2
8245898 Smith et al. Aug 2012 B2
8245899 Swensgard et al. Aug 2012 B2
8245900 Scirica Aug 2012 B2
8245901 Stopek Aug 2012 B2
8246608 Omori et al. Aug 2012 B2
8246637 Viola et al. Aug 2012 B2
8256654 Bettuchi et al. Sep 2012 B2
8256655 Sniffin et al. Sep 2012 B2
8256656 Milliman et al. Sep 2012 B2
8257251 Shelton, IV et al. Sep 2012 B2
8257356 Bleich et al. Sep 2012 B2
8257386 Lee et al. Sep 2012 B2
8257391 Orban, III et al. Sep 2012 B2
8257634 Scirica Sep 2012 B2
8258745 Smith et al. Sep 2012 B2
8262560 Whitman Sep 2012 B2
8262655 Ghabrial et al. Sep 2012 B2
8267300 Boudreaux Sep 2012 B2
8267924 Zemlok et al. Sep 2012 B2
8267946 Whitfield et al. Sep 2012 B2
8267951 Whayne et al. Sep 2012 B2
8269121 Smith Sep 2012 B2
8272553 Mastri et al. Sep 2012 B2
8272554 Whitman et al. Sep 2012 B2
8272918 Lam Sep 2012 B2
8273404 Dave et al. Sep 2012 B2
8276801 Zemlok et al. Oct 2012 B2
8276802 Kostrzewski Oct 2012 B2
8277473 Sunaoshi et al. Oct 2012 B2
8281446 Moskovich Oct 2012 B2
8281973 Wenchell et al. Oct 2012 B2
8281974 Hessler et al. Oct 2012 B2
8282654 Ferrari et al. Oct 2012 B2
8285367 Hyde et al. Oct 2012 B2
8286723 Puzio et al. Oct 2012 B2
8286845 Perry et al. Oct 2012 B2
8286846 Smith et al. Oct 2012 B2
8286847 Taylor Oct 2012 B2
8287487 Estes Oct 2012 B2
8287522 Moses et al. Oct 2012 B2
8287561 Nunez et al. Oct 2012 B2
8292147 Viola Oct 2012 B2
8292148 Viola Oct 2012 B2
8292150 Bryant Oct 2012 B2
8292151 Viola Oct 2012 B2
8292152 Milliman et al. Oct 2012 B2
8292155 Shelton, IV et al. Oct 2012 B2
8292157 Smith et al. Oct 2012 B2
8292158 Sapienza Oct 2012 B2
8292801 Dejima et al. Oct 2012 B2
8292888 Whitman Oct 2012 B2
8294399 Suzuki et al. Oct 2012 B2
8298161 Vargas Oct 2012 B2
8298189 Fisher et al. Oct 2012 B2
8298233 Mueller Oct 2012 B2
8298677 Wiesner et al. Oct 2012 B2
8302323 Fortier et al. Nov 2012 B2
8308040 Huang et al. Nov 2012 B2
8308041 Kostrzewski Nov 2012 B2
8308042 Aranyi Nov 2012 B2
8308043 Bindra et al. Nov 2012 B2
8308046 Prommersberger Nov 2012 B2
8308659 Scheibe et al. Nov 2012 B2
8308725 Bell et al. Nov 2012 B2
8310188 Nakai Nov 2012 B2
8313496 Sauer et al. Nov 2012 B2
8313499 Magnusson et al. Nov 2012 B2
8313509 Kostrzewski Nov 2012 B2
8317070 Hueil et al. Nov 2012 B2
8317071 Knodel Nov 2012 B1
8317074 Ortiz et al. Nov 2012 B2
8317437 Merkley et al. Nov 2012 B2
8317744 Kirschenman Nov 2012 B2
8317790 Bell et al. Nov 2012 B2
8319002 Daniels et al. Nov 2012 B2
8322455 Shelton, IV et al. Dec 2012 B2
8322589 Boudreaux Dec 2012 B2
8322590 Patel et al. Dec 2012 B2
8322901 Michelotti Dec 2012 B2
8323789 Rozhin et al. Dec 2012 B2
8328061 Kasvikis Dec 2012 B2
8328062 Viola Dec 2012 B2
8328063 Milliman et al. Dec 2012 B2
8328064 Racenet et al. Dec 2012 B2
8328802 Deville et al. Dec 2012 B2
8328823 Aranyi et al. Dec 2012 B2
8333313 Boudreaux et al. Dec 2012 B2
8333691 Schaaf Dec 2012 B2
8333764 Francischelli et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8336753 Olson et al. Dec 2012 B2
8336754 Cappola et al. Dec 2012 B2
8342377 Milliman et al. Jan 2013 B2
8342378 Marczyk et al. Jan 2013 B2
8342379 Whitman et al. Jan 2013 B2
8343150 Artale Jan 2013 B2
8347978 Forster et al. Jan 2013 B2
8348118 Segura Jan 2013 B2
8348123 Scirica et al. Jan 2013 B2
8348124 Scirica Jan 2013 B2
8348125 Viola et al. Jan 2013 B2
8348126 Olson et al. Jan 2013 B2
8348127 Marczyk Jan 2013 B2
8348129 Bedi et al. Jan 2013 B2
8348130 Shah et al. Jan 2013 B2
8348131 Omaits et al. Jan 2013 B2
8348837 Wenchell Jan 2013 B2
8348959 Wolford et al. Jan 2013 B2
8348972 Soltz et al. Jan 2013 B2
8349987 Kapiamba et al. Jan 2013 B2
8352004 Mannheimer et al. Jan 2013 B2
8353437 Boudreaux Jan 2013 B2
8353438 Baxter, III et al. Jan 2013 B2
8353439 Baxter, III et al. Jan 2013 B2
8356740 Knodel Jan 2013 B1
8357144 Whitman et al. Jan 2013 B2
8357158 McKenna et al. Jan 2013 B2
8357161 Mueller Jan 2013 B2
8359174 Nakashima et al. Jan 2013 B2
8360296 Zingman Jan 2013 B2
8360297 Shelton, IV et al. Jan 2013 B2
8360298 Farascioni et al. Jan 2013 B2
8360299 Zemlok et al. Jan 2013 B2
8361501 DiTizio et al. Jan 2013 B2
D676866 Chaudhri Feb 2013 S
8365973 White et al. Feb 2013 B1
8365975 Manoux et al. Feb 2013 B1
8365976 Hess et al. Feb 2013 B2
8366559 Papenfuss et al. Feb 2013 B2
8366719 Markey et al. Feb 2013 B2
8366787 Brown et al. Feb 2013 B2
8369056 Senriuchi et al. Feb 2013 B2
8371393 Higuchi et al. Feb 2013 B2
8371491 Huitema et al. Feb 2013 B2
8371492 Aranyi et al. Feb 2013 B2
8371493 Aranyi et al. Feb 2013 B2
8371494 Racenet et al. Feb 2013 B2
8372094 Bettuchi et al. Feb 2013 B2
8376865 Forster et al. Feb 2013 B2
8377029 Nagao et al. Feb 2013 B2
8377044 Coe et al. Feb 2013 B2
8382773 Whitfield et al. Feb 2013 B2
8382790 Uenohara et al. Feb 2013 B2
D677273 Randall et al. Mar 2013 S
8387848 Johnson et al. Mar 2013 B2
8388633 Rousseau et al. Mar 2013 B2
8389588 Ringeisen et al. Mar 2013 B2
8393513 Jankowski Mar 2013 B2
8393514 Shelton, IV et al. Mar 2013 B2
8393516 Kostrzewski Mar 2013 B2
8397832 Blickle et al. Mar 2013 B2
8397971 Yates et al. Mar 2013 B2
8397973 Hausen Mar 2013 B1
8398633 Mueller Mar 2013 B2
8398669 Kim Mar 2013 B2
8398673 Hinchliffe et al. Mar 2013 B2
8398674 Prestel Mar 2013 B2
8400851 Byun Mar 2013 B2
8403138 Weisshaupt et al. Mar 2013 B2
8403198 Sorrentino et al. Mar 2013 B2
8403832 Cunningham et al. Mar 2013 B2
8403945 Whitfield et al. Mar 2013 B2
8403946 Whitfield et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8408439 Huang et al. Apr 2013 B2
8408442 Racenet et al. Apr 2013 B2
8409079 Okamoto et al. Apr 2013 B2
8409174 Omori Apr 2013 B2
8409175 Lee et al. Apr 2013 B2
8409222 Whitfield et al. Apr 2013 B2
8409223 Sorrentino et al. Apr 2013 B2
8411500 Gapihan et al. Apr 2013 B2
8413661 Rousseau et al. Apr 2013 B2
8413870 Pastorelli et al. Apr 2013 B2
8413871 Racenet et al. Apr 2013 B2
8413872 Patel Apr 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8414598 Brock et al. Apr 2013 B2
8418073 Mohr et al. Apr 2013 B2
8418906 Farascioni et al. Apr 2013 B2
8418907 Johnson et al. Apr 2013 B2
8418908 Beardsley Apr 2013 B1
8418909 Kostrzewski Apr 2013 B2
8419635 Shelton, IV et al. Apr 2013 B2
8419717 Diolaiti et al. Apr 2013 B2
8419747 Hinman et al. Apr 2013 B2
8419754 Laby et al. Apr 2013 B2
8423182 Robinson et al. Apr 2013 B2
8424737 Scirica Apr 2013 B2
8424739 Racenet et al. Apr 2013 B2
8424740 Shelton, IV et al. Apr 2013 B2
8424741 McGuckin, Jr. et al. Apr 2013 B2
8425600 Maxwell Apr 2013 B2
8427430 Lee et al. Apr 2013 B2
8430292 Patel et al. Apr 2013 B2
8430892 Bindra et al. Apr 2013 B2
8430898 Wiener et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8439246 Knodel May 2013 B1
8444036 Shelton, IV May 2013 B2
8444037 Nicholas et al. May 2013 B2
8444549 Viola et al. May 2013 B2
8449536 Selig May 2013 B2
8449560 Roth et al. May 2013 B2
8453904 Eskaros et al. Jun 2013 B2
8453906 Huang et al. Jun 2013 B2
8453907 Laurent et al. Jun 2013 B2
8453908 Bedi et al. Jun 2013 B2
8453912 Mastri et al. Jun 2013 B2
8453914 Laurent et al. Jun 2013 B2
8454495 Kawano et al. Jun 2013 B2
8454551 Allen et al. Jun 2013 B2
8454628 Smith et al. Jun 2013 B2
8454640 Johnston et al. Jun 2013 B2
8457757 Cauller et al. Jun 2013 B2
8459520 Giordano et al. Jun 2013 B2
8459521 Zemlok et al. Jun 2013 B2
8459524 Pribanic et al. Jun 2013 B2
8459525 Yates et al. Jun 2013 B2
8464922 Marczyk Jun 2013 B2
8464923 Shelton, IV Jun 2013 B2
8464924 Gresham et al. Jun 2013 B2
8464925 Hull et al. Jun 2013 B2
8465475 Isbell, Jr. Jun 2013 B2
8465502 Zergiebel Jun 2013 B2
8465515 Drew et al. Jun 2013 B2
8469254 Czernik et al. Jun 2013 B2
8469946 Sugita Jun 2013 B2
8469973 Meade et al. Jun 2013 B2
8470355 Skalla et al. Jun 2013 B2
D686240 Lin Jul 2013 S
8474677 Woodard, Jr. et al. Jul 2013 B2
8475453 Marczyk et al. Jul 2013 B2
8475454 Alshemari Jul 2013 B1
8475474 Bombard et al. Jul 2013 B2
8479968 Hodgkinson et al. Jul 2013 B2
8479969 Shelton, IV Jul 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8483509 Matsuzaka Jul 2013 B2
8485412 Shelton, IV et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8485970 Widenhouse et al. Jul 2013 B2
8487199 Palmer et al. Jul 2013 B2
8487487 Dietz et al. Jul 2013 B2
8490851 Blier et al. Jul 2013 B2
8490853 Criscuolo et al. Jul 2013 B2
8491581 Deville et al. Jul 2013 B2
8491603 Yeung et al. Jul 2013 B2
8496153 Demmy et al. Jul 2013 B2
8496154 Marczyk et al. Jul 2013 B2
8496156 Sniffin et al. Jul 2013 B2
8496683 Prommersberger et al. Jul 2013 B2
8499992 Whitman et al. Aug 2013 B2
8499993 Shelton, IV et al. Aug 2013 B2
8500721 Jinno Aug 2013 B2
8500762 Sholev et al. Aug 2013 B2
8502091 Palmer et al. Aug 2013 B2
8505799 Viola et al. Aug 2013 B2
8505801 Ehrenfels et al. Aug 2013 B2
8506555 Ruiz Morales Aug 2013 B2
8506557 Zemlok et al. Aug 2013 B2
8506580 Zergiebel et al. Aug 2013 B2
8506581 Wingardner, III et al. Aug 2013 B2
8511308 Hecox et al. Aug 2013 B2
8512359 Whitman et al. Aug 2013 B2
8512402 Marczyk et al. Aug 2013 B2
8517239 Scheib et al. Aug 2013 B2
8517241 Nicholas et al. Aug 2013 B2
8517243 Giordano et al. Aug 2013 B2
8517244 Shelton, IV et al. Aug 2013 B2
8518024 Williams et al. Aug 2013 B2
8521273 Kliman Aug 2013 B2
8523042 Masiakos et al. Sep 2013 B2
8523043 Ullrich et al. Sep 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8523900 Jinno et al. Sep 2013 B2
8529588 Ahlberg et al. Sep 2013 B2
8529600 Woodard, Jr. et al. Sep 2013 B2
8529819 Ostapoff et al. Sep 2013 B2
8532747 Nock et al. Sep 2013 B2
8534527 Brendel et al. Sep 2013 B2
8534528 Shelton, IV Sep 2013 B2
8535304 Sklar et al. Sep 2013 B2
8535340 Allen Sep 2013 B2
8539866 Nayak et al. Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8540129 Baxter, III et al. Sep 2013 B2
8540130 Moore et al. Sep 2013 B2
8540131 Swayze Sep 2013 B2
8540133 Bedi et al. Sep 2013 B2
8540733 Whitman et al. Sep 2013 B2
8540735 Mitelberg et al. Sep 2013 B2
8550984 Takemoto Oct 2013 B2
8551076 Duval et al. Oct 2013 B2
8555660 Takenaka et al. Oct 2013 B2
8556151 Viola Oct 2013 B2
8556918 Bauman et al. Oct 2013 B2
8556935 Knodel et al. Oct 2013 B1
8560147 Taylor et al. Oct 2013 B2
8561617 Lindh et al. Oct 2013 B2
8561870 Baxter, III et al. Oct 2013 B2
8561871 Rajappa et al. Oct 2013 B2
8561873 Ingmanson et al. Oct 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8567656 Shelton, IV et al. Oct 2013 B2
8568416 Schmitz et al. Oct 2013 B2
8568425 Ross et al. Oct 2013 B2
D692916 Granchi et al. Nov 2013 S
8573459 Smith et al. Nov 2013 B2
8573461 Shelton, IV et al. Nov 2013 B2
8573462 Smith et al. Nov 2013 B2
8573465 Shelton, IV Nov 2013 B2
8574199 von Bulow et al. Nov 2013 B2
8574263 Mueller Nov 2013 B2
8575880 Grantz Nov 2013 B2
8575895 Garrastacho et al. Nov 2013 B2
8579176 Smith et al. Nov 2013 B2
8579178 Holsten et al. Nov 2013 B2
8579897 Vakharia et al. Nov 2013 B2
8579937 Gresham Nov 2013 B2
8584919 Hueil et al. Nov 2013 B2
8584920 Hodgkinson Nov 2013 B2
8584921 Scirica Nov 2013 B2
8585583 Sakaguchi et al. Nov 2013 B2
8585721 Kirsch Nov 2013 B2
8590760 Cummins et al. Nov 2013 B2
8590762 Hess et al. Nov 2013 B2
8590764 Hartwick et al. Nov 2013 B2
8596515 Okoniewski Dec 2013 B2
8597745 Farnsworth et al. Dec 2013 B2
8599450 Kubo et al. Dec 2013 B2
8602287 Yates et al. Dec 2013 B2
8602288 Shelton, IV et al. Dec 2013 B2
8603077 Cooper et al. Dec 2013 B2
8603089 Viola Dec 2013 B2
8603110 Maruyama et al. Dec 2013 B2
8603135 Mueller Dec 2013 B2
8608043 Scirica Dec 2013 B2
8608044 Hueil et al. Dec 2013 B2
8608045 Smith et al. Dec 2013 B2
8608046 Laurent et al. Dec 2013 B2
8608745 Guzman et al. Dec 2013 B2
8613383 Beckman et al. Dec 2013 B2
8616427 Viola Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8622274 Yates et al. Jan 2014 B2
8622275 Baxter, III et al. Jan 2014 B2
8627993 Smith et al. Jan 2014 B2
8627994 Zemlok et al. Jan 2014 B2
8627995 Smith et al. Jan 2014 B2
8628518 Blumenkranz et al. Jan 2014 B2
8628545 Cabrera et al. Jan 2014 B2
8631987 Shelton, IV et al. Jan 2014 B2
8631992 Hausen et al. Jan 2014 B1
8631993 Kostrzewski Jan 2014 B2
8632462 Yoo et al. Jan 2014 B2
8632525 Kerr et al. Jan 2014 B2
8632535 Shelton, IV et al. Jan 2014 B2
8632563 Nagase et al. Jan 2014 B2
8636187 Hueil et al. Jan 2014 B2
8636190 Zemlok et al. Jan 2014 B2
8636191 Meagher Jan 2014 B2
8636193 Whitman et al. Jan 2014 B2
8636736 Yates et al. Jan 2014 B2
8636766 Milliman et al. Jan 2014 B2
8639936 Hu et al. Jan 2014 B2
8640788 Dachs, II et al. Feb 2014 B2
8646674 Schulte et al. Feb 2014 B2
8647258 Aranyi et al. Feb 2014 B2
8652120 Giordano et al. Feb 2014 B2
8652151 Lehman et al. Feb 2014 B2
8657174 Yates et al. Feb 2014 B2
8657175 Sonnenschein et al. Feb 2014 B2
8657176 Shelton, IV et al. Feb 2014 B2
8657177 Scirica et al. Feb 2014 B2
8657178 Hueil et al. Feb 2014 B2
8657482 Malackowski et al. Feb 2014 B2
8657808 McPherson et al. Feb 2014 B2
8657814 Werneth et al. Feb 2014 B2
8657821 Palermo Feb 2014 B2
D701238 Lai et al. Mar 2014 S
8662370 Takei Mar 2014 B2
8663106 Stivoric et al. Mar 2014 B2
8663192 Hester et al. Mar 2014 B2
8663245 Francischelli et al. Mar 2014 B2
8663262 Smith et al. Mar 2014 B2
8663270 Donnigan et al. Mar 2014 B2
8664792 Rebsdorf Mar 2014 B2
8668129 Olson Mar 2014 B2
8668130 Hess et al. Mar 2014 B2
8672206 Aranyi et al. Mar 2014 B2
8672207 Shelton, IV et al. Mar 2014 B2
8672208 Hess et al. Mar 2014 B2
8672922 Loh et al. Mar 2014 B2
8672935 Okada et al. Mar 2014 B2
8672951 Smith et al. Mar 2014 B2
8673210 Deshays Mar 2014 B2
8675820 Baic et al. Mar 2014 B2
8678263 Viola Mar 2014 B2
8678994 Sonnenschein et al. Mar 2014 B2
8679093 Farra Mar 2014 B2
8679098 Hart Mar 2014 B2
8679137 Bauman et al. Mar 2014 B2
8679154 Smith et al. Mar 2014 B2
8679156 Smith et al. Mar 2014 B2
8679454 Guire et al. Mar 2014 B2
8684248 Milliman Apr 2014 B2
8684249 Racenet et al. Apr 2014 B2
8684250 Bettuchi et al. Apr 2014 B2
8684253 Giordano et al. Apr 2014 B2
8684962 Kirschenman et al. Apr 2014 B2
8685004 Zemlock et al. Apr 2014 B2
8685020 Weizman et al. Apr 2014 B2
8690893 Deitch et al. Apr 2014 B2
8695866 Leimbach et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8701958 Shelton, IV et al. Apr 2014 B2
8701959 Shah Apr 2014 B2
8708210 Zemlok et al. Apr 2014 B2
8708211 Zemlok et al. Apr 2014 B2
8708213 Shelton, IV et al. Apr 2014 B2
8714352 Farascioni et al. May 2014 B2
8714429 Demmy May 2014 B2
8714430 Natarajan et al. May 2014 B2
8715256 Greener May 2014 B2
8715302 Ibrahim et al. May 2014 B2
8720766 Hess et al. May 2014 B2
8721630 Ortiz et al. May 2014 B2
8721666 Schroeder et al. May 2014 B2
8727197 Hess et al. May 2014 B2
8727199 Wenchell May 2014 B2
8727200 Roy May 2014 B2
8727961 Ziv May 2014 B2
8728099 Cohn et al. May 2014 B2
8728119 Cummins May 2014 B2
8733470 Matthias et al. May 2014 B2
8733612 Ma May 2014 B2
8733613 Huitema et al. May 2014 B2
8733614 Ross et al. May 2014 B2
8734336 Bonadio et al. May 2014 B2
8734359 Ibanez et al. May 2014 B2
8734478 Widenhouse et al. May 2014 B2
8739033 Rosenberg May 2014 B2
8739417 Tokunaga et al. Jun 2014 B2
8740034 Morgan et al. Jun 2014 B2
8740037 Shelton, IV et al. Jun 2014 B2
8740038 Shelton, IV et al. Jun 2014 B2
8740987 Geremakis et al. Jun 2014 B2
8746529 Shelton, IV et al. Jun 2014 B2
8746530 Giordano et al. Jun 2014 B2
8746533 Whitman et al. Jun 2014 B2
8746535 Shelton, IV et al. Jun 2014 B2
8747238 Shelton, IV et al. Jun 2014 B2
8747441 Konieczynski et al. Jun 2014 B2
8752264 Ackley et al. Jun 2014 B2
8752699 Morgan et al. Jun 2014 B2
8752747 Shelton, IV et al. Jun 2014 B2
8752748 Whitman et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8753664 Dao et al. Jun 2014 B2
8757287 Mak et al. Jun 2014 B2
8757465 Woodard, Jr. et al. Jun 2014 B2
8758235 Jaworek Jun 2014 B2
8758366 McLean et al. Jun 2014 B2
8758391 Swayze et al. Jun 2014 B2
8758438 Boyce et al. Jun 2014 B2
8763875 Morgan et al. Jul 2014 B2
8763877 Schall et al. Jul 2014 B2
8763879 Shelton, IV et al. Jul 2014 B2
8764732 Hartwell Jul 2014 B2
8770458 Scirica Jul 2014 B2
8770459 Racenet et al. Jul 2014 B2
8770460 Belzer Jul 2014 B2
8771169 Whitman et al. Jul 2014 B2
8771260 Conlon et al. Jul 2014 B2
8777004 Shelton, IV et al. Jul 2014 B2
8777082 Scirica Jul 2014 B2
8777083 Racenet et al. Jul 2014 B2
8777898 Suon et al. Jul 2014 B2
8783541 Shelton, IV et al. Jul 2014 B2
8783542 Riestenberg et al. Jul 2014 B2
8783543 Shelton, IV et al. Jul 2014 B2
8784304 Mikkaichi et al. Jul 2014 B2
8784404 Doyle et al. Jul 2014 B2
8784415 Malackowski et al. Jul 2014 B2
8789737 Hodgkinson et al. Jul 2014 B2
8789739 Swensgard Jul 2014 B2
8789740 Baxter, III et al. Jul 2014 B2
8789741 Baxter, III et al. Jul 2014 B2
8790658 Cigarini et al. Jul 2014 B2
8790684 Dave et al. Jul 2014 B2
D711905 Morrison et al. Aug 2014 S
8794496 Scirica Aug 2014 B2
8794497 Zingman Aug 2014 B2
8795276 Dietz et al. Aug 2014 B2
8795308 Valin Aug 2014 B2
8795324 Kawai et al. Aug 2014 B2
8796995 Cunanan et al. Aug 2014 B2
8800681 Rousson et al. Aug 2014 B2
8800837 Zemlok Aug 2014 B2
8800838 Shelton, IV Aug 2014 B2
8800839 Beetel Aug 2014 B2
8800840 Jankowski Aug 2014 B2
8800841 Ellerhorst et al. Aug 2014 B2
8801710 Ullrich et al. Aug 2014 B2
8801734 Shelton, IV et al. Aug 2014 B2
8801735 Shelton, IV et al. Aug 2014 B2
8801752 Fortier et al. Aug 2014 B2
8801801 Datta et al. Aug 2014 B2
8806973 Ross et al. Aug 2014 B2
8807414 Ross et al. Aug 2014 B2
8808161 Gregg et al. Aug 2014 B2
8808164 Hoffman et al. Aug 2014 B2
8808274 Hartwell Aug 2014 B2
8808294 Fox et al. Aug 2014 B2
8808308 Boukhny et al. Aug 2014 B2
8808311 Heinrich et al. Aug 2014 B2
8808325 Hess et al. Aug 2014 B2
8810197 Juergens Aug 2014 B2
8811017 Fujii et al. Aug 2014 B2
8813866 Suzuki Aug 2014 B2
8814024 Woodard, Jr. et al. Aug 2014 B2
8814025 Miller et al. Aug 2014 B2
8814836 Ignon et al. Aug 2014 B2
8818523 Olson et al. Aug 2014 B2
8820603 Shelton, IV et al. Sep 2014 B2
8820605 Shelton, IV Sep 2014 B2
8820606 Hodgkinson Sep 2014 B2
8820607 Marczyk Sep 2014 B2
8820608 Miyamoto Sep 2014 B2
8821514 Aranyi Sep 2014 B2
8822934 Sayeh et al. Sep 2014 B2
8825164 Tweden et al. Sep 2014 B2
8827133 Shelton, IV et al. Sep 2014 B2
8827134 Viola et al. Sep 2014 B2
8827903 Shelton, IV et al. Sep 2014 B2
8833219 Pierce Sep 2014 B2
8833630 Milliman Sep 2014 B2
8833632 Swensgard Sep 2014 B2
8834353 Dejima et al. Sep 2014 B2
8834498 Byrum et al. Sep 2014 B2
8834518 Faller et al. Sep 2014 B2
8840003 Morgan et al. Sep 2014 B2
8840603 Shelton, IV et al. Sep 2014 B2
8840609 Stuebe Sep 2014 B2
8840876 Eemeta et al. Sep 2014 B2
8844789 Shelton, IV et al. Sep 2014 B2
8844790 Demmy et al. Sep 2014 B2
8851215 Goto Oct 2014 B2
8851354 Swensgard et al. Oct 2014 B2
8852174 Burbank Oct 2014 B2
8852185 Twomey Oct 2014 B2
8852199 Deslauriers et al. Oct 2014 B2
8857693 Schuckmann et al. Oct 2014 B2
8857694 Shelton, IV et al. Oct 2014 B2
8858538 Belson et al. Oct 2014 B2
8858571 Shelton, IV et al. Oct 2014 B2
8858590 Shelton, IV et al. Oct 2014 B2
8864007 Widenhouse et al. Oct 2014 B2
8864009 Shelton, IV et al. Oct 2014 B2
8864010 Williams Oct 2014 B2
8870050 Hodgkinson Oct 2014 B2
8870912 Brisson et al. Oct 2014 B2
8875971 Hall et al. Nov 2014 B2
8875972 Weisenburgh, II et al. Nov 2014 B2
8876857 Burbank Nov 2014 B2
8876858 Braun Nov 2014 B2
8887979 Mastri et al. Nov 2014 B2
8888688 Julian et al. Nov 2014 B2
8888695 Piskun et al. Nov 2014 B2
8888792 Harris et al. Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8893946 Boudreaux et al. Nov 2014 B2
8893949 Shelton, IV et al. Nov 2014 B2
8894647 Beardsley et al. Nov 2014 B2
8894654 Anderson Nov 2014 B2
8899460 Wojcicki Dec 2014 B2
8899461 Farascioni Dec 2014 B2
8899462 Kostrzewski et al. Dec 2014 B2
8899463 Schall et al. Dec 2014 B2
8899464 Hueil et al. Dec 2014 B2
8899465 Shelton, IV et al. Dec 2014 B2
8899466 Baxter, III et al. Dec 2014 B2
8900267 Woolfson et al. Dec 2014 B2
8905287 Racenet et al. Dec 2014 B2
8905977 Shelton et al. Dec 2014 B2
8910846 Viola Dec 2014 B2
8911426 Coppeta et al. Dec 2014 B2
8911448 Stein Dec 2014 B2
8911460 Neurohr et al. Dec 2014 B2
8911471 Spivey et al. Dec 2014 B2
8920433 Barrier et al. Dec 2014 B2
8920435 Smith et al. Dec 2014 B2
8920438 Aranyi et al. Dec 2014 B2
8920443 Hiles et al. Dec 2014 B2
8920444 Hiles et al. Dec 2014 B2
8922163 Macdonald Dec 2014 B2
8925782 Shelton, IV Jan 2015 B2
8925783 Zemlok et al. Jan 2015 B2
8925788 Hess et al. Jan 2015 B2
8926506 Widenhouse et al. Jan 2015 B2
8926598 Mollere et al. Jan 2015 B2
8931576 Iwata Jan 2015 B2
8931679 Kostrzewski Jan 2015 B2
8931680 Milliman Jan 2015 B2
8931682 Timm et al. Jan 2015 B2
8936614 Allen, IV Jan 2015 B2
8939343 Milliman et al. Jan 2015 B2
8939344 Olson et al. Jan 2015 B2
8945163 Voegele et al. Feb 2015 B2
8955732 Zemlok et al. Feb 2015 B2
8956342 Russo et al. Feb 2015 B1
8956390 Shah et al. Feb 2015 B2
8958860 Banerjee et al. Feb 2015 B2
8960519 Whitman et al. Feb 2015 B2
8960520 McCuen Feb 2015 B2
8960521 Kostrzewski Feb 2015 B2
8961191 Hanshew Feb 2015 B2
8961504 Hoarau et al. Feb 2015 B2
8963714 Medhal et al. Feb 2015 B2
D725674 Jung et al. Mar 2015 S
8967443 McCuen Mar 2015 B2
8967444 Beetel Mar 2015 B2
8967446 Beardsley et al. Mar 2015 B2
8967448 Carter et al. Mar 2015 B2
8968276 Zemlok et al. Mar 2015 B2
8968308 Horner et al. Mar 2015 B2
8968312 Marczyk et al. Mar 2015 B2
8968337 Whitfield et al. Mar 2015 B2
8968340 Chowaniec et al. Mar 2015 B2
8968355 Malkowski et al. Mar 2015 B2
8968358 Reschke Mar 2015 B2
8970507 Holbein et al. Mar 2015 B2
8973803 Hall et al. Mar 2015 B2
8973804 Hess et al. Mar 2015 B2
8973805 Scirica et al. Mar 2015 B2
8974440 Farritor et al. Mar 2015 B2
8974932 McGahan et al. Mar 2015 B2
8978954 Shelton, IV et al. Mar 2015 B2
8978955 Aronhalt et al. Mar 2015 B2
8978956 Schall et al. Mar 2015 B2
8979843 Timm et al. Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8982195 Claus et al. Mar 2015 B2
8985429 Balek et al. Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
8991676 Hess et al. Mar 2015 B2
8991677 Moore et al. Mar 2015 B2
8991678 Wellman et al. Mar 2015 B2
8992042 Eichenholz Mar 2015 B2
8992422 Spivey et al. Mar 2015 B2
8992565 Brisson et al. Mar 2015 B2
8996165 Wang et al. Mar 2015 B2
8998058 Moore et al. Apr 2015 B2
8998059 Smith et al. Apr 2015 B2
8998060 Bruewer et al. Apr 2015 B2
8998061 Williams et al. Apr 2015 B2
8998939 Price et al. Apr 2015 B2
9000720 Stulen et al. Apr 2015 B2
9002518 Manzo et al. Apr 2015 B2
9004339 Park Apr 2015 B1
9005230 Yates et al. Apr 2015 B2
9005238 DeSantis et al. Apr 2015 B2
9005243 Stopek et al. Apr 2015 B2
9010606 Aranyi et al. Apr 2015 B2
9010608 Casasanta, Jr. et al. Apr 2015 B2
9010611 Ross et al. Apr 2015 B2
9011439 Shalaby et al. Apr 2015 B2
9011471 Timm et al. Apr 2015 B2
9016539 Kostrzewski et al. Apr 2015 B2
9016540 Whitman et al. Apr 2015 B2
9016541 Viola et al. Apr 2015 B2
9016542 Shelton, IV et al. Apr 2015 B2
9016545 Aranyi et al. Apr 2015 B2
9017331 Fox Apr 2015 B2
9017355 Smith et al. Apr 2015 B2
9017369 Renger et al. Apr 2015 B2
9017371 Whitman et al. Apr 2015 B2
9021684 Lenker et al. May 2015 B2
9023014 Chowaniec et al. May 2015 B2
9023069 Kasvikis et al. May 2015 B2
9023071 Miller et al. May 2015 B2
9026347 Gadh et al. May 2015 B2
9027817 Milliman et al. May 2015 B2
9028494 Shelton, IV et al. May 2015 B2
9028495 Mueller et al. May 2015 B2
9028519 Yates et al. May 2015 B2
9030169 Christensen et al. May 2015 B2
9033203 Woodard, Jr. et al. May 2015 B2
9033204 Shelton, IV et al. May 2015 B2
9034505 Detry et al. May 2015 B2
9038881 Schaller et al. May 2015 B1
9039690 Kersten et al. May 2015 B2
9039694 Ross et al. May 2015 B2
9039720 Madan May 2015 B2
9043027 Durant et al. May 2015 B2
9044227 Shelton, IV et al. Jun 2015 B2
9044228 Woodard, Jr. et al. Jun 2015 B2
9044229 Scheib et al. Jun 2015 B2
9044230 Morgan et al. Jun 2015 B2
9044241 Barner et al. Jun 2015 B2
9044261 Houser Jun 2015 B2
9044281 Pool et al. Jun 2015 B2
9050083 Yates et al. Jun 2015 B2
9050084 Schmid et al. Jun 2015 B2
9050100 Yates et al. Jun 2015 B2
9050120 Swarup et al. Jun 2015 B2
9050123 Krause et al. Jun 2015 B2
9050176 Datta et al. Jun 2015 B2
9055941 Schmid et al. Jun 2015 B2
9055942 Balbierz et al. Jun 2015 B2
9055943 Zemlok et al. Jun 2015 B2
9055944 Hodgkinson et al. Jun 2015 B2
9055961 Manzo et al. Jun 2015 B2
9060770 Shelton, IV et al. Jun 2015 B2
9060776 Yates et al. Jun 2015 B2
9060794 Kang et al. Jun 2015 B2
9060894 Wubbeling Jun 2015 B2
9061392 Forgues et al. Jun 2015 B2
9072515 Hall et al. Jul 2015 B2
9072523 Houser et al. Jul 2015 B2
9072535 Shelton, IV et al. Jul 2015 B2
9072536 Shelton, IV et al. Jul 2015 B2
9078653 Leimbach et al. Jul 2015 B2
9084601 Moore et al. Jul 2015 B2
9084602 Gleiman Jul 2015 B2
9086875 Harrat et al. Jul 2015 B2
9089326 Krumanaker et al. Jul 2015 B2
9089330 Widenhouse et al. Jul 2015 B2
9089352 Jeong Jul 2015 B2
9089360 Messerly et al. Jul 2015 B2
9091588 Lefler Jul 2015 B2
D736792 Brinda et al. Aug 2015 S
9095339 Moore et al. Aug 2015 B2
9095346 Houser et al. Aug 2015 B2
9095362 Dachs, II et al. Aug 2015 B2
9095367 Olson et al. Aug 2015 B2
9096033 Holop et al. Aug 2015 B2
9099863 Smith et al. Aug 2015 B2
9099877 Banos et al. Aug 2015 B2
9101358 Kerr et al. Aug 2015 B2
9101385 Shelton, IV et al. Aug 2015 B2
9101475 Wei et al. Aug 2015 B2
9107663 Swensgard Aug 2015 B2
9107690 Bales, Jr. et al. Aug 2015 B2
9110587 Kim et al. Aug 2015 B2
9113862 Morgan et al. Aug 2015 B2
9113864 Morgan et al. Aug 2015 B2
9113865 Shelton, IV et al. Aug 2015 B2
9113873 Marczyk et al. Aug 2015 B2
9113874 Shelton, IV et al. Aug 2015 B2
9113876 Zemlok et al. Aug 2015 B2
9113879 Felder et al. Aug 2015 B2
9113880 Zemlok et al. Aug 2015 B2
9113881 Scirica Aug 2015 B2
9113883 Aronhalt et al. Aug 2015 B2
9113884 Shelton, IV et al. Aug 2015 B2
9113887 Behnke, II et al. Aug 2015 B2
9119615 Felder et al. Sep 2015 B2
9119657 Shelton, IV et al. Sep 2015 B2
9119898 Bayon et al. Sep 2015 B2
9119957 Gantz et al. Sep 2015 B2
9123286 Park Sep 2015 B2
9124097 Cruz Sep 2015 B2
9125654 Aronhalt et al. Sep 2015 B2
9125662 Shelton, IV Sep 2015 B2
9126317 Lawton et al. Sep 2015 B2
9131835 Widenhouse et al. Sep 2015 B2
9131940 Huitema et al. Sep 2015 B2
9131950 Matthew Sep 2015 B2
9131957 Skarbnik et al. Sep 2015 B2
9138225 Huang et al. Sep 2015 B2
9138226 Racenet et al. Sep 2015 B2
9144455 Kennedy et al. Sep 2015 B2
D741882 Shmilov et al. Oct 2015 S
9149274 Spivey et al. Oct 2015 B2
9149324 Huang et al. Oct 2015 B2
9149325 Worrell et al. Oct 2015 B2
9153994 Wood et al. Oct 2015 B2
9161753 Prior Oct 2015 B2
9161769 Stoddard et al. Oct 2015 B2
9161803 Yates et al. Oct 2015 B2
9161807 Garrison Oct 2015 B2
9168038 Shelton, IV et al. Oct 2015 B2
9168039 Knodel Oct 2015 B1
9168042 Milliman Oct 2015 B2
9168054 Turner et al. Oct 2015 B2
9168144 Rivin et al. Oct 2015 B2
9179911 Morgan et al. Nov 2015 B2
9179912 Yates et al. Nov 2015 B2
9182244 Luke et al. Nov 2015 B2
9186046 Ramamurthy et al. Nov 2015 B2
9186137 Farascioni et al. Nov 2015 B2
9186140 Hiles et al. Nov 2015 B2
9186142 Fanelli et al. Nov 2015 B2
9186143 Timm et al. Nov 2015 B2
9186148 Felder et al. Nov 2015 B2
9186221 Burbank Nov 2015 B2
9192380 (Tarinelli) Racenet et al. Nov 2015 B2
9192384 Bettuchi Nov 2015 B2
9192430 Rachlin et al. Nov 2015 B2
9192434 Twomey et al. Nov 2015 B2
9193045 Saur et al. Nov 2015 B2
9197079 Yip et al. Nov 2015 B2
D744528 Agrawal Dec 2015 S
9198642 Storz Dec 2015 B2
9198644 Balek et al. Dec 2015 B2
9198661 Swensgard Dec 2015 B2
9198662 Barton et al. Dec 2015 B2
9198683 Friedman et al. Dec 2015 B2
9204830 Zand et al. Dec 2015 B2
9204877 Whitman et al. Dec 2015 B2
9204878 Hall et al. Dec 2015 B2
9204879 Shelton, IV Dec 2015 B2
9204880 Baxter, III et al. Dec 2015 B2
9204923 Manzo et al. Dec 2015 B2
9204924 Marczyk et al. Dec 2015 B2
9211120 Scheib et al. Dec 2015 B2
9211121 Hall et al. Dec 2015 B2
9211122 Hagerty et al. Dec 2015 B2
9216013 Scirica et al. Dec 2015 B2
9216019 Schmid et al. Dec 2015 B2
9216020 Zhang et al. Dec 2015 B2
9216030 Fan et al. Dec 2015 B2
9216062 Duque et al. Dec 2015 B2
9220500 Swayze et al. Dec 2015 B2
9220501 Baxter, III et al. Dec 2015 B2
9220502 Zemlok et al. Dec 2015 B2
9220508 Dannaher Dec 2015 B2
9220559 Worrell et al. Dec 2015 B2
9220570 Kim et al. Dec 2015 B2
D746854 Shardlow et al. Jan 2016 S
9226750 Weir et al. Jan 2016 B2
9226751 Shelton, IV et al. Jan 2016 B2
9226754 D'Agostino et al. Jan 2016 B2
9226761 Burbank Jan 2016 B2
9226767 Stulen et al. Jan 2016 B2
9232945 Zingman Jan 2016 B2
9232979 Parihar et al. Jan 2016 B2
9233610 Kim et al. Jan 2016 B2
9237891 Shelton, IV Jan 2016 B2
9237892 Hodgkinson Jan 2016 B2
9237895 McCarthy et al. Jan 2016 B2
9237921 Messerly et al. Jan 2016 B2
9239064 Helbig et al. Jan 2016 B2
9240740 Zeng et al. Jan 2016 B2
9241711 Ivanko Jan 2016 B2
9241712 Zemlok et al. Jan 2016 B2
9241714 Timm et al. Jan 2016 B2
9241716 Whitman Jan 2016 B2
9241731 Boudreaux et al. Jan 2016 B2
9244524 Inoue et al. Jan 2016 B2
D748668 Kim et al. Feb 2016 S
D749623 Gray et al. Feb 2016 S
D750122 Shardlow et al. Feb 2016 S
D750129 Kwon Feb 2016 S
9254131 Soltz et al. Feb 2016 B2
9259274 Prisco Feb 2016 B2
9261172 Solomon et al. Feb 2016 B2
9265500 Sorrentino et al. Feb 2016 B2
9265516 Casey et al. Feb 2016 B2
9265585 Wingardner et al. Feb 2016 B2
9271718 Milad et al. Mar 2016 B2
9271727 McGuckin, Jr. et al. Mar 2016 B2
9271753 Butler et al. Mar 2016 B2
9271799 Shelton, IV et al. Mar 2016 B2
9272406 Aronhalt et al. Mar 2016 B2
9274095 Humayun et al. Mar 2016 B2
9277919 Timmer et al. Mar 2016 B2
9277922 Carter et al. Mar 2016 B2
9282962 Schmid et al. Mar 2016 B2
9282963 Bryant Mar 2016 B2
9282966 Shelton, IV et al. Mar 2016 B2
9282974 Shelton, IV Mar 2016 B2
9283028 Johnson Mar 2016 B2
9283045 Rhee et al. Mar 2016 B2
9283054 Morgan et al. Mar 2016 B2
9289206 Hess et al. Mar 2016 B2
9289207 Shelton, IV Mar 2016 B2
9289210 Baxter, III et al. Mar 2016 B2
9289211 Williams et al. Mar 2016 B2
9289212 Shelton, IV et al. Mar 2016 B2
9289225 Shelton, IV et al. Mar 2016 B2
9289256 Shelton, IV et al. Mar 2016 B2
9293757 Toussaint et al. Mar 2016 B2
9295465 Farascioni Mar 2016 B2
9295466 Hodgkinson et al. Mar 2016 B2
9295468 Heinrich et al. Mar 2016 B2
9295514 Shelton, IV et al. Mar 2016 B2
9295522 Kostrzewski Mar 2016 B2
9295784 Eggert et al. Mar 2016 B2
9301691 Hufnagel et al. Apr 2016 B2
9301752 Mandakolathur Vasudevan et al. Apr 2016 B2
9301753 Aldridge et al. Apr 2016 B2
9301755 Shelton, IV et al. Apr 2016 B2
9301759 Spivey et al. Apr 2016 B2
9307965 Ming et al. Apr 2016 B2
9307986 Hall et al. Apr 2016 B2
9307987 Swensgard et al. Apr 2016 B2
9307988 Shelton, IV Apr 2016 B2
9307989 Shelton, IV et al. Apr 2016 B2
9307994 Gresham et al. Apr 2016 B2
9308009 Madan et al. Apr 2016 B2
9308011 Chao et al. Apr 2016 B2
9308646 Lim et al. Apr 2016 B2
9313915 Niu et al. Apr 2016 B2
9314246 Shelton, IV et al. Apr 2016 B2
9314247 Shelton, IV et al. Apr 2016 B2
9314261 Bales, Jr. et al. Apr 2016 B2
9314908 Tanimoto et al. Apr 2016 B2
9320518 Henderson et al. Apr 2016 B2
9320520 Shelton, IV et al. Apr 2016 B2
9320521 Shelton, IV et al. Apr 2016 B2
9320523 Shelton, IV et al. Apr 2016 B2
9325516 Pera et al. Apr 2016 B2
D755196 Meyers et al. May 2016 S
D756373 Raskin et al. May 2016 S
D756377 Connolly et al. May 2016 S
D757028 Goldenberg et al. May 2016 S
9326767 Koch, Jr. et al. May 2016 B2
9326768 Shelton, IV May 2016 B2
9326769 Shelton, IV et al. May 2016 B2
9326770 Shelton, IV et al. May 2016 B2
9326771 Baxter, III et al. May 2016 B2
9326788 Batross et al. May 2016 B2
9326812 Waaler et al. May 2016 B2
9331721 Martinez Nuevo et al. May 2016 B2
9332890 Ozawa May 2016 B2
9332974 Henderson et al. May 2016 B2
9332984 Weaner et al. May 2016 B2
9332987 Leimbach et al. May 2016 B2
9333040 Shellenberger et al. May 2016 B2
9333082 Wei et al. May 2016 B2
9337668 Yip May 2016 B2
9339226 van der Walt et al. May 2016 B2
9345477 Anim et al. May 2016 B2
9345479 (Tarinelli) Racenet et al. May 2016 B2
9345480 Hessler et al. May 2016 B2
9345481 Hall et al. May 2016 B2
9351726 Leimbach et al. May 2016 B2
9351727 Leimbach et al. May 2016 B2
9351728 Sniffin et al. May 2016 B2
9351730 Schmid et al. May 2016 B2
9351731 Carter et al. May 2016 B2
9351732 Hodgkinson May 2016 B2
D758433 Lee et al. Jun 2016 S
D759063 Chen Jun 2016 S
9358003 Hall et al. Jun 2016 B2
9358005 Shelton, IV et al. Jun 2016 B2
9358015 Sorrentino et al. Jun 2016 B2
9358031 Manzo Jun 2016 B2
9364217 Kostrzewski et al. Jun 2016 B2
9364219 Olson et al. Jun 2016 B2
9364220 Williams Jun 2016 B2
9364226 Zemlok et al. Jun 2016 B2
9364229 D'Agostino et al. Jun 2016 B2
9364230 Shelton, IV et al. Jun 2016 B2
9364231 Wenchell Jun 2016 B2
9364233 Alexander, III et al. Jun 2016 B2
9364279 Houser et al. Jun 2016 B2
9368991 Qahouq Jun 2016 B2
9370341 Ceniccola et al. Jun 2016 B2
9370358 Shelton, IV et al. Jun 2016 B2
9370364 Smith et al. Jun 2016 B2
9375206 Vidal et al. Jun 2016 B2
9375230 Ross et al. Jun 2016 B2
9375232 Hunt et al. Jun 2016 B2
9375255 Houser et al. Jun 2016 B2
D761309 Lee et al. Jul 2016 S
9381058 Houser et al. Jul 2016 B2
9386983 Swensgard et al. Jul 2016 B2
9386984 Aronhalt et al. Jul 2016 B2
9386985 Koch, Jr. et al. Jul 2016 B2
9386988 Baxter, III et al. Jul 2016 B2
9387003 Kaercher et al. Jul 2016 B2
9393015 Laurent et al. Jul 2016 B2
9393017 Flanagan et al. Jul 2016 B2
9393018 Wang et al. Jul 2016 B2
9398911 Auld Jul 2016 B2
D763277 Ahmed et al. Aug 2016 S
D764498 Capela et al. Aug 2016 S
9402604 Williams et al. Aug 2016 B2
9402626 Ortiz et al. Aug 2016 B2
9402627 Stevenson et al. Aug 2016 B2
9402629 Ehrenfels et al. Aug 2016 B2
9408604 Shelton, IV et al. Aug 2016 B2
9408606 Shelton, IV Aug 2016 B2
9408622 Stulen et al. Aug 2016 B2
9411370 Benni et al. Aug 2016 B2
9413128 Tien et al. Aug 2016 B2
9414838 Shelton, IV et al. Aug 2016 B2
9414849 Nagashimada Aug 2016 B2
9414880 Monson et al. Aug 2016 B2
9420967 Zand et al. Aug 2016 B2
9421003 Williams et al. Aug 2016 B2
9421014 Ingmanson et al. Aug 2016 B2
9421030 Cole et al. Aug 2016 B2
9421060 Monson et al. Aug 2016 B2
9421062 Houser et al. Aug 2016 B2
9427223 Park et al. Aug 2016 B2
9427231 Racenet et al. Aug 2016 B2
D767624 Lee et al. Sep 2016 S
9433411 Racenet et al. Sep 2016 B2
9433419 Gonzalez et al. Sep 2016 B2
9433420 Hodgkinson Sep 2016 B2
9439649 Shelton, IV et al. Sep 2016 B2
9439650 McGuckin, Jr. et al. Sep 2016 B2
9439651 Smith et al. Sep 2016 B2
9439668 Timm et al. Sep 2016 B2
9445808 Woodard, Jr. et al. Sep 2016 B2
9445813 Shelton, IV et al. Sep 2016 B2
9445817 Bettuchi Sep 2016 B2
9446226 Zilberman Sep 2016 B2
9451938 Overes et al. Sep 2016 B2
9451958 Shelton, IV et al. Sep 2016 B2
D768152 Gutierrez et al. Oct 2016 S
D768156 Frincke Oct 2016 S
D769315 Scotti Oct 2016 S
D769930 Agrawal Oct 2016 S
9461340 Li et al. Oct 2016 B2
9463040 Jeong et al. Oct 2016 B2
9463260 Stopek Oct 2016 B2
9468438 Baber et al. Oct 2016 B2
9468447 Aman et al. Oct 2016 B2
9470297 Aranyi et al. Oct 2016 B2
9471969 Zeng et al. Oct 2016 B2
9474506 Magnin et al. Oct 2016 B2
9474523 Meade et al. Oct 2016 B2
9474540 Stokes et al. Oct 2016 B2
9475180 Eshleman et al. Oct 2016 B2
D770476 Jitkoff et al. Nov 2016 S
D770515 Cho et al. Nov 2016 S
D771116 Dellinger et al. Nov 2016 S
D772905 Ingenlath Nov 2016 S
9480476 Aldridge et al. Nov 2016 B2
9480492 Aranyi et al. Nov 2016 B2
9483095 Tran et al. Nov 2016 B2
9486186 Fiebig et al. Nov 2016 B2
9486213 Altman et al. Nov 2016 B2
9486214 Shelton, IV Nov 2016 B2
9486302 Boey et al. Nov 2016 B2
9488197 Wi Nov 2016 B2
9492146 Kostrzewski et al. Nov 2016 B2
9492167 Shelton, IV et al. Nov 2016 B2
9492170 Bear et al. Nov 2016 B2
9492189 Williams et al. Nov 2016 B2
9492192 To et al. Nov 2016 B2
9498213 Marczyk et al. Nov 2016 B2
9498219 Moore et al. Nov 2016 B2
9504483 Houser et al. Nov 2016 B2
9504521 Deutmeyer et al. Nov 2016 B2
D774547 Capela et al. Dec 2016 S
D775336 Shelton, IV et al. Dec 2016 S
9510827 Kostrzewski Dec 2016 B2
9510828 Yates et al. Dec 2016 B2
9510830 Shelton, IV et al. Dec 2016 B2
9510846 Sholev et al. Dec 2016 B2
9510895 Houser et al. Dec 2016 B2
9510925 Hotter et al. Dec 2016 B2
9517063 Swayze et al. Dec 2016 B2
9517068 Shelton, IV et al. Dec 2016 B2
9521996 Armstrong Dec 2016 B2
9522029 Yates et al. Dec 2016 B2
9526481 Storz et al. Dec 2016 B2
9526499 Kostrzewski et al. Dec 2016 B2
9526563 Twomey Dec 2016 B2
9526564 Rusin Dec 2016 B2
D776683 Gobinski et al. Jan 2017 S
D777773 Shi Jan 2017 S
9532783 Swayze et al. Jan 2017 B2
9539726 Simaan et al. Jan 2017 B2
9545258 Smith et al. Jan 2017 B2
9549732 Yates et al. Jan 2017 B2
9549735 Shelton, IV et al. Jan 2017 B2
9554794 Baber et al. Jan 2017 B2
9554796 Kostrzewski Jan 2017 B2
9554812 Inkpen et al. Jan 2017 B2
9559624 Philipp Jan 2017 B2
9561013 Tsuchiya Feb 2017 B2
9561030 Zhang et al. Feb 2017 B2
9561031 Heinrich et al. Feb 2017 B2
9561032 Shelton, IV et al. Feb 2017 B2
9561038 Shelton, IV et al. Feb 2017 B2
9561045 Hinman et al. Feb 2017 B2
9566061 Aronhalt et al. Feb 2017 B2
9566062 Boudreaux Feb 2017 B2
9566065 Knodel Feb 2017 B2
9566067 Milliman et al. Feb 2017 B2
9572574 Shelton, IV et al. Feb 2017 B2
9572577 Lloyd et al. Feb 2017 B2
9572592 Price et al. Feb 2017 B2
9574644 Parihar Feb 2017 B2
D780803 Gill et al. Mar 2017 S
D781879 Butcher et al. Mar 2017 S
D782530 Paek et al. Mar 2017 S
9585550 Abel et al. Mar 2017 B2
9585657 Shelton, IV et al. Mar 2017 B2
9585658 Shelton, IV Mar 2017 B2
9585659 Viola et al. Mar 2017 B2
9585660 Laurent et al. Mar 2017 B2
9585662 Shelton, IV et al. Mar 2017 B2
9585663 Shelton, IV et al. Mar 2017 B2
9585672 Bastia Mar 2017 B2
9590433 Li Mar 2017 B2
9592050 Schmid et al. Mar 2017 B2
9592052 Shelton, IV Mar 2017 B2
9592053 Shelton, IV et al. Mar 2017 B2
9592054 Schmid et al. Mar 2017 B2
9597073 Sorrentino et al. Mar 2017 B2
9597075 Shelton, IV et al. Mar 2017 B2
9597080 Milliman et al. Mar 2017 B2
9597104 Nicholas et al. Mar 2017 B2
9597143 Madan et al. Mar 2017 B2
9603595 Shelton, IV et al. Mar 2017 B2
9603598 Shelton, IV et al. Mar 2017 B2
9603599 Miller et al. Mar 2017 B2
9603991 Shelton, IV et al. Mar 2017 B2
D783658 Hurst et al. Apr 2017 S
9610080 Whitfield et al. Apr 2017 B2
9614258 Takahashi et al. Apr 2017 B2
9615826 Shelton, IV et al. Apr 2017 B2
9622745 Ingmanson et al. Apr 2017 B2
9629623 Lytle, IV et al. Apr 2017 B2
9629626 Soltz et al. Apr 2017 B2
9629627 Kostrzewski et al. Apr 2017 B2
9629628 Aranyi Apr 2017 B2
9629629 Leimbach et al. Apr 2017 B2
9629652 Mumaw et al. Apr 2017 B2
9629814 Widenhouse et al. Apr 2017 B2
D786280 Ma May 2017 S
D786896 Kim et al. May 2017 S
D787547 Basargin et al. May 2017 S
D788123 Shan et al. May 2017 S
D788140 Hemsley et al. May 2017 S
9636111 Wenchell May 2017 B2
9636850 Stopek (nee Prommersberger) et al. May 2017 B2
9641122 Romanowich et al. May 2017 B2
9642620 Baxter, III et al. May 2017 B2
9649096 Sholev May 2017 B2
9649110 Parihar et al. May 2017 B2
9649111 Shelton, IV et al. May 2017 B2
9655613 Schaller May 2017 B2
9655614 Swensgard et al. May 2017 B2
9655615 Knodel et al. May 2017 B2
9655616 Aranyi May 2017 B2
9655624 Shelton, IV et al. May 2017 B2
9662108 Williams May 2017 B2
9662110 Huang et al. May 2017 B2
9662116 Smith et al. May 2017 B2
9662131 Omori et al. May 2017 B2
D788792 Alessandri et al. Jun 2017 S
D789384 Lin et al. Jun 2017 S
D790570 Butcher et al. Jun 2017 S
9668728 Williams et al. Jun 2017 B2
9668729 Williams et al. Jun 2017 B2
9668732 Patel et al. Jun 2017 B2
9668733 Williams Jun 2017 B2
9668734 Kostrzewski et al. Jun 2017 B2
9675344 Combrowski et al. Jun 2017 B2
9675351 Hodgkinson et al. Jun 2017 B2
9675355 Shelton, IV et al. Jun 2017 B2
9675372 Laurent et al. Jun 2017 B2
9675375 Houser et al. Jun 2017 B2
9675405 Trees et al. Jun 2017 B2
9675819 Dunbar et al. Jun 2017 B2
9681870 Baxter, III et al. Jun 2017 B2
9681873 Smith et al. Jun 2017 B2
9681884 Clem et al. Jun 2017 B2
9687230 Leimbach et al. Jun 2017 B2
9687231 Baxter, III et al. Jun 2017 B2
9687232 Shelton, IV et al. Jun 2017 B2
9687233 Fernandez et al. Jun 2017 B2
9687236 Leimbach et al. Jun 2017 B2
9687237 Schmid et al. Jun 2017 B2
9687253 Detry et al. Jun 2017 B2
9689466 Kanai et al. Jun 2017 B2
9690362 Leimbach et al. Jun 2017 B2
9693772 Ingmanson et al. Jul 2017 B2
9693774 Gettinger et al. Jul 2017 B2
9693777 Schellin et al. Jul 2017 B2
9700309 Jaworek et al. Jul 2017 B2
9700310 Morgan et al. Jul 2017 B2
9700312 Kostrzewski et al. Jul 2017 B2
9700317 Aronhalt et al. Jul 2017 B2
9700318 Scirica et al. Jul 2017 B2
9700319 Motooka et al. Jul 2017 B2
9700320 Dinardo et al. Jul 2017 B2
9700321 Shelton, IV et al. Jul 2017 B2
9706981 Nicholas et al. Jul 2017 B2
9706991 Hess et al. Jul 2017 B2
9706993 Hessler et al. Jul 2017 B2
9707005 Strobl et al. Jul 2017 B2
9707026 Malackowski et al. Jul 2017 B2
9707043 Bozung Jul 2017 B2
9707684 Ruiz Morales et al. Jul 2017 B2
9713468 Harris et al. Jul 2017 B2
9713470 Scirica et al. Jul 2017 B2
9713474 Lorenz Jul 2017 B2
9717497 Zerkle et al. Aug 2017 B2
9717498 Aranyi et al. Aug 2017 B2
9722236 Sathrum Aug 2017 B2
9724091 Shelton, IV et al. Aug 2017 B2
9724092 Baxter, III et al. Aug 2017 B2
9724094 Baber et al. Aug 2017 B2
9724096 Thompson et al. Aug 2017 B2
9724098 Baxter, III et al. Aug 2017 B2
9724118 Schulte et al. Aug 2017 B2
9724163 Orban Aug 2017 B2
9730692 Shelton, IV et al. Aug 2017 B2
9730695 Leimbach et al. Aug 2017 B2
9730697 Morgan et al. Aug 2017 B2
9730717 Katsuki et al. Aug 2017 B2
9731410 Hirabayashi et al. Aug 2017 B2
9733663 Leimbach et al. Aug 2017 B2
9737297 Racenet et al. Aug 2017 B2
9737301 Baber et al. Aug 2017 B2
9737302 Shelton, IV et al. Aug 2017 B2
9737303 Shelton, IV et al. Aug 2017 B2
9737365 Hegeman et al. Aug 2017 B2
9743927 Whitman Aug 2017 B2
9743928 Shelton, IV et al. Aug 2017 B2
9743929 Leimbach et al. Aug 2017 B2
D798319 Bergstrand et al. Sep 2017 S
9750498 Timm et al. Sep 2017 B2
9750499 Leimbach et al. Sep 2017 B2
9750501 Shelton, IV et al. Sep 2017 B2
9750502 Scirica et al. Sep 2017 B2
9750639 Barnes et al. Sep 2017 B2
9757123 Giordano et al. Sep 2017 B2
9757124 Schellin et al. Sep 2017 B2
9757126 Cappola Sep 2017 B2
9757128 Baber et al. Sep 2017 B2
9757129 Williams Sep 2017 B2
9757130 Shelton, IV Sep 2017 B2
9763662 Shelton, IV et al. Sep 2017 B2
9763668 Whitfield et al. Sep 2017 B2
9770245 Swayze et al. Sep 2017 B2
9770274 Pool et al. Sep 2017 B2
D798886 Prophete et al. Oct 2017 S
D800742 Rhodes Oct 2017 S
D800744 Jitkoff et al. Oct 2017 S
D800766 Park et al. Oct 2017 S
D800904 Leimbach et al. Oct 2017 S
9775608 Aronhalt et al. Oct 2017 B2
9775609 Shelton, IV et al. Oct 2017 B2
9775610 Nicholas et al. Oct 2017 B2
9775611 Kostrzewski Oct 2017 B2
9775613 Shelton, IV et al. Oct 2017 B2
9775614 Shelton, IV et al. Oct 2017 B2
9775618 Bettuchi et al. Oct 2017 B2
9775635 Takei Oct 2017 B2
9782169 Kimsey et al. Oct 2017 B2
9782170 Zemlok et al. Oct 2017 B2
9782180 Smith et al. Oct 2017 B2
9782193 Thistle Oct 2017 B2
9782214 Houser et al. Oct 2017 B2
9788834 Schmid et al. Oct 2017 B2
9788835 Morgan et al. Oct 2017 B2
9788836 Overmyer et al. Oct 2017 B2
9788847 Jinno Oct 2017 B2
9788851 Dannaher et al. Oct 2017 B2
9788902 Inoue et al. Oct 2017 B2
9795379 Leimbach et al. Oct 2017 B2
9795380 Shelton, IV et al. Oct 2017 B2
9795381 Shelton, IV Oct 2017 B2
9795382 Shelton, IV Oct 2017 B2
9795383 Aldridge et al. Oct 2017 B2
9795384 Weaner et al. Oct 2017 B2
9797486 Zergiebel et al. Oct 2017 B2
9801626 Parihar et al. Oct 2017 B2
9801627 Harris et al. Oct 2017 B2
9801628 Harris et al. Oct 2017 B2
9801634 Shelton, IV et al. Oct 2017 B2
9802033 Hibner et al. Oct 2017 B2
9804618 Leimbach et al. Oct 2017 B2
D803234 Day et al. Nov 2017 S
D803235 Markson et al. Nov 2017 S
D803850 Chang et al. Nov 2017 S
9808244 Leimbach et al. Nov 2017 B2
9808246 Shelton, IV et al. Nov 2017 B2
9808247 Shelton, IV et al. Nov 2017 B2
9808249 Shelton, IV Nov 2017 B2
9814460 Kimsey et al. Nov 2017 B2
9814462 Woodard, Jr. et al. Nov 2017 B2
9814561 Forsell Nov 2017 B2
9820445 Simpson et al. Nov 2017 B2
9820737 Beardsley et al. Nov 2017 B2
9820738 Lytle, IV et al. Nov 2017 B2
9820741 Kostrzewski Nov 2017 B2
9820768 Gee et al. Nov 2017 B2
9825455 Sandhu et al. Nov 2017 B2
9826976 Parihar et al. Nov 2017 B2
9826977 Leimbach et al. Nov 2017 B2
9826978 Shelton, IV et al. Nov 2017 B2
9829698 Haraguchi et al. Nov 2017 B2
D806108 Day Dec 2017 S
9833236 Shelton, IV et al. Dec 2017 B2
9833238 Baxter, III et al. Dec 2017 B2
9833239 Yates et al. Dec 2017 B2
9833241 Huitema et al. Dec 2017 B2
9833242 Baxter, III et al. Dec 2017 B2
9839420 Shelton, IV et al. Dec 2017 B2
9839421 Zerkle et al. Dec 2017 B2
9839422 Schellin et al. Dec 2017 B2
9839423 Vendely et al. Dec 2017 B2
9839427 Swayze et al. Dec 2017 B2
9839428 Baxter, III et al. Dec 2017 B2
9839429 Weisenburgh, II et al. Dec 2017 B2
9839480 Pribanic et al. Dec 2017 B2
9844368 Boudreaux et al. Dec 2017 B2
9844369 Huitema et al. Dec 2017 B2
9844372 Shelton, IV et al. Dec 2017 B2
9844373 Swayze et al. Dec 2017 B2
9844374 Lytle, IV et al. Dec 2017 B2
9844375 Overmyer et al. Dec 2017 B2
9844376 Baxter, III et al. Dec 2017 B2
9844379 Shelton, IV et al. Dec 2017 B2
9848871 Harris et al. Dec 2017 B2
9848873 Shelton, IV Dec 2017 B2
9848875 Aronhalt et al. Dec 2017 B2
9848877 Shelton, IV et al. Dec 2017 B2
9855040 Kostrzewski Jan 2018 B2
9855662 Ruiz Morales et al. Jan 2018 B2
9861261 Shahinian Jan 2018 B2
9861359 Shelton, IV et al. Jan 2018 B2
9861361 Aronhalt et al. Jan 2018 B2
9861382 Smith et al. Jan 2018 B2
9867612 Parihar et al. Jan 2018 B2
9867618 Hall et al. Jan 2018 B2
9867620 Fischvogt et al. Jan 2018 B2
9868198 Nicholas et al. Jan 2018 B2
9872682 Hess et al. Jan 2018 B2
9872683 Hopkins et al. Jan 2018 B2
9872684 Hall et al. Jan 2018 B2
9877721 Schellin et al. Jan 2018 B2
9877723 Hall et al. Jan 2018 B2
D810099 Riedel Feb 2018 S
9883843 Garlow Feb 2018 B2
9883860 Leimbach et al. Feb 2018 B2
9883861 Shelton, IV et al. Feb 2018 B2
9884456 Schellin et al. Feb 2018 B2
9888919 Leimbach et al. Feb 2018 B2
9888921 Williams et al. Feb 2018 B2
9888924 Ebersole et al. Feb 2018 B2
9889230 Bennett et al. Feb 2018 B2
9895147 Shelton, IV Feb 2018 B2
9895148 Shelton, IV et al. Feb 2018 B2
9895813 Blumenkranz et al. Feb 2018 B2
9901341 Kostrzewski Feb 2018 B2
9901342 Shelton, IV et al. Feb 2018 B2
9901344 Moore et al. Feb 2018 B2
9901345 Moore et al. Feb 2018 B2
9901346 Moore et al. Feb 2018 B2
9901412 Lathrop et al. Feb 2018 B2
D813899 Erant et al. Mar 2018 S
9907456 Miyoshi Mar 2018 B2
9907553 Cole et al. Mar 2018 B2
9907600 Stulen et al. Mar 2018 B2
9907620 Shelton, IV et al. Mar 2018 B2
9913642 Leimbach et al. Mar 2018 B2
9913644 McCuen Mar 2018 B2
9913646 Shelton, IV Mar 2018 B2
9913647 Weisenburgh, II et al. Mar 2018 B2
9913648 Shelton, IV et al. Mar 2018 B2
9913694 Brisson Mar 2018 B2
9913733 Piron et al. Mar 2018 B2
9918704 Shelton, IV et al. Mar 2018 B2
9918714 Gibbons, Jr. Mar 2018 B2
9918715 Menn Mar 2018 B2
9918716 Baxter, III et al. Mar 2018 B2
9918717 Czernik Mar 2018 B2
9924942 Swayze et al. Mar 2018 B2
9924944 Shelton, IV et al. Mar 2018 B2
9924945 Zheng et al. Mar 2018 B2
9924946 Vendely et al. Mar 2018 B2
9924947 Shelton, IV et al. Mar 2018 B2
9924961 Shelton, IV et al. Mar 2018 B2
9931106 Au et al. Apr 2018 B2
9931116 Racenet et al. Apr 2018 B2
9931118 Shelton, IV et al. Apr 2018 B2
9936949 Measamer et al. Apr 2018 B2
9936950 Shelton, IV et al. Apr 2018 B2
9936951 Hufnagel et al. Apr 2018 B2
9936954 Shelton, IV et al. Apr 2018 B2
9937626 Rockrohr Apr 2018 B2
9943309 Shelton, IV et al. Apr 2018 B2
9943310 Harris et al. Apr 2018 B2
9943312 Posada et al. Apr 2018 B2
D819072 Clediere May 2018 S
9955965 Chen et al. May 2018 B2
9955966 Zergiebel May 2018 B2
9962158 Hall et al. May 2018 B2
9962159 Heinrich et al. May 2018 B2
9962161 Scheib et al. May 2018 B2
9968354 Shelton, IV et al. May 2018 B2
9968355 Shelton, IV et al. May 2018 B2
9968356 Shelton, IV et al. May 2018 B2
9968397 Taylor et al. May 2018 B2
9974529 Shelton, IV et al. May 2018 B2
9974538 Baxter, III et al. May 2018 B2
9974539 Yates et al. May 2018 B2
9974541 Calderoni May 2018 B2
9974542 Hodgkinson May 2018 B2
9980713 Aronhalt et al. May 2018 B2
9980724 Farascioni et al. May 2018 B2
9980729 Moore et al. May 2018 B2
9980769 Trees et al. May 2018 B2
D819680 Nguyen Jun 2018 S
D819682 Howard et al. Jun 2018 S
D819684 Dart Jun 2018 S
D820307 Jian et al. Jun 2018 S
D820867 Dickens et al. Jun 2018 S
9987000 Shelton, IV et al. Jun 2018 B2
9987003 Timm et al. Jun 2018 B2
9987006 Morgan et al. Jun 2018 B2
9987095 Chowaniec et al. Jun 2018 B2
9987099 Chen et al. Jun 2018 B2
9993248 Shelton, IV et al. Jun 2018 B2
9993258 Shelton, IV et al. Jun 2018 B2
9999408 Boudreaux et al. Jun 2018 B2
9999423 Schuckmann et al. Jun 2018 B2
9999426 Moore et al. Jun 2018 B2
9999431 Shelton, IV et al. Jun 2018 B2
9999472 Weir et al. Jun 2018 B2
10004497 Overmyer et al. Jun 2018 B2
10004498 Morgan et al. Jun 2018 B2
10004500 Shelton, IV et al. Jun 2018 B2
10004501 Shelton, IV et al. Jun 2018 B2
10004505 Moore et al. Jun 2018 B2
10004506 Shelton, IV et al. Jun 2018 B2
D822206 Shelton, IV et al. Jul 2018 S
10010322 Shelton, IV et al. Jul 2018 B2
10010324 Huitema et al. Jul 2018 B2
10013049 Leimbach et al. Jul 2018 B2
10016199 Baber et al. Jul 2018 B2
10022125 (Prommersberger) Stopek Jul 2018 B2
10024407 Aranyi et al. Jul 2018 B2
10028742 Shelton, IV et al. Jul 2018 B2
10028743 Shelton, IV et al. Jul 2018 B2
10028744 Shelton, IV et al. Jul 2018 B2
10028761 Leimbach et al. Jul 2018 B2
10029125 Shapiro et al. Jul 2018 B2
10034344 Yoshida Jul 2018 B2
10034668 Ebner Jul 2018 B2
D826405 Shelton, IV et al. Aug 2018 S
10039440 Fenech et al. Aug 2018 B2
10039529 Kerr et al. Aug 2018 B2
10039532 Srinivas et al. Aug 2018 B2
10039545 Sadowski et al. Aug 2018 B2
10041822 Zemlok Aug 2018 B2
10045769 Aronhalt et al. Aug 2018 B2
10045776 Shelton, IV et al. Aug 2018 B2
10045778 Yates et al. Aug 2018 B2
10045779 Savage et al. Aug 2018 B2
10045781 Cropper et al. Aug 2018 B2
10052044 Shelton, IV et al. Aug 2018 B2
10052099 Morgan et al. Aug 2018 B2
10052100 Morgan et al. Aug 2018 B2
10052102 Baxter, III et al. Aug 2018 B2
10052104 Shelton, IV et al. Aug 2018 B2
10052164 Overmyer Aug 2018 B2
10058317 Fan et al. Aug 2018 B2
10058327 Weisenburgh, II et al. Aug 2018 B2
10058395 Devengenzo et al. Aug 2018 B2
10058963 Shelton, IV et al. Aug 2018 B2
10064620 Gettinger et al. Sep 2018 B2
10064621 Kerr et al. Sep 2018 B2
10064624 Shelton, IV et al. Sep 2018 B2
10064639 Ishida et al. Sep 2018 B2
10064649 Golebieski et al. Sep 2018 B2
10064688 Shelton, IV et al. Sep 2018 B2
10070861 Spivey et al. Sep 2018 B2
10070863 Swayze et al. Sep 2018 B2
10071452 Shelton, IV et al. Sep 2018 B2
10076325 Huang et al. Sep 2018 B2
10076326 Yates et al. Sep 2018 B2
10076340 Belagali et al. Sep 2018 B2
D831209 Huitema et al. Oct 2018 S
D831676 Park et al. Oct 2018 S
D832301 Smith Oct 2018 S
10085624 Isoda et al. Oct 2018 B2
10085728 Jogasaki et al. Oct 2018 B2
10085748 Morgan et al. Oct 2018 B2
10085749 Cappola et al. Oct 2018 B2
10085751 Overmyer et al. Oct 2018 B2
10085754 Sniffin et al. Oct 2018 B2
10085806 Hagn et al. Oct 2018 B2
10092292 Boudreaux et al. Oct 2018 B2
10098635 Burbank Oct 2018 B2
10098636 Shelton, IV et al. Oct 2018 B2
10098640 Bertolero et al. Oct 2018 B2
10098642 Baxter, III et al. Oct 2018 B2
10099303 Yoshida et al. Oct 2018 B2
10105128 Cooper et al. Oct 2018 B2
10105136 Yates et al. Oct 2018 B2
10105139 Yates et al. Oct 2018 B2
10105140 Malinouskas et al. Oct 2018 B2
10106932 Anderson et al. Oct 2018 B2
10111679 Baber et al. Oct 2018 B2
10111702 Kostrzewski Oct 2018 B2
10117649 Baxter, III et al. Nov 2018 B2
10117652 Schmid et al. Nov 2018 B2
10117653 Leimbach et al. Nov 2018 B2
10117654 Ingmanson et al. Nov 2018 B2
10123798 Baxter, III et al. Nov 2018 B2
10124493 Rothfuss et al. Nov 2018 B2
10130352 Widenhouse et al. Nov 2018 B2
10130359 Hess et al. Nov 2018 B2
10130361 Yates et al. Nov 2018 B2
10130363 Huitema et al. Nov 2018 B2
10130366 Shelton, IV et al. Nov 2018 B2
10130367 Cappola et al. Nov 2018 B2
10130738 Shelton, IV et al. Nov 2018 B2
10130830 Miret Carceller et al. Nov 2018 B2
10133248 Fitzsimmons et al. Nov 2018 B2
10135242 Baber et al. Nov 2018 B2
10136887 Shelton, IV et al. Nov 2018 B2
10136889 Shelton, IV et al. Nov 2018 B2
10136890 Shelton, IV et al. Nov 2018 B2
D835659 Anzures et al. Dec 2018 S
D836124 Fan Dec 2018 S
10143474 Bucciaglia et al. Dec 2018 B2
10149679 Shelton, IV et al. Dec 2018 B2
10149680 Parihar et al. Dec 2018 B2
10149682 Shelton, IV et al. Dec 2018 B2
10149683 Smith et al. Dec 2018 B2
10149712 Manwaring et al. Dec 2018 B2
10154841 Weaner et al. Dec 2018 B2
10159482 Swayze et al. Dec 2018 B2
10159483 Beckman et al. Dec 2018 B2
10163589 Zergiebel et al. Dec 2018 B2
D837244 Kuo et al. Jan 2019 S
D837245 Kuo et al. Jan 2019 S
10166025 Leimbach et al. Jan 2019 B2
10166026 Shelton, IV et al. Jan 2019 B2
10172611 Shelton, IV et al. Jan 2019 B2
10172615 Marczyk et al. Jan 2019 B2
10172616 Murray et al. Jan 2019 B2
10172617 Shelton, IV et al. Jan 2019 B2
10172619 Harris et al. Jan 2019 B2
10172620 Harris et al. Jan 2019 B2
10172636 Stulen et al. Jan 2019 B2
10175127 Collins et al. Jan 2019 B2
10178992 Wise et al. Jan 2019 B2
10180463 Beckman et al. Jan 2019 B2
10182813 Leimbach et al. Jan 2019 B2
10182816 Shelton, IV et al. Jan 2019 B2
10182818 Hensel et al. Jan 2019 B2
10182819 Shelton, IV Jan 2019 B2
10188385 Kerr et al. Jan 2019 B2
10188393 Smith et al. Jan 2019 B2
10188394 Shelton, IV et al. Jan 2019 B2
D839900 Gan Feb 2019 S
D841667 Coren Feb 2019 S
10194904 Viola et al. Feb 2019 B2
10194910 Shelton, IV et al. Feb 2019 B2
10194913 Nalagatla et al. Feb 2019 B2
10194976 Boudreaux Feb 2019 B2
10201348 Scheib et al. Feb 2019 B2
10201349 Leimbach et al. Feb 2019 B2
10201363 Shelton, IV Feb 2019 B2
10201364 Leimbach et al. Feb 2019 B2
10201365 Boudreaux et al. Feb 2019 B2
10201381 Zergiebel et al. Feb 2019 B2
10206605 Shelton, IV et al. Feb 2019 B2
10206676 Shelton, IV Feb 2019 B2
10206677 Harris et al. Feb 2019 B2
10206678 Shelton, IV et al. Feb 2019 B2
10211586 Adams et al. Feb 2019 B2
10213198 Aronhalt et al. Feb 2019 B2
10213201 Shelton, IV et al. Feb 2019 B2
10213202 Flanagan et al. Feb 2019 B2
10213203 Swayze et al. Feb 2019 B2
10213262 Shelton, IV et al. Feb 2019 B2
D842328 Jian et al. Mar 2019 S
10219832 Bagwell et al. Mar 2019 B2
10220522 Rockrohr Mar 2019 B2
10226249 Jaworek et al. Mar 2019 B2
10226250 Beckman et al. Mar 2019 B2
10226274 Worrell et al. Mar 2019 B2
10231634 Zand et al. Mar 2019 B2
10231653 Bohm et al. Mar 2019 B2
10231794 Shelton, IV et al. Mar 2019 B2
10238385 Yates et al. Mar 2019 B2
10238386 Overmyer et al. Mar 2019 B2
10238387 Yates et al. Mar 2019 B2
10238389 Yates et al. Mar 2019 B2
10238390 Harris et al. Mar 2019 B2
10238391 Leimbach et al. Mar 2019 B2
D844666 Espeleta et al. Apr 2019 S
D844667 Espeleta et al. Apr 2019 S
D845342 Espeleta et al. Apr 2019 S
10245027 Shelton, IV et al. Apr 2019 B2
10245028 Shelton, IV et al. Apr 2019 B2
10245029 Hunter et al. Apr 2019 B2
10245030 Hunter et al. Apr 2019 B2
10245032 Shelton, IV Apr 2019 B2
10245033 Overmyer et al. Apr 2019 B2
10245034 Shelton, IV et al. Apr 2019 B2
10245035 Swayze et al. Apr 2019 B2
10245058 Omori et al. Apr 2019 B2
10251648 Harris et al. Apr 2019 B2
10251725 Valentine et al. Apr 2019 B2
10258322 Fanton et al. Apr 2019 B2
10258330 Shelton, IV et al. Apr 2019 B2
10258331 Shelton, IV et al. Apr 2019 B2
10258332 Schmid et al. Apr 2019 B2
10258333 Shelton, IV et al. Apr 2019 B2
10258336 Baxter, III et al. Apr 2019 B2
10258418 Shelton, IV et al. Apr 2019 B2
10264797 Zhang et al. Apr 2019 B2
10265065 Shelton, IV et al. Apr 2019 B2
10265067 Yates et al. Apr 2019 B2
10265068 Harris et al. Apr 2019 B2
10265072 Shelton, IV et al. Apr 2019 B2
10265074 Shelton, IV et al. Apr 2019 B2
10265090 Ingmanson et al. Apr 2019 B2
10271844 Valentine et al. Apr 2019 B2
10271845 Shelton, IV Apr 2019 B2
10271846 Shelton, IV et al. Apr 2019 B2
10271849 Vendely et al. Apr 2019 B2
10271851 Shelton, IV et al. Apr 2019 B2
D847989 Shelton, IV et al. May 2019 S
D848473 Zhu et al. May 2019 S
D849046 Kuo et al. May 2019 S
10278696 Gurumurthy et al. May 2019 B2
10278697 Shelton, IV et al. May 2019 B2
10278702 Shelton, IV et al. May 2019 B2
10278703 Nativ et al. May 2019 B2
10278707 Thompson et al. May 2019 B2
10278722 Shelton, IV et al. May 2019 B2
10278780 Shelton, IV May 2019 B2
10285694 Viola et al. May 2019 B2
10285695 Jaworek et al. May 2019 B2
10285699 Vendely et al. May 2019 B2
10285705 Shelton, IV et al. May 2019 B2
10292701 Scheib et al. May 2019 B2
10292704 Harris et al. May 2019 B2
10292707 Shelton, IV et al. May 2019 B2
10293100 Shelton, IV et al. May 2019 B2
10293553 Racenet et al. May 2019 B2
10299787 Shelton, IV May 2019 B2
10299788 Heinrich et al. May 2019 B2
10299792 Huitema et al. May 2019 B2
10299817 Shelton, IV et al. May 2019 B2
10299818 Riva May 2019 B2
10299878 Shelton, IV et al. May 2019 B2
D850617 Shelton, IV et al. Jun 2019 S
D851676 Foss et al. Jun 2019 S
D851762 Shelton, IV et al. Jun 2019 S
10307159 Harris et al. Jun 2019 B2
10307160 Vendely et al. Jun 2019 B2
10307163 Moore et al. Jun 2019 B2
10307170 Parfett et al. Jun 2019 B2
10307202 Smith et al. Jun 2019 B2
10314577 Laurent et al. Jun 2019 B2
10314582 Shelton, IV et al. Jun 2019 B2
10314587 Harris et al. Jun 2019 B2
10314588 Turner et al. Jun 2019 B2
10314589 Shelton, IV et al. Jun 2019 B2
10314590 Shelton, IV et al. Jun 2019 B2
10315566 Choi et al. Jun 2019 B2
10321907 Shelton, IV et al. Jun 2019 B2
10321909 Shelton, IV et al. Jun 2019 B2
10321927 Hinman Jun 2019 B2
10327764 Harris et al. Jun 2019 B2
10327765 Timm et al. Jun 2019 B2
10327767 Shelton, IV et al. Jun 2019 B2
10327769 Overmyer et al. Jun 2019 B2
10327776 Harris et al. Jun 2019 B2
10327777 Harris et al. Jun 2019 B2
D854151 Shelton, IV et al. Jul 2019 S
10335144 Shelton, IV et al. Jul 2019 B2
10335145 Harris et al. Jul 2019 B2
10335147 Rector et al. Jul 2019 B2
10335148 Shelton, IV et al. Jul 2019 B2
10335149 Baxter, III et al. Jul 2019 B2
10335150 Shelton, IV Jul 2019 B2
10335151 Shelton, IV et al. Jul 2019 B2
10342533 Shelton, IV et al. Jul 2019 B2
10342541 Shelton, IV et al. Jul 2019 B2
10342543 Shelton, IV et al. Jul 2019 B2
10342623 Huelman et al. Jul 2019 B2
10349939 Shelton, IV et al. Jul 2019 B2
10357246 Shelton, IV et al. Jul 2019 B2
10357247 Shelton, IV et al. Jul 2019 B2
10357248 Dalessandro et al. Jul 2019 B2
10357252 Harris et al. Jul 2019 B2
10363031 Alexander, III et al. Jul 2019 B2
10363033 Timm et al. Jul 2019 B2
10363036 Yates et al. Jul 2019 B2
10363037 Aronhalt et al. Jul 2019 B2
10363045 Whitfield et al. Jul 2019 B2
10368838 Williams et al. Aug 2019 B2
10368861 Baxter, III et al. Aug 2019 B2
10368863 Timm et al. Aug 2019 B2
10368864 Harris et al. Aug 2019 B2
10368865 Harris et al. Aug 2019 B2
10368867 Harris et al. Aug 2019 B2
10368892 Stulen et al. Aug 2019 B2
10376262 Zemlok et al. Aug 2019 B2
10376263 Morgan et al. Aug 2019 B2
10383626 Soltz Aug 2019 B2
10383628 Kang et al. Aug 2019 B2
10383629 Ross et al. Aug 2019 B2
10383630 Shelton, IV et al. Aug 2019 B2
10383633 Shelton, IV et al. Aug 2019 B2
10383634 Shelton, IV et al. Aug 2019 B2
10390823 Shelton, IV et al. Aug 2019 B2
10390825 Shelton, IV et al. Aug 2019 B2
10390828 Vendely et al. Aug 2019 B2
10390829 Eckert et al. Aug 2019 B2
10390830 Schulz Aug 2019 B2
10390841 Shelton, IV et al. Aug 2019 B2
10398433 Boudreaux et al. Sep 2019 B2
10398434 Shelton, IV et al. Sep 2019 B2
10398436 Shelton, IV et al. Sep 2019 B2
10405854 Schmid et al. Sep 2019 B2
10405857 Shelton, IV et al. Sep 2019 B2
10405859 Harris et al. Sep 2019 B2
10405863 Wise et al. Sep 2019 B2
10405914 Manwaring et al. Sep 2019 B2
10413291 Worthington et al. Sep 2019 B2
10413293 Shelton, IV et al. Sep 2019 B2
10413294 Shelton, IV et al. Sep 2019 B2
10413297 Harris et al. Sep 2019 B2
10413373 Yates et al. Sep 2019 B2
10420549 Yates et al. Sep 2019 B2
10420550 Shelton, IV Sep 2019 B2
10420552 Shelton, IV et al. Sep 2019 B2
10420553 Shelton, IV et al. Sep 2019 B2
10420555 Shelton, IV et al. Sep 2019 B2
10420558 Nalagatla et al. Sep 2019 B2
10420559 Marczyk et al. Sep 2019 B2
10420560 Shelton, IV et al. Sep 2019 B2
10420561 Shelton, IV et al. Sep 2019 B2
10420577 Chowaniec et al. Sep 2019 B2
10426463 Shelton, IV et al. Oct 2019 B2
10426467 Miller et al. Oct 2019 B2
10426468 Contini et al. Oct 2019 B2
10426469 Shelton, IV et al. Oct 2019 B2
10426471 Shelton, IV et al. Oct 2019 B2
10426476 Harris et al. Oct 2019 B2
10426477 Harris et al. Oct 2019 B2
10426478 Shelton, IV et al. Oct 2019 B2
10426481 Aronhalt et al. Oct 2019 B2
10433837 Worthington et al. Oct 2019 B2
10433839 Scheib et al. Oct 2019 B2
10433840 Shelton, IV et al. Oct 2019 B2
10433844 Shelton, IV et al. Oct 2019 B2
10433845 Baxter, III et al. Oct 2019 B2
10433846 Vendely et al. Oct 2019 B2
10433849 Shelton, IV et al. Oct 2019 B2
10433918 Shelton, IV et al. Oct 2019 B2
20010000531 Casscells et al. Apr 2001 A1
20010025183 Shahidi Sep 2001 A1
20010025184 Messerly Sep 2001 A1
20020014510 Richter et al. Feb 2002 A1
20020022810 Urich Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020022861 Jacobs et al. Feb 2002 A1
20020029032 Arkin Mar 2002 A1
20020029036 Goble et al. Mar 2002 A1
20020042620 Julian et al. Apr 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020091374 Cooper Jul 2002 A1
20020095175 Brock et al. Jul 2002 A1
20020103494 Pacey Aug 2002 A1
20020116063 Giannetti et al. Aug 2002 A1
20020117534 Green et al. Aug 2002 A1
20020127265 Bowman et al. Sep 2002 A1
20020128633 Brock et al. Sep 2002 A1
20020134811 Napier et al. Sep 2002 A1
20020135474 Sylliassen Sep 2002 A1
20020143340 Kaneko Oct 2002 A1
20020158593 Henderson et al. Oct 2002 A1
20020185514 Adams et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020188287 Zvuloni et al. Dec 2002 A1
20030009193 Corsaro Jan 2003 A1
20030011245 Fiebig Jan 2003 A1
20030066858 Holgersson Apr 2003 A1
20030078647 Vallana et al. Apr 2003 A1
20030083648 Wang et al. May 2003 A1
20030084983 Rangachari et al. May 2003 A1
20030093103 Malackowski et al. May 2003 A1
20030094356 Waldron May 2003 A1
20030096158 Takano et al. May 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030149406 Martineau et al. Aug 2003 A1
20030153908 Goble et al. Aug 2003 A1
20030153968 Geis et al. Aug 2003 A1
20030163085 Tanner et al. Aug 2003 A1
20030181900 Long Sep 2003 A1
20030190584 Heasley Oct 2003 A1
20030195387 Kortenbach et al. Oct 2003 A1
20030205029 Chapolini et al. Nov 2003 A1
20030212005 Petito et al. Nov 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030236505 Bonadio et al. Dec 2003 A1
20040006335 Garrison Jan 2004 A1
20040006340 Latterell et al. Jan 2004 A1
20040007608 Ehrenfels et al. Jan 2004 A1
20040024457 Boyce et al. Feb 2004 A1
20040028502 Cummins Feb 2004 A1
20040030333 Goble Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040044295 Reinert et al. Mar 2004 A1
20040044364 DeVries et al. Mar 2004 A1
20040049121 Yaron Mar 2004 A1
20040049172 Root et al. Mar 2004 A1
20040059362 Knodel et al. Mar 2004 A1
20040068161 Couvillon Apr 2004 A1
20040068224 Couvillon et al. Apr 2004 A1
20040068307 Goble Apr 2004 A1
20040070369 Sakakibara Apr 2004 A1
20040073222 Koseki Apr 2004 A1
20040078037 Batchelor et al. Apr 2004 A1
20040082952 Dycus et al. Apr 2004 A1
20040085180 Juang May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040098040 Taniguchi et al. May 2004 A1
20040101822 Wiesner et al. May 2004 A1
20040102783 Sutterlin et al. May 2004 A1
20040108357 Milliman et al. Jun 2004 A1
20040110439 Chaikof et al. Jun 2004 A1
20040115022 Albertson et al. Jun 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040119185 Chen Jun 2004 A1
20040122419 Neuberger Jun 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040133095 Dunki-Jacobs et al. Jul 2004 A1
20040133189 Sakurai Jul 2004 A1
20040143297 Ramsey Jul 2004 A1
20040147909 Johnston et al. Jul 2004 A1
20040153100 Ahlberg et al. Aug 2004 A1
20040158261 Vu Aug 2004 A1
20040164123 Racenet et al. Aug 2004 A1
20040166169 Malaviya et al. Aug 2004 A1
20040167572 Roth et al. Aug 2004 A1
20040181219 Goble et al. Sep 2004 A1
20040193189 Kortenbach et al. Sep 2004 A1
20040197367 Rezania et al. Oct 2004 A1
20040199181 Knodel et al. Oct 2004 A1
20040204735 Shiroff et al. Oct 2004 A1
20040218451 Said et al. Nov 2004 A1
20040222268 Bilotti et al. Nov 2004 A1
20040225186 Horne et al. Nov 2004 A1
20040232201 Wenchell et al. Nov 2004 A1
20040236352 Wang et al. Nov 2004 A1
20040243147 Lipow Dec 2004 A1
20040243151 Demmy et al. Dec 2004 A1
20040243163 Casiano et al. Dec 2004 A1
20040247415 Mangone Dec 2004 A1
20040249366 Kunz Dec 2004 A1
20040254455 Iddan Dec 2004 A1
20040254566 Plicchi et al. Dec 2004 A1
20040254590 Hoffman et al. Dec 2004 A1
20040260315 Dell et al. Dec 2004 A1
20040267310 Racenet et al. Dec 2004 A1
20050010158 Brugger et al. Jan 2005 A1
20050010213 Stad et al. Jan 2005 A1
20050021078 Vleugels et al. Jan 2005 A1
20050032511 Malone et al. Feb 2005 A1
20050033352 Zepf et al. Feb 2005 A1
20050051163 Deem et al. Mar 2005 A1
20050054946 Krzyzanowski Mar 2005 A1
20050057225 Marquet Mar 2005 A1
20050058890 Brazell et al. Mar 2005 A1
20050059997 Bauman et al. Mar 2005 A1
20050070929 Dalessandro et al. Mar 2005 A1
20050075561 Golden Apr 2005 A1
20050080342 Gilreath et al. Apr 2005 A1
20050085693 Belson et al. Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050096683 Ellins et al. May 2005 A1
20050116673 Carl et al. Jun 2005 A1
20050124855 Jaffe et al. Jun 2005 A1
20050125897 Wyslucha et al. Jun 2005 A1
20050130682 Takara et al. Jun 2005 A1
20050131173 McDaniel et al. Jun 2005 A1
20050131211 Bayley et al. Jun 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050131436 Johnston et al. Jun 2005 A1
20050131457 Douglas et al. Jun 2005 A1
20050137454 Saadat et al. Jun 2005 A1
20050137455 Ewers et al. Jun 2005 A1
20050139636 Schwemberger et al. Jun 2005 A1
20050143759 Kelly Jun 2005 A1
20050143769 White et al. Jun 2005 A1
20050145671 Viola Jul 2005 A1
20050150928 Kameyama et al. Jul 2005 A1
20050154258 Tartaglia et al. Jul 2005 A1
20050154406 Bombard et al. Jul 2005 A1
20050159778 Heinrich et al. Jul 2005 A1
20050165419 Sauer et al. Jul 2005 A1
20050169974 Tenerz et al. Aug 2005 A1
20050171522 Christopherson Aug 2005 A1
20050177181 Kagan et al. Aug 2005 A1
20050177249 Kladakis et al. Aug 2005 A1
20050182298 Ikeda et al. Aug 2005 A1
20050184121 Heinrich Aug 2005 A1
20050186240 Ringeisen et al. Aug 2005 A1
20050187545 Hooven et al. Aug 2005 A1
20050203550 Laufer et al. Sep 2005 A1
20050209614 Fenter et al. Sep 2005 A1
20050216055 Scirica et al. Sep 2005 A1
20050222587 Jinno et al. Oct 2005 A1
20050222611 Weitkamp Oct 2005 A1
20050222616 Rethy et al. Oct 2005 A1
20050222665 Aranyi Oct 2005 A1
20050228224 Okada et al. Oct 2005 A1
20050228446 Mooradian et al. Oct 2005 A1
20050230453 Viola Oct 2005 A1
20050240178 Morley et al. Oct 2005 A1
20050245965 Orban, III et al. Nov 2005 A1
20050246881 Kelly et al. Nov 2005 A1
20050251063 Basude Nov 2005 A1
20050256452 DeMarchi et al. Nov 2005 A1
20050261676 Hall et al. Nov 2005 A1
20050263563 Racenet et al. Dec 2005 A1
20050267455 Eggers et al. Dec 2005 A1
20050274034 Hayashida et al. Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060008787 Hayman et al. Jan 2006 A1
20060015009 Jaffe et al. Jan 2006 A1
20060020258 Strauss et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025812 Shelton Feb 2006 A1
20060041188 Dirusso et al. Feb 2006 A1
20060047275 Goble Mar 2006 A1
20060049229 Milliman et al. Mar 2006 A1
20060052824 Ransick et al. Mar 2006 A1
20060052825 Ransick et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060079735 Martone et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060086032 Valencic et al. Apr 2006 A1
20060087746 Lipow Apr 2006 A1
20060089535 Raz et al. Apr 2006 A1
20060097699 Kamenoff May 2006 A1
20060100643 Laufer et al. May 2006 A1
20060100649 Hart May 2006 A1
20060111711 Goble May 2006 A1
20060111723 Chapolini et al. May 2006 A1
20060116634 Shachar Jun 2006 A1
20060142772 Ralph et al. Jun 2006 A1
20060154546 Murphy et al. Jul 2006 A1
20060161050 Butler et al. Jul 2006 A1
20060161185 Saadat et al. Jul 2006 A1
20060167471 Phillips Jul 2006 A1
20060173470 Oray et al. Aug 2006 A1
20060176031 Forman et al. Aug 2006 A1
20060178556 Hasser et al. Aug 2006 A1
20060180633 Emmons Aug 2006 A1
20060180634 Shelton et al. Aug 2006 A1
20060185682 Marczyk Aug 2006 A1
20060199999 Ikeda et al. Sep 2006 A1
20060201989 Ojeda Sep 2006 A1
20060206100 Eskridge et al. Sep 2006 A1
20060217729 Eskridge et al. Sep 2006 A1
20060235368 Oz Oct 2006 A1
20060241666 Briggs et al. Oct 2006 A1
20060244460 Weaver Nov 2006 A1
20060252990 Kubach Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060258904 Stefanchik et al. Nov 2006 A1
20060259073 Miyamoto et al. Nov 2006 A1
20060261763 Iott et al. Nov 2006 A1
20060263444 Ming et al. Nov 2006 A1
20060264831 Skwarek et al. Nov 2006 A1
20060264929 Goble et al. Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20060271102 Bosshard et al. Nov 2006 A1
20060282064 Shimizu et al. Dec 2006 A1
20060284730 Schmid et al. Dec 2006 A1
20060287576 Tsuji et al. Dec 2006 A1
20060289602 Wales et al. Dec 2006 A1
20060291981 Viola et al. Dec 2006 A1
20070010702 Wang et al. Jan 2007 A1
20070010838 Shelton et al. Jan 2007 A1
20070016235 Tanaka et al. Jan 2007 A1
20070026039 Drumheller et al. Feb 2007 A1
20070026040 Crawley et al. Feb 2007 A1
20070027468 Wales et al. Feb 2007 A1
20070027551 Farnsworth et al. Feb 2007 A1
20070043387 Vargas et al. Feb 2007 A1
20070049951 Menn Mar 2007 A1
20070049966 Bonadio et al. Mar 2007 A1
20070051375 Milliman Mar 2007 A1
20070055228 Berg et al. Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070073389 Bolduc et al. Mar 2007 A1
20070078328 Ozaki et al. Apr 2007 A1
20070078484 Talarico et al. Apr 2007 A1
20070084897 Shelton et al. Apr 2007 A1
20070088376 Zacharias Apr 2007 A1
20070090788 Hansford et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070102472 Shelton May 2007 A1
20070106113 Ravo May 2007 A1
20070106317 Shelton et al. May 2007 A1
20070134251 Ashkenazi et al. Jun 2007 A1
20070135686 Pruitt et al. Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070152612 Chen et al. Jul 2007 A1
20070155010 Farnsworth et al. Jul 2007 A1
20070170225 Shelton et al. Jul 2007 A1
20070173687 Shima et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070175950 Shelton et al. Aug 2007 A1
20070175951 Shelton et al. Aug 2007 A1
20070175955 Shelton et al. Aug 2007 A1
20070179477 Danger Aug 2007 A1
20070185545 Duke Aug 2007 A1
20070190110 Pameijer et al. Aug 2007 A1
20070191868 Theroux et al. Aug 2007 A1
20070194079 Hueil et al. Aug 2007 A1
20070194082 Morgan et al. Aug 2007 A1
20070197954 Keenan Aug 2007 A1
20070198039 Jones et al. Aug 2007 A1
20070203510 Bettuchi Aug 2007 A1
20070207010 Caspi Sep 2007 A1
20070208359 Hoffman Sep 2007 A1
20070208375 Nishizawa et al. Sep 2007 A1
20070213750 Weadock Sep 2007 A1
20070225562 Spivey et al. Sep 2007 A1
20070233163 Bombard et al. Oct 2007 A1
20070243227 Gertner Oct 2007 A1
20070244471 Malackowski Oct 2007 A1
20070246505 Pace-Floridia et al. Oct 2007 A1
20070262592 Hwang et al. Nov 2007 A1
20070275035 Herman et al. Nov 2007 A1
20070276409 Ortiz et al. Nov 2007 A1
20070279011 Jones et al. Dec 2007 A1
20070286892 Herzberg et al. Dec 2007 A1
20070296286 Avenell Dec 2007 A1
20080003196 Jonn et al. Jan 2008 A1
20080015598 Prommersberger Jan 2008 A1
20080021486 Oyola et al. Jan 2008 A1
20080029570 Shelton et al. Feb 2008 A1
20080029573 Shelton et al. Feb 2008 A1
20080029574 Shelton et al. Feb 2008 A1
20080029575 Shelton et al. Feb 2008 A1
20080030170 Dacquay et al. Feb 2008 A1
20080042861 Dacquay et al. Feb 2008 A1
20080051833 Gramuglia et al. Feb 2008 A1
20080064921 Larkin et al. Mar 2008 A1
20080065153 Allard et al. Mar 2008 A1
20080071328 Haubrich et al. Mar 2008 A1
20080078802 Hess et al. Apr 2008 A1
20080082114 McKenna et al. Apr 2008 A1
20080082125 Murray et al. Apr 2008 A1
20080082126 Murray et al. Apr 2008 A1
20080083807 Beardsley et al. Apr 2008 A1
20080085296 Powell et al. Apr 2008 A1
20080086078 Powell et al. Apr 2008 A1
20080091072 Omori et al. Apr 2008 A1
20080108443 Jinno et al. May 2008 A1
20080114250 Urbano et al. May 2008 A1
20080125634 Ryan et al. May 2008 A1
20080125749 Olson May 2008 A1
20080128469 Dalessandro et al. Jun 2008 A1
20080129253 Shiue et al. Jun 2008 A1
20080135600 Hiranuma et al. Jun 2008 A1
20080140115 Stopek Jun 2008 A1
20080140159 Bornhoft et al. Jun 2008 A1
20080154299 Livneh Jun 2008 A1
20080154335 Thrope et al. Jun 2008 A1
20080169328 Shelton Jul 2008 A1
20080169332 Shelton et al. Jul 2008 A1
20080169333 Shelton et al. Jul 2008 A1
20080172087 Fuchs et al. Jul 2008 A1
20080190989 Crews et al. Aug 2008 A1
20080196253 Ezra et al. Aug 2008 A1
20080196419 Dube Aug 2008 A1
20080197167 Viola et al. Aug 2008 A1
20080200755 Bakos Aug 2008 A1
20080200762 Stokes et al. Aug 2008 A1
20080200835 Monson et al. Aug 2008 A1
20080200911 Long Aug 2008 A1
20080200933 Bakos et al. Aug 2008 A1
20080200934 Fox Aug 2008 A1
20080234709 Houser Sep 2008 A1
20080242939 Johnston Oct 2008 A1
20080249536 Stahler et al. Oct 2008 A1
20080249608 Dave Oct 2008 A1
20080255413 Zemlok et al. Oct 2008 A1
20080262654 Omori et al. Oct 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080281171 Fennell et al. Nov 2008 A1
20080287944 Pearson et al. Nov 2008 A1
20080293910 Kapiamba et al. Nov 2008 A1
20080294179 Balbierz et al. Nov 2008 A1
20080296346 Shelton, IV et al. Dec 2008 A1
20080297287 Shachar et al. Dec 2008 A1
20080308602 Timm et al. Dec 2008 A1
20080308603 Shelton et al. Dec 2008 A1
20080312687 Blier Dec 2008 A1
20080315829 Jones et al. Dec 2008 A1
20090001121 Hess et al. Jan 2009 A1
20090001130 Hess et al. Jan 2009 A1
20090004455 Gravagna et al. Jan 2009 A1
20090005809 Hess et al. Jan 2009 A1
20090012534 Madhani et al. Jan 2009 A1
20090015195 Loth-Krausser Jan 2009 A1
20090020958 Soul Jan 2009 A1
20090048583 Williams et al. Feb 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090078736 Van Lue Mar 2009 A1
20090081313 Aghion et al. Mar 2009 A1
20090088659 Graham et al. Apr 2009 A1
20090090763 Zemlok et al. Apr 2009 A1
20090092651 Shah et al. Apr 2009 A1
20090099579 Nentwick et al. Apr 2009 A1
20090099876 Whitman Apr 2009 A1
20090119011 Kondo et al. May 2009 A1
20090131819 Ritchie et al. May 2009 A1
20090132400 Conway May 2009 A1
20090143855 Weber et al. Jun 2009 A1
20090149871 Kagan et al. Jun 2009 A9
20090171147 Lee et al. Jul 2009 A1
20090177226 Reinprecht et al. Jul 2009 A1
20090181290 Baldwin et al. Jul 2009 A1
20090188964 Orlov Jul 2009 A1
20090192534 Ortiz et al. Jul 2009 A1
20090198272 Kerver et al. Aug 2009 A1
20090204108 Steffen Aug 2009 A1
20090204109 Grove et al. Aug 2009 A1
20090206125 Huitema et al. Aug 2009 A1
20090206126 Huitema et al. Aug 2009 A1
20090206131 Weisenburgh, II et al. Aug 2009 A1
20090206133 Morgan et al. Aug 2009 A1
20090206137 Hall et al. Aug 2009 A1
20090206139 Hall et al. Aug 2009 A1
20090206141 Huitema et al. Aug 2009 A1
20090206142 Huitema et al. Aug 2009 A1
20090221993 Sohi et al. Sep 2009 A1
20090234273 Intoccia et al. Sep 2009 A1
20090242610 Shelton, IV et al. Oct 2009 A1
20090247368 Chiang Oct 2009 A1
20090247901 Zimmer Oct 2009 A1
20090253959 Yoshie et al. Oct 2009 A1
20090255974 Viola Oct 2009 A1
20090262078 Pizzi Oct 2009 A1
20090270895 Churchill et al. Oct 2009 A1
20090290016 Suda Nov 2009 A1
20090292283 Odom Nov 2009 A1
20090306639 Nevo et al. Dec 2009 A1
20090308907 Nalagatla et al. Dec 2009 A1
20090318557 Stockel Dec 2009 A1
20100005035 Carpenter et al. Jan 2010 A1
20100012703 Calabrese et al. Jan 2010 A1
20100016888 Calabrese et al. Jan 2010 A1
20100017715 Balassanian Jan 2010 A1
20100023024 Zeiner et al. Jan 2010 A1
20100030233 Whitman et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100051668 Milliman et al. Mar 2010 A1
20100057118 Dietz et al. Mar 2010 A1
20100065604 Weng Mar 2010 A1
20100069942 Shelton, IV Mar 2010 A1
20100076483 Imuta Mar 2010 A1
20100076489 Stopek et al. Mar 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100094340 Stopek et al. Apr 2010 A1
20100100123 Bennett Apr 2010 A1
20100100124 Calabrese et al. Apr 2010 A1
20100116519 Gareis May 2010 A1
20100122339 Boccacci May 2010 A1
20100133317 Shelton, IV et al. Jun 2010 A1
20100137990 Apatsidis et al. Jun 2010 A1
20100145146 Melder Jun 2010 A1
20100147921 Olson Jun 2010 A1
20100147922 Olson Jun 2010 A1
20100179022 Shirokoshi Jul 2010 A1
20100180711 Kilibarda et al. Jul 2010 A1
20100191262 Harris et al. Jul 2010 A1
20100191292 DeMeo et al. Jul 2010 A1
20100193566 Scheib et al. Aug 2010 A1
20100204717 Knodel Aug 2010 A1
20100204721 Young et al. Aug 2010 A1
20100217281 Matsuoka et al. Aug 2010 A1
20100222901 Swayze et al. Sep 2010 A1
20100241137 Doyle et al. Sep 2010 A1
20100249497 Peine et al. Sep 2010 A1
20100249947 Lesh et al. Sep 2010 A1
20100256675 Romans Oct 2010 A1
20100258327 Esenwein et al. Oct 2010 A1
20100267662 Fielder et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20100292540 Hess et al. Nov 2010 A1
20100298636 Castro et al. Nov 2010 A1
20100312261 Suzuki et al. Dec 2010 A1
20100318085 Austin et al. Dec 2010 A1
20100331856 Carlson et al. Dec 2010 A1
20110006101 Hall et al. Jan 2011 A1
20110011916 Levine Jan 2011 A1
20110016960 Debrailly Jan 2011 A1
20110021871 Berkelaar Jan 2011 A1
20110022032 Zemlok et al. Jan 2011 A1
20110024477 Hall Feb 2011 A1
20110024478 Shelton, IV Feb 2011 A1
20110025311 Chauvin et al. Feb 2011 A1
20110036891 Zemlok et al. Feb 2011 A1
20110046667 Culligan et al. Feb 2011 A1
20110060363 Hess et al. Mar 2011 A1
20110066156 McGahan et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087276 Bedi et al. Apr 2011 A1
20110088921 Forgues et al. Apr 2011 A1
20110091515 Zilberman et al. Apr 2011 A1
20110095064 Taylor et al. Apr 2011 A1
20110101069 Bombard et al. May 2011 A1
20110101794 Schroeder et al. May 2011 A1
20110112517 Peine et al. May 2011 A1
20110112530 Keller May 2011 A1
20110114697 Baxter, III et al. May 2011 A1
20110121049 Malinouskas et al. May 2011 A1
20110125176 Yates et al. May 2011 A1
20110127945 Yoneda Jun 2011 A1
20110129706 Takahashi et al. Jun 2011 A1
20110144764 Bagga et al. Jun 2011 A1
20110147433 Shelton, IV et al. Jun 2011 A1
20110160725 Kabaya et al. Jun 2011 A1
20110163146 Ortiz et al. Jul 2011 A1
20110172495 Armstrong Jul 2011 A1
20110174861 Shelton, IV et al. Jul 2011 A1
20110192882 Hess et al. Aug 2011 A1
20110199225 Touchberry et al. Aug 2011 A1
20110218400 Ma et al. Sep 2011 A1
20110218550 Ma Sep 2011 A1
20110230713 Kleemann et al. Sep 2011 A1
20110238044 Main et al. Sep 2011 A1
20110241597 Zhu et al. Oct 2011 A1
20110271186 Owens Nov 2011 A1
20110275901 Shelton, IV Nov 2011 A1
20110276083 Shelton, IV et al. Nov 2011 A1
20110278343 Knodel et al. Nov 2011 A1
20110279268 Konishi et al. Nov 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20110293690 Griffin et al. Dec 2011 A1
20110295295 Shelton, IV et al. Dec 2011 A1
20110313894 Dye et al. Dec 2011 A1
20110315413 Fisher et al. Dec 2011 A1
20120004636 Lo Jan 2012 A1
20120007442 Rhodes et al. Jan 2012 A1
20120016239 Barthe et al. Jan 2012 A1
20120016413 Timm et al. Jan 2012 A1
20120016467 Chen et al. Jan 2012 A1
20120029272 Shelton, IV et al. Feb 2012 A1
20120033360 Hsu Feb 2012 A1
20120059286 Hastings et al. Mar 2012 A1
20120064483 Lint et al. Mar 2012 A1
20120074200 Schmid et al. Mar 2012 A1
20120078139 Aldridge et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120080336 Shelton, IV et al. Apr 2012 A1
20120080344 Shelton, IV Apr 2012 A1
20120080478 Morgan et al. Apr 2012 A1
20120080488 Shelton, IV Apr 2012 A1
20120080498 Shelton, IV et al. Apr 2012 A1
20120086276 Sawyers Apr 2012 A1
20120095458 Cybulski et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116261 Mumaw et al. May 2012 A1
20120116262 Houser et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116266 Houser et al. May 2012 A1
20120118595 Pellenc May 2012 A1
20120123463 Jacobs May 2012 A1
20120125792 Cassivi May 2012 A1
20120130217 Kauphusman et al. May 2012 A1
20120132286 Lim et al. May 2012 A1
20120171539 Rejman et al. Jul 2012 A1
20120175398 Sandborn et al. Jul 2012 A1
20120197272 Oray et al. Aug 2012 A1
20120211542 Racenet Aug 2012 A1
20120234895 O'Connor et al. Sep 2012 A1
20120234897 Shelton, IV et al. Sep 2012 A1
20120239068 Morris et al. Sep 2012 A1
20120241497 Mandakolathur Vasudevan Sep 2012 A1
20120248169 Widenhouse et al. Oct 2012 A1
20120251861 Liang et al. Oct 2012 A1
20120253328 Cunningham et al. Oct 2012 A1
20120283707 Giordano et al. Nov 2012 A1
20120289979 Eskaros et al. Nov 2012 A1
20120292367 Morgan et al. Nov 2012 A1
20120298722 Hess et al. Nov 2012 A1
20120303002 Chowaniec et al. Nov 2012 A1
20130006227 Takashino Jan 2013 A1
20130012983 Kleyman Jan 2013 A1
20130018400 Milton et al. Jan 2013 A1
20130020375 Shelton, IV et al. Jan 2013 A1
20130020376 Shelton, IV et al. Jan 2013 A1
20130023861 Shelton, IV et al. Jan 2013 A1
20130023910 Solomon et al. Jan 2013 A1
20130026208 Shelton, IV et al. Jan 2013 A1
20130026210 Shelton, IV et al. Jan 2013 A1
20130030462 Keating et al. Jan 2013 A1
20130041292 Cunningham Feb 2013 A1
20130057162 Pollischansky Mar 2013 A1
20130068816 Mandakolathur Vasudevan et al. Mar 2013 A1
20130087597 Shelton, IV et al. Apr 2013 A1
20130090534 Burns et al. Apr 2013 A1
20130096568 Justis Apr 2013 A1
20130098970 Racenet et al. Apr 2013 A1
20130105552 Weir et al. May 2013 A1
20130106352 Nagamine May 2013 A1
20130116669 Shelton, IV et al. May 2013 A1
20130123816 Hodgkinson et al. May 2013 A1
20130126202 Oomori et al. May 2013 A1
20130131476 Siu et al. May 2013 A1
20130131651 Strobl et al. May 2013 A1
20130136969 Yasui et al. May 2013 A1
20130153641 Shelton, IV et al. Jun 2013 A1
20130158390 Tan et al. Jun 2013 A1
20130162198 Yokota et al. Jun 2013 A1
20130169217 Watanabe et al. Jul 2013 A1
20130172878 Smith Jul 2013 A1
20130175317 Yates et al. Jul 2013 A1
20130214025 Zemlok et al. Aug 2013 A1
20130233906 Hess et al. Sep 2013 A1
20130238021 Gross et al. Sep 2013 A1
20130245704 Koltz et al. Sep 2013 A1
20130248578 Arteaga Gonzalez Sep 2013 A1
20130253480 Kimball et al. Sep 2013 A1
20130256373 Schmid et al. Oct 2013 A1
20130256380 Schmid et al. Oct 2013 A1
20130267978 Trissel Oct 2013 A1
20130270322 Scheib et al. Oct 2013 A1
20130277410 Fernandez et al. Oct 2013 A1
20130306704 Balbierz et al. Nov 2013 A1
20130317753 Kamen et al. Nov 2013 A1
20130324982 Smith et al. Dec 2013 A1
20130327552 Lovelass et al. Dec 2013 A1
20130333910 Tanimoto et al. Dec 2013 A1
20130334280 Krehel et al. Dec 2013 A1
20130334283 Swayze et al. Dec 2013 A1
20130334285 Swayze et al. Dec 2013 A1
20130341374 Shelton, IV et al. Dec 2013 A1
20140001231 Shelton, IV et al. Jan 2014 A1
20140001234 Shelton, IV et al. Jan 2014 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005678 Shelton, IV et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140012289 Snow et al. Jan 2014 A1
20140012299 Stoddard et al. Jan 2014 A1
20140014705 Baxter, III Jan 2014 A1
20140018832 Shelton, IV Jan 2014 A1
20140039549 Belsky et al. Feb 2014 A1
20140048580 Merchant et al. Feb 2014 A1
20140081176 Hassan Mar 2014 A1
20140094681 Valentine et al. Apr 2014 A1
20140100558 Schmitz et al. Apr 2014 A1
20140107640 Yates et al. Apr 2014 A1
20140110456 Taylor Apr 2014 A1
20140115229 Kothamasu et al. Apr 2014 A1
20140131418 Kostrzewski May 2014 A1
20140135832 Park et al. May 2014 A1
20140151433 Shelton, IV et al. Jun 2014 A1
20140158747 Measamer et al. Jun 2014 A1
20140166724 Schellin et al. Jun 2014 A1
20140166725 Schellin et al. Jun 2014 A1
20140166726 Schellin et al. Jun 2014 A1
20140171966 Giordano et al. Jun 2014 A1
20140175147 Manoux et al. Jun 2014 A1
20140175150 Shelton, IV et al. Jun 2014 A1
20140175152 Hess et al. Jun 2014 A1
20140181710 Baalu et al. Jun 2014 A1
20140188091 Vidal et al. Jul 2014 A1
20140188159 Steege Jul 2014 A1
20140207124 Aldridge et al. Jul 2014 A1
20140207125 Applegate et al. Jul 2014 A1
20140209658 Skalla et al. Jul 2014 A1
20140224857 Schmid Aug 2014 A1
20140228867 Thomas et al. Aug 2014 A1
20140230595 Butt et al. Aug 2014 A1
20140239047 Hodgkinson et al. Aug 2014 A1
20140243865 Swayze et al. Aug 2014 A1
20140246475 Hall et al. Sep 2014 A1
20140248167 Sugimoto et al. Sep 2014 A1
20140249557 Koch, Jr. et al. Sep 2014 A1
20140249573 Arav Sep 2014 A1
20140252061 Estrella et al. Sep 2014 A1
20140263541 Leimbach et al. Sep 2014 A1
20140263552 Hall et al. Sep 2014 A1
20140263554 Leimbach et al. Sep 2014 A1
20140263558 Hausen et al. Sep 2014 A1
20140276730 Boudreaux et al. Sep 2014 A1
20140284371 Morgan et al. Sep 2014 A1
20140288460 Ouyang et al. Sep 2014 A1
20140291379 Schellin et al. Oct 2014 A1
20140291383 Spivey et al. Oct 2014 A1
20140299648 Shelton, IV et al. Oct 2014 A1
20140303645 Morgan et al. Oct 2014 A1
20140303660 Boyden et al. Oct 2014 A1
20140330161 Swayze et al. Nov 2014 A1
20140330298 Arshonsky et al. Nov 2014 A1
20140330579 Cashman et al. Nov 2014 A1
20140367445 Ingmanson et al. Dec 2014 A1
20140374130 Nakamura et al. Dec 2014 A1
20140378950 Chiu Dec 2014 A1
20150002089 Rejman et al. Jan 2015 A1
20150008248 Giordano et al. Jan 2015 A1
20150053737 Leimbach et al. Feb 2015 A1
20150053742 Shelton, IV et al. Feb 2015 A1
20150053743 Yates et al. Feb 2015 A1
20150053746 Shelton, IV et al. Feb 2015 A1
20150053748 Yates et al. Feb 2015 A1
20150060518 Shelton, IV et al. Mar 2015 A1
20150060519 Shelton, IV et al. Mar 2015 A1
20150060520 Shelton, IV et al. Mar 2015 A1
20150060521 Weisenburgh, II et al. Mar 2015 A1
20150066000 An et al. Mar 2015 A1
20150076208 Shelton, IV Mar 2015 A1
20150076209 Shelton, IV et al. Mar 2015 A1
20150076210 Shelton, IV et al. Mar 2015 A1
20150076212 Shelton, IV Mar 2015 A1
20150080868 Kerr Mar 2015 A1
20150083781 Giordano et al. Mar 2015 A1
20150083782 Scheib et al. Mar 2015 A1
20150088547 Balram et al. Mar 2015 A1
20150090760 Giordano et al. Apr 2015 A1
20150090761 Giordano et al. Apr 2015 A1
20150090762 Giordano et al. Apr 2015 A1
20150108199 Shelton, IV et al. Apr 2015 A1
20150122870 Zemlok et al. May 2015 A1
20150134077 Shelton, IV et al. May 2015 A1
20150150620 Miyamoto et al. Jun 2015 A1
20150173749 Shelton, IV et al. Jun 2015 A1
20150173756 Baxter, III et al. Jun 2015 A1
20150173789 Baxter, III et al. Jun 2015 A1
20150182220 Yates et al. Jul 2015 A1
20150196295 Shelton, IV et al. Jul 2015 A1
20150196296 Swayze et al. Jul 2015 A1
20150196299 Swayze et al. Jul 2015 A1
20150196348 Yates et al. Jul 2015 A1
20150201918 Kumar et al. Jul 2015 A1
20150201932 Swayze et al. Jul 2015 A1
20150201936 Swayze et al. Jul 2015 A1
20150201937 Swayze et al. Jul 2015 A1
20150201938 Swayze et al. Jul 2015 A1
20150201939 Swayze et al. Jul 2015 A1
20150201940 Swayze et al. Jul 2015 A1
20150201941 Swayze et al. Jul 2015 A1
20150222212 Iwata Aug 2015 A1
20150223868 Brandt et al. Aug 2015 A1
20150231409 Racenet et al. Aug 2015 A1
20150238118 Legassey et al. Aug 2015 A1
20150272557 Overmyer et al. Oct 2015 A1
20150272571 Leimbach et al. Oct 2015 A1
20150272580 Leimbach et al. Oct 2015 A1
20150272582 Leimbach et al. Oct 2015 A1
20150273671 Totsu Oct 2015 A1
20150297200 Fitzsimmons et al. Oct 2015 A1
20150297222 Huitema et al. Oct 2015 A1
20150297223 Huitema et al. Oct 2015 A1
20150297225 Huitema et al. Oct 2015 A1
20150297228 Huitema et al. Oct 2015 A1
20150297229 Schellin et al. Oct 2015 A1
20150297233 Huitema et al. Oct 2015 A1
20150297234 Schellin et al. Oct 2015 A1
20150297235 Harris et al. Oct 2015 A1
20150302539 Mazar et al. Oct 2015 A1
20150303417 Koeder et al. Oct 2015 A1
20150313594 Shelton, IV et al. Nov 2015 A1
20150324317 Collins et al. Nov 2015 A1
20150327864 Hodgkinson et al. Nov 2015 A1
20150336249 Iwata et al. Nov 2015 A1
20150352699 Sakai et al. Dec 2015 A1
20150366585 Lemay et al. Dec 2015 A1
20150372265 Morisaku et al. Dec 2015 A1
20150374361 Gettinger et al. Dec 2015 A1
20150374369 Yates et al. Dec 2015 A1
20150374371 Richard et al. Dec 2015 A1
20150374372 Zergiebel et al. Dec 2015 A1
20150374378 Giordano et al. Dec 2015 A1
20160000430 Ming et al. Jan 2016 A1
20160000431 Giordano et al. Jan 2016 A1
20160000437 Giordano et al. Jan 2016 A1
20160000438 Swayze et al. Jan 2016 A1
20160000442 Shelton, IV Jan 2016 A1
20160000452 Yates et al. Jan 2016 A1
20160000453 Yates et al. Jan 2016 A1
20160023342 Koenig et al. Jan 2016 A1
20160030042 Heinrich et al. Feb 2016 A1
20160058443 Yates et al. Mar 2016 A1
20160066913 Swayze et al. Mar 2016 A1
20160069449 Kanai et al. Mar 2016 A1
20160074040 Widenhouse et al. Mar 2016 A1
20160074103 Sartor Mar 2016 A1
20160082161 Zilberman et al. Mar 2016 A1
20160089137 Hess et al. Mar 2016 A1
20160089198 Arya et al. Mar 2016 A1
20160095585 Zergiebel et al. Apr 2016 A1
20160106431 Shelton, IV et al. Apr 2016 A1
20160113653 Zingman Apr 2016 A1
20160120544 Shelton, IV et al. May 2016 A1
20160120545 Shelton, IV et al. May 2016 A1
20160135835 Onuma May 2016 A1
20160166248 Deville et al. Jun 2016 A1
20160166256 Baxter, III et al. Jun 2016 A1
20160174974 Schmid et al. Jun 2016 A1
20160183939 Shelton, IV et al. Jun 2016 A1
20160183943 Shelton, IV Jun 2016 A1
20160183944 Swensgard et al. Jun 2016 A1
20160192916 Shelton, IV et al. Jul 2016 A1
20160192917 Shelton, IV et al. Jul 2016 A1
20160192918 Shelton, IV et al. Jul 2016 A1
20160192960 Bueno et al. Jul 2016 A1
20160192977 Manwaring et al. Jul 2016 A1
20160199063 Mandakolathur Vasudevan et al. Jul 2016 A1
20160199089 Hess et al. Jul 2016 A1
20160199956 Shelton, IV et al. Jul 2016 A1
20160206310 Shelton, IV Jul 2016 A1
20160206314 Scheib et al. Jul 2016 A1
20160220248 Timm et al. Aug 2016 A1
20160220266 Shelton, IV et al. Aug 2016 A1
20160235404 Shelton, IV Aug 2016 A1
20160235405 Shelton, IV et al. Aug 2016 A1
20160235409 Shelton, IV et al. Aug 2016 A1
20160235467 Godara et al. Aug 2016 A1
20160235494 Shelton, IV et al. Aug 2016 A1
20160242782 Shelton, IV et al. Aug 2016 A1
20160242783 Shelton, IV et al. Aug 2016 A1
20160249910 Shelton, IV et al. Sep 2016 A1
20160249922 Morgan et al. Sep 2016 A1
20160256071 Shelton, IV et al. Sep 2016 A1
20160256154 Shelton, IV et al. Sep 2016 A1
20160256159 Pinjala et al. Sep 2016 A1
20160256160 Shelton, IV et al. Sep 2016 A1
20160256185 Shelton, IV et al. Sep 2016 A1
20160256229 Morgan et al. Sep 2016 A1
20160262745 Morgan et al. Sep 2016 A1
20160262746 Shelton, IV et al. Sep 2016 A1
20160262921 Balbierz et al. Sep 2016 A1
20160270780 Hall et al. Sep 2016 A1
20160278765 Shelton, IV et al. Sep 2016 A1
20160278771 Shelton, IV et al. Sep 2016 A1
20160287279 Bovay et al. Oct 2016 A1
20160310143 Bettuchi Oct 2016 A1
20160345976 Gonzalez et al. Dec 2016 A1
20160346034 Arya et al. Dec 2016 A1
20160354085 Shelton, IV et al. Dec 2016 A1
20160354088 Cabrera et al. Dec 2016 A1
20160367122 Ichimura et al. Dec 2016 A1
20160374672 Bear et al. Dec 2016 A1
20160374675 Shelton, IV et al. Dec 2016 A1
20160374678 Becerra et al. Dec 2016 A1
20170007236 Shelton, IV et al. Jan 2017 A1
20170007237 Yates et al. Jan 2017 A1
20170007243 Shelton, IV et al. Jan 2017 A1
20170007244 Shelton, IV et al. Jan 2017 A1
20170007245 Shelton, IV et al. Jan 2017 A1
20170007246 Shelton, IV et al. Jan 2017 A1
20170007247 Shelton, IV et al. Jan 2017 A1
20170007248 Shelton, IV et al. Jan 2017 A1
20170007249 Shelton, IV et al. Jan 2017 A1
20170007250 Shelton, IV et al. Jan 2017 A1
20170007251 Yates et al. Jan 2017 A1
20170007347 Jaworek et al. Jan 2017 A1
20170014125 Shelton, IV et al. Jan 2017 A1
20170027572 Nalagatla et al. Feb 2017 A1
20170027573 Nalagatla et al. Feb 2017 A1
20170049444 Schellin et al. Feb 2017 A1
20170049447 Barton et al. Feb 2017 A1
20170049448 Widenhouse et al. Feb 2017 A1
20170055986 Harris et al. Mar 2017 A1
20170055999 Baxter, III et al. Mar 2017 A1
20170056000 Nalagatla et al. Mar 2017 A1
20170056002 Nalagatla et al. Mar 2017 A1
20170056005 Shelton, IV et al. Mar 2017 A1
20170056006 Shelton, IV et al. Mar 2017 A1
20170079642 Overmyer et al. Mar 2017 A1
20170086827 Vendely et al. Mar 2017 A1
20170086829 Vendely et al. Mar 2017 A1
20170086830 Yates et al. Mar 2017 A1
20170086831 Shelton, IV et al. Mar 2017 A1
20170086832 Harris et al. Mar 2017 A1
20170086836 Harris et al. Mar 2017 A1
20170086838 Harris et al. Mar 2017 A1
20170086842 Shelton, IV et al. Mar 2017 A1
20170086843 Vendely et al. Mar 2017 A1
20170095250 Kostrzewski et al. Apr 2017 A1
20170119390 Schellin et al. May 2017 A1
20170119392 Shelton, IV et al. May 2017 A1
20170119397 Harris et al. May 2017 A1
20170135697 Mozdzierz et al. May 2017 A1
20170150965 Williams Jun 2017 A1
20170150983 Ingmanson et al. Jun 2017 A1
20170172382 Nir et al. Jun 2017 A1
20170172550 Mukherjee et al. Jun 2017 A1
20170172662 Panescu et al. Jun 2017 A1
20170172672 Bailey et al. Jun 2017 A1
20170182211 Raxworthy et al. Jun 2017 A1
20170196558 Morgan et al. Jul 2017 A1
20170196561 Shelton, IV et al. Jul 2017 A1
20170196562 Shelton, IV et al. Jul 2017 A1
20170196637 Shelton, IV et al. Jul 2017 A1
20170196649 Yates et al. Jul 2017 A1
20170202571 Shelton, IV et al. Jul 2017 A1
20170202596 Shelton, IV et al. Jul 2017 A1
20170202770 Friedrich et al. Jul 2017 A1
20170209145 Swayze et al. Jul 2017 A1
20170209146 Yates et al. Jul 2017 A1
20170209226 Overmyer et al. Jul 2017 A1
20170215881 Shelton, IV et al. Aug 2017 A1
20170215943 Allen, IV Aug 2017 A1
20170224331 Worthington et al. Aug 2017 A1
20170224332 Hunter et al. Aug 2017 A1
20170224334 Worthington et al. Aug 2017 A1
20170224335 Weaner et al. Aug 2017 A1
20170224339 Huang et al. Aug 2017 A1
20170224343 Baxter, III et al. Aug 2017 A1
20170231626 Shelton, IV et al. Aug 2017 A1
20170231627 Shelton, IV et al. Aug 2017 A1
20170231628 Shelton, IV et al. Aug 2017 A1
20170238928 Morgan et al. Aug 2017 A1
20170238929 Yates et al. Aug 2017 A1
20170245854 Zemlok et al. Aug 2017 A1
20170245952 Shelton, IV et al. Aug 2017 A1
20170249431 Shelton, IV et al. Aug 2017 A1
20170258469 Shelton, IV et al. Sep 2017 A1
20170265856 Shelton, IV et al. Sep 2017 A1
20170281155 Shelton, IV et al. Oct 2017 A1
20170281164 Harris et al. Oct 2017 A1
20170281166 Morgan et al. Oct 2017 A1
20170281167 Shelton, IV et al. Oct 2017 A1
20170281169 Harris et al. Oct 2017 A1
20170281171 Shelton, IV et al. Oct 2017 A1
20170281173 Shelton, IV et al. Oct 2017 A1
20170281174 Harris et al. Oct 2017 A1
20170281179 Shelton, IV et al. Oct 2017 A1
20170281183 Miller et al. Oct 2017 A1
20170281184 Shelton, IV et al. Oct 2017 A1
20170281185 Miller et al. Oct 2017 A1
20170281186 Shelton, IV et al. Oct 2017 A1
20170281187 Shelton, IV et al. Oct 2017 A1
20170281189 Nalagatla et al. Oct 2017 A1
20170290584 Jasemian et al. Oct 2017 A1
20170290585 Shelton, IV et al. Oct 2017 A1
20170296169 Yates et al. Oct 2017 A1
20170296170 Shelton, IV et al. Oct 2017 A1
20170296173 Shelton, IV et al. Oct 2017 A1
20170296177 Harris et al. Oct 2017 A1
20170296179 Shelton, IV et al. Oct 2017 A1
20170296185 Swensgard et al. Oct 2017 A1
20170296189 Vendely et al. Oct 2017 A1
20170296213 Swensgard et al. Oct 2017 A1
20170311944 Morgan et al. Nov 2017 A1
20170311949 Shelton, IV Nov 2017 A1
20170311950 Shelton, IV et al. Nov 2017 A1
20170312041 Giordano et al. Nov 2017 A1
20170312042 Giordano et al. Nov 2017 A1
20170319201 Morgan et al. Nov 2017 A1
20170319207 Shelton, IV et al. Nov 2017 A1
20170319209 Morgan et al. Nov 2017 A1
20170325813 Aranyi et al. Nov 2017 A1
20170333034 Morgan et al. Nov 2017 A1
20170333035 Morgan et al. Nov 2017 A1
20170333070 Laurent et al. Nov 2017 A1
20170348010 Chiang Dec 2017 A1
20170348043 Wang et al. Dec 2017 A1
20170354413 Chen et al. Dec 2017 A1
20170354415 Casasanta, Jr. et al. Dec 2017 A1
20170358052 Yuan Dec 2017 A1
20170360441 Sgroi Dec 2017 A1
20170360442 Shelton, IV et al. Dec 2017 A1
20170367695 Shelton, IV et al. Dec 2017 A1
20170367696 Shelton, IV et al. Dec 2017 A1
20170367697 Shelton, IV et al. Dec 2017 A1
20170367698 Shelton, IV et al. Dec 2017 A1
20170367699 Shelton, IV et al. Dec 2017 A1
20170367700 Leimbach et al. Dec 2017 A1
20170367991 Widenhouse et al. Dec 2017 A1
20180000483 Leimbach et al. Jan 2018 A1
20180000545 Giordano et al. Jan 2018 A1
20180008270 Moore et al. Jan 2018 A1
20180008271 Moore et al. Jan 2018 A1
20180008356 Giordano et al. Jan 2018 A1
20180008357 Giordano et al. Jan 2018 A1
20180028184 Shelton, IV et al. Feb 2018 A1
20180028185 Shelton, IV et al. Feb 2018 A1
20180042611 Swayze et al. Feb 2018 A1
20180049824 Harris et al. Feb 2018 A1
20180049883 Moskowitz et al. Feb 2018 A1
20180055513 Shelton, IV et al. Mar 2018 A1
20180055524 Shelton, IV et al. Mar 2018 A1
20180055525 Shelton, IV et al. Mar 2018 A1
20180055526 Shelton, IV et al. Mar 2018 A1
20180064437 Yates et al. Mar 2018 A1
20180064440 Shelton, IV et al. Mar 2018 A1
20180064441 Shelton, IV et al. Mar 2018 A1
20180064442 Shelton, IV et al. Mar 2018 A1
20180064443 Shelton, IV et al. Mar 2018 A1
20180070939 Giordano et al. Mar 2018 A1
20180070942 Shelton, IV et al. Mar 2018 A1
20180078248 Swayze et al. Mar 2018 A1
20180078268 Messerly et al. Mar 2018 A1
20180085116 Yates et al. Mar 2018 A1
20180085117 Shelton, IV et al. Mar 2018 A1
20180103953 Shelton, IV et al. Apr 2018 A1
20180103955 Shelton, IV et al. Apr 2018 A1
20180110516 Baxter, III et al. Apr 2018 A1
20180110518 Overmyer et al. Apr 2018 A1
20180110519 Lytle, IV et al. Apr 2018 A1
20180110520 Shelton, IV et al. Apr 2018 A1
20180110521 Shelton, IV et al. Apr 2018 A1
20180110522 Shelton, IV et al. Apr 2018 A1
20180110523 Shelton, IV Apr 2018 A1
20180110574 Shelton, IV et al. Apr 2018 A1
20180110575 Shelton, IV et al. Apr 2018 A1
20180114591 Pribanic et al. Apr 2018 A1
20180116658 Aronhalt, IV et al. May 2018 A1
20180116662 Shelton, IV et al. May 2018 A1
20180116665 Hall et al. May 2018 A1
20180125481 Yates et al. May 2018 A1
20180125487 Beardsley May 2018 A1
20180125488 Morgan et al. May 2018 A1
20180125489 Leimbach et al. May 2018 A1
20180125590 Giordano et al. May 2018 A1
20180126504 Shelton, IV et al. May 2018 A1
20180132845 Schmid et al. May 2018 A1
20180132849 Miller et al. May 2018 A1
20180132850 Leimbach et al. May 2018 A1
20180132851 Hall et al. May 2018 A1
20180132926 Asher et al. May 2018 A1
20180132952 Spivey et al. May 2018 A1
20180133856 Shelton, IV et al. May 2018 A1
20180140299 Weaner et al. May 2018 A1
20180140368 Shelton, IV et al. May 2018 A1
20180146960 Shelton, IV et al. May 2018 A1
20180153542 Shelton, IV et al. Jun 2018 A1
20180161034 Scheib et al. Jun 2018 A1
20180168575 Simms et al. Jun 2018 A1
20180168576 Hunter et al. Jun 2018 A1
20180168577 Aronhalt et al. Jun 2018 A1
20180168578 Aronhalt et al. Jun 2018 A1
20180168579 Aronhalt et al. Jun 2018 A1
20180168580 Hunter et al. Jun 2018 A1
20180168581 Hunter et al. Jun 2018 A1
20180168582 Swayze et al. Jun 2018 A1
20180168583 Hunter et al. Jun 2018 A1
20180168584 Harris et al. Jun 2018 A1
20180168585 Shelton, IV et al. Jun 2018 A1
20180168586 Shelton, IV et al. Jun 2018 A1
20180168589 Swayze et al. Jun 2018 A1
20180168590 Overmyer et al. Jun 2018 A1
20180168591 Swayze et al. Jun 2018 A1
20180168592 Overmyer et al. Jun 2018 A1
20180168593 Overmyer et al. Jun 2018 A1
20180168594 Shelton, IV et al. Jun 2018 A1
20180168595 Overmyer et al. Jun 2018 A1
20180168596 Beckman et al. Jun 2018 A1
20180168597 Fanelli et al. Jun 2018 A1
20180168598 Shelton, IV et al. Jun 2018 A1
20180168599 Bakos et al. Jun 2018 A1
20180168600 Shelton, IV et al. Jun 2018 A1
20180168601 Bakos et al. Jun 2018 A1
20180168602 Bakos et al. Jun 2018 A1
20180168603 Morgan et al. Jun 2018 A1
20180168604 Shelton, IV et al. Jun 2018 A1
20180168605 Baber et al. Jun 2018 A1
20180168606 Shelton, IV et al. Jun 2018 A1
20180168607 Shelton, IV et al. Jun 2018 A1
20180168608 Shelton, IV et al. Jun 2018 A1
20180168609 Fanelli et al. Jun 2018 A1
20180168610 Shelton, IV et al. Jun 2018 A1
20180168611 Shelton, IV et al. Jun 2018 A1
20180168612 Shelton, IV et al. Jun 2018 A1
20180168613 Shelton, IV et al. Jun 2018 A1
20180168614 Shelton, IV et al. Jun 2018 A1
20180168615 Shelton, IV et al. Jun 2018 A1
20180168616 Shelton, IV et al. Jun 2018 A1
20180168617 Shelton, IV et al. Jun 2018 A1
20180168618 Scott et al. Jun 2018 A1
20180168619 Scott et al. Jun 2018 A1
20180168620 Huang et al. Jun 2018 A1
20180168621 Shelton, IV et al. Jun 2018 A1
20180168623 Simms et al. Jun 2018 A1
20180168624 Shelton, IV et al. Jun 2018 A1
20180168625 Posada et al. Jun 2018 A1
20180168626 Shelton, IV et al. Jun 2018 A1
20180168627 Weaner et al. Jun 2018 A1
20180168628 Hunter et al. Jun 2018 A1
20180168629 Shelton, IV et al. Jun 2018 A1
20180168630 Shelton, IV et al. Jun 2018 A1
20180168631 Harris et al. Jun 2018 A1
20180168632 Harris et al. Jun 2018 A1
20180168633 Shelton, IV et al. Jun 2018 A1
20180168634 Harris et al. Jun 2018 A1
20180168635 Shelton, IV et al. Jun 2018 A1
20180168636 Shelton, IV et al. Jun 2018 A1
20180168637 Harris et al. Jun 2018 A1
20180168638 Harris et al. Jun 2018 A1
20180168639 Shelton, IV et al. Jun 2018 A1
20180168640 Shelton, IV et al. Jun 2018 A1
20180168641 Harris et al. Jun 2018 A1
20180168642 Shelton, IV et al. Jun 2018 A1
20180168643 Shelton, IV et al. Jun 2018 A1
20180168644 Shelton, IV et al. Jun 2018 A1
20180168645 Shelton, IV et al. Jun 2018 A1
20180168646 Shelton, IV et al. Jun 2018 A1
20180168647 Shelton, IV et al. Jun 2018 A1
20180168648 Shelton, IV et al. Jun 2018 A1
20180168649 Shelton, IV et al. Jun 2018 A1
20180168650 Shelton, IV et al. Jun 2018 A1
20180168651 Shelton, IV et al. Jun 2018 A1
20180199940 Zergiebel et al. Jul 2018 A1
20180206843 Yates et al. Jul 2018 A1
20180206906 Moua et al. Jul 2018 A1
20180214147 Merchant et al. Aug 2018 A1
20180221046 Demmy et al. Aug 2018 A1
20180221050 Kostrzewski et al. Aug 2018 A1
20180228490 Richard et al. Aug 2018 A1
20180250001 Aronhalt et al. Sep 2018 A1
20180250020 Carusillo Sep 2018 A1
20180256184 Shelton, IV et al. Sep 2018 A1
20180271520 Shelton, IV et al. Sep 2018 A1
20180273597 Stimson Sep 2018 A1
20180280020 Hess et al. Oct 2018 A1
20180286274 Kamiguchi et al. Oct 2018 A1
20180289369 Shelton, IV et al. Oct 2018 A1
20180296211 Timm et al. Oct 2018 A1
20180296215 Baxter, III et al. Oct 2018 A1
20180296216 Shelton, IV et al. Oct 2018 A1
20180296217 Moore et al. Oct 2018 A1
20180303481 Shelton, IV et al. Oct 2018 A1
20180303482 Shelton, IV et al. Oct 2018 A1
20180310931 Hall et al. Nov 2018 A1
20180311002 Giordano et al. Nov 2018 A1
20180317907 Kostrzewski Nov 2018 A1
20180317916 Wixey Nov 2018 A1
20180317917 Huang et al. Nov 2018 A1
20180317918 Shelton, IV Nov 2018 A1
20180317919 Shelton, IV et al. Nov 2018 A1
20180325528 Windolf et al. Nov 2018 A1
20180333155 Hall et al. Nov 2018 A1
20180333169 Leimbach et al. Nov 2018 A1
20180344319 Shelton, IV et al. Dec 2018 A1
20180353170 Overmyer et al. Dec 2018 A1
20180353176 Shelton, IV et al. Dec 2018 A1
20180353177 Shelton, IV et al. Dec 2018 A1
20180353178 Shelton, IV et al. Dec 2018 A1
20180353179 Shelton, IV et al. Dec 2018 A1
20180360443 Shelton, IV et al. Dec 2018 A1
20180360445 Shelton, IV et al. Dec 2018 A1
20180360446 Shelton, IV et al. Dec 2018 A1
20180360447 Shelton, IV et al. Dec 2018 A1
20180360448 Harris et al. Dec 2018 A1
20180360449 Shelton, IV et al. Dec 2018 A1
20180360450 Shelton, IV et al. Dec 2018 A1
20180360452 Shelton, IV et al. Dec 2018 A1
20180360454 Shelton, IV et al. Dec 2018 A1
20180360455 Shelton, IV et al. Dec 2018 A1
20180360456 Shelton, IV et al. Dec 2018 A1
20180360471 Parfett et al. Dec 2018 A1
20180360472 Harris et al. Dec 2018 A1
20180360473 Shelton, IV et al. Dec 2018 A1
20180360549 Hares et al. Dec 2018 A1
20180368822 Shelton, IV et al. Dec 2018 A1
20180368833 Shelton, IV et al. Dec 2018 A1
20180368837 Morgan et al. Dec 2018 A1
20180368838 Shelton, IV et al. Dec 2018 A1
20180368839 Shelton, IV et al. Dec 2018 A1
20180368840 Shelton, IV et al. Dec 2018 A1
20180368841 Shelton, IV et al. Dec 2018 A1
20180368842 Shelton, IV et al. Dec 2018 A1
20180368843 Shelton, IV et al. Dec 2018 A1
20180368844 Bakos et al. Dec 2018 A1
20180368845 Bakos et al. Dec 2018 A1
20180368846 Shelton, IV et al. Dec 2018 A1
20180368847 Shelton, IV et al. Dec 2018 A1
20190000446 Shelton, IV et al. Jan 2019 A1
20190000448 Shelton, IV et al. Jan 2019 A1
20190000450 Shelton, IV et al. Jan 2019 A1
20190000454 Swayze et al. Jan 2019 A1
20190000456 Shelton, IV et al. Jan 2019 A1
20190000457 Shelton, IV et al. Jan 2019 A1
20190000458 Shelton, IV et al. Jan 2019 A1
20190000459 Shelton, IV et al. Jan 2019 A1
20190000460 Shelton, IV et al. Jan 2019 A1
20190000461 Shelton, IV et al. Jan 2019 A1
20190000462 Shelton, IV et al. Jan 2019 A1
20190000463 Shelton, IV et al. Jan 2019 A1
20190000464 Shelton, IV et al. Jan 2019 A1
20190000465 Shelton, IV et al. Jan 2019 A1
20190000466 Shelton, IV et al. Jan 2019 A1
20190000467 Shelton, IV et al. Jan 2019 A1
20190000468 Adams et al. Jan 2019 A1
20190000469 Shelton, IV et al. Jan 2019 A1
20190000470 Yates et al. Jan 2019 A1
20190000471 Shelton, IV et al. Jan 2019 A1
20190000472 Shelton, IV et al. Jan 2019 A1
20190000473 Shelton, IV et al. Jan 2019 A1
20190000474 Shelton, IV et al. Jan 2019 A1
20190000475 Shelton, IV et al. Jan 2019 A1
20190000476 Shelton, IV et al. Jan 2019 A1
20190000477 Shelton, IV et al. Jan 2019 A1
20190000478 Messerly et al. Jan 2019 A1
20190000479 Harris et al. Jan 2019 A1
20190000525 Messerly et al. Jan 2019 A1
20190000528 Yates et al. Jan 2019 A1
20190000530 Yates et al. Jan 2019 A1
20190000531 Messerly et al. Jan 2019 A1
20190000534 Messerly et al. Jan 2019 A1
20190000538 Widenhouse et al. Jan 2019 A1
20190000555 Schings et al. Jan 2019 A1
20190000565 Shelton, IV et al. Jan 2019 A1
20190008509 Shelton, IV et al. Jan 2019 A1
20190008511 Kerr et al. Jan 2019 A1
20190015096 Shelton, IV et al. Jan 2019 A1
20190015102 Baber et al. Jan 2019 A1
20190015165 Giordano et al. Jan 2019 A1
20190029675 Yates et al. Jan 2019 A1
20190029676 Yates et al. Jan 2019 A1
20190029677 Yates et al. Jan 2019 A1
20190029678 Shelton, IV et al. Jan 2019 A1
20190029681 Swayze et al. Jan 2019 A1
20190029682 Huitema et al. Jan 2019 A1
20190029701 Shelton, IV et al. Jan 2019 A1
20190033955 Leimbach et al. Jan 2019 A1
20190038279 Shelton, IV et al. Feb 2019 A1
20190038281 Shelton, IV et al. Feb 2019 A1
20190038282 Shelton, IV et al. Feb 2019 A1
20190038283 Shelton, IV et al. Feb 2019 A1
20190038371 Wixey et al. Feb 2019 A1
20190046187 Yates et al. Feb 2019 A1
20190059886 Shelton, IV et al. Feb 2019 A1
20190090870 Shelton, IV et al. Mar 2019 A1
20190090871 Shelton, IV et al. Mar 2019 A1
20190099177 Yates et al. Apr 2019 A1
20190099178 Leimbach et al. Apr 2019 A1
20190099179 Leimbach et al. Apr 2019 A1
20190099180 Leimbach et al. Apr 2019 A1
20190099181 Shelton, IV et al. Apr 2019 A1
20190099182 Bakos et al. Apr 2019 A1
20190099183 Leimbach et al. Apr 2019 A1
20190099184 Setser et al. Apr 2019 A1
20190099224 Leimbach et al. Apr 2019 A1
20190099229 Spivey et al. Apr 2019 A1
20190102930 Leimbach et al. Apr 2019 A1
20190105035 Shelton, IV et al. Apr 2019 A1
20190105036 Morgan et al. Apr 2019 A1
20190105037 Morgan et al. Apr 2019 A1
20190105038 Schmid et al. Apr 2019 A1
20190105039 Morgan et al. Apr 2019 A1
20190105043 Jaworek et al. Apr 2019 A1
20190105044 Shelton, IV et al. Apr 2019 A1
20190105049 Moore et al. Apr 2019 A1
20190110791 Shelton, IV et al. Apr 2019 A1
20190110792 Shelton, IV et al. Apr 2019 A1
20190110793 Parihar et al. Apr 2019 A1
20190117216 Overmyer et al. Apr 2019 A1
20190117217 Overmyer et al. Apr 2019 A1
20190117222 Shelton, IV et al. Apr 2019 A1
20190117224 Setser et al. Apr 2019 A1
20190117225 Moore et al. Apr 2019 A1
20190125343 Wise et al. May 2019 A1
20190125344 DiNardo et al. May 2019 A1
20190125345 Baber et al. May 2019 A1
20190125365 Parfett et al. May 2019 A1
20190125380 Hunter et al. May 2019 A1
20190125475 Wise et al. May 2019 A1
20190133585 Smith et al. May 2019 A1
20190142421 Shelton, IV May 2019 A1
20190183490 Shelton, IV et al. Jun 2019 A1
20190183491 Shelton, IV et al. Jun 2019 A1
20190183492 Shelton, IV et al. Jun 2019 A1
20190183493 Shelton, IV et al. Jun 2019 A1
20190183494 Shelton, IV et al. Jun 2019 A1
20190183495 Shelton, IV et al. Jun 2019 A1
20190183496 Shelton, IV et al. Jun 2019 A1
20190183497 Shelton, IV et al. Jun 2019 A1
20190183498 Shelton, IV et al. Jun 2019 A1
20190183499 Shelton, IV et al. Jun 2019 A1
20190183500 Shelton, IV et al. Jun 2019 A1
20190183501 Shelton, IV et al. Jun 2019 A1
20190183502 Shelton, IV et al. Jun 2019 A1
20190183503 Shelton, IV et al. Jun 2019 A1
20190183504 Shelton, IV et al. Jun 2019 A1
20190183505 Vendely et al. Jun 2019 A1
20190183592 Shelton, IV et al. Jun 2019 A1
20190183594 Shelton, IV et al. Jun 2019 A1
20190183597 Shelton, IV et al. Jun 2019 A1
20190192137 Shelton, IV et al. Jun 2019 A1
20190192138 Shelton, IV et al. Jun 2019 A1
20190192141 Shelton, IV et al. Jun 2019 A1
20190192144 Parfett et al. Jun 2019 A1
20190192145 Shelton, IV et al. Jun 2019 A1
20190192146 Widenhouse et al. Jun 2019 A1
20190192147 Shelton, IV et al. Jun 2019 A1
20190192148 Shelton, IV et al. Jun 2019 A1
20190192149 Shelton, IV et al. Jun 2019 A1
20190192150 Widenhouse et al. Jun 2019 A1
20190192151 Shelton, IV et al. Jun 2019 A1
20190192152 Morgan et al. Jun 2019 A1
20190192153 Shelton, IV et al. Jun 2019 A1
20190192154 Shelton, IV et al. Jun 2019 A1
20190192155 Shelton, IV et al. Jun 2019 A1
20190192156 Simms et al. Jun 2019 A1
20190192157 Scott et al. Jun 2019 A1
20190192158 Scott et al. Jun 2019 A1
20190192159 Simms et al. Jun 2019 A1
20190192227 Shelton, IV et al. Jun 2019 A1
20190192235 Harris et al. Jun 2019 A1
20190192236 Shelton, IV et al. Jun 2019 A1
20190200895 Shelton, IV et al. Jul 2019 A1
20190200991 Moore et al. Jul 2019 A1
20190200992 Moore et al. Jul 2019 A1
20190200993 Moore et al. Jul 2019 A1
20190200994 Moore et al. Jul 2019 A1
20190209164 Timm et al. Jul 2019 A1
20190209165 Timm et al. Jul 2019 A1
20190209171 Shelton, IV et al. Jul 2019 A1
20190209172 Shelton, IV et al. Jul 2019 A1
20190209247 Giordano et al. Jul 2019 A1
20190209248 Giordano et al. Jul 2019 A1
20190209249 Giordano et al. Jul 2019 A1
20190209250 Giordano et al. Jul 2019 A1
20190216558 Giordano et al. Jul 2019 A1
20190223865 Shelton, IV et al. Jul 2019 A1
20190223871 Moore et al. Jul 2019 A1
20190261991 Beckman et al. Aug 2019 A1
20190267403 Li et al. Aug 2019 A1
20190269400 Mandakolathur Vasudevan et al. Sep 2019 A1
20190269402 Murray et al. Sep 2019 A1
20190269403 Baxter, III et al. Sep 2019 A1
20190269407 Swensgard et al. Sep 2019 A1
20190290263 Morgan et al. Sep 2019 A1
20190290264 Morgan et al. Sep 2019 A1
20190290265 Shelton, IV et al. Sep 2019 A1
20190290274 Shelton, IV Sep 2019 A1
Foreign Referenced Citations (384)
Number Date Country
2011218702 Jun 2013 AU
2012200178 Jul 2013 AU
1015829 Aug 1977 CA
1125615 Jun 1982 CA
2520413 Mar 2007 CA
2725181 Nov 2007 CA
2851239 Nov 2007 CA
2664874 Nov 2009 CA
2813230 Apr 2012 CA
2940510 Aug 2015 CA
1163558 Oct 1997 CN
2488482 May 2002 CN
1634601 Jul 2005 CN
2716900 Aug 2005 CN
2738962 Nov 2005 CN
1777406 May 2006 CN
2796654 Jul 2006 CN
2868212 Feb 2007 CN
200942099 Sep 2007 CN
200984209 Dec 2007 CN
200991269 Dec 2007 CN
201001747 Jan 2008 CN
101143105 Mar 2008 CN
201029899 Mar 2008 CN
101378791 Mar 2009 CN
101522120 Sep 2009 CN
101669833 Mar 2010 CN
101721236 Jun 2010 CN
101828940 Sep 2010 CN
101873834 Oct 2010 CN
201719298 Jan 2011 CN
102038532 May 2011 CN
201879759 Jun 2011 CN
201949071 Aug 2011 CN
102217963 Oct 2011 CN
101779977 Dec 2011 CN
101912284 Jul 2012 CN
102125450 Jul 2012 CN
202313537 Jul 2012 CN
202397539 Aug 2012 CN
202426586 Sep 2012 CN
202489990 Oct 2012 CN
102228387 Nov 2012 CN
102835977 Dec 2012 CN
203564285 Apr 2014 CN
203564287 Apr 2014 CN
203597997 May 2014 CN
103829981 Jun 2014 CN
103829983 Jun 2014 CN
103908313 Jul 2014 CN
203693685 Jul 2014 CN
203736251 Jul 2014 CN
103981635 Aug 2014 CN
203815517 Sep 2014 CN
102783741 Oct 2014 CN
102973300 Oct 2014 CN
104337556 Feb 2015 CN
204158441 Feb 2015 CN
102469995 Mar 2015 CN
204636451 Sep 2015 CN
103860225 Mar 2016 CN
103750872 May 2016 CN
273689 May 1914 DE
1775926 Jan 1972 DE
3036217 Apr 1982 DE
3210466 Sep 1983 DE
3709067 Sep 1988 DE
19534043 Mar 1997 DE
19851291 Jan 2000 DE
19924311 Nov 2000 DE
20016423 Feb 2001 DE
20112837 Oct 2001 DE
20121753 Apr 2003 DE
202004012389 Sep 2004 DE
10314072 Oct 2004 DE
102004014011 Oct 2005 DE
102004063606 Jul 2006 DE
202007003114 Jun 2007 DE
102010013150 Sep 2011 DE
0000756 Feb 1979 EP
0122046 Oct 1984 EP
0129442 Nov 1987 EP
0255631 Feb 1988 EP
0169044 Jun 1991 EP
0541950 May 1993 EP
0548998 Jun 1993 EP
0594148 Apr 1994 EP
0646357 Apr 1995 EP
0505036 May 1995 EP
0669104 Aug 1995 EP
0705571 Apr 1996 EP
0528478 May 1996 EP
0770355 May 1997 EP
0625335 Nov 1997 EP
0879742 Nov 1998 EP
0650701 Mar 1999 EP
0923907 Jun 1999 EP
0484677 Jul 2000 EP
1034747 Sep 2000 EP
1034748 Sep 2000 EP
0726632 Oct 2000 EP
1053719 Nov 2000 EP
1055399 Nov 2000 EP
1055400 Nov 2000 EP
1080694 Mar 2001 EP
1090592 Apr 2001 EP
1095627 May 2001 EP
0806914 Sep 2001 EP
1234587 Aug 2002 EP
1284120 Feb 2003 EP
0717967 May 2003 EP
0869742 May 2003 EP
1374788 Jan 2004 EP
1407719 Apr 2004 EP
0996378 Jun 2004 EP
1157666 Sep 2005 EP
0880338 Oct 2005 EP
1158917 Nov 2005 EP
1344498 Nov 2005 EP
1330989 Dec 2005 EP
1632191 Mar 2006 EP
1082944 May 2006 EP
1253866 Jul 2006 EP
1723914 Nov 2006 EP
1285633 Dec 2006 EP
1011494 Jan 2007 EP
1767163 Mar 2007 EP
1837041 Sep 2007 EP
0922435 Oct 2007 EP
1599146 Oct 2007 EP
1330201 Jun 2008 EP
2039302 Mar 2009 EP
1719461 Jun 2009 EP
2116196 Nov 2009 EP
1769754 Jun 2010 EP
1627605 Dec 2010 EP
2316345 May 2011 EP
1962711 Feb 2012 EP
2486862 Aug 2012 EP
2486868 Aug 2012 EP
2517638 Oct 2012 EP
2606812 Jun 2013 EP
2649948 Oct 2013 EP
2649949 Oct 2013 EP
2668910 Dec 2013 EP
2687164 Jan 2014 EP
2713902 Apr 2014 EP
2743042 Jun 2014 EP
2764827 Aug 2014 EP
2777524 Sep 2014 EP
2842500 Mar 2015 EP
2853220 Apr 2015 EP
2298220 Jun 2016 EP
2510891 Jun 2016 EP
3031404 Jun 2016 EP
3047806 Jul 2016 EP
2364651 Nov 2016 EP
2747235 Nov 2016 EP
2789299 May 2017 EP
3363378 Aug 2018 EP
459743 Nov 1913 FR
999646 Feb 1952 FR
1112936 Mar 1956 FR
2598905 Nov 1987 FR
2689749 Jul 1994 FR
2765794 Jan 1999 FR
2815842 May 2002 FR
939929 Oct 1963 GB
1210522 Oct 1970 GB
1217159 Dec 1970 GB
1339394 Dec 1973 GB
2024012 Jan 1980 GB
2109241 Jun 1983 GB
2090534 Jun 1984 GB
2272159 May 1994 GB
2336214 Oct 1999 GB
2509523 Jul 2014 GB
930100110 Nov 1993 GR
S4711908 May 1972 JP
S5033988 Apr 1975 JP
S56112235 Sep 1981 JP
S60113007 Jun 1985 JP
S62170011 Oct 1987 JP
S63270040 Nov 1988 JP
H0129503 Jun 1989 JP
H0378514 Aug 1991 JP
H0385009 Aug 1991 JP
H04215747 Aug 1992 JP
H04131860 Dec 1992 JP
H0584252 Apr 1993 JP
H05123325 May 1993 JP
H05226945 Sep 1993 JP
H0630945 Feb 1994 JP
H06237937 Aug 1994 JP
H06327684 Nov 1994 JP
H079622 Feb 1995 JP
H07124166 May 1995 JP
H07163573 Jun 1995 JP
H07255735 Oct 1995 JP
H07285089 Oct 1995 JP
H0833642 Feb 1996 JP
H08164141 Jun 1996 JP
H08182684 Jul 1996 JP
H08507708 Aug 1996 JP
H08229050 Sep 1996 JP
H08289895 Nov 1996 JP
H09-323068 Dec 1997 JP
H10118090 May 1998 JP
H10-200699 Jul 1998 JP
H10296660 Nov 1998 JP
2000014632 Jan 2000 JP
2000033071 Feb 2000 JP
2000112002 Apr 2000 JP
2000166932 Jun 2000 JP
2000171730 Jun 2000 JP
2000271141 Oct 2000 JP
2000287987 Oct 2000 JP
2000325303 Nov 2000 JP
2001087272 Apr 2001 JP
2001514541 Sep 2001 JP
2001276091 Oct 2001 JP
2002051974 Feb 2002 JP
2002054903 Feb 2002 JP
2002085415 Mar 2002 JP
2002143078 May 2002 JP
2002153481 May 2002 JP
2002528161 Sep 2002 JP
2002314298 Oct 2002 JP
2003135473 May 2003 JP
2003521301 Jul 2003 JP
3442423 Sep 2003 JP
2003300416 Oct 2003 JP
2004147701 May 2004 JP
2004162035 Jun 2004 JP
2004229976 Aug 2004 JP
2005013573 Jan 2005 JP
2005080702 Mar 2005 JP
2005131163 May 2005 JP
2005131164 May 2005 JP
2005131173 May 2005 JP
2005131211 May 2005 JP
2005131212 May 2005 JP
2005137423 Jun 2005 JP
2005187954 Jul 2005 JP
2005211455 Aug 2005 JP
2005328882 Dec 2005 JP
2005335432 Dec 2005 JP
2005342267 Dec 2005 JP
3791856 Jun 2006 JP
2006187649 Jul 2006 JP
2006218228 Aug 2006 JP
2006281405 Oct 2006 JP
2006346445 Dec 2006 JP
2008220032 Sep 2008 JP
2009507526 Feb 2009 JP
200990113 Apr 2009 JP
2009189838 Aug 2009 JP
2009189846 Aug 2009 JP
2009207260 Sep 2009 JP
2009226028 Oct 2009 JP
2009538684 Nov 2009 JP
2009539420 Nov 2009 JP
2010069307 Apr 2010 JP
2010069310 Apr 2010 JP
2010098844 Apr 2010 JP
2011072574 Apr 2011 JP
4722849 Jul 2011 JP
2011524199 Sep 2011 JP
2012143283 Aug 2012 JP
2012145767 Aug 2012 JP
2012232121 Nov 2012 JP
5154710 Feb 2013 JP
2014121599 Jul 2014 JP
2016512057 Apr 2016 JP
20100110134 Oct 2010 KR
20110003229 Jan 2011 KR
1814161 May 1993 RU
2008830 Mar 1994 RU
2052979 Jan 1996 RU
2066128 Sep 1996 RU
2069981 Dec 1996 RU
2098025 Dec 1997 RU
2104671 Feb 1998 RU
2110965 May 1998 RU
2141279 Nov 1999 RU
2144791 Jan 2000 RU
2161450 Jan 2001 RU
2181566 Apr 2002 RU
2187249 Aug 2002 RU
32984 Oct 2003 RU
2225170 Mar 2004 RU
42750 Dec 2004 RU
61114 Feb 2007 RU
61122 Feb 2007 RU
189517 Jan 1967 SU
297156 May 1971 SU
328636 Sep 1972 SU
511939 Apr 1976 SU
674747 Jul 1979 SU
728848 Apr 1980 SU
1009439 Apr 1983 SU
1271497 Nov 1986 SU
1333319 Aug 1987 SU
1377052 Feb 1988 SU
1377053 Feb 1988 SU
1443874 Dec 1988 SU
1509051 Sep 1989 SU
1561964 May 1990 SU
1708312 Jan 1992 SU
1722476 Mar 1992 SU
1752361 Aug 1992 SU
1814161 May 1993 SU
WO-9315648 Aug 1993 WO
WO-9420030 Sep 1994 WO
WO-9517855 Jul 1995 WO
WO-9520360 Aug 1995 WO
WO-9623448 Aug 1996 WO
WO-9635464 Nov 1996 WO
WO-9639086 Dec 1996 WO
WO-9639088 Dec 1996 WO
WO-9724073 Jul 1997 WO
WO-9734533 Sep 1997 WO
WO-9903407 Jan 1999 WO
WO-9903409 Jan 1999 WO
WO-9948430 Sep 1999 WO
WO-0024322 May 2000 WO
WO-0024330 May 2000 WO
WO-0053112 Sep 2000 WO
WO-0057796 Oct 2000 WO
WO-0105702 Jan 2001 WO
WO-0154594 Aug 2001 WO
WO-0158371 Aug 2001 WO
WO-0162164 Aug 2001 WO
WO-0162169 Aug 2001 WO
WO-0191646 Dec 2001 WO
WO-0219932 Mar 2002 WO
WO-0226143 Apr 2002 WO
WO-0236028 May 2002 WO
WO-02065933 Aug 2002 WO
WO-03055402 Jul 2003 WO
WO-03094747 Nov 2003 WO
WO-03079909 Mar 2004 WO
WO-2004019803 Mar 2004 WO
WO-2004032783 Apr 2004 WO
WO-2004047626 Jun 2004 WO
WO-2004047653 Jun 2004 WO
WO-2004056277 Jul 2004 WO
WO-2004078050 Sep 2004 WO
WO-2004078051 Sep 2004 WO
WO-2004096015 Nov 2004 WO
WO-2006044581 Apr 2006 WO
WO-2006051252 May 2006 WO
WO-2006059067 Jun 2006 WO
WO-2006073581 Jul 2006 WO
WO-2006085389 Aug 2006 WO
WO-2007015971 Feb 2007 WO
WO-2007074430 Jul 2007 WO
WO-2007129121 Nov 2007 WO
WO-2007137304 Nov 2007 WO
WO-2007142625 Dec 2007 WO
WO-2008021969 Feb 2008 WO
WO-2008061566 May 2008 WO
WO-2008089404 Jul 2008 WO
WO-2009005969 Jan 2009 WO
WO-2009067649 May 2009 WO
WO-2009091497 Jul 2009 WO
WO-2010126129 Nov 2010 WO
WO-2010134913 Nov 2010 WO
WO-2011008672 Jan 2011 WO
WO-2011044343 Apr 2011 WO
WO-2012006306 Jan 2012 WO
WO-2012013577 Feb 2012 WO
WO-2012044606 Apr 2012 WO
WO-2012061725 May 2012 WO
WO-2012072133 Jun 2012 WO
WO-2012166503 Dec 2012 WO
WO-2013087092 Jun 2013 WO
WO-2013151888 Oct 2013 WO
WO-2014004209 Jan 2014 WO
WO-2014113438 Jul 2014 WO
WO-2015032797 Mar 2015 WO
WO-2015138760 Sep 2015 WO
WO-2015187107 Dec 2015 WO
WO-2016057225 Apr 2016 WO
Non-Patent Literature Citations (77)
Entry
Disclosed Anonymously, “Motor-Driven Surgical Stapler Improvements,” Research Disclosure Database No. 526041, Published: Feb. 2008.
B.R. Coolman, DVM, MS et al., “Comparison of Skin Staples With Sutures for Anastomosis of the Small Intestine in Dogs,” Abstract; http://www.blackwell-synergy.com/doi/abs/10.1053/jvet.2000.7539?cookieSet=1&journalCode=vsu which redirects to http://www3.interscience.wiley.com/journal/119040681/abstract?CRETRY=1&SRETRY=0; [online] accessed: Sep. 22, 2008 (2 pages).
Van Meer et al., “A Disposable Plastic Compact Wrist for Smart Minimally Invasive Surgical Tools,” LAAS/CNRS (Aug. 2005).
Breedveld et al., “A New, Easily Miniaturized Sterrable Endoscope,” IEEE Engineering in Medicine and Biology Magazine (Nov./Dec. 2005).
D. Tuite, Ed., “Get the Lowdown on Ultracapacitors,” Nov. 15, 2007; [online] URL: http://electronicdesign.com/Articles/Print.cfm?ArticleID=17465, accessed Jan. 15, 2008 (5 pages).
Datasheet for Panasonic TK Relays Ultra Low Profile 2 A Polarized Relay, Copyright Matsushita Electric Works, Ltd. (Known of at least as early as Aug. 17, 2010), 5 pages.
ASTM procedure D2240-00, “Standard Test Method for Rubber Property—Durometer Hardness,” (Published Aug. 2000).
ASTM procedure D2240-05, “Standard Test Method for Rubber Property—Durometer Hardness,” (Published Apr. 2010).
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology,” (2010), 1 page.
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology and Endo GIA™ Ultra Universal Staplers,” (2010), 2 pages.
Covidien Brochure, “Endo GIA™ Curved Tip Reload with Tri-Staple™ Technology,” (2012), 2 pages.
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology,” (2010), 2 pages.
Covidien Brochure, “Endo GIA™ Ultra Universal Stapler,” (2010), 2 pages.
Miyata et al., “Biomolecule-Sensitive Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 79-98.
Jeong et al., “Thermosensitive Sol-Gel Reversible Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 37-51.
Qiu et al., “Environment-Sensitive Hydrogels for Drug Delivery,” Advanced Drug Delivery Reviews, 53 (2001) pp. 321-339.
Hoffman, “Hydrogels for Biomedical Applications,” Advanced Drug Delivery Reviews, 43 (2002) pp. 3-12.
Hoffman, “Hydrogels for Biomedical Applications,” Advanced Drug Delivery Reviews, 54 (2002) pp. 3-12.
Peppas, “Physiologically Responsive Hydrogels,” Journal of Bioactive and Compatible Polymers, vol. 6 (Jul. 1991) pp. 241-246.
Peppas, Editor “Hydrogels in Medicine and Pharmacy,” vol. I, Fundamentals, CRC Press, 1986.
Young, “Microcellular foams via phase separation,” Journal of Vacuum Science & Technology A 4(3), (May/Jun. 1986).
Pitt et al., “Attachment of Hyaluronan to Metallic Surfaces,” J. Biomed. Mater. Res. 68A: pp. 95-106, 2004.
Solorio et al., “Gelatin Microspheres Crosslinked with Genipin for Local Delivery of Growth Factors,” J. Tissue Eng. Regen. Med. (2010), 4(7): pp. 514-523.
http://ninpgan.net/publications/51-100/89.pdf; 2004, Ning Pan, On Uniqueness of Fibrous Materials, Design & Nature II. Eds: Colins, M. and Brebbia, C. WIT Press, Boston, 493-504.
Covidien iDrive™ Ultra in Service Reference Card, “iDrive™ Ultra Powered Stapling Device,” (4 pages).
Covidien “iDrive™ Ultra Powered Stapling System, A Guide for Surgeons,” (6 pages).
Covidien “iDrive™ Ultra Powered Stapling System, Cleaning and Sterilization Guide,” (2 pages).
Covidien Brochure “iDrive™ Ultra Powered Stapling System,” (6 pages).
“Indian Standard: Automotive Vehicles—Brakes and Braking Systems (IS 11852-1:2001)”, Mar. 1, 2001.
Ebara, “Carbohydrate-Derived Hydrogels and Microgels,” Engineered Carbohydrate-Based Materials for Biomedical Applications: Polymers, Surfaes, Dendrimers, Nanoparticles, and Hydrogels, Edited by Ravin Narain, 2011, pp. 337-345.
Schellhammer et al., “Poly-Lactic-Acid for Coating of Endovascular Stents: Preliminary Results in Canine Experimental Av-Fistulae,” Mat.-wiss. u. Werkstofftech., 32, pp. 193-199 (2001).
Covidien iDrive™ Ultra Powered Stapling System ibrochure, “The Power of iDrive™ Ultra Powered Stapling System and Tri-Staple™ Technology,” (23 pages).
Patrick J. Sweeney: “RFID for Dummies”, Mar. 11, 2010, pp. 365-365, XP055150775, ISBN: 978-1-11-805447-5, Retrieved from the Internet: URL: books.google.de/books?isbn=1118054474 [retrieved on Nov. 4, 2014]—book not attached.
Allegro MicroSystems, LLC, Automotive Full Bridge MOSFET Driver, A3941-DS, Rev. 5, 21 pages, http://www.allegromicro.com/˜/media/Files/Datasheets/A3941-Datasheet.ashx?la=en.
Data Sheet of LM4F230H5QR, 2007.
Seils et al., Covidien Summary: Clinical Study “UCONN Biodynamics: Final Report on Results,” (2 pages).
Byrne et al., “Molecular Imprinting Within Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 149-161.
Fast, Versatile Blackfin Processors Handle Advanced RFID Reader Applications; Analog Dialogue: vol. 40—Sep. 2006; http://www.analog.com/library/analogDialogue/archives/40-09/rfid.pdf; Wayback Machine to Feb. 15, 2012.
Chen et al., “Elastomeric Biomaterials for Tissue Engineering,” Progress in Polymer Science 38 (2013), pp. 584-671.
Matsuda, “Thermodynamics of Formation of Porous Polymeric Membrane from Solutions,” Polymer Journal, vol. 23, No. 5, pp. 435-444 (1991).
Covidien Brochure, “Endo GIA™ Black Reload with Tri-Staple™ Technology,” (2012), 2 pages.
“Biomedical Coatings,” Fort Wayne Metals, Research Products Corporation, obtained online at www.fwmetals.com on Jun. 21, 2010 (1 page).
The Sodem Aseptic Battery Transfer Kit, Sodem Systems, 2000, 3 pages.
C.C. Thompson et al., “Peroral Endoscopic Reduction of Dilated Gastrojejunal Anastomosis After Roux-en-Y Gastric Bypass: A Possible New Option for Patients with Weight Regain,” Surg Endosc (2006) vol. 20., pp. 1744-1748.
Serial Communication Protocol; Michael Lemmon Feb. 1, 2009; http://www3.nd.ed/˜lemmon/courses/ee224/web-manual/web-manual/lab12/node2.html; Wayback Machine to Apr. 29, 2012.
Lyon et al. “The Relationship Between Current Load and Temperature for Quasi-Steady State and Transient Conditions,” SPIE—International Society for Optical Engineering. Proceedings, vol. 4020, (pp. 62-70), Mar. 30, 2000.
Anonymous: “Sense & Control Application Note Current Sensing Using Linear Hall Sensors,” Feb. 3, 2009, pp. 1-18. Retrieved from the Internet: URL: http://www.infineon.com/dgdl/Current_Sensing_Rev.1.1.pdf?fileId=db3a304332d040720132d939503e5f17 [retrieved on Oct. 18, 2016].
Mouser Electronics, “LM317M 3-Terminal Adjustable Regulator with Overcurrent/Overtemperature Self Protection”, Mar. 31, 2014 (Mar. 31, 2014), XP0555246104, Retrieved from the Internet: URL: http://www.mouser.com/ds/2/405/lm317m-440423.pdf, pp. 1-8.
Mouser Electronics, “LM317 3-Terminal Adjustable Regulator with Overcurrent/Overtemperature Self Protection”, Sep. 30, 2016 (Sep. 30, 2016), XP0555246104, Retrieved from the Internet: URL: http://www.mouser.com/ds/2/405/lm317m-440423.pdf, pp. 1-9.
Cuper et al., “The Use of Near-Infrared Light for Safe and Effective Visualization of Subsurface Blood Vessels to Facilitate Blood Withdrawal in Children,” Medical Engineering & Physics, vol. 35, No. 4, pp. 433-440 (2013).
Yan et al, Comparison of the effects of Mg—6Zn and Ti—3AI-2.5V alloys on TGF-β/TNF-α/VEGF/b-FGF in the healing of the intestinal track in vivo, Biomed. Mater. 9 (2014), 11 pages.
Pellicer et al. “On the biodegradability, mechanical behavior, and cytocompatibility of amorphous Mg72Zn23Ca5 and crystalline Mg70Zn23Ca5Pd2 alloys as temporary implant materials,” J Biomed Mater Res Part A ,2013:101A:502-517.
Anonymous, Analog Devices Wiki, Chapter 11: The Current Mirror, Aug. 20, 2017, 22 pages. https://wiki.analog.com/university/courses/electronics/text/chapter-11?rev=1503222341.
Yan et al., “Comparison of the effects of Mg—6Zn and titanium on intestinal tract in vivo,” J Mater Sci: Mater Med (2013), 11 pages.
Brar et al., “Investigation of the mechanical and degradation properties of Mg—Sr and Mg—Zn—Sr alloys for use as potential biodegradable implant materials,” J. Mech. Behavior of Biomed. Mater. 7 (2012) pp. 87-95.
Texas Instruments: “Current Recirculation and Decay Modes,” Application Report SLVA321—Mar. 2009; Retrieved from the Internet: URL:http://www.ti.com/lit/an/slva321/slva321 [retrieved on Apr. 25, 2017], 7 pages.
Qiu Li Loh et al.: “Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size”, Tissue Engineering Part B—Reviews, vol. 19, No. 6, Dec. 1, 2013, pp. 485-502.
Gao et al., “Mechanical Signature Enhancement of Response Vibrations in the Time Lag Domain,” Fifth International Congress on Sound and Vibration, Dec. 15-18, 1997, pp. 1-8.
Trendafilova et al., “Vibration-based Methods for Structural and Machinery Fault Diagnosis Based on Nonlinear Dynamics Tools,” In: Fault Diagnosis in Robotic and Industrial Systems, IConcept Press LTD, 2012, pp. 1-29.
Youtube.com; video by Fibran (retrieved from URL https://www.youtube.com/watch?v=vN2Qjt51gFQ); (Year: 2018).
“Foot and Ankle: Core Knowledge in Orthopaedics”; by DiGiovanni MD, Elsevier; (p. 27, left column, heading “Materials for Soft Orthoses”, 7th bullet point); (Year: 2007).
Lee, Youbok, “Antenna Circuit Design for RFID Applications,” 2003, pp. 1-50, DS00710C, Microchip Technology Inc., Available: http://ww1.microchip.com/downloads/en/AppNotes/00710c.pdf.
Kawamura, Atsuo, et al. “Wireless Transmission of Power and Information Through One High-Frequency Resonant AC Link Inverter for Robot Manipulator Applications,” Journal, May/Jun. 1996, pp. 503-508, vol. 32, No. 3, IEEE Transactions on Industry Applications.
Honda HS1332AT and ATD Model Info, powerequipment.honda.com [online], published on or before Mar. 22, 2016, [retrieved on May 31, 2019], retrieved from the Internet [URL: https://powerequipment.honda.com/snowblowers/models/hss1332at-hss1332atd] {Year: 2016).
Slow Safety Sign, shutterstock.com [online], published on or before May 9, 2017, [retrieved on May 31, 2019], retrieved from the https://www.shutterstock.com/image-victor/slow-safety-sign-twodimensional-turtle-symbolizing- . . . see PDF in file for full URL] (Year: 2017).
Warning Sign Beveled Buttons, by Peter, flarestock.com [online], published on or before Jan. 1, 2017, [retrieved on Jun. 4, 2019], retrieved from the Internet [URL: https://www.flarestock.com/stock-images/warning-sign-beveled-buttons/70257] (Year: 2017).
Arrow Sign Icon Next Button, by Blan-k, shutterstock.com [online], published on or before Aug. 6, 2014, [retrieved on Jun. 4, 2019], retrieved from the Internet [URL:https://www.shutterstock.com/de/image-vector/arrow-sign-icon-next-button-navigation-207700303?irgwc=1&utm . . . see PDF in file for full URL] (Year: 2014).
Elite Icons, by smart/icons, iconfinder.com [online], published on Aug. 18, 2016, [retrieved on Jun. 4, 2019], retrieved from the Internet [URL: https://www.iconfinder.com/iconsets/elite] (Year: 2016).
“Tutorial overview of inductively coupled RFID Systems,” UPM, May 2003, pp. 1-7, UPM Rafsec,<http://cdn.mobiusconsulting.com/papers/rfidsystems.pdf>.
Schroeter, John, “Demystifying UHF Gen 2 RFID, HF RFID,” Online Article, Jun. 2, 2008, pp. 1-3, <https://www.edn.com/design/industrial-control/4019123/Demystifying-UHF-Gen-2-RFID-HF-RFID>.
Adeeb, et al., “An Inductive Link-Based Wireless Power Transfer System for Biomedical Applications,” Research Article, Nov. 14, 2011, pp. 1-12, vol. 2012, Article ID 879294, Hindawi Publishing Corporation.
“Pushing Pixels (GIF)”, published on dribble.com, 2013.
“Sodium stearate C18H35NaO2”, Chemspider Search and Share Chemistry, Royal Society of Chemistry, pp. 1-3, 2015, http://www.chemspider.com/Chemical-Structure.12639.html, accessed May 23, 2016.
NF Monographs: Sodium Stearate, U.S. Pharmacopeia, http://www.pharmacopeia.cn/v29240/usp29nf24s0_m77360.html, accessed May 23, 2016.
Fischer, Martin H, “Colloid—Chemical Studies on Soaps”, The Chemical Engineer, pp. 184-193, Aug. 1919.
V.K. Ahluwalia and Madhuri Goyal, A Textbook of Organic Chemistry, Section 19.11.3, p. 356, 2000.
A.V. Kasture and S.G. Wadodkar, Pharmaceutical Chemistry-II: Second Year Diploma in Pharmacy, Nirali Prakashan, p. 339, 2007.
Related Publications (1)
Number Date Country
20170086844 A1 Mar 2017 US